US20070265687A1 - Apparatuses for renal neuromodulation - Google Patents
Apparatuses for renal neuromodulation Download PDFInfo
- Publication number
- US20070265687A1 US20070265687A1 US11/782,451 US78245107A US2007265687A1 US 20070265687 A1 US20070265687 A1 US 20070265687A1 US 78245107 A US78245107 A US 78245107A US 2007265687 A1 US2007265687 A1 US 2007265687A1
- Authority
- US
- United States
- Prior art keywords
- electrode
- renal
- electric field
- electrodes
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B18/1233—Generators therefor with circuits for assuring patient safety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0891—Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36057—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for stimulating afferent nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36103—Neuro-rehabilitation; Repair or reorganisation of neural tissue, e.g. after stroke
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36135—Control systems using physiological parameters
- A61N1/36139—Control systems using physiological parameters with automatic adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00059—Material properties
- A61B2018/00071—Electrical conductivity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00434—Neural system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00505—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00505—Urinary tract
- A61B2018/00511—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00904—Automatic detection of target tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
- A61N1/36117—Cardiac control, e.g. by vagal stimulation for treating hypertension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
- A61N2007/003—Destruction of nerve tissue
Definitions
- the present invention relates to methods and apparatus for renal neuromodulation. More particularly, the present invention relates to methods and apparatus for achieving renal neuromodulation via a pulsed electric field and/or electroporation or electrofusion.
- CHF Congestive Heart Failure
- CHF While many different diseases may initially damage the heart, once present, CHF is split into two types: Chronic CHF and Acute (or Decompensated-Chronic) CHF.
- Chronic Congestive Heart Failure is a longer term, slowly progressive, degenerative disease. Over years, chronic congestive heart failure leads to cardiac insufficiency.
- Chronic CHF is clinically categorized by the patient's ability to exercise or perform normal activities of daily living (such as defined by the New York Heart Association Functional Class). Chronic CHF patients are usually managed on an outpatient basis, typically with drugs.
- Acute Congestive Heart Failure a chronic deterioration in heart function
- Acute CHF deteriorations can occur when extra stress (such as an infection or excessive fluid overload) significantly increases the workload on the heart in a stable chronic CHF patient.
- extra stress such as an infection or excessive fluid overload
- a patient suffering acute CHF may deteriorate from even the earliest stages of CHF to severe hemodynamic collapse.
- Acute CHF can occur within hours or days following an Acute Myocardial Infarction (“AMI”), which is a sudden, irreversible injury to the heart muscle, commonly referred to as a heart attack.
- AMI Acute Myocardial Infarction
- kidneys play a significant role in the progression of CHF, as well as in Chronic Renal Failure (“CRF”), End-Stage Renal Disease (“ESRD”), hypertension (pathologically high blood pressure) and other cardio-renal diseases.
- CRF Chronic Renal Failure
- ESRD End-Stage Renal Disease
- hypertension pathologically high blood pressure
- Other cardio-renal diseases The functions of the kidney can be summarized under three broad categories: filtering blood and excreting waste products generated by the body's metabolism; regulating salt, water, electrolyte and acid-base balance; and secreting hormones to maintain vital organ blood flow.
- a patient Without properly functioning kidneys, a patient will suffer water retention, reduced urine flow and an accumulation of waste toxins in the blood and body.
- kidney failure are believed to increase the workload of the heart.
- renal failure will cause the heart to further deteriorate as the water build-up and blood toxins accumulate due to the poorly functioning kidneys and, in turn, cause the heart further harm.
- the primary functional unit of the kidneys that is involved in urine formation is called the “nephron”.
- Each kidney consists of about one million nephrons.
- the nephron is made up of a glomerulus and its tubules, which can be separated into a number of sections: the proximal tubule, the medullary loop (loop of Henle), and the distal tubule.
- Each nephron is surrounded by different types of cells that have the ability to secrete several substances and hormones (such as renin and erythropoietin).
- Urine is formed as a result of a complex process starting with the filtration of plasma water from blood into the glomerulus.
- the walls of the glomerulus are freely permeable to water and small molecules but almost impermeable to proteins and large molecules.
- the filtrate is virtually free of protein and has no cellular elements.
- the filtered fluid that eventually becomes urine flows through the tubules.
- the final chemical composition of the urine is determined by the secretion into, and re-absorption of substances from, the urine required to maintain homeostasis.
- the two kidneys filter about 125 ml of plasma water per minute. Filtration occurs because of a pressure gradient across the glomerular membrane. The pressure in the arteries of the kidney pushes plasma water into the glomerulus causing filtration. To keep the Glomerulur Filtration Rate (“GFR”) relatively constant, pressure in the glomerulus is held constant by the constriction or dilatation of the afferent and efferent arterioles, the muscular walled vessels leading to and from each glomerulus.
- GFR Glomerulur Filtration Rate
- a combination of complex mechanisms contribute to deleterious fluid overload in CHF.
- the kidneys cannot function and become impaired due to insufficient blood pressure for perfusion. This impairment in renal function ultimately leads to the decrease in urine output. Without sufficient urine output, the body retains fluids, and the resulting fluid overload causes peripheral edema (swelling of the legs), shortness of breath (due to fluid in the lungs), and fluid retention in the abdomen, among other undesirable conditions in the patient.
- cardiac output leads to reduced renal blood flow, increased neurohormonal stimulus, and release of the hormone renin from the juxtaglomerular apparatus of the kidney.
- Increased renin results in the formation of angiotensin, a potent vasoconstrictor.
- Heart failure and the resulting reduction in blood pressure also reduce the blood flow and perfusion pressure through organs in the body other than the kidneys. As they suffer reduced blood pressure, these organs may become hypoxic, resulting in a metabolic acidosis that reduces the effectiveness of pharmacological therapy and increases a risk of sudden death.
- CHF is associated with an abnormally elevated peripheral vascular resistance and is dominated by alterations of the circulation resulting from an intense disturbance of sympathetic nervous system function.
- Increased activity of the sympathetic nervous system promotes a downward vicious cycle of increased arterial vasoconstriction (increased resistance of vessels to blood flow) followed by a further reduction of cardiac output, causing even more diminished blood flow to the vital organs.
- the heart and circulatory system dramatically reduce blood flow to the kidneys.
- the kidneys receive a command from higher neural centers via neural pathways and hormonal messengers to retain fluid and sodium in the body.
- the neural centers command the kidneys to reduce their filtering functions. While in the short term, these commands can be beneficial, if these commands continue over hours and days they can jeopardize the person's life or make the person dependent on artificial kidney for life by causing the kidneys to cease functioning.
- the hemodynamic impairment resulting from CHF activates several neurohormonal systems, such as the renin-angiotensin and aldosterone system, sympatho-adrenal system and vasopressin release.
- neurohormonal systems such as the renin-angiotensin and aldosterone system, sympatho-adrenal system and vasopressin release.
- the GFR drops, and the sodium load in the circulatory system increases.
- more renin is liberated from the juxtaglomerular of the kidney.
- the combined effects of reduced kidney functioning include reduced glomerular sodium load, an aldosterone-mediated increase in tubular reabsorption of sodium, and retention in the body of sodium and water.
- CHF is progressive, and as of now, not curable.
- Surgical therapies are effective in some cases, but limited to the end-stage patient population because of the associated risk and cost.
- the dramatic role played by kidneys in the deterioration of CHF patients is not adequately addressed by current surgical therapies.
- the autonomic nervous system is recognized as an important pathway for control signals that are responsible for the regulation of body functions critical for maintaining vascular fluid balance and blood pressure.
- the autonomic nervous system conducts information in the form of signals from the body's biologic sensors such as baroreceptors (responding to pressure and volume of blood) and chemoreceptors (responding to chemical composition of blood) to the central nervous system via its sensory fibers. It also conducts command signals from the central nervous system that control the various innervated components of the vascular system via its motor fibers.
- renin is a hormone responsible for the “vicious cycle” of vasoconstriction and water and sodium retention in heart failure patients. It was demonstrated that an increase or decrease in renal sympathetic nerve activity produced parallel increases and decreases in the renin secretion rate by the kidney, respectively.
- baroreceptors If exposed to a reduced level of arterial pressure for a prolonged time, baroreceptors normally “reset”, i.e., return to a baseline level of activity, until a new disturbance is introduced. Therefore, it is believed that in chronic CHF patients, the components of the autonomic-nervous system responsible for the control of blood pressure and the neural control of the kidney function become abnormal. The exact mechanisms that cause this abnormality are not fully understood, but its effects on the overall condition of the CHF patients are profoundly negative.
- End-Stage Renal Disease is another condition at least partially controlled by renal neural activity.
- ESRD end-Stage Renal Disease
- Chronic Renal Failure slowly progresses to ESRD.
- CRF represents a critical period in the evolution of ESRD.
- the signs and symptoms of CRF are initially minor, but over the course of 2-5 years, become progressive and irreversible. While some progress has been made in combating the progression to, and complications of, ESRD, the clinical benefits of existing interventions remain limited.
- kidneys are damaged by direct renal toxicity from the release of sympathetic neurotransmitters (such as norepinephrine) in the kidneys independent of the hypertension. Furthermore, secretion of renin that activates Angiotensin II is increased, which increases systemic vasoconstriction and exacerbates hypertension.
- sympathetic neurotransmitters such as norepinephrine
- the present invention provides methods and apparatus for renal neuromodulation (e.g., denervation) using a pulsed electric field (PEF).
- a pulsed electric field to effectuate electroporation and/or electrofusion in renal nerves, other neural fibers that contribute to renal neural function, or other neural features.
- Several embodiments of the invention are intravascular devices for inducing renal neuromodulation.
- the apparatus and methods described herein may utilize any suitable electrical signal or field parameters that achieve neuromodulation, including denervation, and/or otherwise create an electroporative and/or electrofusion effect.
- the electrical signal may incorporate a nanosecond pulsed electric field (nsPEF) and/or a PEF for effectuating electroporation.
- nsPEF nanosecond pulsed electric field
- One specific embodiment comprises applying a first course of PEF electroporation followed by a second course of nsPEF electroporation to induce apoptosis in any cells left intact after the PEF treatment, or vice versa.
- An alternative embodiment comprises fusing nerve cells by applying a PEF in a manner that is expected to reduce or eliminate the ability of the nerves to conduct electrical impulses.
- Pulsed electric field parameters can include, but are not limited to, field strength, pulse width, the shape of the pulse, the number of pulses and/or the interval between pulses (e.g., duty cycle).
- Suitable field strengths include, for example, strengths of up to about 10,000 V/cm.
- Suitable pulse widths include, for example, widths of up to about 1 second.
- Suitable shapes of the pulse waveform include, for example, AC waveforms, sinusoidal waves, cosine waves, combinations of sine and cosine waves, DC waveforms, DC-shifted AC waveforms, RF waveforms, square waves, trapezoidal waves, exponentially-decaying waves, combinations thereof, etc.
- Suitable numbers of pulses include, for example, at least one pulse.
- Suitable pulse intervals include, for example, intervals less than about 10 seconds. Any combination of these parameters may be utilized as desired. These parameters are provided for the sake of illustration and should in no way be considered limiting. Additional and alternative waveform parameters will be apparent.
- one embodiment of the invention comprises treating a patient for an infarction, e.g., via coronary angioplasty and/or stenting, and performing an intra-arterial pulsed electric field renal denervation procedure under fluoroscopic guidance.
- PEF therapy could be delivered in a separate session soon after the AMI had been stabilized.
- Renal neuromodulation also may be used as an adjunctive therapy to renal surgical procedures.
- the anticipated increase in urine output and/or control of blood pressure provided by the renal PEF therapy is expected to reduce the load on the heart to inhibit expansion of the infarct and prevent CHF.
- intravascular pulsed electric field systems described herein may denervate or reduce the activity of the renal nervous supply immediately post-infarct, or at any time thereafter, without leaving behind a permanent implant in the patient.
- These embodiments are expected to increase urine output and/or control blood pressure for a period of several months during which the patient's heart can heal. If it is determined that repeat and/or chronic neuromodulation would be beneficial after this period of healing, renal PEF treatment can be repeated as needed.
- systems described herein are also expected to treat CHF, hypertension, renal failure, and other renal or cardio-renal diseases influenced or affected by increased renal sympathetic nervous activity.
- the systems may be used to treat CHF at any time by advancing the PEF system to a treatment site via a vascular structure and then delivering a PEF therapy to the treatment site. This may, for example, modify a level of fluid offload.
- Embodiments of intravascular PEF systems described herein may be used similarly to angioplasty or electrophysiology catheters which are well known in the art.
- arterial access may be gained through a standard Seldinger Technique, and an arterial sheath optionally may be placed to provide catheter access.
- a guidewire may be advanced through the vasculature and into the renal artery of the patient, and then an intravascular PEF may be advanced over the guidewire and/or through the sheath into the renal artery.
- the sheath optionally may be placed before inserting the PEF catheter or advanced along with the PEF catheter such that the sheath partially or completely covers the catheter.
- the PEF catheter may be advanced directly through the vasculature without the use of a guide wire and/or introduced and advanced into the vasculature without a sheath.
- the PEF system may be placed within a vein.
- Venous access may, for example, be achieved via a jugular approach.
- PEF systems may be utilized, for example, within the renal artery, within the renal vein or within both the renal artery and the renal vein to facilitate more complete denervation.
- the PEF catheter After the PEF catheter is positioned within the vessel at a desired location with respect to the target neurons, it is stabilized within the vessel (e.g., braced against the vessel wall) and energy is delivered to the target nerve or neurons.
- pulsed RF energy is delivered to the target to create a non-thermal nerve block, reduce neural signaling, or otherwise modulate neural activity.
- cooling, cryogenic, thermal RF, thermal or non-thermal microwave, focused or unfocused ultrasound, thermal or non-thermal DC, as well as any combination thereof, may be employed to reduce or otherwise control neural signaling.
- non-renal neural structures may be targeted from within arterial or venous conduits in addition to or in lieu of renal neural structures.
- a PEF catheter can be navigated through the aorta or the vena cava and brought into apposition with various neural structures to treat other conditions or augment the treatment of renal-cardiac conditions.
- nerve bodies of the lumbar sympathetic chain may be accessed and modulated, blocked or ablated, etc., in this manner.
- PEF systems may completely block or denervate the target neural structures, or the PEF systems may otherwise modulate the renal nervous activity.
- the PEF systems may otherwise modulate the renal nervous activity.
- other neuromodulation produces a less-than-complete change in the level of renal nervous activity between the kidney(s) and the rest of the body. Accordingly, varying the pulsed electric field parameters will produce different effects on the nervous activity.
- the device includes one or more electrodes that are configured to physically contact a target region of a renal vasculature for delivery of a pulsed electric field.
- the device can comprise a catheter having an expandable helical section and one or more electrodes at the helical section.
- the catheter may be positioned in the renal vasculature while in a low profile configuration.
- the expandable section can then be expanded to contact the inner surface of the vessel wall.
- the catheter can have one or more expandable helical electrodes.
- first and second expandable electrodes may be positioned within the vessel at a desired distance from one another to provide an active electrode and a return electrode.
- the expandable electrodes may comprise shape-memory materials, inflatable balloons, expandable meshes, linkage systems and other types of devices that can expand in a controlled manner.
- Suitable expandable linkage systems include expandable baskets, having a plurality of shape-memory wires or slotted hypotubes, and/or expandable rings.
- the expandable electrodes may be point contact electrodes arranged along a balloon portion of a catheter.
- pulsed electric field systems include electrodes that do not physically contact the vessel wall.
- RF energy both traditional thermal energy and relatively non-thermal pulsed RF
- pulsed electric fields can be conducted into tissue to be treated from a short distance away from the tissue itself.
- Other types of pulsed electric fields can also be used in situations in which the electrodes do not physically contact the vessel wall.
- the pulsed electric fields can be applied directly to the nerve via physical contact between the electrode contacts and the vessel wall or other tissue, or the pulsed electric fields can be applied indirectly to the nerve without physically contacting the electrode contacts with the vessel wall.
- the device has a centering element configured to position the electrodes in a central region of the vessel or otherwise space the electrodes apart from the vessel wall.
- the centering element may comprise, for example, a balloon or an expandable basket.
- One or more electrodes may be positioned on a central shaft of the centering element—either longitudinally aligned with the element or positioned on either side of the element.
- the inflated balloon may act as an insulator of increased impedance for orienting or directing a pulsed electric field along a desired electric flow path.
- alternative insulators may be utilized.
- a combination apparatus in another embodiment, includes an intravascular catheter having a first electrode configured to physically contact the vessel wall and a second electrode configured to be positioned within the vessel but spaced apart from the vessel wall.
- an expandable helical electrode may be used in combination with a centrally-disposed electrode to provide such a bipolar electrode pair.
- a radial position of one or more electrodes relative to a vessel wall may be altered dynamically to focus the pulsed electric field delivered by the electrode(s).
- the electrodes may be configured for partial or complete passage across the vessel wall.
- the electrode(s) may be positioned within the renal vein, then passed across the wall of the renal vein into the perivascular space such that they at least partially encircle the renal artery and/or vein prior to delivery of a pulsed electric field.
- Bipolar embodiments of the present invention may be configured for dynamic movement or operation relative to a spacing between the active and ground electrodes to achieve treatment over a desired distance, volume or other dimension.
- a plurality of electrodes may be arranged such that a bipolar pair of electrodes can move longitudinally relative to each other for adjusting the separation distance between the electrodes and/or for altering the location of treatment.
- One specific embodiment includes a first electrode coupled to a catheter and a moveable second electrode that can move through a lumen of the catheter.
- a first electrode can be attached to a catheter and a second electrode can be attached to an endoluminally-delivered device such that the first and second electrodes may be repositioned relative to one another to alter a separation distance between the electrodes.
- Such embodiments may facilitate treatment of a variety of renal vasculature anatomies.
- any of the embodiments of the present invention described herein optionally may be configured for infusing agents into the treatment area before, during or after energy application.
- the infused agents can be selected to enhance or modify the neuromodulatory effect of the energy application.
- the agents can also protect or temporarily displace non-target cells, and/or facilitate visualization.
- Detectors for monitoring of such physiological responses include, for example, Doppler elements, thermocouples, pressure sensors, and imaging modalities (e.g., fluoroscopy, intravascular ultrasound, etc.).
- electroporation may be monitored directly using, for example, Electrical Impedance Tomography (“EIT”) or other electrical impedance measurements. Additional monitoring techniques and elements will be apparent.
- EIT Electrical Impedance Tomography
- Such detector(s) may be integrated with the PEF systems or they may be separate elements.
- Still other specific embodiments include electrodes configured to align the electric field with the longer dimension of the target cells.
- nerve cells tend to be elongate structures with lengths that greatly exceed their lateral dimensions (e.g., diameter).
- lateral dimensions e.g., diameter
- inventions of the invention are directed to applications in which the longitudinal dimensions of cells in tissues overlying or underlying the nerve are transverse (e.g., orthogonal or otherwise at an angle) with respect to the longitudinal direction of the nerve cells.
- Another aspect of these embodiments is to align the directionality of the PEF such that the field aligns with the longer dimensions of the target cells and the shorter dimensions of the non-target cells.
- arterial smooth muscle cells are typically elongate cells which surround the arterial circumference in a generally spiraling orientation so that their longer dimensions are circumferential rather than running longitudinally along the artery. Nerves of the renal plexus, on the other hand, run along the outside of the artery generally in the longitudinal direction of the artery.
- applying a PEF which is generally aligned with the longitudinal direction of the artery is expected to preferentially cause electroporation in the target nerve cells without affecting at least some of the non-target arterial smooth muscle cells to the same degree. This may enable preferential denervation of nerve cells (target cells) in the adventitia or periarterial region from an intravascular device without affecting the smooth muscle cells of the vessel to an undesirable extent.
- FIG. 1 is a schematic view illustrating human renal anatomy.
- FIG. 2 is a schematic detail view showing the location of the renal nerves relative to the renal artery.
- FIGS. 3A and 3B are schematic side- and end-views, respectively, illustrating a direction of electrical current flow for selectively affecting renal nerves.
- FIG. 4 is a schematic side-view, partially in section, of an intravascular catheter having a plurality of electrodes in accordance with one embodiment of the invention.
- FIG. 5 is a schematic side-view, partially in section, of an intravascular device having a pair of expanding helical electrodes arranged at a desired distance from one another in accordance with another embodiment of the invention.
- FIG. 6 is a schematic side-view, partially in section, of an intravascular device having a first electrode on an expandable balloon, and a second electrode on a catheter shaft in accordance with another embodiment of the invention.
- FIG. 7 is a schematic side-view, partially in section, of an intravascular device having an expanding first electrode delivered through the lumen of a catheter and a complementary second electrode carried by the catheter in accordance with another embodiment of the invention.
- FIG. 8 is a schematic side-view, partially in section, of an intravascular device having an expandable basket and a plurality of electrodes at the basket in accordance with another embodiment of the invention.
- FIG. 9 is a schematic detail view of the apparatus of FIG. 8 illustrating one embodiment of the electrodes in accordance with another embodiment of the invention.
- FIG. 10 is a schematic side-view, partially in section, of an intravascular device having expandable ring electrodes for contacting the vessel wall and an optional insulation element in accordance with another embodiment of the invention.
- FIGS. 11A-11C are schematic detail views of embodiments of different windings for the ring electrodes of FIG. 10 .
- FIG. 12 is a schematic side-view, partially in section, of an intravascular device having ring electrodes of FIG. 10 with the windings shown in FIGS. 11A-11C .
- FIG. 13 is a schematic side-view, partially in section, of an intravascular device having a ring electrode and a luminally-delivered electrode in accordance with another embodiment of the invention.
- FIG. 14 is a schematic side-view, partially in section, of an intravascular device having a balloon catheter and expandable point contact electrodes arranged proximally and distally of the balloon in accordance with another embodiment of the invention.
- FIG. 15 is a schematic side-view of an intravascular device having a balloon catheter and electrodes arranged proximally and distally of the balloon in accordance with another embodiment of the invention.
- FIGS. 16A and 16B are schematic side-views, partially in section, illustrating stages of a method of using the apparatus of FIG. 15 in accordance with an embodiment of the invention.
- FIG. 17 is a schematic side-view of an intravascular device having a balloon catheter and a plurality of dynamically operable electrodes in accordance with another embodiment of the invention.
- FIG. 18 is a schematic side-view of an intravascular device having a distal electrode deployed through a lumen of the balloon catheter in accordance with another embodiment of the invention.
- FIGS. 19A and 19B are side-views, partially in section, illustrating methods of using the intravascular device shown in FIG. 18 to modulate renal neural activity in patients with various renal vasculatures.
- FIG. 20 is a side view, partially in section, illustrating an intravascular device having a plurality of electrodes arranged along the shaft of, and in line with, a centering element in accordance with another embodiment of the invention.
- FIG. 21 is a side-view, partially in section, illustrating an intravascular device having electrodes configured for dynamic radial repositioning to facilitate focusing of a pulsed electric field in accordance with another embodiment of the invention.
- FIG. 22 is a side-view, partially in section, of an intravascular device having an infusion/aspiration catheter in accordance with another embodiment of the invention.
- FIGS. 23A-23C are, respectively, a side-view, partially in section, and cross-sectional views along section line A-A of FIG. 23A , illustrating a method of using an intravascular device in accordance with an embodiment of the invention configured for passage of electrode(s) at least partially across the vessel wall.
- FIGS. 24A and 24B are side-views, partially in section, illustrating an intravascular device having detectors for measuring or monitoring treatment efficacy in accordance with another embodiment of the invention.
- the present invention relates to methods and apparatus for renal neuromodulation and/or other neuromodulation. More particularly, the present invention relates to methods and apparatus for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion.
- electroporation and electropermeabilization are methods of manipulating the cell membrane or intracellular apparatus. For example, short high-energy pulses cause pores to open in cell membranes. The extent of porosity in the cell membrane (e.g., size and number of pores) and the duration of the pores (e.g., temporary or permanent) are a function of the field strength, pulse width, duty cycle, field orientation, cell type and other parameters.
- pores will generally close spontaneously upon termination of lower strength fields or shorter pulse widths (herein defined as “reversible electroporation”).
- reversible electroporation Each cell type has a critical threshold above which pores do not close such that pore formation is no longer reversible; this result is defined as “irreversible electroporation,” “irreversible breakdown” or “irreversible damage.”
- the cell membrane ruptures and/or irreversible chemical imbalances caused by the high porosity occur.
- Such high porosity can be the result of a single large hole and/or a plurality of smaller holes.
- nsPEF nanosecond pulsed electric fields
- Certain applications of nsPEF have been shown to cause cell death by inducing apoptosis, or programmed cell death, rather than acute cell death.
- the term “comprising” is used throughout to mean including at least the recited feature such that any greater number of the same feature and/or additional types features are not precluded.
- Several embodiments of the present invention provide intravascular devices for inducing renal neuromodulation, such as a temporary change in target nerves that dissipates over time, continuous control over neural function, and/or denervation.
- the apparatus and methods described herein may utilize any suitable electrical signal or field parameters, e.g., any electric field, that will achieve the desired neuromodulation (e.g., electroporative effect).
- any suitable electrical signal or field parameters e.g., any electric field
- the human renal anatomy includes kidneys K that are supplied with oxygenated blood by renal arteries RA, which are connected to the heart by the abdominal aorta AA. Deoxygenated blood flows from the kidneys to the heart via renal veins RV and the inferior vena cava IVC.
- FIG. 2 illustrates a portion of the renal anatomy in greater detail. More specifically, the renal anatomy also includes renal nerves RN extending longitudinally along the lengthwise dimension L of renal artery RA generally within the adventitia of the artery.
- the renal artery RA has smooth muscle cells SMC that surround the arterial circumference spiral around the angular axis ⁇ of the artery, i.e., around the circumference of the artery.
- the smooth muscle cells of the renal artery accordingly have a lengthwise or longer dimension extending transverse (i.e., non-parallel) to the lengthwise dimension of the renal artery.
- the misalignment of the lengthwise dimensions of the renal nerves and the smooth muscle cells is defined as “cellular misalignment.”
- the cellular misalignment of the renal nerves and the smooth muscle cells may be exploited to selectively affect renal nerve cells with reduced effect on smooth muscle cells. More specifically, because larger cells require less energy to exceed the irreversibility threshold of electroporation, several embodiments of electrodes of the present invention are configured to align at least a portion of an electric field generated by the electrodes with or near the longer dimensions of the cells to be affected.
- the intravascular device has electrodes configured to create an electrical field aligned with or near the lengthwise dimension of the renal artery RA to affect renal nerves RN.
- the lengthwise or longer dimensions of tissues overlying or underlying the target nerve are orthogonal or otherwise off-axis (e.g., transverse) with respect to the longer dimensions of the nerve cells.
- the PEF may propagate along the lateral or shorter dimensions of the non-target cells (i.e. such that the PEF propagates at least partially out of alignment with non-target smooth muscle cells SMC). Therefore, as seen in FIG.
- applying a PEF with propagation lines Li generally aligned with the longitudinal dimension L of the renal artery RA is expected to preferentially cause electroporation, electrofusion, denervation or other neuromodulation in cells of the target renal nerves RN without unduly affecting the non-target arterial smooth muscle cells SMC.
- the pulsed electric field may propagate in a single plane along the longitudinal axis of the renal artery, or may propagate in the longitudinal direction along any angular segment ⁇ through a range of 0°-360°.
- Embodiments of the method shown in FIG. 3 may have particular application with the intravascular methods and apparatus of the present invention.
- a PEF catheter placed within the renal artery may propagate an electric field having a longitudinal portion that is aligned to run with the longitudinal dimension of the artery in the region of the renal nerves RN and the smooth muscle cell SMC of the vessel wall so that the wall of the artery remains at least substantially intact while the outer nerve cells are destroyed.
- FIG. 4 shows one embodiment of an intravascular pulsed electric field apparatus 200 in accordance with the present invention that includes one or more electrodes configured to physically contact a target region within the renal vasculature and deliver a pulsed electric field across a wall of the vasculature.
- the apparatus 200 is shown within a patient's renal artery RA, but it can be positioned in other intravascular locations (e.g., the renal vein).
- This embodiment of the apparatus 200 comprises an intravascular catheter 210 having a proximal section 211 a , a distal section 211 b , and a plurality of distal electrodes 212 at the distal section 211 b .
- the proximal section 211 a generally has an electrical connector to couple the catheter 210 to a pulse generator, and the distal section 211 b in this embodiment has a helical configuration.
- the apparatus 200 is electrically coupled to a pulsed electric field generator 100 located proximal and external to the patient; the electrodes 212 are electrically coupled to the generator via catheter 210 .
- the generator 100 may be utilized with any embodiment of the present invention described hereinafter for delivery of a PEF with desired field parameters. It should be understood that electrodes of embodiments described hereinafter may be connected to the generator, even if the generator is not explicitly shown or described with each variation.
- the helical distal section 211 b of catheter 210 is configured to appose the vessel wall and bring electrodes 212 into close proximity to extra-vascular neural structures.
- the pitch of the helix can be varied to provide a longer treatment zone, or to minimize circumferential overlap of adjacent treatments zones in order to reduce a risk of stenosis formation. This pitch change can be achieved by combining a plurality of catheters of different pitches to form catheter 210 , or by adjusting the pitch of catheter 210 through the use of internal pull wires, adjusting mandrels inserted into the catheter, shaping sheaths placed over the catheter, or by any other suitable means for changing the pitch either in-situ or before introduction into the body.
- the electrodes 212 along the length of the pitch can be individual electrodes, a common but segmented electrode, or a common and continuous electrode.
- a common and continuous electrode may, for example, comprise a conductive coil formed into or placed over the helical portion of catheter 210 .
- a common but segmented electrode may, for example, be formed by providing a slotted tube fitted onto or into the helical portion of the catheter, or by electrically connecting a series of individual electrodes.
- Electrodes 212 may be configured to provide a bipolar signal, or all or a subset of the electrodes may be used together in conjunction with a separate external patient ground for monopolar use (the ground pad may, for example, be placed on the patient's leg). Electrodes 212 may be dynamically assignable to facilitate monopolar and/or bipolar energy delivery between any of the electrodes and/or between any of the electrodes and an external ground.
- Catheter 210 may be delivered to renal artery RA in a low profile delivery configuration within sheath 150 .
- the catheter Once positioned within the artery, the catheter may self-expand or may be expanded actively, e.g., via a pull wire or a balloon, into contact with an interior wall of the artery.
- a pulsed electric field then may be generated by the PEF generator 100 , transferred through catheter 210 to electrodes 212 , and delivered via the electrodes 212 across the wall of the artery.
- the electrodes are arranged so that the pulsed electric field is aligned with the longitudinal dimension of the artery to modulate the neural activity along the renal nerves (e.g., denervation). This may be achieved, for example, via irreversible electroporation, electrofusion and/or inducement of apoptosis in the nerve cells.
- FIG. 5 illustrates an apparatus 220 for neural modulation in accordance with another embodiment of the invention.
- the apparatus 220 includes a pair of catheters 222 a and 222 b having expandable distal sections 223 a and 223 b with helical electrodes 224 a and 224 b , respectively.
- the helical electrodes 224 a and 224 b are spaced apart from each other by a desired distance within a patient's renal vasculature. Electrodes 224 a - b may be actuated in a bipolar fashion such that one electrode is an active electrode and the other is a return electrode. The distance between the electrodes may be altered as desired to change the field strength and/or the length of nerve segment modulated by the electrodes.
- the expandable helical electrodes may comprise shape-memory properties that facilitate self-expansion, e.g., after passage through sheath 150 , or the electrodes may be actively expanded into contact with the vessel wall, e.g., via an inflatable balloon or via pull wires, etc.
- the catheters 222 a - b preferably are electrically insulated in areas other than the distal helices of electrodes 224 a - b.
- FIG. 6 illustrates an apparatus 230 comprising a balloon catheter 232 having expandable balloon 234 , a helical electrode 236 arranged about the balloon 234 , and a shaft electrode 238 on the shaft of catheter 232 .
- the shaft electrode 238 can be located proximal of expandable balloon 234 as shown, or the shaft electrode 238 can be located distal of the expandable balloon 234 .
- the expandable balloon 234 and the helical electrode 236 are arranged in a low profile delivery configuration.
- expandable balloon 234 may be inflated to drive the helical electrode 236 into physical contact with the wall of the vessel.
- the shaft electrode 238 does not physically contact the vessel wall.
- a centering element optionally may be provided to place electrodes in a central region of the vessel.
- the centering element may comprise, for example, an expandable balloon, such as balloon 234 of apparatus 230 , or an expandable basket as described hereinafter.
- One or more electrodes may be positioned on a central shaft of the centering element—either longitudinally aligned with the element or positioned on one or both sides of the element—as is shaft electrode 238 of apparatus 230 .
- the inflated balloon may act as an insulator of increased impedance for directing a pulsed electric field along a desired electric flow path.
- alternative insulators may be utilized.
- the generator 100 may generate a PEF such that current passes between the helical electrode 236 and the shaft electrode 238 in a bipolar fashion.
- the PEF travels between the electrodes along lines Li that generally extend along the longitudinal dimension of the artery.
- the balloon 234 locally insulates and/or increases the impedance within the patient's vessel such that the PEF travels through the wall of the vessel between the helical and shaft electrodes. This focuses the energy to enhance denervation and/or other neuromodulation of the patient's renal nerves, e.g., via irreversible electroporation.
- FIG. 7 illustrates an apparatus 240 similar to those shown in FIGS. 4-6 in accordance with another embodiment of the invention.
- the apparatus 240 comprises a balloon catheter 242 having an expandable balloon 244 and a shaft electrode 246 located proximal of the expandable balloon 244 .
- the apparatus 240 further comprises an expandable helical electrode 248 configured for delivery through a guidewire lumen 243 of the catheter 242 .
- the helical electrode 248 shown in FIG. 7 is self-expanding.
- the balloon 244 is inflated until it contacts the wall of the vessel to hold the shaft electrode 246 at a desired location within the vessel and to insulate or increase the impedance of the interior of the vessel.
- the balloon 244 is generally configured to also center the shaft electrode 246 within the vessel or otherwise space the shaft electrode apart from the vessel wall by a desired distance.
- the helical electrode 248 is pushed through lumen 243 until the helical electrode 248 extends beyond the catheter shaft; the electrode 248 then expands or otherwise moves into the helical configuration to physically contact the vessel wall.
- a bipolar pulsed electric field may then be delivered between the helical electrode 248 and the shaft electrode 246 along lines Li.
- the helical electrode 248 may comprise the active electrode and the shaft electrode 246 may comprise the return electrode, or vice versa.
- Apparatus 250 comprises catheter 252 having expandable distal basket 254 formed from a plurality of circumferential struts or members.
- a plurality of electrodes 256 are formed along the members of basket 254 .
- Each member of the basket illustratively comprises a bipolar electrode pair configured to contact a wall of renal artery RA or another desired blood vessel.
- Basket 254 may be fabricated, for example, from a plurality of shape-memory wires or ribbons, such as Nitinol, spring steel or eigiloy wires or ribbons, that form basket members 253 .
- the ribbons may be moved such that a surface area contacting the vessel wall is increased.
- Basket members 253 are coupled to catheter 252 at proximal and distal connections 255 a and 255 b , respectively.
- the basket may be collapsed for delivery within sheath 150 , and may self-expand into contact with the wall of the artery upon removal from the sheath.
- Proximal and/or distal connection 255 optionally may be configured to translate along the shaft of catheter 252 for a specified or unspecified distance in order to facilitate expansion and collapse of the basket.
- Basket 254 alternatively may be formed from a slotted and/or laser-cut hypotube.
- catheter 252 may, for example, comprise inner and outer shafts that are moveable relative to one another.
- Distal connection 255 b of basket 254 may be coupled to the inner shaft and proximal connection 255 a of the basket may be coupled to the outer shaft.
- Basket 254 may be expanded from a collapsed delivery configuration to the deployed configuration of FIG. 8 by approximating the inner and outer shafts of catheter 252 , thereby approximating the proximal and distal connections 255 of the basket and expanding the basket.
- the basket may be collapsed by separating the inner and outer shafts of the catheter.
- individual electrodes may be arranged along a basket strut or member 253 .
- the strut is formed from a conductive material coated with a dielectric material, and the electrodes 256 may be formed by removing regions of the dielectric coating.
- the insulation optionally may be removed only along a radially outer surface of the member such that electrodes 256 remain insulated on their radially interior surfaces; it is expected that this will direct the current flow outward into the vessel wall.
- the electrodes may be affixed to the inside surface, outside surface or embedded within the struts or members of basket 254 .
- the electrodes placed along each strut or member may comprise individual electrodes, a common but segmented electrode, or a common and continuous electrode. Individual electrodes or groups of electrodes may be configured to provide a bipolar signal, or all or a subset of the electrodes may be actuated together in conjunction with an external patient ground for monopolar use.
- Electrodes 256 contact the vessel wall as shown in the embodiment of FIG. 8 may reduce the need for an insulating element, such as an expandable balloon, to achieve renal denervation or other neuromodulation.
- an insulating element such as an expandable balloon
- having the electrodes contact the wall may provide improved field geometry, i.e., may provide an electric field more aligned with the longitudinal axis of the vessel.
- Such contacting electrodes also may facilitate stimulation of the renal nerves before, during or after neuromodulation to better position the catheter 252 before treatment or for monitoring the effectiveness of treatment.
- electrodes 256 may be disposed along the central shaft of catheter 252 , and basket 254 may simply center the electrodes within the vessel to facilitate more precise delivery of energy across the vessel wall.
- This configuration may be well suited to precise targeting of vascular or extra-vascular tissue, such as the renal nerves surrounding the renal artery. Correctly sizing the basket or other centering element to the artery provides a known distance between the centered electrodes and the arterial wall that may be utilized to direct and/or focus the electric field as desired.
- This configuration may be utilized in high-intensity focused ultrasound or microwave applications, but also may be adapted for use with any other energy modality as desired.
- Apparatus 260 comprises catheter 262 having expandable ring electrodes 264 a and 264 b configured to contact the wall of the vessel.
- the electrodes may be attached to the shaft of catheter 262 via struts 266 , and catheter 262 may be configured for delivery to renal artery RA through sheath 150 in a low profile configuration.
- Struts 266 may self-expanding or may be actively or mechanically expanded.
- Catheter 262 comprises guidewire lumen 263 for advancement over a guidewire.
- Catheter 262 also comprises optional inflatable balloon 268 that may act as an insulating element of increased impedance for preferentially directing current flow that is traveling between electrodes 264 across the wall of the artery.
- FIGS. 11A-11C illustrate various embodiments of windings for ring electrodes 264 .
- the ring electrodes may, for example, be wound in a coil ( FIG. 11A ), a zigzag ( FIG. 11B ) or a serpentine configuration ( FIG. 11C ).
- the periodicity of the winding may be specified, as desired. Furthermore, the type of winding, the periodicity, etc., may vary along the circumference of the electrodes.
- apparatus 260 comprising ring electrodes 264 ′ having a sinusoidal winding in one embodiment of the serpentine winding shown in FIG. 11C .
- Struts 266 illustratively are attached to apexes of the sinusoid.
- the winding of electrodes 264 ′ may provide for greater contact area along the vessel wall than do electrodes 264 , while still facilitating sheathing of apparatus 260 within sheath 150 for delivery and retrieval.
- FIG. 13 illustrates another variation of apparatus 260 comprising a proximal ring electrode 264 a , and further comprising a distal electrode 270 delivered through guidewire lumen 263 of catheter 262 .
- the distal electrode 270 is non-expanding and is centered within the vessel via catheter 262 .
- the distal electrode 270 may be a standard guide wire which is connected to the pulsed electric field generator and used as an electrode.
- electrode 270 alternatively may be configured for expansion into contact with the vessel wall, e.g., may comprise a ring or helical electrode.
- Delivering the distal electrode through the lumen of catheter 262 may reduce a delivery profile of apparatus 260 and/or may improve flexibility of the device. Furthermore, delivery of the distal electrode through the guidewire lumen may serve as a safety feature that ensures that the medical practitioner removes any guidewire disposed within lumen 263 prior to delivery of a PEF. It also allows for customization of treatment length, as well as for treatment in side branches, as described hereinafter.
- Ring electrodes 264 and 264 ′ optionally may be electrically insulated along their radially inner surfaces, while their radially outer surfaces that contact the vessel wall are exposed. This may reduce a risk of thrombus formation and also may improve or enhance the directionality of the electric field along the longitudinal axis of the vessel. This also may facilitate a reduction of field voltage necessary to disrupt neural fibers.
- Materials utilized to at least partially insulate the ring electrodes may comprise, for example, PTFE, ePTFE, FEP, chronoprene, silicone, urethane, Pebax, etc.
- catheter 262 illustratively comprises four point electrodes 272 on either side of balloon 268 . However, it should be understood that any desired number of struts and point electrodes may be provided around the circumference of catheter 262 .
- apparatus 260 illustratively comprises four struts 266 and four point electrodes 272 on either side of balloon 268 .
- lines Li along which the electric field propagates may be aligned with the longitudinal axis of a vessel.
- a degree of line Li overlap along the rotational axis of the vessel may be specified by specifying the angular placement and density of point electrodes 272 about the circumference of the catheter, as well as by specifying parameters of the PEF.
- Apparatus 280 comprises catheter 282 having optional inflatable balloon or centering element 284 , shaft electrodes 286 a and 286 b disposed along the shaft of the catheter on either side of the balloon, as well as optional radiopaque markers 288 disposed along the shaft of the catheter, illustratively in line with the balloon.
- Balloon 284 serves as both a centering element for electrodes 286 and as an electrical insulator for directing the electric field, as described previously.
- Apparatus 280 may be particularly well-suited for achieving precise targeting of desired arterial or extra-arterial tissue, since properly sizing balloon 284 to the target artery sets a known distance between centered electrodes 286 and the arterial wall that may be utilized when specifying parameters of the PEF. Electrodes 286 alternatively may be attached to balloon 284 rather than to the central shaft of catheter 282 such that they contact the wall of the artery. In such a variation, the electrodes may be affixed to the inside surface, outside surface or embedded within the wall of the balloon.
- Electrodes 286 arranged along the length of catheter 282 can be individual electrodes, a common but segmented electrode, or a common and continuous electrode. Furthermore, electrodes 286 may be configured to provide a bipolar signal, or electrodes 286 may be used together or individually in conjunction with a separate patient ground for monopolar use.
- catheter 282 may be disposed at a desired location within renal artery RA, balloon or centering element 284 may be expanded to center electrodes 286 and to optionally provide electrical insulation, and a PEF may be delivered, e.g., in a bipolar fashion between the proximal and distal electrodes 286 . It is expected that the PEF will achieve renal denervation and/or neuromodulation along treatment zone one T 1 .
- balloon 284 may be at least partially deflated, and the catheter may be positioned at a second desired treatment zone T 2 , as in FIG. 16B .
- the medical practitioner optionally may utilize fluoroscopic imaging of radiopaque markers 288 to orient catheter 282 at desired locations for treatment. For example, the medical practitioner may use the markers to ensure a region of overlap O between treatment zones T 1 and T 2 , as shown.
- a variation of apparatus 280 comprising a plurality of dynamically controllable electrodes 286 disposed on the proximal side of balloon 284 .
- any one of proximal electrodes 286 a may be energized in a bipolar fashion with distal electrode 286 b to provide dynamic control of the longitudinal distance between the active and return electrodes. This alters the size and shape of the zone of treatment.
- any subset of proximal electrodes 286 a may be energized together as the active or return electrodes of a bipolar electric field established between the proximal electrodes and distal electrode 286 b.
- the apparatus 280 shown in FIG. 17 has three proximal electrodes 286 a , it should be understood that the apparatus 280 can have any alternative number of proximal electrodes. Furthermore, the apparatus 280 can have a plurality of distal electrodes 286 b in addition, or as an alternative, to multiple proximal electrodes. Additionally, one electrode of a pair may be coupled to the catheter 282 , and the other electrode may be delivered through a lumen of the catheter, e.g., through a guidewire lumen. The catheter and endoluminally-delivered electrode may be repositioned relative to one another to alter a separation distance between the electrodes. Such a variation also may facilitate treatment of a variety of renal vasculature anatomies.
- distal electrode 286 b is coupled to the shaft of catheter 282 distal of balloon 284 .
- the distal electrode may utilize a lumen within catheter 282 , e.g., for routing of a lead wire that acts as ground. Additionally, the portion of catheter 282 distal of balloon 284 is long enough to accommodate the distal electrode.
- Catheters commonly are delivered over metallic and/or conductive guidewires. In many interventional therapies involving catheters, guidewires are not removed during treatment. As apparatus 280 is configured for delivery of a pulsed electric field, if the guidewire is not removed, there may be a risk of electric shock to anyone in contact with the guidewire during energy delivery. This risk may be reduced by using polymer-coated guidewires.
- distal electrode 286 b of FIGS. 16 and 17 has been replaced with a distal electrode 270 configured to be moved through a lumen of the catheter as described previously with respect to FIG. 13 .
- proximal electrode 286 a alternatively may be replaced with the luminally-delivered electrode, such that electrodes 286 b and 270 form a bipolar electrode pair.
- Electrode 270 does not utilize an additional lumen within catheter 282 , which may reduce profile. Additionally, the length of the catheter distal of the balloon need not account for the length of the distal electrode, which may enhance flexibility.
- electrode 270 optionally may be used as the guidewire over which catheter 282 is advanced into position prior to delivery of the PEF, thereby obviating a need for exchange of the guidewire for the electrode.
- a standard metallic guidewire may be used as the electrode 270 simply by connecting the standard guidewire to the pulsed electric field generator.
- the distal electrode 270 may be extended any desired distance beyond the distal end of catheter 282 . This may provide for dynamic alteration of the length of a treatment zone. Furthermore, this might facilitate treatment within distal vasculature of reduced diameter.
- distal electrode 270 may be placed in such a branch of renal artery RA, while catheter 282 is positioned within the main branch of the artery.
- multiple distal electrodes 270 might be provided and placed in various common or uncommon branches of the renal artery, while the catheter remains in the main arterial branch.
- Apparatus 290 comprises catheter 292 having a plurality of shaft electrodes 294 disposed in line with centering element 296 .
- Centering element 296 illustratively comprises an expandable basket, such as previously described expandable basket 254 of FIG. 8 .
- the centering element alternatively may comprise a balloon or any other centering element.
- Electrodes 294 may be utilized in a bipolar or a monopolar fashion.
- Apparatus 300 comprises catheter 302 having electrodes 304 disposed in line with nested expandable elements.
- the nested expandable elements comprise an inner expandable element 306 and an outer expandable centering element 308 .
- Electrodes 304 are disposed along the inner expandable element, while the outer expandable centering element is configured to center and stabilize catheter 302 within the vessel.
- Inner element 306 may be expanded to varying degrees, as desired by a medical practitioner, to dynamically alter the radial positions of electrodes 304 . This dynamic radial repositioning may be utilized to focus energy delivered by electrodes 304 such that it is delivered to target tissue.
- Nested elements 306 and 308 may comprise a balloon-in-balloon arrangement, a basket-in-basket arrangement, some combination of a balloon and a basket, or any other expandable nested structure.
- inner expandable element 306 illustratively comprises an expandable basket
- outer expandable centering element 308 illustratively comprises an expandable balloon.
- Electrodes 302 are positioned along the surface of inner balloon 306 .
- any of the variations of the present invention described herein optionally may be configured for infusion of agents into the treatment area before, during or after energy application, for example, to enhance or modify the neurodestructive or neuromodulatory effect of the energy, to protect or temporarily displace non-target cells, and/or to facilitate visualization. Additional applications for infused agents will be apparent. If desired, uptake of infused agents by cells may be enhanced via initiation of reversible electroporation in the cells in the presence of the infused agents. Infusion may be especially desirable when a balloon centering element is utilized.
- the infusate may comprise, for example, saline or heparinized saline, protective agents, such as Poloxamer-188, or anti-proliferative agents.
- Variations of the present invention additionally or alternatively may be configured for aspiration.
- infusion ports or outlets may be provided on a catheter shaft adjacent a centering device, the centering device may be porous (for instance, a “weeping” balloon), or basket struts may be made of hollow hypotubes and slotted or perforated to allow infusion or aspiration.
- Apparatus 310 comprises catheter 312 having proximal and distal inflatable balloons 314 a and 314 b , respectively.
- Proximal shaft electrode 316 a is disposed between the balloons along the shaft of catheter 312
- distal electrode 316 b is disposed distal of the balloons along the catheter shaft.
- One or more infusion or aspiration holes 318 are disposed along the shaft of catheter 312 between the balloons in proximity to proximal electrode 316 a.
- Apparatus 310 may be used in a variety of ways.
- catheter 312 is disposed within the target vessel, such as renal artery RA, at a desired location.
- One or both balloons 314 are inflated, and a protective agent or other infusate is infused through hole(s) 318 between the balloons in proximity to electrode 316 a .
- a PEF suitable for initiation of reversible electroporation is delivered across electrodes 316 to facilitate uptake of the infusate by non-target cells within the vessel wall.
- Delivery of the protective agent may be enhanced by first inflating distal balloon 314 b , then infusing the protective agent, which displaces blood, then inflating proximal balloon 314 a.
- Remaining infusate optionally may be aspirated such that it is unavailable during subsequent PEF application when irreversible electroporation of nerve cells is initiated.
- Aspiration may be achieved by at least partially deflating one balloon during aspiration.
- aspiration may be achieved with both balloons inflated, for example, by infusing saline in conjunction with the aspiration to flush out the vessel segment between the inflated balloons.
- Such blood flushing may reduce a risk of clot formation along proximal electrode 316 a during PEF application.
- flushing during energy application may cool the electrode and/or cells of the wall of the artery. Such cooling of the wall cells might protect the cells from irreversible electroporative damage, possibly reducing a need for infusion of a protective agent.
- a PEF suitable for initiation of irreversible electroporation in target nerve cells may be delivered across electrodes 316 to denervate or to modulate neural activity.
- infusion of a protective agent may be performed during or after initiation of irreversible electroporation in order to protect non-target cells.
- the protective agent may, for example, plug or fill pores formed in the non-target cells via the irreversible electroporation.
- a solution of chilled (i.e., less than body temperature) heparinized saline may be simultaneously infused and aspirated between the inflated balloons to flush the region between the balloons and decrease the sensitivity of vessel wall cells to electroporation. This is expected to further protect the cells during application of the PEF suitable for initiation of irreversible electroporation.
- flushing optionally may be continuous throughout application of the pulsed electric field.
- a thermocouple or other temperature sensor optionally may be positioned between the balloons such that a rate of chilled infusate infusion may be adjusted to maintain a desired temperature.
- the chilled infusate preferably does not cool the target tissue, e.g., the renal nerves.
- a protective agent, such as Poloxamer-188 optionally may be infused post-treatment as an added safety measure.
- cryoballoon catheter having at least one electrode may be utilized.
- the cryoballoon may be inflated within a vessel segment to locally reduce the temperature of the vessel segment, for example, to protect the segment and/or to induce thermal apoptosis of the vessel wall during delivery of an electric field.
- the electric field may, for example, comprise a PEF or a thermal, non-pulsed electric field, such as a thermal RF field.
- the electrode(s) may be positioned within the renal vein and then passed across the wall of the renal vein such that they are disposed in Gerota's or renal fascia and near or at least partially around the renal artery. In this manner, the electrode(s) may be positioned in close proximity to target renal nerve fibers prior to delivery of a pulsed electric field.
- apparatus 320 comprises catheter 322 having needle ports 324 and centering element 326 , illustratively an inflatable balloon.
- Catheter 322 also optionally may comprise radiopaque markers 328 .
- Needle ports 324 are configured for passage of needles 330 therethrough, while needles 330 are configured for passage of electrodes 340 .
- Renal vein RV runs parallel to renal artery RA.
- An imaging modality such as intravascular ultrasound, may be used to identify the position of the renal artery relative to the renal vein.
- intravascular ultrasound elements optionally may be integrated into catheter 322 .
- Catheter 322 may be positioned within renal vein RV using well-known percutaneous techniques, and centering element 326 may be expanded to stabilize the catheter within the vein.
- Needles 330 then may be passed through catheter 322 and out through needle ports 324 in a manner whereby the needles penetrate the wall of the renal vein and enter into Gerota's or renal fascia F.
- Radiopaque markers 328 may be visualized with fluoroscopy to properly orient needle ports 324 prior to deployment of needles 330 .
- Electrodes 340 are deployed through needles 330 to at least partially encircle renal artery RA, as in FIGS. 23A and 23B . Continued advancement of the electrodes may further encircle the artery, as in FIG. 23C . With the electrodes deployed, stimulation and/or PEF electroporation waveforms may be applied to denervate or modulate the renal nerves. Needles 330 optionally may be partially or completely retracted prior to treatment such that electrodes 340 encircle a greater portion of the renal artery. Additionally, a single electrode 340 may be provided and/or actuated in order to provide a monopolar PEF.
- Infusate optionally may be infused from needles 330 into fascia F to facilitate placement of electrodes 340 by creating a space for placement of the electrodes.
- the infusate may comprise, for example, fluids, heated or chilled fluids, air, CO 2 , saline, contrast agents, gels, conductive fluids or any other space-occupying material—be it gas, solid or liquid. Heparinized saline also may be injected. Saline or hypertonic saline may enhance conductivity between electrodes 340 . Additionally or alternatively, drugs and/or drug delivery elements may be infused or placed into the fascia through the needles.
- Electrodes 340 may be retracted within needles 330 , and needles 330 may be retracted within catheter 322 via needle ports 324 .
- Needles 330 preferably are small enough that minimal bleeding occurs and hemostasis is achieved fairly quickly.
- Balloon centering element 326 optionally may remain inflated for some time after retrieval of needles 330 in order to block blood flow and facilitate the clotting process.
- a balloon catheter may be advanced into the renal vein and inflated after removal of apparatus 320 .
- Variations of the invention comprising detectors or other elements for measuring or monitoring treatment efficacy are described.
- Variations of the invention may be configured to deliver stimulation electric fields, in addition to denervating or modulating PEFs. These stimulation fields may be utilized to properly position the apparatus for treatment and/or to monitor the effectiveness of treatment in modulating neural activity. This may be achieved by monitoring the responses of physiologic parameters known to be affected by stimulation of the renal nerves. Such parameters comprise, for example, renin levels, sodium levels, renal blood flow and blood pressure. Stimulation also may be used to challenge the denervation for monitoring of treatment efficacy: upon denervation of the renal nerves, the known physiologic responses to stimulation should no longer occur in response to such stimulation.
- Efferent nerve stimulation waveforms may, for example, comprise frequencies of about 1-10 Hz, while afferent nerve stimulation waveforms may, for example, comprise frequencies of up to about 50 Hz.
- Waveform amplitudes may, for example, range up to about 50V, while pulse durations may, for example, range up to about 20 milliseconds.
- field parameters such as frequency, amplitude and pulse duration may be modulated to facilitate passage of the waveforms through the wall of the vessel for delivery to target nerves.
- exemplary parameters for stimulation waveforms have been described, it should be understood that any alternative parameters may be utilized as desired.
- the electrodes used to deliver PEFs in any of the previously described variations of the present invention also may be used to deliver stimulation waveforms to the renal vasculature.
- the variations may comprise independent electrodes configured for stimulation.
- a separate stimulation apparatus may be provided.
- stimulation One way to use stimulation to identify renal nerves is to stimulate the nerves such that renal blood flow is affected—or would be affected if the renal nerves had not been denervated or modulated. Stimulation acts to reduce renal blood flow, and this response may be attenuated or abolished with denervation. Thus, stimulation prior to neural modulation would be expected to reduce blood flow, while stimulation after neural modulation would not be expected to reduce blood flow to the same degree when utilizing similar stimulation parameters and location(s) as prior to neural modulation. This phenomenon may be utilized to quantify an extent of renal neuromodulation. Variations of the present invention may comprise elements for monitoring renal blood flow or for monitoring any of the other physiological parameters known to be affected by renal stimulation.
- FIG. 24A a variation of apparatus 280 of FIG. 16 is described having an element for monitoring of renal blood flow.
- Guidewire 350 having Doppler ultrasound sensor 352 has been advanced through the lumen of catheter 282 for monitoring blood flow within renal artery RA.
- Doppler ultrasound sensor 352 is configured to measure the velocity of flow through the artery.
- a baseline of renal blood flow may be determined via measurements from sensor 352 prior to delivery of a stimulation waveform, then stimulation may be delivered between electrodes 286 , preferably with balloon 284 deflated. Alteration of renal blood flow from the baseline, or lack thereof, may be monitored with sensor 352 to identify optimal locations for neuromodulation and/or denervation of the renal nerves.
- FIG. 24B illustrates a variation of the apparatus of FIG. 24A , wherein Doppler ultrasound sensor 352 is coupled to the shaft of catheter 282 .
- Sensor 352 illustratively is disposed proximal of balloon 284 , but it should be understood that the sensor alternatively may be disposed distal of the balloon.
- intravascular monitoring of renal blood flow via Doppler ultrasound such monitoring optionally may be performed from external to the patient whereby renal blood flow is visualized through the skin (e.g., using an ultrasound transducer).
- one or more intravascular pressure transducers may be used to sense local changes in pressure that may be indicative of renal blood flow.
- blood velocity may be determined, for example, via thermodilution by measuring the time lag for an intravascular temperature input to travel between points of known separation distance.
- thermocouple may be incorporated into, or provided in proximity to, each electrode 286 , and chilled (i.e., lower than body temperature) fluid or saline may be infused proximally of the thermocouple(s).
- chilled (i.e., lower than body temperature) fluid or saline may be infused proximally of the thermocouple(s).
- a time lag for the temperature decrease to register between the thermocouple(s) may be used to quantify flow characteristic(s).
- a baseline estimate of the flow characteristic(s) of interest may be determined prior to stimulation of the renal nerves and may be compared with a second estimate of the characteristic(s) determined after stimulation.
- EIT Electrical Impedance Tomography
Abstract
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.
Description
- This application claims the benefit of the filing date of U.S. provisional patent application Ser. No. 60/616,254, filed Oct. 5, 2004; and Ser. No. 60/624,793, filed Nov. 2, 2004; both of which are incorporated herein by reference in their entireties. Furthermore, this application is a Continuation-In-Part of U.S. patent application Ser. No. 10/408,665, filed Apr. 8, 2003, which published as United States Patent Publication 2003/0216792 on Nov. 20, 2003, and which claims the benefit of the filing dates of U.S. provisional patent application Ser. No. 60/370,190, filed Apr. 8, 2002; Ser. No. 60/415,575, filed Oct. 3, 2002; and Ser. No. 60/442,970, filed Jan. 29, 2003; all of which are incorporated herein by reference in their entireties.
- All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
- The present invention relates to methods and apparatus for renal neuromodulation. More particularly, the present invention relates to methods and apparatus for achieving renal neuromodulation via a pulsed electric field and/or electroporation or electrofusion.
- Congestive Heart Failure (“CHF”) is a condition that occurs when the heart becomes damaged and reduces blood flow to the organs of the body. If blood flow decreases sufficiently, kidney function becomes impaired and results in fluid retention, abnormal hormone secretions and increased constriction of blood vessels. These results increase the workload of the heart and further decrease the capacity of the heart to pump blood through the kidney and circulatory system.
- This reduced capacity further reduces blood flow to the kidney, which in turn further reduces the capacity of the heart. It is believed that progressively decreasing perfusion of the kidney is a principal non-cardiac cause perpetuating the downward spiral of CHF. Moreover, the fluid overload and associated clinical symptoms resulting from these physiologic changes are predominant causes for excessive hospital admissions, terrible quality of life and overwhelming costs to the health care system due to CHF.
- While many different diseases may initially damage the heart, once present, CHF is split into two types: Chronic CHF and Acute (or Decompensated-Chronic) CHF. Chronic Congestive Heart Failure is a longer term, slowly progressive, degenerative disease. Over years, chronic congestive heart failure leads to cardiac insufficiency. Chronic CHF is clinically categorized by the patient's ability to exercise or perform normal activities of daily living (such as defined by the New York Heart Association Functional Class). Chronic CHF patients are usually managed on an outpatient basis, typically with drugs.
- Chronic CHF patients may experience an abrupt, severe deterioration in heart function, termed Acute Congestive Heart Failure, resulting in the inability of the heart to maintain sufficient blood flow and pressure to keep vital organs of the body alive. These Acute CHF deteriorations can occur when extra stress (such as an infection or excessive fluid overload) significantly increases the workload on the heart in a stable chronic CHF patient. In contrast to the stepwise downward progression of chronic CHF, a patient suffering acute CHF may deteriorate from even the earliest stages of CHF to severe hemodynamic collapse. In addition, Acute CHF can occur within hours or days following an Acute Myocardial Infarction (“AMI”), which is a sudden, irreversible injury to the heart muscle, commonly referred to as a heart attack.
- As mentioned, the kidneys play a significant role in the progression of CHF, as well as in Chronic Renal Failure (“CRF”), End-Stage Renal Disease (“ESRD”), hypertension (pathologically high blood pressure) and other cardio-renal diseases. The functions of the kidney can be summarized under three broad categories: filtering blood and excreting waste products generated by the body's metabolism; regulating salt, water, electrolyte and acid-base balance; and secreting hormones to maintain vital organ blood flow. Without properly functioning kidneys, a patient will suffer water retention, reduced urine flow and an accumulation of waste toxins in the blood and body. These conditions resulting from reduced renal function or renal failure (kidney failure) are believed to increase the workload of the heart. In a CHF patient, renal failure will cause the heart to further deteriorate as the water build-up and blood toxins accumulate due to the poorly functioning kidneys and, in turn, cause the heart further harm.
- The primary functional unit of the kidneys that is involved in urine formation is called the “nephron”. Each kidney consists of about one million nephrons. The nephron is made up of a glomerulus and its tubules, which can be separated into a number of sections: the proximal tubule, the medullary loop (loop of Henle), and the distal tubule. Each nephron is surrounded by different types of cells that have the ability to secrete several substances and hormones (such as renin and erythropoietin). Urine is formed as a result of a complex process starting with the filtration of plasma water from blood into the glomerulus. The walls of the glomerulus are freely permeable to water and small molecules but almost impermeable to proteins and large molecules. Thus, in a healthy kidney, the filtrate is virtually free of protein and has no cellular elements. The filtered fluid that eventually becomes urine flows through the tubules. The final chemical composition of the urine is determined by the secretion into, and re-absorption of substances from, the urine required to maintain homeostasis.
- Receiving about 20% of cardiac output, the two kidneys filter about 125 ml of plasma water per minute. Filtration occurs because of a pressure gradient across the glomerular membrane. The pressure in the arteries of the kidney pushes plasma water into the glomerulus causing filtration. To keep the Glomerulur Filtration Rate (“GFR”) relatively constant, pressure in the glomerulus is held constant by the constriction or dilatation of the afferent and efferent arterioles, the muscular walled vessels leading to and from each glomerulus.
- In a CHF patient, the heart will progressively fail, and blood flow and pressure will drop in the patient's circulatory system. During acute heart failure, short-term compensations serve to maintain perfusion to critical organs, notably the brain and the heart that cannot survive prolonged reduction in blood flow. However, these same responses that initially aid survival during acute heart failure become deleterious during chronic heart failure.
- A combination of complex mechanisms contribute to deleterious fluid overload in CHF. As the heart fails and blood pressure drops, the kidneys cannot function and become impaired due to insufficient blood pressure for perfusion. This impairment in renal function ultimately leads to the decrease in urine output. Without sufficient urine output, the body retains fluids, and the resulting fluid overload causes peripheral edema (swelling of the legs), shortness of breath (due to fluid in the lungs), and fluid retention in the abdomen, among other undesirable conditions in the patient.
- In addition, the decrease in cardiac output leads to reduced renal blood flow, increased neurohormonal stimulus, and release of the hormone renin from the juxtaglomerular apparatus of the kidney. This results in avid retention of sodium and, thus, volume expansion. Increased renin results in the formation of angiotensin, a potent vasoconstrictor. Heart failure and the resulting reduction in blood pressure also reduce the blood flow and perfusion pressure through organs in the body other than the kidneys. As they suffer reduced blood pressure, these organs may become hypoxic, resulting in a metabolic acidosis that reduces the effectiveness of pharmacological therapy and increases a risk of sudden death.
- This spiral of deterioration that physicians observe in heart failure patients is believed to be mediated, at least in part, by activation of a subtle interaction between heart function and kidney function, known as the renin-angiotensin system. Disturbances in the heart's pumping function results in decreased cardiac output and diminished blood flow. The kidneys respond to the diminished blood flow as though the total blood volume was decreased, when in fact the measured volume is normal or even increased. This leads to fluid retention by the kidneys and formation of edema, thereby causing the fluid overload and increased stress on the heart.
- Systemically, CHF is associated with an abnormally elevated peripheral vascular resistance and is dominated by alterations of the circulation resulting from an intense disturbance of sympathetic nervous system function. Increased activity of the sympathetic nervous system promotes a downward vicious cycle of increased arterial vasoconstriction (increased resistance of vessels to blood flow) followed by a further reduction of cardiac output, causing even more diminished blood flow to the vital organs.
- In CHF via the previously explained mechanism of vasoconstriction, the heart and circulatory system dramatically reduce blood flow to the kidneys. During CHF, the kidneys receive a command from higher neural centers via neural pathways and hormonal messengers to retain fluid and sodium in the body. In response to stress on the heart, the neural centers command the kidneys to reduce their filtering functions. While in the short term, these commands can be beneficial, if these commands continue over hours and days they can jeopardize the person's life or make the person dependent on artificial kidney for life by causing the kidneys to cease functioning.
- When the kidneys do not fully filter the blood, a huge amount of fluid is retained in the body, which results in bloating (fluid retention in tissues) and increases the workload of the heart. Fluid can penetrate into the lungs, and the patient becomes short of breath. This odd and self-destructive phenomenon is most likely explained by the effects of normal compensatory mechanisms of the body that improperly perceive the chronically low blood pressure of CHF as a sign of temporary disturbance, such as bleeding.
- In an acute situation, the body tries to protect its most vital organs, the brain and the heart, from the hazards of oxygen deprivation. Commands are issued via neural and hormonal pathways and messengers. These commands are directed toward the goal of maintaining blood pressure to the brain and heart, which are treated by the body as the most vital organs. The brain and heart cannot sustain low perfusion for any substantial period of time. A stroke or a cardiac arrest will result if the blood pressure to these organs is reduced to unacceptable levels. Other organs, such as the kidneys, can withstand somewhat longer periods of ischemia without suffering long-term damage. Accordingly, the body sacrifices blood supply to these other organs in favor of the brain and the heart.
- The hemodynamic impairment resulting from CHF activates several neurohormonal systems, such as the renin-angiotensin and aldosterone system, sympatho-adrenal system and vasopressin release. As the kidneys suffer from increased renal vasoconstriction, the GFR drops, and the sodium load in the circulatory system increases. Simultaneously, more renin is liberated from the juxtaglomerular of the kidney. The combined effects of reduced kidney functioning include reduced glomerular sodium load, an aldosterone-mediated increase in tubular reabsorption of sodium, and retention in the body of sodium and water. These effects lead to several signs and symptoms of the CHF condition, including an enlarged heart, increased systolic wall stress, an increased myocardial oxygen demand, and the formation of edema on the basis of fluid and sodium retention in the kidney. Accordingly, sustained reduction in renal blood flow and vasoconstriction is directly responsible for causing the fluid retention associated with CHF.
- CHF is progressive, and as of now, not curable. The limitations of drug therapy and its inability to reverse or even arrest the deterioration of CHF patients are clear. Surgical therapies are effective in some cases, but limited to the end-stage patient population because of the associated risk and cost. Furthermore, the dramatic role played by kidneys in the deterioration of CHF patients is not adequately addressed by current surgical therapies.
- The autonomic nervous system is recognized as an important pathway for control signals that are responsible for the regulation of body functions critical for maintaining vascular fluid balance and blood pressure. The autonomic nervous system conducts information in the form of signals from the body's biologic sensors such as baroreceptors (responding to pressure and volume of blood) and chemoreceptors (responding to chemical composition of blood) to the central nervous system via its sensory fibers. It also conducts command signals from the central nervous system that control the various innervated components of the vascular system via its motor fibers.
- Experience with human kidney transplantation provided early evidence of the role of the nervous system in kidney function. It was noted that after transplant, when all the kidney nerves were totally severed, the kidney increased the excretion of water and sodium. This phenomenon was also observed in animals when the renal nerves were cut or chemically destroyed. The phenomenon was called “denervation diuresis” since the denervation acted on a kidney similar to a diuretic medication. Later the “denervation diuresis” was found to be associated with vasodilatation of the renal arterial system that led to increased blood flow through the kidney. This observation was confirmed by the observation in animals that reducing blood pressure supplying the kidneys reversed the “denervation diuresis”.
- It was also observed that after several months passed after the transplant surgery in successful cases, the “denervation diuresis” in transplant recipients stopped and the kidney function returned to normal. Originally, it was believed that the “renal diuresis” was a transient phenomenon and that the nerves conducting signals from the central nervous system to the kidney were not essential to kidney function. Later discoveries suggested that the renal nerves had a profound ability to regenerate and that the reversal of “denervation diuresis” could be attributed to the growth of new nerve fibers supplying the kidneys with necessary stimuli.
- Another body of research focused on the role of the neural control of secretion of the hormone renin by the kidney. As was discussed previously, renin is a hormone responsible for the “vicious cycle” of vasoconstriction and water and sodium retention in heart failure patients. It was demonstrated that an increase or decrease in renal sympathetic nerve activity produced parallel increases and decreases in the renin secretion rate by the kidney, respectively.
- In summary, it is known from clinical experience and the large body of animal research that an increase in renal sympathetic nerve activity leads to vasoconstriction of blood vessels supplying the kidney, decreased renal blood flow, decreased removal of water and sodium from the body, and increased renin secretion. It is also known that reduction of sympathetic renal nerve activity, e.g., via denervation, may reverse these processes.
- It has been established in animal models that the heart failure condition results in abnormally high sympathetic stimulation of the kidney. This phenomenon was traced back to the sensory nerves conducting signals from baroreceptors to the central nervous system. Baroreceptors are present in the different locations of the vascular system. Powerful relationships exist between baroreceptors in the carotid arteries (supplying the brain with arterial blood) and sympathetic nervous stimulus to the kidneys. When arterial blood pressure was suddenly reduced in experimental animals with heart failure, sympathetic tone increased. Nevertheless, the normal baroreflex likely is not solely responsible for elevated renal nerve activity in chronic CHF patients. If exposed to a reduced level of arterial pressure for a prolonged time, baroreceptors normally “reset”, i.e., return to a baseline level of activity, until a new disturbance is introduced. Therefore, it is believed that in chronic CHF patients, the components of the autonomic-nervous system responsible for the control of blood pressure and the neural control of the kidney function become abnormal. The exact mechanisms that cause this abnormality are not fully understood, but its effects on the overall condition of the CHF patients are profoundly negative.
- End-Stage Renal Disease is another condition at least partially controlled by renal neural activity. There has been a dramatic increase in patients with ESRD due to diabetic nephropathy, chronic glomerulonephritis and uncontrolled hypertension. Chronic Renal Failure slowly progresses to ESRD. CRF represents a critical period in the evolution of ESRD. The signs and symptoms of CRF are initially minor, but over the course of 2-5 years, become progressive and irreversible. While some progress has been made in combating the progression to, and complications of, ESRD, the clinical benefits of existing interventions remain limited.
- It has been known for several decades that renal diseases of diverse etiology (hypotension, infection, trauma, autoimmune disease, etc.) can lead to the syndrome of CRF characterized by systemic hypertension, proteinuria (excess protein filtered from the blood into the urine) and a progressive decline in GFR ultimately resulting in ESRD. These observations suggest that CRF progresses via a common pathway of mechanisms and that therapeutic interventions inhibiting this common pathway may be successful in slowing the rate of progression of CRF irrespective of the initiating cause.
- To start the vicious cycle of CRF, an initial insult to the kidney causes loss of some nephrons. To maintain normal GFR, there is an activation of compensatory renal and systemic mechanisms resulting in a state of hyperfiltration in the remaining nephrons. Eventually, however, the increasing numbers of nephrons “overworked” and damaged by hyperfiltration are lost. At some point, a sufficient number of nephrons are lost so that normal GFR can no longer be maintained. These pathologic changes of CRF produce worsening systemic hypertension, thus high glomerular pressure and increased hyperfiltration. Increased glomerular hyperfiltration and permeability in CRF pushes an increased amount of protein from the blood, across the glomerulus and into the renal tubules. This protein is directly toxic to the tubules and leads to further loss of nephrons, increasing the rate of progression of CRF. This vicious cycle of CRF continues as the GFR drops with loss of additional nephrons leading to further hyperfiltration and eventually to ESRD requiring dialysis. Clinically, hypertension and excess protein filtration have been shown to be two major determining factors in the rate of progression of CRF to ESRD.
- Though previously clinically known, it was not until the 1980s that the physiologic link between hypertension, proteinuria, nephron loss and CRF was identified. In 1990s the role of sympathetic nervous system activity was elucidated. Afferent signals arising from the damaged kidneys due to the activation of mechanoreceptors and chemoreceptors stimulate areas of the brain responsible for blood pressure control. In response, the brain increases sympathetic stimulation on the systemic level, resulting in increased blood pressure primarily through vasoconstriction of blood vessels. When elevated sympathetic stimulation reaches the kidney via the efferent sympathetic nerve fibers, it produces major deleterious effects in two forms. The kidneys are damaged by direct renal toxicity from the release of sympathetic neurotransmitters (such as norepinephrine) in the kidneys independent of the hypertension. Furthermore, secretion of renin that activates Angiotensin II is increased, which increases systemic vasoconstriction and exacerbates hypertension.
- Over time, damage to the kidneys leads to a further increase of afferent sympathetic signals from the kidney to the brain. Elevated Angiotensin II further facilitates internal renal release of neurotransmitters. The feedback loop is therefore closed, which accelerates deterioration of the kidneys.
- In view of the foregoing, it would be desirable to provide methods and apparatus for the treatment of congestive heart failure, renal disease, hypertension and/or other cardio-renal diseases via renal neuromodulation and/or denervation.
- The present invention provides methods and apparatus for renal neuromodulation (e.g., denervation) using a pulsed electric field (PEF). Several aspects of the invention apply a pulsed electric field to effectuate electroporation and/or electrofusion in renal nerves, other neural fibers that contribute to renal neural function, or other neural features. Several embodiments of the invention are intravascular devices for inducing renal neuromodulation. The apparatus and methods described herein may utilize any suitable electrical signal or field parameters that achieve neuromodulation, including denervation, and/or otherwise create an electroporative and/or electrofusion effect. For example, the electrical signal may incorporate a nanosecond pulsed electric field (nsPEF) and/or a PEF for effectuating electroporation. One specific embodiment comprises applying a first course of PEF electroporation followed by a second course of nsPEF electroporation to induce apoptosis in any cells left intact after the PEF treatment, or vice versa. An alternative embodiment comprises fusing nerve cells by applying a PEF in a manner that is expected to reduce or eliminate the ability of the nerves to conduct electrical impulses. When the methods and apparatus are applied to renal nerves and/or other neural fibers that contribute to renal neural functions, this present inventors believe that urine output will increase and/or blood pressure will be controlled in a manner that will prevent or treat CHF, hypertension, renal system diseases, and other renal anomalies.
- Several aspects of particular embodiments can achieve such results by selecting suitable parameters for the PEFs and/or nsPEFs. Pulsed electric field parameters can include, but are not limited to, field strength, pulse width, the shape of the pulse, the number of pulses and/or the interval between pulses (e.g., duty cycle). Suitable field strengths include, for example, strengths of up to about 10,000 V/cm. Suitable pulse widths include, for example, widths of up to about 1 second. Suitable shapes of the pulse waveform include, for example, AC waveforms, sinusoidal waves, cosine waves, combinations of sine and cosine waves, DC waveforms, DC-shifted AC waveforms, RF waveforms, square waves, trapezoidal waves, exponentially-decaying waves, combinations thereof, etc. Suitable numbers of pulses include, for example, at least one pulse. Suitable pulse intervals include, for example, intervals less than about 10 seconds. Any combination of these parameters may be utilized as desired. These parameters are provided for the sake of illustration and should in no way be considered limiting. Additional and alternative waveform parameters will be apparent.
- Several embodiments are directed to percutaneous intravascular systems for providing long-lasting denervation to minimize acute myocardial infarct (“AMI”) expansion and for helping to prevent the onset of morphological changes that are affiliated with congestive heart failure. For example, one embodiment of the invention comprises treating a patient for an infarction, e.g., via coronary angioplasty and/or stenting, and performing an intra-arterial pulsed electric field renal denervation procedure under fluoroscopic guidance. Alternatively, PEF therapy could be delivered in a separate session soon after the AMI had been stabilized. Renal neuromodulation also may be used as an adjunctive therapy to renal surgical procedures. In these embodiments, the anticipated increase in urine output and/or control of blood pressure provided by the renal PEF therapy is expected to reduce the load on the heart to inhibit expansion of the infarct and prevent CHF.
- Several embodiments of intravascular pulsed electric field systems described herein may denervate or reduce the activity of the renal nervous supply immediately post-infarct, or at any time thereafter, without leaving behind a permanent implant in the patient. These embodiments are expected to increase urine output and/or control blood pressure for a period of several months during which the patient's heart can heal. If it is determined that repeat and/or chronic neuromodulation would be beneficial after this period of healing, renal PEF treatment can be repeated as needed.
- In addition to efficaciously treating AMI, several embodiments of systems described herein are also expected to treat CHF, hypertension, renal failure, and other renal or cardio-renal diseases influenced or affected by increased renal sympathetic nervous activity. For example, the systems may be used to treat CHF at any time by advancing the PEF system to a treatment site via a vascular structure and then delivering a PEF therapy to the treatment site. This may, for example, modify a level of fluid offload.
- Embodiments of intravascular PEF systems described herein may be used similarly to angioplasty or electrophysiology catheters which are well known in the art. For example, arterial access may be gained through a standard Seldinger Technique, and an arterial sheath optionally may be placed to provide catheter access. A guidewire may be advanced through the vasculature and into the renal artery of the patient, and then an intravascular PEF may be advanced over the guidewire and/or through the sheath into the renal artery. The sheath optionally may be placed before inserting the PEF catheter or advanced along with the PEF catheter such that the sheath partially or completely covers the catheter. Alternatively, the PEF catheter may be advanced directly through the vasculature without the use of a guide wire and/or introduced and advanced into the vasculature without a sheath.
- In addition to arterial placement, the PEF system may be placed within a vein. Venous access may, for example, be achieved via a jugular approach. PEF systems may be utilized, for example, within the renal artery, within the renal vein or within both the renal artery and the renal vein to facilitate more complete denervation.
- After the PEF catheter is positioned within the vessel at a desired location with respect to the target neurons, it is stabilized within the vessel (e.g., braced against the vessel wall) and energy is delivered to the target nerve or neurons. In one variation, pulsed RF energy is delivered to the target to create a non-thermal nerve block, reduce neural signaling, or otherwise modulate neural activity. Alternatively or additionally, cooling, cryogenic, thermal RF, thermal or non-thermal microwave, focused or unfocused ultrasound, thermal or non-thermal DC, as well as any combination thereof, may be employed to reduce or otherwise control neural signaling.
- In still other embodiments of the invention, other non-renal neural structures may be targeted from within arterial or venous conduits in addition to or in lieu of renal neural structures. For instance, a PEF catheter can be navigated through the aorta or the vena cava and brought into apposition with various neural structures to treat other conditions or augment the treatment of renal-cardiac conditions. For example, nerve bodies of the lumbar sympathetic chain may be accessed and modulated, blocked or ablated, etc., in this manner.
- Several embodiments of the PEF systems may completely block or denervate the target neural structures, or the PEF systems may otherwise modulate the renal nervous activity. As opposed to a full neural blockade such as denervation, other neuromodulation produces a less-than-complete change in the level of renal nervous activity between the kidney(s) and the rest of the body. Accordingly, varying the pulsed electric field parameters will produce different effects on the nervous activity.
- In one embodiment of an intravascular pulsed electric field system, the device includes one or more electrodes that are configured to physically contact a target region of a renal vasculature for delivery of a pulsed electric field. For example, the device can comprise a catheter having an expandable helical section and one or more electrodes at the helical section. The catheter may be positioned in the renal vasculature while in a low profile configuration. The expandable section can then be expanded to contact the inner surface of the vessel wall. Alternatively, the catheter can have one or more expandable helical electrodes. For example, first and second expandable electrodes may be positioned within the vessel at a desired distance from one another to provide an active electrode and a return electrode. The expandable electrodes may comprise shape-memory materials, inflatable balloons, expandable meshes, linkage systems and other types of devices that can expand in a controlled manner. Suitable expandable linkage systems include expandable baskets, having a plurality of shape-memory wires or slotted hypotubes, and/or expandable rings. Additionally, the expandable electrodes may be point contact electrodes arranged along a balloon portion of a catheter.
- Other embodiments of pulsed electric field systems include electrodes that do not physically contact the vessel wall. RF energy, both traditional thermal energy and relatively non-thermal pulsed RF, are examples of pulsed electric fields that can be conducted into tissue to be treated from a short distance away from the tissue itself. Other types of pulsed electric fields can also be used in situations in which the electrodes do not physically contact the vessel wall. As such, the pulsed electric fields can be applied directly to the nerve via physical contact between the electrode contacts and the vessel wall or other tissue, or the pulsed electric fields can be applied indirectly to the nerve without physically contacting the electrode contacts with the vessel wall. The term “nerve contact” accordingly includes physical contact of a system element with the nerve and/or tissue proximate to the nerve, and also electrical contact alone without physically contacting the nerve or tissue. To indirectly apply the pulsed electrical field, the device has a centering element configured to position the electrodes in a central region of the vessel or otherwise space the electrodes apart from the vessel wall. The centering element may comprise, for example, a balloon or an expandable basket. One or more electrodes may be positioned on a central shaft of the centering element—either longitudinally aligned with the element or positioned on either side of the element. When utilizing a balloon catheter, the inflated balloon may act as an insulator of increased impedance for orienting or directing a pulsed electric field along a desired electric flow path. As will be apparent, alternative insulators may be utilized.
- In another embodiment of the system, a combination apparatus includes an intravascular catheter having a first electrode configured to physically contact the vessel wall and a second electrode configured to be positioned within the vessel but spaced apart from the vessel wall. For example, an expandable helical electrode may be used in combination with a centrally-disposed electrode to provide such a bipolar electrode pair.
- In yet another embodiment, a radial position of one or more electrodes relative to a vessel wall may be altered dynamically to focus the pulsed electric field delivered by the electrode(s). In still another variation, the electrodes may be configured for partial or complete passage across the vessel wall. For example, the electrode(s) may be positioned within the renal vein, then passed across the wall of the renal vein into the perivascular space such that they at least partially encircle the renal artery and/or vein prior to delivery of a pulsed electric field.
- Bipolar embodiments of the present invention may be configured for dynamic movement or operation relative to a spacing between the active and ground electrodes to achieve treatment over a desired distance, volume or other dimension. For example, a plurality of electrodes may be arranged such that a bipolar pair of electrodes can move longitudinally relative to each other for adjusting the separation distance between the electrodes and/or for altering the location of treatment. One specific embodiment includes a first electrode coupled to a catheter and a moveable second electrode that can move through a lumen of the catheter. In alternative embodiments, a first electrode can be attached to a catheter and a second electrode can be attached to an endoluminally-delivered device such that the first and second electrodes may be repositioned relative to one another to alter a separation distance between the electrodes. Such embodiments may facilitate treatment of a variety of renal vasculature anatomies.
- Any of the embodiments of the present invention described herein optionally may be configured for infusing agents into the treatment area before, during or after energy application. The infused agents can be selected to enhance or modify the neuromodulatory effect of the energy application. The agents can also protect or temporarily displace non-target cells, and/or facilitate visualization.
- Several embodiments of the present invention may comprise detectors or other elements that facilitate identification of locations for treatment and/or that measure or confirm the success of treatment. For example, the system can be configured to also deliver stimulation waveforms and monitor physiological parameters known to respond to stimulation of the renal nerves. Based on the results of the monitored parameters, the system can determine the location of renal nerves and/or whether denervation has occurred. Detectors for monitoring of such physiological responses include, for example, Doppler elements, thermocouples, pressure sensors, and imaging modalities (e.g., fluoroscopy, intravascular ultrasound, etc.). Alternatively, electroporation may be monitored directly using, for example, Electrical Impedance Tomography (“EIT”) or other electrical impedance measurements. Additional monitoring techniques and elements will be apparent. Such detector(s) may be integrated with the PEF systems or they may be separate elements.
- Still other specific embodiments include electrodes configured to align the electric field with the longer dimension of the target cells. For instance, nerve cells tend to be elongate structures with lengths that greatly exceed their lateral dimensions (e.g., diameter). By aligning an electric field so that the directionality of field propagation preferentially affects the longitudinal aspect of the cell rather than the lateral aspect of the cell, it is expected that lower field strengths can to be used to kill or disable target cells. This is expected to conserve the battery life of implantable devices, reduce collateral effects on adjacent structures, and otherwise enhance the ability to modulate the neural activity of target cells.
- Other embodiments of the invention are directed to applications in which the longitudinal dimensions of cells in tissues overlying or underlying the nerve are transverse (e.g., orthogonal or otherwise at an angle) with respect to the longitudinal direction of the nerve cells. Another aspect of these embodiments is to align the directionality of the PEF such that the field aligns with the longer dimensions of the target cells and the shorter dimensions of the non-target cells. More specifically, arterial smooth muscle cells are typically elongate cells which surround the arterial circumference in a generally spiraling orientation so that their longer dimensions are circumferential rather than running longitudinally along the artery. Nerves of the renal plexus, on the other hand, run along the outside of the artery generally in the longitudinal direction of the artery. Therefore, applying a PEF which is generally aligned with the longitudinal direction of the artery is expected to preferentially cause electroporation in the target nerve cells without affecting at least some of the non-target arterial smooth muscle cells to the same degree. This may enable preferential denervation of nerve cells (target cells) in the adventitia or periarterial region from an intravascular device without affecting the smooth muscle cells of the vessel to an undesirable extent.
- Several embodiments of the present invention will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:
-
FIG. 1 is a schematic view illustrating human renal anatomy. -
FIG. 2 is a schematic detail view showing the location of the renal nerves relative to the renal artery. -
FIGS. 3A and 3B are schematic side- and end-views, respectively, illustrating a direction of electrical current flow for selectively affecting renal nerves. -
FIG. 4 is a schematic side-view, partially in section, of an intravascular catheter having a plurality of electrodes in accordance with one embodiment of the invention. -
FIG. 5 is a schematic side-view, partially in section, of an intravascular device having a pair of expanding helical electrodes arranged at a desired distance from one another in accordance with another embodiment of the invention. -
FIG. 6 is a schematic side-view, partially in section, of an intravascular device having a first electrode on an expandable balloon, and a second electrode on a catheter shaft in accordance with another embodiment of the invention. -
FIG. 7 is a schematic side-view, partially in section, of an intravascular device having an expanding first electrode delivered through the lumen of a catheter and a complementary second electrode carried by the catheter in accordance with another embodiment of the invention. -
FIG. 8 is a schematic side-view, partially in section, of an intravascular device having an expandable basket and a plurality of electrodes at the basket in accordance with another embodiment of the invention. -
FIG. 9 is a schematic detail view of the apparatus ofFIG. 8 illustrating one embodiment of the electrodes in accordance with another embodiment of the invention. -
FIG. 10 is a schematic side-view, partially in section, of an intravascular device having expandable ring electrodes for contacting the vessel wall and an optional insulation element in accordance with another embodiment of the invention. -
FIGS. 11A-11C are schematic detail views of embodiments of different windings for the ring electrodes ofFIG. 10 . -
FIG. 12 is a schematic side-view, partially in section, of an intravascular device having ring electrodes ofFIG. 10 with the windings shown inFIGS. 11A-11C . -
FIG. 13 is a schematic side-view, partially in section, of an intravascular device having a ring electrode and a luminally-delivered electrode in accordance with another embodiment of the invention. -
FIG. 14 is a schematic side-view, partially in section, of an intravascular device having a balloon catheter and expandable point contact electrodes arranged proximally and distally of the balloon in accordance with another embodiment of the invention. -
FIG. 15 is a schematic side-view of an intravascular device having a balloon catheter and electrodes arranged proximally and distally of the balloon in accordance with another embodiment of the invention. -
FIGS. 16A and 16B are schematic side-views, partially in section, illustrating stages of a method of using the apparatus ofFIG. 15 in accordance with an embodiment of the invention. -
FIG. 17 is a schematic side-view of an intravascular device having a balloon catheter and a plurality of dynamically operable electrodes in accordance with another embodiment of the invention. -
FIG. 18 is a schematic side-view of an intravascular device having a distal electrode deployed through a lumen of the balloon catheter in accordance with another embodiment of the invention. -
FIGS. 19A and 19B are side-views, partially in section, illustrating methods of using the intravascular device shown inFIG. 18 to modulate renal neural activity in patients with various renal vasculatures. -
FIG. 20 is a side view, partially in section, illustrating an intravascular device having a plurality of electrodes arranged along the shaft of, and in line with, a centering element in accordance with another embodiment of the invention. -
FIG. 21 is a side-view, partially in section, illustrating an intravascular device having electrodes configured for dynamic radial repositioning to facilitate focusing of a pulsed electric field in accordance with another embodiment of the invention. -
FIG. 22 is a side-view, partially in section, of an intravascular device having an infusion/aspiration catheter in accordance with another embodiment of the invention. -
FIGS. 23A-23C are, respectively, a side-view, partially in section, and cross-sectional views along section line A-A ofFIG. 23A , illustrating a method of using an intravascular device in accordance with an embodiment of the invention configured for passage of electrode(s) at least partially across the vessel wall. -
FIGS. 24A and 24B are side-views, partially in section, illustrating an intravascular device having detectors for measuring or monitoring treatment efficacy in accordance with another embodiment of the invention. - The present invention relates to methods and apparatus for renal neuromodulation and/or other neuromodulation. More particularly, the present invention relates to methods and apparatus for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. As used herein, electroporation and electropermeabilization are methods of manipulating the cell membrane or intracellular apparatus. For example, short high-energy pulses cause pores to open in cell membranes. The extent of porosity in the cell membrane (e.g., size and number of pores) and the duration of the pores (e.g., temporary or permanent) are a function of the field strength, pulse width, duty cycle, field orientation, cell type and other parameters. In general, pores will generally close spontaneously upon termination of lower strength fields or shorter pulse widths (herein defined as “reversible electroporation”). Each cell type has a critical threshold above which pores do not close such that pore formation is no longer reversible; this result is defined as “irreversible electroporation,” “irreversible breakdown” or “irreversible damage.” At this point, the cell membrane ruptures and/or irreversible chemical imbalances caused by the high porosity occur. Such high porosity can be the result of a single large hole and/or a plurality of smaller holes. Certain types of electroporation energy parameters also appropriate for use in renal neuromodulation are high voltage pulses with a duration in the sub-microsecond range (nanosecond pulsed electric fields, or nsPEF) which may leave the cellular membrane intact, but alter the intracellular apparatus or function of the cell in ways which cause cell death or disruption. Certain applications of nsPEF have been shown to cause cell death by inducing apoptosis, or programmed cell death, rather than acute cell death. Also, the term “comprising” is used throughout to mean including at least the recited feature such that any greater number of the same feature and/or additional types features are not precluded.
- Several embodiments of the present invention provide intravascular devices for inducing renal neuromodulation, such as a temporary change in target nerves that dissipates over time, continuous control over neural function, and/or denervation. The apparatus and methods described herein may utilize any suitable electrical signal or field parameters, e.g., any electric field, that will achieve the desired neuromodulation (e.g., electroporative effect). To better understand the structures of the intravascular devices and the methods of using these devices for neuromodulation, it is useful to understand the renal anatomy in humans.
- With reference now to
FIG. 1 , the human renal anatomy includes kidneys K that are supplied with oxygenated blood by renal arteries RA, which are connected to the heart by the abdominal aorta AA. Deoxygenated blood flows from the kidneys to the heart via renal veins RV and the inferior vena cava IVC.FIG. 2 illustrates a portion of the renal anatomy in greater detail. More specifically, the renal anatomy also includes renal nerves RN extending longitudinally along the lengthwise dimension L of renal artery RA generally within the adventitia of the artery. The renal artery RA has smooth muscle cells SMC that surround the arterial circumference spiral around the angular axis θ of the artery, i.e., around the circumference of the artery. The smooth muscle cells of the renal artery accordingly have a lengthwise or longer dimension extending transverse (i.e., non-parallel) to the lengthwise dimension of the renal artery. The misalignment of the lengthwise dimensions of the renal nerves and the smooth muscle cells is defined as “cellular misalignment.” - Referring to
FIG. 3 , the cellular misalignment of the renal nerves and the smooth muscle cells may be exploited to selectively affect renal nerve cells with reduced effect on smooth muscle cells. More specifically, because larger cells require less energy to exceed the irreversibility threshold of electroporation, several embodiments of electrodes of the present invention are configured to align at least a portion of an electric field generated by the electrodes with or near the longer dimensions of the cells to be affected. In specific embodiments, the intravascular device has electrodes configured to create an electrical field aligned with or near the lengthwise dimension of the renal artery RA to affect renal nerves RN. By aligning an electric field so that the field preferentially affects the lengthwise aspect of the cell rather than the diametric or radial aspect of the cell, lower field strengths may be used to necrose cells. As mentioned above, this is expected to reduce power consumption and mitigate effects on non-target cells in the electric field. - Similarly, the lengthwise or longer dimensions of tissues overlying or underlying the target nerve are orthogonal or otherwise off-axis (e.g., transverse) with respect to the longer dimensions of the nerve cells. Thus, in addition to aligning the PEF with the lengthwise or longer dimensions of the target cells, the PEF may propagate along the lateral or shorter dimensions of the non-target cells (i.e. such that the PEF propagates at least partially out of alignment with non-target smooth muscle cells SMC). Therefore, as seen in
FIG. 3 , applying a PEF with propagation lines Li generally aligned with the longitudinal dimension L of the renal artery RA is expected to preferentially cause electroporation, electrofusion, denervation or other neuromodulation in cells of the target renal nerves RN without unduly affecting the non-target arterial smooth muscle cells SMC. The pulsed electric field may propagate in a single plane along the longitudinal axis of the renal artery, or may propagate in the longitudinal direction along any angular segment θ through a range of 0°-360°. - Embodiments of the method shown in
FIG. 3 may have particular application with the intravascular methods and apparatus of the present invention. For instance, a PEF catheter placed within the renal artery may propagate an electric field having a longitudinal portion that is aligned to run with the longitudinal dimension of the artery in the region of the renal nerves RN and the smooth muscle cell SMC of the vessel wall so that the wall of the artery remains at least substantially intact while the outer nerve cells are destroyed. -
FIG. 4 shows one embodiment of an intravascular pulsedelectric field apparatus 200 in accordance with the present invention that includes one or more electrodes configured to physically contact a target region within the renal vasculature and deliver a pulsed electric field across a wall of the vasculature. Theapparatus 200 is shown within a patient's renal artery RA, but it can be positioned in other intravascular locations (e.g., the renal vein). This embodiment of theapparatus 200 comprises anintravascular catheter 210 having a proximal section 211 a, a distal section 211 b, and a plurality ofdistal electrodes 212 at the distal section 211 b. The proximal section 211 a generally has an electrical connector to couple thecatheter 210 to a pulse generator, and the distal section 211 b in this embodiment has a helical configuration. Theapparatus 200 is electrically coupled to a pulsedelectric field generator 100 located proximal and external to the patient; theelectrodes 212 are electrically coupled to the generator viacatheter 210. Thegenerator 100 may be utilized with any embodiment of the present invention described hereinafter for delivery of a PEF with desired field parameters. It should be understood that electrodes of embodiments described hereinafter may be connected to the generator, even if the generator is not explicitly shown or described with each variation. - The helical distal section 211 b of
catheter 210 is configured to appose the vessel wall and bringelectrodes 212 into close proximity to extra-vascular neural structures. The pitch of the helix can be varied to provide a longer treatment zone, or to minimize circumferential overlap of adjacent treatments zones in order to reduce a risk of stenosis formation. This pitch change can be achieved by combining a plurality of catheters of different pitches to formcatheter 210, or by adjusting the pitch ofcatheter 210 through the use of internal pull wires, adjusting mandrels inserted into the catheter, shaping sheaths placed over the catheter, or by any other suitable means for changing the pitch either in-situ or before introduction into the body. - The
electrodes 212 along the length of the pitch can be individual electrodes, a common but segmented electrode, or a common and continuous electrode. A common and continuous electrode may, for example, comprise a conductive coil formed into or placed over the helical portion ofcatheter 210. A common but segmented electrode may, for example, be formed by providing a slotted tube fitted onto or into the helical portion of the catheter, or by electrically connecting a series of individual electrodes. - Individual electrodes or groups of
electrodes 212 may be configured to provide a bipolar signal, or all or a subset of the electrodes may be used together in conjunction with a separate external patient ground for monopolar use (the ground pad may, for example, be placed on the patient's leg).Electrodes 212 may be dynamically assignable to facilitate monopolar and/or bipolar energy delivery between any of the electrodes and/or between any of the electrodes and an external ground. -
Catheter 210 may be delivered to renal artery RA in a low profile delivery configuration withinsheath 150. Once positioned within the artery, the catheter may self-expand or may be expanded actively, e.g., via a pull wire or a balloon, into contact with an interior wall of the artery. A pulsed electric field then may be generated by thePEF generator 100, transferred throughcatheter 210 toelectrodes 212, and delivered via theelectrodes 212 across the wall of the artery. In many applications, the electrodes are arranged so that the pulsed electric field is aligned with the longitudinal dimension of the artery to modulate the neural activity along the renal nerves (e.g., denervation). This may be achieved, for example, via irreversible electroporation, electrofusion and/or inducement of apoptosis in the nerve cells. -
FIG. 5 illustrates anapparatus 220 for neural modulation in accordance with another embodiment of the invention. Theapparatus 220 includes a pair ofcatheters helical electrodes helical electrodes sheath 150, or the electrodes may be actively expanded into contact with the vessel wall, e.g., via an inflatable balloon or via pull wires, etc. The catheters 222 a-b preferably are electrically insulated in areas other than the distal helices of electrodes 224 a-b. -
FIG. 6 illustrates anapparatus 230 comprising aballoon catheter 232 havingexpandable balloon 234, ahelical electrode 236 arranged about theballoon 234, and ashaft electrode 238 on the shaft ofcatheter 232. Theshaft electrode 238 can be located proximal ofexpandable balloon 234 as shown, or theshaft electrode 238 can be located distal of theexpandable balloon 234. - When the
apparatus 230 is delivered to a target vessel, e.g., within renal artery RA, theexpandable balloon 234 and thehelical electrode 236 are arranged in a low profile delivery configuration. As seen inFIG. 6 , once the apparatus has been positioned as desired,expandable balloon 234 may be inflated to drive thehelical electrode 236 into physical contact with the wall of the vessel. In this embodiment, theshaft electrode 238 does not physically contact the vessel wall. - It is well known in the art of both traditional thermal RF energy delivery and of relatively non-thermal pulsed RF energy delivery that energy may be conducted to tissue to be treated from a short distance away from the tissue itself. Thus, it may be appreciated that “nerve contact” comprises both physical contact of a system element with a nerve, as well as electrical contact alone without physical contact, or a combination of the two. A centering element optionally may be provided to place electrodes in a central region of the vessel. The centering element may comprise, for example, an expandable balloon, such as
balloon 234 ofapparatus 230, or an expandable basket as described hereinafter. One or more electrodes may be positioned on a central shaft of the centering element—either longitudinally aligned with the element or positioned on one or both sides of the element—as isshaft electrode 238 ofapparatus 230. When utilizing a balloon catheter such ascatheter 232, the inflated balloon may act as an insulator of increased impedance for directing a pulsed electric field along a desired electric flow path. As will be apparent, alternative insulators may be utilized. - As seen in
FIG. 6 , when thehelical electrode 236 physically contacts the wall of renal artery RA, thegenerator 100 may generate a PEF such that current passes between thehelical electrode 236 and theshaft electrode 238 in a bipolar fashion. The PEF travels between the electrodes along lines Li that generally extend along the longitudinal dimension of the artery. Theballoon 234 locally insulates and/or increases the impedance within the patient's vessel such that the PEF travels through the wall of the vessel between the helical and shaft electrodes. This focuses the energy to enhance denervation and/or other neuromodulation of the patient's renal nerves, e.g., via irreversible electroporation. -
FIG. 7 illustrates anapparatus 240 similar to those shown inFIGS. 4-6 in accordance with another embodiment of the invention. Theapparatus 240 comprises aballoon catheter 242 having anexpandable balloon 244 and ashaft electrode 246 located proximal of theexpandable balloon 244. Theapparatus 240 further comprises an expandablehelical electrode 248 configured for delivery through aguidewire lumen 243 of thecatheter 242. Thehelical electrode 248 shown inFIG. 7 is self-expanding. - As seen in
FIG. 7 , after positioning thecatheter 242 in a target vessel (e.g. renal artery RA), theballoon 244 is inflated until it contacts the wall of the vessel to hold theshaft electrode 246 at a desired location within the vessel and to insulate or increase the impedance of the interior of the vessel. Theballoon 244 is generally configured to also center theshaft electrode 246 within the vessel or otherwise space the shaft electrode apart from the vessel wall by a desired distance. After inflating theballoon 244, thehelical electrode 248 is pushed throughlumen 243 until thehelical electrode 248 extends beyond the catheter shaft; theelectrode 248 then expands or otherwise moves into the helical configuration to physically contact the vessel wall. A bipolar pulsed electric field may then be delivered between thehelical electrode 248 and theshaft electrode 246 along lines Li. For example, thehelical electrode 248 may comprise the active electrode and theshaft electrode 246 may comprise the return electrode, or vice versa. - With reference now to
FIG. 8 , apparatus comprising an expandable basket having a plurality of electrodes that may be expanded into contact with the vessel wall is described.Apparatus 250 comprisescatheter 252 having expandabledistal basket 254 formed from a plurality of circumferential struts or members. A plurality ofelectrodes 256 are formed along the members ofbasket 254. Each member of the basket illustratively comprises a bipolar electrode pair configured to contact a wall of renal artery RA or another desired blood vessel. -
Basket 254 may be fabricated, for example, from a plurality of shape-memory wires or ribbons, such as Nitinol, spring steel or eigiloy wires or ribbons, thatform basket members 253. When the basket members comprise ribbons, the ribbons may be moved such that a surface area contacting the vessel wall is increased.Basket members 253 are coupled tocatheter 252 at proximal anddistal connections sheath 150, and may self-expand into contact with the wall of the artery upon removal from the sheath. Proximal and/or distal connection 255 optionally may be configured to translate along the shaft ofcatheter 252 for a specified or unspecified distance in order to facilitate expansion and collapse of the basket. -
Basket 254 alternatively may be formed from a slotted and/or laser-cut hypotube. In such a configuration,catheter 252 may, for example, comprise inner and outer shafts that are moveable relative to one another.Distal connection 255 b ofbasket 254 may be coupled to the inner shaft andproximal connection 255 a of the basket may be coupled to the outer shaft.Basket 254 may be expanded from a collapsed delivery configuration to the deployed configuration ofFIG. 8 by approximating the inner and outer shafts ofcatheter 252, thereby approximating the proximal and distal connections 255 of the basket and expanding the basket. Likewise, the basket may be collapsed by separating the inner and outer shafts of the catheter. - As seen in
FIG. 9 , individual electrodes may be arranged along a basket strut ormember 253. In one embodiment, the strut is formed from a conductive material coated with a dielectric material, and theelectrodes 256 may be formed by removing regions of the dielectric coating. The insulation optionally may be removed only along a radially outer surface of the member such thatelectrodes 256 remain insulated on their radially interior surfaces; it is expected that this will direct the current flow outward into the vessel wall. - In addition, or as an alternative, to the fabrication technique of
FIG. 9 , the electrodes may be affixed to the inside surface, outside surface or embedded within the struts or members ofbasket 254. The electrodes placed along each strut or member may comprise individual electrodes, a common but segmented electrode, or a common and continuous electrode. Individual electrodes or groups of electrodes may be configured to provide a bipolar signal, or all or a subset of the electrodes may be actuated together in conjunction with an external patient ground for monopolar use. - One advantage of having
electrodes 256 contact the vessel wall as shown in the embodiment ofFIG. 8 is that it may reduce the need for an insulating element, such as an expandable balloon, to achieve renal denervation or other neuromodulation. However, it should be understood that such an insulating element may be provided and, for example, expanded within the basket. Furthermore, having the electrodes contact the wall may provide improved field geometry, i.e., may provide an electric field more aligned with the longitudinal axis of the vessel. Such contacting electrodes also may facilitate stimulation of the renal nerves before, during or after neuromodulation to better position thecatheter 252 before treatment or for monitoring the effectiveness of treatment. - In a variation of
apparatus 250,electrodes 256 may be disposed along the central shaft ofcatheter 252, andbasket 254 may simply center the electrodes within the vessel to facilitate more precise delivery of energy across the vessel wall. This configuration may be well suited to precise targeting of vascular or extra-vascular tissue, such as the renal nerves surrounding the renal artery. Correctly sizing the basket or other centering element to the artery provides a known distance between the centered electrodes and the arterial wall that may be utilized to direct and/or focus the electric field as desired. This configuration may be utilized in high-intensity focused ultrasound or microwave applications, but also may be adapted for use with any other energy modality as desired. - Referring now to
FIG. 10 , it is expected that electrodes forming a circumferential contact with the wall of the renal artery may provide for more complete renal denervation or renal neuromodulation. InFIG. 10 , a variation of the present invention comprising ring electrodes is described.Apparatus 260 comprisescatheter 262 havingexpandable ring electrodes catheter 262 viastruts 266, andcatheter 262 may be configured for delivery to renal artery RA throughsheath 150 in a low profile configuration.Struts 266 may self-expanding or may be actively or mechanically expanded.Catheter 262 comprisesguidewire lumen 263 for advancement over a guidewire.Catheter 262 also comprises optionalinflatable balloon 268 that may act as an insulating element of increased impedance for preferentially directing current flow that is traveling betweenelectrodes 264 across the wall of the artery. -
FIGS. 11A-11C illustrate various embodiments of windings forring electrodes 264. As shown, the ring electrodes may, for example, be wound in a coil (FIG. 11A ), a zigzag (FIG. 11B ) or a serpentine configuration (FIG. 11C ). The periodicity of the winding may be specified, as desired. Furthermore, the type of winding, the periodicity, etc., may vary along the circumference of the electrodes. - With reference to
FIG. 12 , a variation ofapparatus 260 is described comprisingring electrodes 264′ having a sinusoidal winding in one embodiment of the serpentine winding shown inFIG. 11C .Struts 266 illustratively are attached to apexes of the sinusoid. The winding ofelectrodes 264′ may provide for greater contact area along the vessel wall than doelectrodes 264, while still facilitating sheathing ofapparatus 260 withinsheath 150 for delivery and retrieval. -
FIG. 13 illustrates another variation ofapparatus 260 comprising aproximal ring electrode 264 a, and further comprising adistal electrode 270 delivered throughguidewire lumen 263 ofcatheter 262. Thedistal electrode 270 is non-expanding and is centered within the vessel viacatheter 262. Thedistal electrode 270 may be a standard guide wire which is connected to the pulsed electric field generator and used as an electrode. However, it should be understood thatelectrode 270 alternatively may be configured for expansion into contact with the vessel wall, e.g., may comprise a ring or helical electrode. - Delivering the distal electrode through the lumen of
catheter 262 may reduce a delivery profile ofapparatus 260 and/or may improve flexibility of the device. Furthermore, delivery of the distal electrode through the guidewire lumen may serve as a safety feature that ensures that the medical practitioner removes any guidewire disposed withinlumen 263 prior to delivery of a PEF. It also allows for customization of treatment length, as well as for treatment in side branches, as described hereinafter. -
Ring electrodes FIG. 14 , another variation ofapparatus 260 is described, wherein the ring electrodes have been replaced withpoint electrodes 272 disposed at the ends ofstruts 266. The point electrodes may be collapsed withstruts 266 for delivery throughsheath 150 and may self-expand with the struts into contact with the vessel wall. InFIG. 14 ,catheter 262 illustratively comprises fourpoint electrodes 272 on either side ofballoon 268. However, it should be understood that any desired number of struts and point electrodes may be provided around the circumference ofcatheter 262. - In
FIG. 14 ,apparatus 260 illustratively comprises fourstruts 266 and fourpoint electrodes 272 on either side ofballoon 268. By utilizing all of the distally disposed electrodes 272 b as active electrodes and all proximal electrodes 272 a as return electrodes, or vice versa, lines Li along which the electric field propagates may be aligned with the longitudinal axis of a vessel. A degree of line Li overlap along the rotational axis of the vessel may be specified by specifying the angular placement and density ofpoint electrodes 272 about the circumference of the catheter, as well as by specifying parameters of the PEF. - With reference now to
FIG. 15 , another variation of an intravascular PEF catheter is described.Apparatus 280 comprisescatheter 282 having optional inflatable balloon or centeringelement 284,shaft electrodes radiopaque markers 288 disposed along the shaft of the catheter, illustratively in line with the balloon.Balloon 284 serves as both a centering element for electrodes 286 and as an electrical insulator for directing the electric field, as described previously. -
Apparatus 280 may be particularly well-suited for achieving precise targeting of desired arterial or extra-arterial tissue, since properly sizingballoon 284 to the target artery sets a known distance between centered electrodes 286 and the arterial wall that may be utilized when specifying parameters of the PEF. Electrodes 286 alternatively may be attached to balloon 284 rather than to the central shaft ofcatheter 282 such that they contact the wall of the artery. In such a variation, the electrodes may be affixed to the inside surface, outside surface or embedded within the wall of the balloon. - Electrodes 286 arranged along the length of
catheter 282 can be individual electrodes, a common but segmented electrode, or a common and continuous electrode. Furthermore, electrodes 286 may be configured to provide a bipolar signal, or electrodes 286 may be used together or individually in conjunction with a separate patient ground for monopolar use. - Referring now to
FIG. 16 , a method of usingapparatus 280 to achieve renal denervation is described. As seen inFIG. 16A ,catheter 282 may be disposed at a desired location within renal artery RA, balloon or centeringelement 284 may be expanded to center electrodes 286 and to optionally provide electrical insulation, and a PEF may be delivered, e.g., in a bipolar fashion between the proximal and distal electrodes 286. It is expected that the PEF will achieve renal denervation and/or neuromodulation along treatment zone one T1. If it is desired to modulate neural activity in other parts of the renal artery,balloon 284 may be at least partially deflated, and the catheter may be positioned at a second desired treatment zone T2, as inFIG. 16B . The medical practitioner optionally may utilize fluoroscopic imaging ofradiopaque markers 288 to orientcatheter 282 at desired locations for treatment. For example, the medical practitioner may use the markers to ensure a region of overlap O between treatment zones T1 and T2, as shown. - With reference to
FIG. 17 , a variation ofapparatus 280 is described comprising a plurality of dynamically controllable electrodes 286 disposed on the proximal side ofballoon 284. In one variation, any one ofproximal electrodes 286 a may be energized in a bipolar fashion withdistal electrode 286 b to provide dynamic control of the longitudinal distance between the active and return electrodes. This alters the size and shape of the zone of treatment. In another variation, any subset ofproximal electrodes 286 a may be energized together as the active or return electrodes of a bipolar electric field established between the proximal electrodes anddistal electrode 286 b. - Although the
apparatus 280 shown inFIG. 17 has threeproximal electrodes 286 a, it should be understood that theapparatus 280 can have any alternative number of proximal electrodes. Furthermore, theapparatus 280 can have a plurality ofdistal electrodes 286 b in addition, or as an alternative, to multiple proximal electrodes. Additionally, one electrode of a pair may be coupled to thecatheter 282, and the other electrode may be delivered through a lumen of the catheter, e.g., through a guidewire lumen. The catheter and endoluminally-delivered electrode may be repositioned relative to one another to alter a separation distance between the electrodes. Such a variation also may facilitate treatment of a variety of renal vasculature anatomies. - In the variations of
apparatus 280 described thus far,distal electrode 286 b is coupled to the shaft ofcatheter 282 distal ofballoon 284. The distal electrode may utilize a lumen withincatheter 282, e.g., for routing of a lead wire that acts as ground. Additionally, the portion ofcatheter 282 distal ofballoon 284 is long enough to accommodate the distal electrode. - Catheters commonly are delivered over metallic and/or conductive guidewires. In many interventional therapies involving catheters, guidewires are not removed during treatment. As
apparatus 280 is configured for delivery of a pulsed electric field, if the guidewire is not removed, there may be a risk of electric shock to anyone in contact with the guidewire during energy delivery. This risk may be reduced by using polymer-coated guidewires. - With reference to
FIG. 18 , another variation ofapparatus 280 is described whereindistal electrode 286 b ofFIGS. 16 and 17 has been replaced with adistal electrode 270 configured to be moved through a lumen of the catheter as described previously with respect toFIG. 13 . As will be apparent,proximal electrode 286 a alternatively may be replaced with the luminally-delivered electrode, such thatelectrodes Electrode 270 does not utilize an additional lumen withincatheter 282, which may reduce profile. Additionally, the length of the catheter distal of the balloon need not account for the length of the distal electrode, which may enhance flexibility. Furthermore, the guidewire must be exchanged forelectrode 270 prior to treatment, which reduces a risk of inadvertent electrical shock. In one variation,electrode 270 optionally may be used as the guidewire over whichcatheter 282 is advanced into position prior to delivery of the PEF, thereby obviating a need for exchange of the guidewire for the electrode. Alternatively, a standard metallic guidewire may be used as theelectrode 270 simply by connecting the standard guidewire to the pulsed electric field generator. Thedistal electrode 270 may be extended any desired distance beyond the distal end ofcatheter 282. This may provide for dynamic alteration of the length of a treatment zone. Furthermore, this might facilitate treatment within distal vasculature of reduced diameter. - With reference to
FIG. 19 , it might be desirable to perform treatments within one or more vascular branches that extend from a main vessel, for example, to perform treatments within the branches of the renal artery in the vicinity of the renal hilum. Furthermore, it might be desirable to perform treatments within abnormal or less common branchings of the renal vasculature, which are observed in a minority of patients. As seen inFIG. 19A ,distal electrode 270 may be placed in such a branch of renal artery RA, whilecatheter 282 is positioned within the main branch of the artery. As seen inFIG. 19B , multipledistal electrodes 270 might be provided and placed in various common or uncommon branches of the renal artery, while the catheter remains in the main arterial branch. - Referring to
FIG. 20 , yet another variation of an intravascular PEF catheter is described.Apparatus 290 comprisescatheter 292 having a plurality ofshaft electrodes 294 disposed in line with centeringelement 296. Centeringelement 296 illustratively comprises an expandable basket, such as previously describedexpandable basket 254 ofFIG. 8 . However, it should be understood that the centering element alternatively may comprise a balloon or any other centering element.Electrodes 294 may be utilized in a bipolar or a monopolar fashion. - Referring now to
FIG. 21 , another variation of the invention is described comprising electrodes configured for dynamic radial repositioning of one or more of the electrodes relative to a vessel wall, thereby facilitating focusing of a pulsed electric field delivered by the electrodes.Apparatus 300 comprisescatheter 302 havingelectrodes 304 disposed in line with nested expandable elements. The nested expandable elements comprise an innerexpandable element 306 and an outer expandable centeringelement 308.Electrodes 304 are disposed along the inner expandable element, while the outer expandable centering element is configured to center and stabilizecatheter 302 within the vessel.Inner element 306 may be expanded to varying degrees, as desired by a medical practitioner, to dynamically alter the radial positions ofelectrodes 304. This dynamic radial repositioning may be utilized to focus energy delivered byelectrodes 304 such that it is delivered to target tissue. -
Nested elements FIG. 21 , innerexpandable element 306 illustratively comprises an expandable basket, while outerexpandable centering element 308 illustratively comprises an expandable balloon.Electrodes 302 are positioned along the surface ofinner balloon 306. - Any of the variations of the present invention described herein optionally may be configured for infusion of agents into the treatment area before, during or after energy application, for example, to enhance or modify the neurodestructive or neuromodulatory effect of the energy, to protect or temporarily displace non-target cells, and/or to facilitate visualization. Additional applications for infused agents will be apparent. If desired, uptake of infused agents by cells may be enhanced via initiation of reversible electroporation in the cells in the presence of the infused agents. Infusion may be especially desirable when a balloon centering element is utilized. The infusate may comprise, for example, saline or heparinized saline, protective agents, such as Poloxamer-188, or anti-proliferative agents. Variations of the present invention additionally or alternatively may be configured for aspiration. For example, infusion ports or outlets may be provided on a catheter shaft adjacent a centering device, the centering device may be porous (for instance, a “weeping” balloon), or basket struts may be made of hollow hypotubes and slotted or perforated to allow infusion or aspiration.
- With reference to
FIG. 22 , a variation of the present invention comprising an infusion/aspiration PEF catheter is described.Apparatus 310 comprisescatheter 312 having proximal and distalinflatable balloons Proximal shaft electrode 316 a is disposed between the balloons along the shaft ofcatheter 312, whiledistal electrode 316 b is disposed distal of the balloons along the catheter shaft. One or more infusion or aspiration holes 318 are disposed along the shaft ofcatheter 312 between the balloons in proximity toproximal electrode 316 a. -
Apparatus 310 may be used in a variety of ways. In a first method of use,catheter 312 is disposed within the target vessel, such as renal artery RA, at a desired location. One or both balloons 314 are inflated, and a protective agent or other infusate is infused through hole(s) 318 between the balloons in proximity to electrode 316 a. A PEF suitable for initiation of reversible electroporation is delivered across electrodes 316 to facilitate uptake of the infusate by non-target cells within the vessel wall. Delivery of the protective agent may be enhanced by first inflatingdistal balloon 314 b, then infusing the protective agent, which displaces blood, then inflatingproximal balloon 314 a. - Remaining infusate optionally may be aspirated such that it is unavailable during subsequent PEF application when irreversible electroporation of nerve cells is initiated. Aspiration may be achieved by at least partially deflating one balloon during aspiration. Alternatively, aspiration may be achieved with both balloons inflated, for example, by infusing saline in conjunction with the aspiration to flush out the vessel segment between the inflated balloons. Such blood flushing may reduce a risk of clot formation along
proximal electrode 316 a during PEF application. Furthermore, flushing during energy application may cool the electrode and/or cells of the wall of the artery. Such cooling of the wall cells might protect the cells from irreversible electroporative damage, possibly reducing a need for infusion of a protective agent. - After infusion and optional aspiration, a PEF suitable for initiation of irreversible electroporation in target nerve cells may be delivered across electrodes 316 to denervate or to modulate neural activity. In an alternative method, infusion of a protective agent may be performed during or after initiation of irreversible electroporation in order to protect non-target cells. The protective agent may, for example, plug or fill pores formed in the non-target cells via the irreversible electroporation.
- In another alternative method, a solution of chilled (i.e., less than body temperature) heparinized saline may be simultaneously infused and aspirated between the inflated balloons to flush the region between the balloons and decrease the sensitivity of vessel wall cells to electroporation. This is expected to further protect the cells during application of the PEF suitable for initiation of irreversible electroporation. Such flushing optionally may be continuous throughout application of the pulsed electric field. A thermocouple or other temperature sensor optionally may be positioned between the balloons such that a rate of chilled infusate infusion may be adjusted to maintain a desired temperature. The chilled infusate preferably does not cool the target tissue, e.g., the renal nerves. A protective agent, such as Poloxamer-188, optionally may be infused post-treatment as an added safety measure.
- Infusion alternatively may be achieved via a weeping balloon catheter. Further still, a cryoballoon catheter having at least one electrode may be utilized. The cryoballoon may be inflated within a vessel segment to locally reduce the temperature of the vessel segment, for example, to protect the segment and/or to induce thermal apoptosis of the vessel wall during delivery of an electric field. The electric field may, for example, comprise a PEF or a thermal, non-pulsed electric field, such as a thermal RF field.
- Referring now to
FIG. 23 , a variation of a PEF catheter configured for passage of electrode(s) at least partially across the vessel wall is described. For example, the electrode(s) may be positioned within the renal vein and then passed across the wall of the renal vein such that they are disposed in Gerota's or renal fascia and near or at least partially around the renal artery. In this manner, the electrode(s) may be positioned in close proximity to target renal nerve fibers prior to delivery of a pulsed electric field. - As seen in
FIG. 23A ,apparatus 320 comprisescatheter 322 havingneedle ports 324 and centeringelement 326, illustratively an inflatable balloon.Catheter 322 also optionally may compriseradiopaque markers 328.Needle ports 324 are configured for passage ofneedles 330 therethrough, whileneedles 330 are configured for passage ofelectrodes 340. - Renal vein RV runs parallel to renal artery RA. An imaging modality, such as intravascular ultrasound, may be used to identify the position of the renal artery relative to the renal vein. For example, intravascular ultrasound elements optionally may be integrated into
catheter 322.Catheter 322 may be positioned within renal vein RV using well-known percutaneous techniques, and centeringelement 326 may be expanded to stabilize the catheter within the vein.Needles 330 then may be passed throughcatheter 322 and out throughneedle ports 324 in a manner whereby the needles penetrate the wall of the renal vein and enter into Gerota's or renal fasciaF. Radiopaque markers 328 may be visualized with fluoroscopy to properly orientneedle ports 324 prior to deployment ofneedles 330. -
Electrodes 340 are deployed throughneedles 330 to at least partially encircle renal artery RA, as inFIGS. 23A and 23B . Continued advancement of the electrodes may further encircle the artery, as inFIG. 23C . With the electrodes deployed, stimulation and/or PEF electroporation waveforms may be applied to denervate or modulate the renal nerves.Needles 330 optionally may be partially or completely retracted prior to treatment such thatelectrodes 340 encircle a greater portion of the renal artery. Additionally, asingle electrode 340 may be provided and/or actuated in order to provide a monopolar PEF. - Infusate optionally may be infused from
needles 330 into fascia F to facilitate placement ofelectrodes 340 by creating a space for placement of the electrodes. The infusate may comprise, for example, fluids, heated or chilled fluids, air, CO2, saline, contrast agents, gels, conductive fluids or any other space-occupying material—be it gas, solid or liquid. Heparinized saline also may be injected. Saline or hypertonic saline may enhance conductivity betweenelectrodes 340. Additionally or alternatively, drugs and/or drug delivery elements may be infused or placed into the fascia through the needles. - After treatment,
electrodes 340 may be retracted withinneedles 330, and needles 330 may be retracted withincatheter 322 vianeedle ports 324.Needles 330 preferably are small enough that minimal bleeding occurs and hemostasis is achieved fairly quickly.Balloon centering element 326 optionally may remain inflated for some time after retrieval ofneedles 330 in order to block blood flow and facilitate the clotting process. Alternatively, a balloon catheter may be advanced into the renal vein and inflated after removal ofapparatus 320. - Referring to
FIG. 24 , variations of the invention comprising detectors or other elements for measuring or monitoring treatment efficacy are described. Variations of the invention may be configured to deliver stimulation electric fields, in addition to denervating or modulating PEFs. These stimulation fields may be utilized to properly position the apparatus for treatment and/or to monitor the effectiveness of treatment in modulating neural activity. This may be achieved by monitoring the responses of physiologic parameters known to be affected by stimulation of the renal nerves. Such parameters comprise, for example, renin levels, sodium levels, renal blood flow and blood pressure. Stimulation also may be used to challenge the denervation for monitoring of treatment efficacy: upon denervation of the renal nerves, the known physiologic responses to stimulation should no longer occur in response to such stimulation. - Efferent nerve stimulation waveforms may, for example, comprise frequencies of about 1-10 Hz, while afferent nerve stimulation waveforms may, for example, comprise frequencies of up to about 50 Hz. Waveform amplitudes may, for example, range up to about 50V, while pulse durations may, for example, range up to about 20 milliseconds. When the nerve stimulation waveforms are delivered intravascularly, as in several embodiments of the present invention, field parameters such as frequency, amplitude and pulse duration may be modulated to facilitate passage of the waveforms through the wall of the vessel for delivery to target nerves. Furthermore, although exemplary parameters for stimulation waveforms have been described, it should be understood that any alternative parameters may be utilized as desired.
- The electrodes used to deliver PEFs in any of the previously described variations of the present invention also may be used to deliver stimulation waveforms to the renal vasculature. Alternatively, the variations may comprise independent electrodes configured for stimulation. As another alternative, a separate stimulation apparatus may be provided.
- One way to use stimulation to identify renal nerves is to stimulate the nerves such that renal blood flow is affected—or would be affected if the renal nerves had not been denervated or modulated. Stimulation acts to reduce renal blood flow, and this response may be attenuated or abolished with denervation. Thus, stimulation prior to neural modulation would be expected to reduce blood flow, while stimulation after neural modulation would not be expected to reduce blood flow to the same degree when utilizing similar stimulation parameters and location(s) as prior to neural modulation. This phenomenon may be utilized to quantify an extent of renal neuromodulation. Variations of the present invention may comprise elements for monitoring renal blood flow or for monitoring any of the other physiological parameters known to be affected by renal stimulation.
- In
FIG. 24A , a variation ofapparatus 280 ofFIG. 16 is described having an element for monitoring of renal blood flow.Guidewire 350 havingDoppler ultrasound sensor 352 has been advanced through the lumen ofcatheter 282 for monitoring blood flow within renal artery RA.Doppler ultrasound sensor 352 is configured to measure the velocity of flow through the artery. A flow rate then may be calculated according to the formula:
Q=VA (1)
where Q equals flow rate, V equals flow velocity and A equals cross-sectional area. A baseline of renal blood flow may be determined via measurements fromsensor 352 prior to delivery of a stimulation waveform, then stimulation may be delivered between electrodes 286, preferably withballoon 284 deflated. Alteration of renal blood flow from the baseline, or lack thereof, may be monitored withsensor 352 to identify optimal locations for neuromodulation and/or denervation of the renal nerves. -
FIG. 24B illustrates a variation of the apparatus ofFIG. 24A , whereinDoppler ultrasound sensor 352 is coupled to the shaft ofcatheter 282.Sensor 352 illustratively is disposed proximal ofballoon 284, but it should be understood that the sensor alternatively may be disposed distal of the balloon. - In addition or as an alternative to intravascular monitoring of renal blood flow via Doppler ultrasound, such monitoring optionally may be performed from external to the patient whereby renal blood flow is visualized through the skin (e.g., using an ultrasound transducer). In another variation, one or more intravascular pressure transducers may be used to sense local changes in pressure that may be indicative of renal blood flow. As yet another alternative, blood velocity may be determined, for example, via thermodilution by measuring the time lag for an intravascular temperature input to travel between points of known separation distance.
- For example, a thermocouple may be incorporated into, or provided in proximity to, each electrode 286, and chilled (i.e., lower than body temperature) fluid or saline may be infused proximally of the thermocouple(s). A time lag for the temperature decrease to register between the thermocouple(s) may be used to quantify flow characteristic(s). A baseline estimate of the flow characteristic(s) of interest may be determined prior to stimulation of the renal nerves and may be compared with a second estimate of the characteristic(s) determined after stimulation.
- Commercially available devices optionally may be utilized to monitor treatment. Such devices include, for example, the SmartWire™, FloWire™ and WaveWire™ devices available from Volcano™ Therapeutics Inc., of Rancho Cordova, Calif., as well as the PressureWire® device available from RADI Medical Systems AB of Uppsala, Sweden. Additional commercially available devices will be apparent. An extent of electroporation additionally or alternatively may be monitored directly using Electrical Impedance Tomography (“EIT”) or other electrical impedance measurements, such as an electrical impedance index.
- Although preferred illustrative variations of the present invention are described above, it will be apparent to those skilled in the art that various changes and modifications may be made thereto without departing from the invention. For example, although the variations primarily have been described for use in combination with pulsed electric fields, it should be understood that any other electric field may be delivered as desired. It is intended in the appended claims to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (52)
1. Apparatus for renal neuromodulation, the apparatus comprising:
a device comprising an electrode, wherein the electrode is configured for percutaneous placement proximate a renal vasculature in a patient; an electric field generator operatively coupled to the electrode; and
a controller configured to operate instructions that cause the electric field generator to deliver an electric field via the electrode to a renal nerves while the electrode is located proximate the renal vasculature.
2. The apparatus of claim 1 wherein
the electrode is configured for placement within the renal vasculature.
3. The apparatus of claim 2 wherein the device further comprises a catheter configured for advancement within the renal vasculature, and
wherein the electrode is carried by the catheter.
4. (canceled)
5. The apparatus of claim 2 wherein the device is configured to be arranged in (a) a reduced delivery configuration for movement within the patient, and (b) an expanded treatment configuration for delivering the electric field to the renal nerves.
6. The apparatus of claim 2 wherein the electrode is configured to physically contact a wall of the renal vasculature.
7. The apparatus of claim 6 wherein the electrode is chosen from the group consisting of expandable helical electrodes, expandable ring electrodes, expandable basket electrodes, expandable point contact electrodes and combinations thereof.
8. The apparatus of claim 2 wherein the device further comprises an expandable centering element configured to physically contact a wall of the renal vasculature.
9. The apparatus of claim 8 wherein the expandable centering element is chosen from the group consisting of inflatable balloons, expandable baskets and combinations thereof.
10. The apparatus of claim 8 wherein the electrode is located on the expandable centering element and configured to physically contact the wall of the renal vasculature.
11. (canceled)
12. The apparatus of claim 8 wherein the device further comprises a shaft longitudinally aligned with the centering element and the electrode is located on the shaft.
13. The apparatus of claim 8 , wherein the electrode comprises a first electrode located proximal of the centering element and the device further comprises a second electrode located distal of the centering element, and wherein the first and second electrodes are a bipolar electrode pair.
14. The apparatus of claim 8 wherein the centering element is configured to electrically insulate a segment of the renal vasculature and direct the electric field to the renal nerves.
15. The apparatus of claim 2 wherein the electrode is a first electrode and the device further comprises a catheter having a guide wire lumen and a second electrode configured for movement through the guide wire lumen.
16. The apparatus of claim 15 wherein the second electrode is electrically coupled to the pulsed electric field generator and is configured for use in a bipolar fashion with the first electrode of the device.
17. The apparatus of claim 1 , wherein the electrode comprises a first electrode and the device further comprises a second electrode to define a bipolar electrode pair.
18. The apparatus of claim 1 wherein the electrode comprises a dynamically controllable electrode.
19. The apparatus of claim 1 wherein the controller is configured to operate instructions that cause the electric field generator to deliver a stimulation electric field to the renal nerve.
20. The apparatus of claim 1 wherein the device is configured to controllably move the electrode radially relative to a wall of the renal vasculature.
21. (canceled)
22. The apparatus of claim 1 wherein the electrode is configured for partial or complete passage across a wall of the renal vasculature.
23. The apparatus of claim 1 wherein the electrode is configured to at least partially encircle a renal artery of the patient.
24. The apparatus of claim 1 , further comprising an infusion element configured to infuse agents proximate the renal vasculature.
25. The apparatus of claim 24 wherein the infusion element is configured to create a working space for advancement of the electrode.
26. The apparatus of claim 1 , wherein the electrode comprises an active electrode, and the device further comprises a return electrode that together define a bipolar electrode pair in which at least one of the active electrode and the return electrode is configured for dynamic movement to vary a longitudinal separation distance between the active and return electrodes of the bipolar electrode pair.
27. The apparatus of claim 1 , wherein the device is configured for infusion or aspiration.
28. The apparatus of claim 1 wherein the device further comprises a monitoring element for monitoring the response of at least one physiological parameter to treatment of the renal nerves.
29. The apparatus of claim 28 wherein the monitoring element is chosen from the group consisting of Doppler ultrasound sensors, thermocouples, pressure sensors, imaging modalities, electrical impedance sensors and combinations thereof.
30. The apparatus of claim 1 wherein the device is configured to orient a longitudinal portion of the electric field with a longitudinal dimension of at least one of the renal nerves and the renal vasculature.
31. The apparatus of claim 1 wherein the electrode comprises an active electrode and the device further comprises a ground electrode configured for exterior attachment to the patient such that the active electrode is configured to deliver the pulsed electric field to the renal nerves in a monopolar fashion.
32-61. (canceled)
62. The apparatus of claim 1 wherein the controller is configured to operate instructions that cause the electric field generator to deliver a thermal electric field to the renal nerve.
63. The apparatus of claim 1 wherein the controller is configured to operate instructions that cause the electric field generator to deliver an electric field that induces a condition in the renal nerve selected from the group consisting of electroporation, electrofusion, thermal alteration, ablation, necrosis, apoptosis, and combinations thereof.
64. The apparatus of claim 1 wherein the controller is configured to operate instructions that cause the electric field generator to deliver a pulsed electric field that induces a condition in the renal nerve selected from the group consisting of electroporation, electrofusion, thermal alteration, ablation, necrosis, apoptosis, and combinations thereof.
65. The apparatus of claim 1 wherein the electric field generator is configured to deliver radio frequency energy via the electrode to the renal nerve.
66. The apparatus of claim 1 wherein the electric field generator is configured to deliver microwave energy via the electrode to the renal nerve.
67. The apparatus of claim 1 wherein the electric field generator is configured to deliver ultrasound energy via the electrode to the renal nerve.
68. The apparatus of claim 67 wherein the ultrasound energy is high intensity focused ultrasound.
69. The apparatus of claim 3 wherein the device further comprises a sheath configured to facilitate advancement of the catheter.
70. The apparatus of claim 69 wherein the device further comprises a thermocouple for monitoring temperature.
71. The apparatus of claim 3 wherein the catheter comprises a proximal section and a distal section, and wherein the electric field generator is electrically coupled to the proximal section and the electrode is coupled to the distal section.
72. The apparatus of claim 11 wherein the electrode is configured to remain out of contact with the wall of the renal vasculature.
73. The apparatus of claim 20 wherein the controller is further configured to operate instructions that cause the electric field generator to deliver the thermal electric field in a manner that at least partially ablates the renal nerve.
74. The apparatus of claim 20 wherein the controller is further configured to operate instructions that cause the electric field generator to deliver the thermal electric field in a manner that at least partially denervates renal tissue of the patient.
75. The apparatus of claim 28 wherein the controller is configured to operate instructions that cause the electric field generator to modulate delivery of the electric field in response to the monitored physiological parameter.
76. Apparatus for renal denervation, the apparatus comprising:
an electrode configured for placement within a renal vasculature in a patient,
an electric field generator operatively coupled to the electrode; and
a controller configured to operate instructions that cause the electric field generator to deliver an electric field via the electrode to a renal nerve while the electrode is located within the renal vasculature.
77. The apparatus of claim 76 , further comprising a catheter configured for advancement within the renal vasculature, wherein the electrode is carried by the catheter.
78. The apparatus of claim 76 wherein the controller is configured to operate instructions that cause the electric field generator to deliver a thermal electric field to the renal nerve.
79. The apparatus of claim 78 wherein the controller is further configured to operate instructions that cause the electric field generator to deliver the thermal electric field in a manner that at least partially ablates the renal nerve.
80. The apparatus of claim 78 wherein the controller is further configured to operate instructions that cause the electric field generator to deliver the thermal electric field in a manner that at least partially denervates renal tissue of the patient.
81. The apparatus of claim 76 wherein the controller is configured to operate instructions that cause the electric field generator to deliver an electric field that induces a condition in the renal nerve selected from the group consisting of electroporation, electrofusion, thermal alteration, ablation, necrosis, apoptosis, and combinations thereof.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/782,451 US20070265687A1 (en) | 2002-04-08 | 2007-07-24 | Apparatuses for renal neuromodulation |
US12/777,892 US8768470B2 (en) | 2002-04-08 | 2010-05-11 | Methods for monitoring renal neuromodulation |
US13/619,851 US8548600B2 (en) | 2002-04-08 | 2012-09-14 | Apparatuses for renal neuromodulation and associated systems and methods |
US13/619,950 US20130116685A1 (en) | 2002-04-08 | 2012-09-14 | Apparatuses for renal neuromodulation and associated systems and methods |
US13/930,863 US8852163B2 (en) | 2002-04-08 | 2013-06-28 | Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods |
US14/056,885 US20140058377A1 (en) | 2002-04-08 | 2013-10-17 | Methods and apparatus for renal neuromodulation |
US14/056,888 US9125661B2 (en) | 2002-04-08 | 2013-10-17 | Methods and apparatus for renal neuromodulation |
US14/258,802 US8934978B2 (en) | 2002-04-08 | 2014-04-22 | Methods and apparatus for renal neuromodulation |
US14/636,317 US9289255B2 (en) | 2002-04-08 | 2015-03-03 | Methods and apparatus for renal neuromodulation |
US15/019,793 US9675413B2 (en) | 2002-04-08 | 2016-02-09 | Methods and apparatus for renal neuromodulation |
US15/141,764 US20160296279A1 (en) | 2002-04-08 | 2016-04-28 | Methods for renal neuromodulation |
US15/667,781 US20170326363A1 (en) | 2002-04-08 | 2017-08-03 | Methods and Apparatus for Renal Neuromodulation |
US15/946,919 US10245429B2 (en) | 2002-04-08 | 2018-04-06 | Methods and apparatus for renal neuromodulation |
US16/271,728 US11033328B2 (en) | 2002-04-08 | 2019-02-08 | Methods and apparatus for renal neuromodulation |
US17/347,179 US11963714B2 (en) | 2002-04-08 | 2021-06-14 | Methods and apparatus for renal neuromodulation |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37019002P | 2002-04-08 | 2002-04-08 | |
US41557502P | 2002-10-03 | 2002-10-03 | |
US44297003P | 2003-01-29 | 2003-01-29 | |
US10/408,665 US7162303B2 (en) | 2002-04-08 | 2003-04-08 | Renal nerve stimulation method and apparatus for treatment of patients |
US61625404P | 2004-10-05 | 2004-10-05 | |
US62479304P | 2004-11-02 | 2004-11-02 | |
US11/129,765 US7653438B2 (en) | 2002-04-08 | 2005-05-13 | Methods and apparatus for renal neuromodulation |
US11/782,451 US20070265687A1 (en) | 2002-04-08 | 2007-07-24 | Apparatuses for renal neuromodulation |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/408,665 Continuation-In-Part US7162303B2 (en) | 2002-04-08 | 2003-04-08 | Renal nerve stimulation method and apparatus for treatment of patients |
US11/129,765 Division US7653438B2 (en) | 2002-04-08 | 2005-05-13 | Methods and apparatus for renal neuromodulation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/777,892 Continuation US8768470B2 (en) | 2002-04-08 | 2010-05-11 | Methods for monitoring renal neuromodulation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070265687A1 true US20070265687A1 (en) | 2007-11-15 |
Family
ID=37889643
Family Applications (16)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/129,765 Expired - Lifetime US7653438B2 (en) | 2002-04-08 | 2005-05-13 | Methods and apparatus for renal neuromodulation |
US11/782,451 Abandoned US20070265687A1 (en) | 2002-04-08 | 2007-07-24 | Apparatuses for renal neuromodulation |
US12/777,892 Expired - Fee Related US8768470B2 (en) | 2002-04-08 | 2010-05-11 | Methods for monitoring renal neuromodulation |
US13/619,851 Expired - Lifetime US8548600B2 (en) | 2002-04-08 | 2012-09-14 | Apparatuses for renal neuromodulation and associated systems and methods |
US13/619,950 Abandoned US20130116685A1 (en) | 2002-04-08 | 2012-09-14 | Apparatuses for renal neuromodulation and associated systems and methods |
US13/930,863 Expired - Lifetime US8852163B2 (en) | 2002-04-08 | 2013-06-28 | Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods |
US14/056,885 Abandoned US20140058377A1 (en) | 2002-04-08 | 2013-10-17 | Methods and apparatus for renal neuromodulation |
US14/056,888 Expired - Lifetime US9125661B2 (en) | 2002-04-08 | 2013-10-17 | Methods and apparatus for renal neuromodulation |
US14/258,802 Expired - Lifetime US8934978B2 (en) | 2002-04-08 | 2014-04-22 | Methods and apparatus for renal neuromodulation |
US14/636,317 Expired - Fee Related US9289255B2 (en) | 2002-04-08 | 2015-03-03 | Methods and apparatus for renal neuromodulation |
US15/019,793 Expired - Fee Related US9675413B2 (en) | 2002-04-08 | 2016-02-09 | Methods and apparatus for renal neuromodulation |
US15/141,764 Abandoned US20160296279A1 (en) | 2002-04-08 | 2016-04-28 | Methods for renal neuromodulation |
US15/667,781 Abandoned US20170326363A1 (en) | 2002-04-08 | 2017-08-03 | Methods and Apparatus for Renal Neuromodulation |
US15/946,919 Expired - Lifetime US10245429B2 (en) | 2002-04-08 | 2018-04-06 | Methods and apparatus for renal neuromodulation |
US16/271,728 Expired - Lifetime US11033328B2 (en) | 2002-04-08 | 2019-02-08 | Methods and apparatus for renal neuromodulation |
US17/347,179 Expired - Lifetime US11963714B2 (en) | 2002-04-08 | 2021-06-14 | Methods and apparatus for renal neuromodulation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/129,765 Expired - Lifetime US7653438B2 (en) | 2002-04-08 | 2005-05-13 | Methods and apparatus for renal neuromodulation |
Family Applications After (14)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/777,892 Expired - Fee Related US8768470B2 (en) | 2002-04-08 | 2010-05-11 | Methods for monitoring renal neuromodulation |
US13/619,851 Expired - Lifetime US8548600B2 (en) | 2002-04-08 | 2012-09-14 | Apparatuses for renal neuromodulation and associated systems and methods |
US13/619,950 Abandoned US20130116685A1 (en) | 2002-04-08 | 2012-09-14 | Apparatuses for renal neuromodulation and associated systems and methods |
US13/930,863 Expired - Lifetime US8852163B2 (en) | 2002-04-08 | 2013-06-28 | Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods |
US14/056,885 Abandoned US20140058377A1 (en) | 2002-04-08 | 2013-10-17 | Methods and apparatus for renal neuromodulation |
US14/056,888 Expired - Lifetime US9125661B2 (en) | 2002-04-08 | 2013-10-17 | Methods and apparatus for renal neuromodulation |
US14/258,802 Expired - Lifetime US8934978B2 (en) | 2002-04-08 | 2014-04-22 | Methods and apparatus for renal neuromodulation |
US14/636,317 Expired - Fee Related US9289255B2 (en) | 2002-04-08 | 2015-03-03 | Methods and apparatus for renal neuromodulation |
US15/019,793 Expired - Fee Related US9675413B2 (en) | 2002-04-08 | 2016-02-09 | Methods and apparatus for renal neuromodulation |
US15/141,764 Abandoned US20160296279A1 (en) | 2002-04-08 | 2016-04-28 | Methods for renal neuromodulation |
US15/667,781 Abandoned US20170326363A1 (en) | 2002-04-08 | 2017-08-03 | Methods and Apparatus for Renal Neuromodulation |
US15/946,919 Expired - Lifetime US10245429B2 (en) | 2002-04-08 | 2018-04-06 | Methods and apparatus for renal neuromodulation |
US16/271,728 Expired - Lifetime US11033328B2 (en) | 2002-04-08 | 2019-02-08 | Methods and apparatus for renal neuromodulation |
US17/347,179 Expired - Lifetime US11963714B2 (en) | 2002-04-08 | 2021-06-14 | Methods and apparatus for renal neuromodulation |
Country Status (11)
Country | Link |
---|---|
US (16) | US7653438B2 (en) |
EP (18) | EP3939531B1 (en) |
JP (7) | JP5646135B2 (en) |
CN (4) | CN101972513B (en) |
AT (1) | ATE494039T1 (en) |
CA (1) | CA2583463C (en) |
DE (9) | DE602005025789D1 (en) |
ES (10) | ES2494119T3 (en) |
MX (1) | MX2007004238A (en) |
PL (1) | PL2561905T3 (en) |
WO (1) | WO2006041881A2 (en) |
Cited By (285)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060212078A1 (en) * | 2002-04-08 | 2006-09-21 | Ardian, Inc. | Methods and apparatus for treating congestive heart failure |
US20070213616A1 (en) * | 2005-10-20 | 2007-09-13 | Thomas Anderson | Systems and methods for arteriotomy localization |
US20080119907A1 (en) * | 2006-11-22 | 2008-05-22 | Cardiac Pacemakers, Inc. | Renal function modulation via application of electrical energy stimulation |
US20090036948A1 (en) * | 2002-04-08 | 2009-02-05 | Ardian, Inc. | Renal nerve stimulation methods for treatment of patients |
US20100010567A1 (en) * | 2005-07-22 | 2010-01-14 | The Foundry, Llc | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US20100114254A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Subclavian ansae stimulation |
US20100114244A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Electrical renal autonomic blockade |
US20100119792A1 (en) * | 2008-11-10 | 2010-05-13 | Zheng-Dong Ma | Three-dimensional auxetic structures and applications thereof |
US20100137860A1 (en) * | 2002-04-08 | 2010-06-03 | Ardian, Inc. | Apparatus for performing a non-continuous circumferential treatment of a body lumen |
US20100152725A1 (en) * | 2008-12-12 | 2010-06-17 | Angiodynamics, Inc. | Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation |
US20100168731A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US20100168739A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US20100179620A1 (en) * | 2009-01-14 | 2010-07-15 | Ramesh Wariar | System and method for promoting diuresis and natriuresis by the application of electric fields to the kidney |
US20100204741A1 (en) * | 2008-08-08 | 2010-08-12 | Tweden Katherine S | Systems for regulation of blood pressure and heart rate |
US20100222851A1 (en) * | 2002-04-08 | 2010-09-02 | Ardian, Inc. | Methods for monitoring renal neuromodulation |
US20100222854A1 (en) * | 2002-04-08 | 2010-09-02 | Ardian, Inc. | Apparatuses for inhibiting renal nerve activity via an intra-to-extravascular approach |
US20100268307A1 (en) * | 2002-04-08 | 2010-10-21 | Ardian,Inc. | Methods for intravascularly-induced neuromodulation |
US20110077628A1 (en) * | 2006-01-10 | 2011-03-31 | Tsunami Medtech, Llc | Medical system and method of use |
US7925352B2 (en) | 2008-03-27 | 2011-04-12 | Synecor Llc | System and method for transvascularly stimulating contents of the carotid sheath |
US20110118600A1 (en) * | 2009-11-16 | 2011-05-19 | Michael Gertner | External Autonomic Modulation |
US20110137149A1 (en) * | 2009-10-12 | 2011-06-09 | Michael Gertner | Nerve treatment system |
WO2011075328A1 (en) | 2009-12-14 | 2011-06-23 | Mayo Foundation For Medical Education And Research | Device and method for treating cardiac disorders by modulating autonomic response |
US20110166499A1 (en) * | 2005-09-20 | 2011-07-07 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
WO2011088399A1 (en) * | 2010-01-18 | 2011-07-21 | Stanford University | Method and apparatus for radioablation of regular targets such as sympathetic nerves |
US20110178417A1 (en) * | 2008-09-22 | 2011-07-21 | Kassab Ghassan S | Methods for determining fractional flow reserve |
US20110200171A1 (en) * | 2010-01-19 | 2011-08-18 | Ardian, Inc. | Methods and apparatus for renal neuromodulation via stereotactic radiotherapy |
US20110202098A1 (en) * | 2002-04-08 | 2011-08-18 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US20110202052A1 (en) * | 2010-02-12 | 2011-08-18 | Daniel Gelbart | System for treating benign prostatic hyperplasia |
US20110208096A1 (en) * | 2002-04-08 | 2011-08-25 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20110257564A1 (en) * | 2002-04-08 | 2011-10-20 | Ardian, Inc. | Methods for thermal modulation of nerves contributing to renal function |
US20110264086A1 (en) * | 2010-04-14 | 2011-10-27 | Frank Ingle | Renal artery denervation apparatus employing helical shaping arrangement |
WO2011150200A2 (en) * | 2010-05-26 | 2011-12-01 | University Of Miami | Non occluding firing catheter for prolonged drug delivery |
US8088127B2 (en) | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
WO2012016135A1 (en) * | 2010-07-30 | 2012-02-02 | Boston Scientific Scimed, Inc. | Balloon with surface electrodes and integral cooling for renal nerve ablation |
US8116883B2 (en) | 2003-06-04 | 2012-02-14 | Synecor Llc | Intravascular device for neuromodulation |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8172827B2 (en) | 2003-05-13 | 2012-05-08 | Innovative Pulmonary Solutions, Inc. | Apparatus for treating asthma using neurotoxin |
US20120116486A1 (en) * | 2010-10-25 | 2012-05-10 | Medtronic Ardian Luxembourg S.A.R.L. | Microwave catheter apparatuses, systems, and methods for renal neuromodulation |
US20120232409A1 (en) * | 2010-12-15 | 2012-09-13 | Stahmann Jeffrey E | System and method for renal artery occlusion during renal denervation therapy |
US8295912B2 (en) | 2009-10-12 | 2012-10-23 | Kona Medical, Inc. | Method and system to inhibit a function of a nerve traveling with an artery |
US20130018247A1 (en) * | 2010-08-31 | 2013-01-17 | Glenn Richard A | Intravascular electrodes and anchoring devices for transvascular stimulation |
US8364237B2 (en) | 2005-03-28 | 2013-01-29 | Vessix Vascular, Inc. | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US8388535B2 (en) | 1999-10-25 | 2013-03-05 | Kona Medical, Inc. | Methods and apparatus for focused ultrasound application |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8401667B2 (en) | 2008-11-17 | 2013-03-19 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
WO2013052595A1 (en) * | 2011-10-05 | 2013-04-11 | St. Jude Medical, Inc. | Catheter device and method for denervation |
US8433423B2 (en) | 2004-10-05 | 2013-04-30 | Ardian, Inc. | Methods for multi-vessel renal neuromodulation |
US20130116683A1 (en) * | 2011-11-09 | 2013-05-09 | Tsunami Medtech, Llc | Medical system and method of use |
US8444636B2 (en) | 2001-12-07 | 2013-05-21 | Tsunami Medtech, Llc | Medical instrument and method of use |
US8469904B2 (en) | 2009-10-12 | 2013-06-25 | Kona Medical, Inc. | Energetic modulation of nerves |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
WO2013116380A1 (en) | 2012-01-30 | 2013-08-08 | Vytronus, Inc. | Tissue necrosis methods and apparatus |
US8512262B2 (en) | 2009-10-12 | 2013-08-20 | Kona Medical, Inc. | Energetic modulation of nerves |
US8517962B2 (en) | 2009-10-12 | 2013-08-27 | Kona Medical, Inc. | Energetic modulation of nerves |
US20130231659A1 (en) * | 2012-03-01 | 2013-09-05 | Boston Scientific Scimed, Inc. | Off-wall and contact electrode devices and methods for nerve modulation |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US8579893B2 (en) | 2005-08-03 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
US8579892B2 (en) | 2003-10-07 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
US8612022B1 (en) | 2012-09-13 | 2013-12-17 | Invatec S.P.A. | Neuromodulation catheters and associated systems and methods |
US8622937B2 (en) | 1999-11-26 | 2014-01-07 | Kona Medical, Inc. | Controlled high efficiency lesion formation using high intensity ultrasound |
US20140025069A1 (en) * | 2012-07-17 | 2014-01-23 | Boston Scientific Scimed, Inc. | Renal nerve modulation catheter design |
US20140114215A1 (en) * | 2012-10-20 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for Renal Neuromodulation and Associated Systems and Devices |
US20140128865A1 (en) * | 2012-11-05 | 2014-05-08 | Yossi Gross | Controlled renal artery ablation |
US8725249B2 (en) | 2008-12-09 | 2014-05-13 | Nephera Ltd. | Stimulation of the urinary system |
US8721632B2 (en) | 2008-09-09 | 2014-05-13 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US8728075B2 (en) | 2010-04-26 | 2014-05-20 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-directional deflectable catheter apparatuses, systems, and methods for renal neuromodulation |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US8771252B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for renal nerve blocking |
US20140213873A1 (en) * | 2011-08-26 | 2014-07-31 | Symap Holding Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US8808345B2 (en) | 2008-12-31 | 2014-08-19 | Medtronic Ardian Luxembourg S.A.R.L. | Handle assemblies for intravascular treatment devices and associated systems and methods |
US20140276756A1 (en) * | 2013-03-15 | 2014-09-18 | Boston Scientific Scimed, Inc. | Wall-sparing renal nerve ablation catheter with spaced electrode structures |
US8858549B2 (en) | 1998-03-27 | 2014-10-14 | Tsunami Medtech, Llc | Medical instruments and techniques for treating pulmonary disorders |
US8888773B2 (en) | 2012-05-11 | 2014-11-18 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US8900223B2 (en) | 2009-11-06 | 2014-12-02 | Tsunami Medtech, Llc | Tissue ablation systems and methods of use |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US8923970B2 (en) | 2008-12-09 | 2014-12-30 | Nephera Ltd. | Stimulation of the urinary system |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8945107B2 (en) | 2010-10-26 | 2015-02-03 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US8951296B2 (en) | 2012-06-29 | 2015-02-10 | Medtronic Ardian Luxembourg S.A.R.L. | Devices and methods for photodynamically modulating neural function in a human |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US8956352B2 (en) | 2010-10-25 | 2015-02-17 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
US8974445B2 (en) | 2009-01-09 | 2015-03-10 | Recor Medical, Inc. | Methods and apparatus for treatment of cardiac valve insufficiency |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US8986211B2 (en) | 2009-10-12 | 2015-03-24 | Kona Medical, Inc. | Energetic modulation of nerves |
US8986231B2 (en) | 2009-10-12 | 2015-03-24 | Kona Medical, Inc. | Energetic modulation of nerves |
US8992447B2 (en) | 2009-10-12 | 2015-03-31 | Kona Medical, Inc. | Energetic modulation of nerves |
US9017317B2 (en) | 2012-12-06 | 2015-04-28 | Medtronic Ardian Luxembourg S.A.R.L. | Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20150126997A1 (en) * | 2010-10-20 | 2015-05-07 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter Apparatuses Having Expandable Mesh Structures for Renal Neuromodulation and Associated Systems and Methods |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9044575B2 (en) | 2012-10-22 | 2015-06-02 | Medtronic Adrian Luxembourg S.a.r.l. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9060754B2 (en) | 2010-10-26 | 2015-06-23 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9066720B2 (en) | 2010-10-25 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
US9066726B2 (en) | 2013-03-15 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode apposition judgment using pressure elements |
US20150190194A1 (en) * | 2014-01-06 | 2015-07-09 | Boston Scientific Scimed, Inc. | Sympathetic nerve ablation devices with an expansion-limiting member |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9084610B2 (en) | 2010-10-21 | 2015-07-21 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9095321B2 (en) | 2012-11-21 | 2015-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices having integral multi-helical balloons and methods of making the same |
US9113944B2 (en) | 2003-01-18 | 2015-08-25 | Tsunami Medtech, Llc | Method for performing lung volume reduction |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US9138578B2 (en) | 2013-09-10 | 2015-09-22 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular catheters with tuned control members and associated systems and methods |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9155590B2 (en) | 2010-03-03 | 2015-10-13 | Medtronic Ablation Frontiers, Llc | Variable-output radiofrequency ablation power supply |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9161801B2 (en) | 2009-12-30 | 2015-10-20 | Tsunami Medtech, Llc | Medical system and method of use |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US9192766B2 (en) | 2011-12-02 | 2015-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and devices for treatment of polycystic kidney disease |
US9192715B2 (en) | 2002-04-08 | 2015-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal nerve blocking |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US20150343221A1 (en) * | 2012-12-19 | 2015-12-03 | Surgical Electronics SA | Systems and Methods for Hypertension Control |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9241752B2 (en) | 2012-04-27 | 2016-01-26 | Medtronic Ardian Luxembourg S.A.R.L. | Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US20160081744A1 (en) * | 2011-08-26 | 2016-03-24 | Symap Holding Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-d mapping and catheters for same |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US9314644B2 (en) | 2006-06-28 | 2016-04-19 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for thermally-induced renal neuromodulation |
US9327123B2 (en) | 2011-11-07 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular nerve monitoring devices and associated systems and methods |
US9326816B2 (en) | 2013-08-30 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation systems having nerve monitoring assemblies and associated devices, systems, and methods |
US9327122B2 (en) | 2002-04-08 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9332916B2 (en) | 2011-10-05 | 2016-05-10 | 3Dt Holdings, Llc | Systems, devices, and methods for determining fractional flow reserve in the presence of a catheter |
US9339332B2 (en) | 2013-08-30 | 2016-05-17 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with nerve monitoring features for transmitting digital neural signals and associated systems and methods |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9381063B2 (en) | 2012-07-13 | 2016-07-05 | Magnetecs Inc. | Method and apparatus for magnetically guided catheter for renal denervation employing MOSFET sensor array |
US9399115B2 (en) | 2012-10-22 | 2016-07-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9433457B2 (en) | 2000-12-09 | 2016-09-06 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9439726B2 (en) | 2002-04-08 | 2016-09-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US9439598B2 (en) | 2012-04-12 | 2016-09-13 | NeuroMedic, Inc. | Mapping and ablation of nerves within arteries and tissues |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US20160331447A1 (en) * | 2013-12-20 | 2016-11-17 | The Johns Hopkins University | Method and apparatus for selective treatment inside a body lumen |
US9510777B2 (en) | 2012-03-08 | 2016-12-06 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring of neuromodulation using biomarkers |
US9561067B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9579149B2 (en) | 2014-03-13 | 2017-02-28 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
US9629679B2 (en) | 2002-04-08 | 2017-04-25 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal denervation |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9687288B2 (en) | 2013-09-30 | 2017-06-27 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9700372B2 (en) | 2002-07-01 | 2017-07-11 | Recor Medical, Inc. | Intraluminal methods of ablating nerve tissue |
US9700365B2 (en) | 2008-10-06 | 2017-07-11 | Santa Anna Tech Llc | Method and apparatus for the ablation of gastrointestinal tissue |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9713483B2 (en) | 1995-10-13 | 2017-07-25 | Medtronic Vascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US9744333B2 (en) | 2012-10-19 | 2017-08-29 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for catheter treatment devices and associated devices, systems and methods |
US9743845B2 (en) | 2011-08-26 | 2017-08-29 | Symap Medical (Suzhou), Ltd | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
US9763743B2 (en) | 2014-07-25 | 2017-09-19 | Arrinex, Inc. | Apparatus and method for treating rhinitis |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US9848950B2 (en) | 2012-04-27 | 2017-12-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for localized disease treatment by ablation |
US9883909B2 (en) | 2012-03-08 | 2018-02-06 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and systems for treatment of hyperaldosteronism |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US9919144B2 (en) | 2011-04-08 | 2018-03-20 | Medtronic Adrian Luxembourg S.a.r.l. | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US9924992B2 (en) | 2008-02-20 | 2018-03-27 | Tsunami Medtech, Llc | Medical system and method of use |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US9943354B2 (en) | 2012-04-27 | 2018-04-17 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for localized inhibition of inflammation by ablation |
US9943666B2 (en) | 2009-10-30 | 2018-04-17 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US20180117363A1 (en) * | 2012-03-08 | 2018-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter-based devices and associated methods for immune system neuromodulation |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9974593B2 (en) | 2012-03-08 | 2018-05-22 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the treatment of sexual dysfunction |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
US9999461B2 (en) | 2011-12-09 | 2018-06-19 | Metavention, Inc. | Therapeutic denervation of nerves surrounding a hepatic vessel |
US10004557B2 (en) | 2012-11-05 | 2018-06-26 | Pythagoras Medical Ltd. | Controlled tissue ablation |
US10004550B2 (en) | 2010-08-05 | 2018-06-26 | Medtronic Ardian Luxembourg S.A.R.L. | Cryoablation apparatuses, systems, and methods for renal neuromodulation |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10166069B2 (en) | 2014-01-27 | 2019-01-01 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10201687B2 (en) | 2013-02-08 | 2019-02-12 | Arrinex, Inc. | Surgical device with integrated visualization and cauterization |
US10230041B2 (en) | 2013-03-14 | 2019-03-12 | Recor Medical, Inc. | Methods of plating or coating ultrasound transducers |
CN109464187A (en) * | 2017-09-08 | 2019-03-15 | 泽丹医疗股份有限公司 | The device and method for treating lung tumors |
US10231784B2 (en) | 2016-10-28 | 2019-03-19 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics |
US10258791B2 (en) | 2012-04-27 | 2019-04-16 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US10292754B2 (en) | 2010-11-17 | 2019-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Therapeutic renal neuromodulation for treating dyspnea and associated systems and methods |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US10342592B2 (en) | 2012-03-07 | 2019-07-09 | Medtronic Ardian Luxembourg S.A.R.L. | Selective modulation of renal nerves |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10350440B2 (en) | 2013-03-14 | 2019-07-16 | Recor Medical, Inc. | Ultrasound-based neuromodulation system |
US10368775B2 (en) | 2014-10-01 | 2019-08-06 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for evaluating neuromodulation therapy via hemodynamic responses |
US10383685B2 (en) | 2015-05-07 | 2019-08-20 | Pythagoras Medical Ltd. | Techniques for use with nerve tissue |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10426545B2 (en) | 2013-04-15 | 2019-10-01 | Mayo Foundation For Medical Education And Research | Method and apparatus for percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
US10463424B2 (en) | 2014-03-11 | 2019-11-05 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with independent radial-expansion members and associated devices, systems, and methods |
US20190343581A1 (en) * | 2017-09-08 | 2019-11-14 | Zidan Medical Inc. | Devices and methods for treating lung tumors |
US10478249B2 (en) | 2014-05-07 | 2019-11-19 | Pythagoras Medical Ltd. | Controlled tissue ablation techniques |
US10492842B2 (en) | 2014-03-07 | 2019-12-03 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring and controlling internally administered cryotherapy |
US10524859B2 (en) | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
US10543037B2 (en) | 2013-03-15 | 2020-01-28 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled neuromodulation systems and methods of use |
US10548663B2 (en) | 2013-05-18 | 2020-02-04 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US20200077907A1 (en) * | 2015-07-29 | 2020-03-12 | NeuroMedic, Inc. | Intraluminal microneurography denervation probe with radio frequency ablation |
US10588682B2 (en) | 2011-04-25 | 2020-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
US10646713B2 (en) | 2017-02-22 | 2020-05-12 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for treating patients via renal neuromodulation to reduce a risk of developing cognitive impairment |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US10667736B2 (en) | 2014-12-17 | 2020-06-02 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing sympathetic nervous system tone for neuromodulation therapy |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10737123B2 (en) | 2012-03-08 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the management of pain |
US10736692B2 (en) | 2016-04-28 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the treatment of cancer |
US10772681B2 (en) | 2009-10-12 | 2020-09-15 | Utsuka Medical Devices Co., Ltd. | Energy delivery to intraparenchymal regions of the kidney |
US20200297418A1 (en) * | 2011-07-29 | 2020-09-24 | Medtronic Ablation Frontiers Llc | Intracardiac tools and methods for delivery of electroporation therapies |
US10813533B2 (en) | 2013-07-24 | 2020-10-27 | Arrinex, Inc. | Direct vision cryosurgical probe and methods of use |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10905490B2 (en) | 2012-04-27 | 2021-02-02 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices for renal neuromodulation and associated systems and methods |
US10925579B2 (en) | 2014-11-05 | 2021-02-23 | Otsuka Medical Devices Co., Ltd. | Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10945788B2 (en) | 2017-07-05 | 2021-03-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating depression in patients via renal neuromodulation |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US10959669B2 (en) | 2018-01-24 | 2021-03-30 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing the efficacy of neuromodulation therapy |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US11013554B2 (en) | 2014-11-14 | 2021-05-25 | Medtronic Ardian Lexembourg S.A.R.L. | Catheter apparatuses for modulation of nerves in communication with pulmonary system and associated systems and methods |
US11013549B2 (en) | 2012-03-08 | 2021-05-25 | Medtronic Ardian Luxembourg S.A.R.L. | Gastrointestinal neuromodulation and associated systems and methods |
US11026738B2 (en) | 2016-06-15 | 2021-06-08 | Arrinex, Inc. | Devices and methods for treating a lateral surface of a nasal cavity |
US11116561B2 (en) | 2018-01-24 | 2021-09-14 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, agents, and associated methods for selective modulation of renal nerves |
US11116564B2 (en) | 2017-07-05 | 2021-09-14 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating anxiety disorders in patients via renal neuromodulation |
US11154712B2 (en) | 2014-08-28 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for assessing efficacy of renal neuromodulation and associated systems and devices |
US11160982B2 (en) | 2017-07-05 | 2021-11-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating post-traumatic stress disorder in patients via renal neuromodulation |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11213678B2 (en) | 2013-09-09 | 2022-01-04 | Medtronic Ardian Luxembourg S.A.R.L. | Method of manufacturing a medical device for neuromodulation |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US11253312B2 (en) | 2016-10-17 | 2022-02-22 | Arrinex, Inc. | Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use |
US11253189B2 (en) | 2018-01-24 | 2022-02-22 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and methods for evaluating neuromodulation therapy via detection of magnetic fields |
US11278356B2 (en) | 2017-04-28 | 2022-03-22 | Arrinex, Inc. | Systems and methods for locating blood vessels in the treatment of rhinitis |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
US11304749B2 (en) | 2017-11-17 | 2022-04-19 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US11478298B2 (en) | 2018-01-24 | 2022-10-25 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled irrigation for neuromodulation systems and associated methods |
US11602260B2 (en) | 2016-02-11 | 2023-03-14 | Arrinex, Inc. | Method and device for image guided post-nasal nerve ablation |
US11633120B2 (en) | 2018-09-04 | 2023-04-25 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing efficacy of renal neuromodulation therapy |
US11678932B2 (en) | 2016-05-18 | 2023-06-20 | Symap Medical (Suzhou) Limited | Electrode catheter with incremental advancement |
US11806066B2 (en) | 2018-06-01 | 2023-11-07 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
US11832965B2 (en) | 2018-10-06 | 2023-12-05 | Symap Medical (Suzhou), Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-D mapping and catheters for same |
Families Citing this family (529)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US6300108B1 (en) | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US8251986B2 (en) | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
US6795728B2 (en) | 2001-08-17 | 2004-09-21 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation |
US6892099B2 (en) | 2001-02-08 | 2005-05-10 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation |
US6697670B2 (en) | 2001-08-17 | 2004-02-24 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients |
USRE42016E1 (en) | 2001-08-13 | 2010-12-28 | Angiodynamics, Inc. | Apparatus and method for the treatment of benign prostatic hyperplasia |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US8974446B2 (en) | 2001-10-11 | 2015-03-10 | St. Jude Medical, Inc. | Ultrasound ablation apparatus with discrete staggered ablation zones |
WO2004037341A2 (en) | 2002-05-07 | 2004-05-06 | Schroeppel Edward A | Method and device for treating concer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
US20100152607A1 (en) * | 2003-02-21 | 2010-06-17 | Kassab Ghassan S | Devices, systems, and methods for measuring parallel tissue conductance, luminal cross-sectional areas, fluid velocity, and/or determining plaque vulnerability using temperature |
PL1696812T3 (en) | 2003-12-24 | 2015-12-31 | Univ California | Tissue ablation with irreversible electroporation |
US8298222B2 (en) * | 2003-12-24 | 2012-10-30 | The Regents Of The University Of California | Electroporation to deliver chemotherapeutics and enhance tumor regression |
US9510930B2 (en) | 2008-10-22 | 2016-12-06 | Contego Medical, Llc | Angioplasty device with embolic filter |
US9707071B2 (en) | 2004-11-24 | 2017-07-18 | Contego Medical Llc | Percutaneous transluminal angioplasty device with integral embolic filter |
CN101076290B (en) | 2004-12-09 | 2011-11-23 | 铸造品股份有限公司 | Aortic valve repair |
US7499748B2 (en) * | 2005-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Transvascular neural stimulation device |
US8114070B2 (en) | 2005-06-24 | 2012-02-14 | Angiodynamics, Inc. | Methods and systems for treating BPH using electroporation |
US20060293730A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating restenosis sites using electroporation |
CN101282677B (en) | 2005-10-05 | 2010-07-28 | 奥林巴斯医疗株式会社 | Capsule type medical device, its guidance system and guidance method and examinee insertion device |
US10716749B2 (en) * | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
US7519253B2 (en) | 2005-11-18 | 2009-04-14 | Omni Sciences, Inc. | Broadband or mid-infrared fiber light sources |
EP1962949B1 (en) * | 2005-12-20 | 2015-02-25 | The Cleveland Clinic Foundation | Apparatus for modulating the baroreflex system |
US7993334B2 (en) * | 2005-12-29 | 2011-08-09 | Boston Scientific Scimed, Inc. | Low-profile, expanding single needle ablation probe |
JP5329978B2 (en) * | 2006-02-24 | 2013-10-30 | イースタン バージニア メディカル スクール | Nanosecond pulsed electric field causing self-destruction of melanoma |
US8571650B2 (en) | 2006-03-03 | 2013-10-29 | Palo Alto Investors | Methods and compositions for treating a renal associated condition in a subject |
US8401650B2 (en) * | 2008-04-10 | 2013-03-19 | Electrocore Llc | Methods and apparatus for electrical treatment using balloon and electrode |
US10499937B2 (en) | 2006-05-19 | 2019-12-10 | Recor Medical, Inc. | Ablation device with optimized input power profile and method of using the same |
WO2007140331A2 (en) | 2006-05-25 | 2007-12-06 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US8126538B2 (en) | 2006-06-06 | 2012-02-28 | Cardiac Pacemakers, Inc. | Method and apparatus for introducing endolymphatic instrumentation |
US7734341B2 (en) | 2006-06-06 | 2010-06-08 | Cardiac Pacemakers, Inc. | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
US7894906B2 (en) | 2006-06-06 | 2011-02-22 | Cardiac Pacemakers, Inc. | Amelioration of chronic pain by endolymphatic stimulation |
US20070282376A1 (en) | 2006-06-06 | 2007-12-06 | Shuros Allan C | Method and apparatus for neural stimulation via the lymphatic system |
US8905999B2 (en) | 2006-09-01 | 2014-12-09 | Cardiac Pacemakers, Inc. | Method and apparatus for endolymphatic drug delivery |
EP2076313A4 (en) | 2006-10-16 | 2012-07-25 | Univ California | Gels with predetermined conductivity used in irreversible electroporation of tissue |
US20080132884A1 (en) * | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Systems for treating tissue sites using electroporation |
US20080132885A1 (en) * | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Methods for treating tissue sites using electroporation |
US7744618B2 (en) * | 2006-12-07 | 2010-06-29 | Cardiac Pacemakers, Inc. | Device and method for modulating renal function |
CA2676119C (en) | 2007-01-29 | 2021-01-19 | Simon Fraser University | Transvascular nerve stimulation apparatus and methods |
WO2008100974A2 (en) | 2007-02-13 | 2008-08-21 | Sharma Virender K | Method and apparatus for electrical stimulation of the pancreatico-biliary system |
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
US7815662B2 (en) | 2007-03-08 | 2010-10-19 | Ethicon Endo-Surgery, Inc. | Surgical suture anchors and deployment device |
US11679261B2 (en) | 2007-03-09 | 2023-06-20 | Mainstay Medical Limited | Systems and methods for enhancing function of spine stabilization muscles associated with a spine surgery intervention |
US9072897B2 (en) | 2007-03-09 | 2015-07-07 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine |
US11679262B2 (en) | 2007-03-09 | 2023-06-20 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine |
WO2008128070A2 (en) | 2007-04-11 | 2008-10-23 | The Cleveland Clinic Foundation | Method and apparatus for renal neuromodulation |
US8075572B2 (en) | 2007-04-26 | 2011-12-13 | Ethicon Endo-Surgery, Inc. | Surgical suturing apparatus |
US8100922B2 (en) | 2007-04-27 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Curved needle suturing tool |
EP2142070B1 (en) * | 2007-04-27 | 2021-01-06 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter |
US8103359B2 (en) * | 2007-05-17 | 2012-01-24 | Cardiac Pacemakers, Inc. | Systems and methods for fixating transvenously implanted medical devices |
US9162073B2 (en) | 2007-05-30 | 2015-10-20 | The Cleveland Clinic Foundation | Method for treating erectile dysfunction |
EP2198797B1 (en) | 2007-08-23 | 2011-04-13 | Aegea Medical, Inc. | Uterine therapy device |
US8579897B2 (en) | 2007-11-21 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
US8262655B2 (en) | 2007-11-21 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
US8568410B2 (en) | 2007-08-31 | 2013-10-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation surgical instruments |
US20100298759A1 (en) * | 2007-10-11 | 2010-11-25 | Region Hovedstaden V/Herlev Hospital | electroporation device for improved electrical field control |
US8480657B2 (en) | 2007-10-31 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Detachable distal overtube section and methods for forming a sealable opening in the wall of an organ |
US20090112059A1 (en) | 2007-10-31 | 2009-04-30 | Nobis Rudolph H | Apparatus and methods for closing a gastrotomy |
US8298216B2 (en) | 2007-11-14 | 2012-10-30 | Myoscience, Inc. | Pain management using cryogenic remodeling |
US8195287B2 (en) | 2007-12-05 | 2012-06-05 | The Invention Science Fund I, Llc | Method for electrical modulation of neural conduction |
US8180447B2 (en) | 2007-12-05 | 2012-05-15 | The Invention Science Fund I, Llc | Method for reversible chemical modulation of neural activity |
US8170659B2 (en) | 2007-12-05 | 2012-05-01 | The Invention Science Fund I, Llc | Method for thermal modulation of neural activity |
US8165669B2 (en) | 2007-12-05 | 2012-04-24 | The Invention Science Fund I, Llc | System for magnetic modulation of neural conduction |
US8170658B2 (en) | 2007-12-05 | 2012-05-01 | The Invention Science Fund I, Llc | System for electrical modulation of neural conduction |
US8989858B2 (en) | 2007-12-05 | 2015-03-24 | The Invention Science Fund I, Llc | Implant system for chemical modulation of neural activity |
US8165668B2 (en) | 2007-12-05 | 2012-04-24 | The Invention Science Fund I, Llc | Method for magnetic modulation of neural conduction |
US8180446B2 (en) | 2007-12-05 | 2012-05-15 | The Invention Science Fund I, Llc | Method and system for cyclical neural modulation based on activity state |
US8262680B2 (en) | 2008-03-10 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Anastomotic device |
WO2009121017A1 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California | Balloon catheter for reducing restenosis via irreversible electroporation |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10702326B2 (en) * | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
WO2009134876A1 (en) | 2008-04-29 | 2009-11-05 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US20090281477A1 (en) | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
US8652150B2 (en) | 2008-05-30 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Multifunction surgical device |
US8771260B2 (en) | 2008-05-30 | 2014-07-08 | Ethicon Endo-Surgery, Inc. | Actuating and articulating surgical device |
US8070759B2 (en) | 2008-05-30 | 2011-12-06 | Ethicon Endo-Surgery, Inc. | Surgical fastening device |
US8679003B2 (en) | 2008-05-30 | 2014-03-25 | Ethicon Endo-Surgery, Inc. | Surgical device and endoscope including same |
US8114072B2 (en) | 2008-05-30 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | Electrical ablation device |
US8317806B2 (en) | 2008-05-30 | 2012-11-27 | Ethicon Endo-Surgery, Inc. | Endoscopic suturing tension controlling and indication devices |
US8906035B2 (en) | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
US8403926B2 (en) | 2008-06-05 | 2013-03-26 | Ethicon Endo-Surgery, Inc. | Manually articulating devices |
US8713026B2 (en) * | 2008-06-13 | 2014-04-29 | Sandisk Technologies Inc. | Method for playing digital media files with a digital media player using a plurality of playlists |
US9173704B2 (en) | 2008-06-20 | 2015-11-03 | Angiodynamics, Inc. | Device and method for the ablation of fibrin sheath formation on a venous catheter |
US9681909B2 (en) | 2008-06-23 | 2017-06-20 | Angiodynamics, Inc. | Treatment devices and methods |
US8361112B2 (en) | 2008-06-27 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Surgical suture arrangement |
WO2010003106A2 (en) * | 2008-07-02 | 2010-01-07 | Niveus Medical Inc. | Systems and methods for automated muscle stimulation |
US8892210B2 (en) | 2008-07-02 | 2014-11-18 | Niveus Medical, Inc. | Devices, systems, and methods for automated optimization of energy delivery |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
US8262563B2 (en) | 2008-07-14 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Endoscopic translumenal articulatable steerable overtube |
WO2010019481A1 (en) | 2008-08-11 | 2010-02-18 | Conceptx Medical, Inc. | Systems and methods for treating dyspnea, including via electrical afferent signal blocking |
US8211125B2 (en) | 2008-08-15 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Sterile appliance delivery device for endoscopic procedures |
US9149386B2 (en) | 2008-08-19 | 2015-10-06 | Niveus Medical, Inc. | Devices and systems for stimulation of tissues |
EP2326273B1 (en) * | 2008-08-20 | 2021-11-24 | Prostacare Pty Ltd | System including a catheter and deployable electrodes for the non-thermal ablation of tissue |
US10842555B2 (en) * | 2008-08-20 | 2020-11-24 | Prostacare Pty Ltd | Catheter for treating tissue with non-thermal ablation |
US8529563B2 (en) | 2008-08-25 | 2013-09-10 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
WO2010027874A2 (en) * | 2008-08-26 | 2010-03-11 | Niveus Medical, Inc. | Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema |
US8241204B2 (en) | 2008-08-29 | 2012-08-14 | Ethicon Endo-Surgery, Inc. | Articulating end cap |
US8480689B2 (en) | 2008-09-02 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Suturing device |
US8409200B2 (en) | 2008-09-03 | 2013-04-02 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
US8114119B2 (en) | 2008-09-09 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
EP2341839B1 (en) * | 2008-09-22 | 2015-10-21 | Vessix Vascular, Inc. | System for vascular ultrasound treatments |
US8337394B2 (en) | 2008-10-01 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Overtube with expandable tip |
US9079028B2 (en) | 2008-10-09 | 2015-07-14 | Virender K. Sharma | Method and apparatus for stimulating the vascular system |
US10603489B2 (en) | 2008-10-09 | 2020-03-31 | Virender K. Sharma | Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage |
ES2615826T3 (en) * | 2008-11-11 | 2017-06-08 | Shifamed Holdings, Llc | Low Profile Electrode Set |
US10987494B2 (en) | 2008-11-11 | 2021-04-27 | Covidien Lp | Pleated or folded catheter-mounted balloon |
US11376061B2 (en) | 2008-11-11 | 2022-07-05 | Covidien Lp | Energy delivery device and methods of use |
US9795442B2 (en) | 2008-11-11 | 2017-10-24 | Shifamed Holdings, Llc | Ablation catheters |
US8382746B2 (en) | 2008-11-21 | 2013-02-26 | C2 Therapeutics, Inc. | Cryogenic ablation system and method |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
US8172772B2 (en) | 2008-12-11 | 2012-05-08 | Ethicon Endo-Surgery, Inc. | Specimen retrieval device |
US8361066B2 (en) * | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8828031B2 (en) | 2009-01-12 | 2014-09-09 | Ethicon Endo-Surgery, Inc. | Apparatus for forming an anastomosis |
WO2010085765A2 (en) | 2009-01-23 | 2010-07-29 | Moshe Meir H | Therapeutic energy delivery device with rotational mechanism |
US9226772B2 (en) | 2009-01-30 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Surgical device |
US8252057B2 (en) | 2009-01-30 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Surgical access device |
US8037591B2 (en) | 2009-02-02 | 2011-10-18 | Ethicon Endo-Surgery, Inc. | Surgical scissors |
WO2010093692A2 (en) | 2009-02-10 | 2010-08-19 | Hobbs Eamonn P | Irreversible electroporation and tissue regeneration |
CA2751527C (en) | 2009-02-20 | 2020-05-05 | Niveus Medical, Inc. | Systems and methods of powered muscle stimulation using an energy guidance field |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
WO2010118387A1 (en) | 2009-04-09 | 2010-10-14 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
USD630321S1 (en) | 2009-05-08 | 2011-01-04 | Angio Dynamics, Inc. | Probe handle |
US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
CA2764859C (en) * | 2009-06-24 | 2018-09-25 | Shifamed, Llc | Steerable medical delivery devices and methods of use |
WO2011008903A2 (en) * | 2009-07-15 | 2011-01-20 | Uab Research Foundation | Catheter having temperature controlled anchor and related methods |
WO2011046879A1 (en) * | 2009-10-12 | 2011-04-21 | Kona Medical, Inc. | Energetic modulation of nerves |
EP2490756A1 (en) * | 2009-10-19 | 2012-08-29 | Cardiac Pacemakers, Inc. | Cardiorenal electrical stimulation system |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
CN102596319B (en) * | 2009-10-30 | 2015-07-15 | 科纳医药股份有限公司 | Method and apparatus for non-invasive treatment of hypertension through ultrasound renal denervation |
US8608652B2 (en) | 2009-11-05 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Vaginal entry surgical devices, kit, system, and method |
US20110112400A1 (en) * | 2009-11-06 | 2011-05-12 | Ardian, Inc. | High intensity focused ultrasound catheter apparatuses, systems, and methods for renal neuromodulation |
US20110112527A1 (en) * | 2009-11-06 | 2011-05-12 | Angiodynamics, Inc. | Flexible medical ablation device and method of use |
AU2010319602B2 (en) * | 2009-11-11 | 2015-09-24 | Sage Products, Llc | Synergistic muscle activation device |
EP2498706B1 (en) | 2009-11-13 | 2016-04-20 | St. Jude Medical, Inc. | Assembly of staggered ablation elements |
US20110118732A1 (en) | 2009-11-19 | 2011-05-19 | The Regents Of The University Of California | Controlled irreversible electroporation |
US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
US8353487B2 (en) | 2009-12-17 | 2013-01-15 | Ethicon Endo-Surgery, Inc. | User interface support devices for endoscopic surgical instruments |
US8496574B2 (en) | 2009-12-17 | 2013-07-30 | Ethicon Endo-Surgery, Inc. | Selectively positionable camera for surgical guide tube assembly |
US9028483B2 (en) * | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US8506564B2 (en) | 2009-12-18 | 2013-08-13 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
WO2011078676A1 (en) | 2009-12-23 | 2011-06-30 | Hitops Gmbh | New use of pulsed radio frequency |
US20110263921A1 (en) * | 2009-12-31 | 2011-10-27 | Anthony Vrba | Patterned Denervation Therapy for Innervated Renal Vasculature |
WO2011084863A2 (en) | 2010-01-07 | 2011-07-14 | Cheetah Omni, Llc | Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy |
WO2011094367A1 (en) | 2010-01-26 | 2011-08-04 | Evans Michael A | Methods, devices, and agents for denervation |
US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110190858A1 (en) * | 2010-01-29 | 2011-08-04 | Medtronic, Inc. | Lead having expandable distal portion |
US20110208175A1 (en) * | 2010-02-24 | 2011-08-25 | Medtronic Vascular, Inc. | Methods for Treating Sleep Apnea Via Renal Denervation |
US11786725B2 (en) | 2012-06-13 | 2023-10-17 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine and kits for implanting the same |
US11684774B2 (en) * | 2010-03-11 | 2023-06-27 | Mainstay Medical Limited | Electrical stimulator for treatment of back pain and methods of use |
US8740898B2 (en) * | 2010-03-22 | 2014-06-03 | Covidien Lp | Surgical forceps |
CN102917748B (en) | 2010-03-24 | 2015-04-01 | 施菲姆德控股有限责任公司 | Intravascular tissue disruption |
EP3175808B1 (en) * | 2010-04-26 | 2019-08-21 | Medtronic Ardian Luxembourg S.à.r.l. | Catheter apparatuses and systems for renal neuromodulation |
EP2568905A4 (en) | 2010-05-12 | 2017-07-26 | Shifamed Holdings, LLC | Low profile electrode assembly |
US9655677B2 (en) | 2010-05-12 | 2017-05-23 | Shifamed Holdings, Llc | Ablation catheters including a balloon and electrodes |
US9554725B2 (en) * | 2010-08-03 | 2017-01-31 | Medtronic Monitoring, Inc. | Medical device and methods of monitoring a patient with renal dysfunction |
US20150150508A1 (en) * | 2010-08-31 | 2015-06-04 | Interventional Autonomics Corporation | Intravascular electrodes and anchoring devices for transvascular stimulation |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US8696581B2 (en) | 2010-10-18 | 2014-04-15 | CardioSonic Ltd. | Ultrasound transducer and uses thereof |
US9566456B2 (en) | 2010-10-18 | 2017-02-14 | CardioSonic Ltd. | Ultrasound transceiver and cooling thereof |
US9028417B2 (en) | 2010-10-18 | 2015-05-12 | CardioSonic Ltd. | Ultrasound emission element |
WO2012052924A1 (en) * | 2010-10-18 | 2012-04-26 | CardioSonic Ltd. | Separation device for ultrasound element |
US20130218068A1 (en) * | 2010-10-18 | 2013-08-22 | CardioSonic Ltd. | Therapeutics reservoir |
US20120109021A1 (en) * | 2010-10-27 | 2012-05-03 | Roger Hastings | Renal denervation catheter employing acoustic wave generator arrangement |
US9743974B2 (en) | 2010-11-09 | 2017-08-29 | Aegea Medical Inc. | Positioning method and apparatus for delivering vapor to the uterus |
US20120265198A1 (en) * | 2010-11-19 | 2012-10-18 | Crow Loren M | Renal nerve detection and ablation apparatus and method |
US9877781B2 (en) | 2010-11-19 | 2018-01-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode catheter device with indifferent electrode for direct current tissue therapies |
US20120157992A1 (en) * | 2010-12-15 | 2012-06-21 | Scott Smith | Off-wall electrode device for renal nerve ablation |
US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
US10016233B2 (en) * | 2010-12-06 | 2018-07-10 | Biosense Webster (Israel) Ltd. | Treatment of atrial fibrillation using high-frequency pacing and ablation of renal nerves |
WO2012088149A2 (en) | 2010-12-20 | 2012-06-28 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
CN203354638U (en) | 2010-12-21 | 2013-12-25 | 泰尔茂株式会社 | Balloon catheter and electrification system |
DE112011104637T5 (en) * | 2010-12-28 | 2015-10-22 | Cibiem, Inc.(n.d.Ges.d.Staates Delaware) | Method for restoring the autonomic balance of a patient |
US10092291B2 (en) | 2011-01-25 | 2018-10-09 | Ethicon Endo-Surgery, Inc. | Surgical instrument with selectively rigidizable features |
WO2012112165A1 (en) | 2011-02-18 | 2012-08-23 | Recor Medical, Inc. | Apparatus for effecting renal denervation using ultrasound |
US9254169B2 (en) * | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US20140012251A1 (en) * | 2011-03-07 | 2014-01-09 | Tidal Wave Technology, Inc. | Ablation devices and methods |
WO2012122157A1 (en) * | 2011-03-07 | 2012-09-13 | Tidal Wave Technology, Inc. | Radiofrequency ablation catheter device |
WO2012135703A2 (en) * | 2011-03-31 | 2012-10-04 | Tidal Wave Technology, Inc. | Radio frequency ablation catheter device |
WO2012125785A1 (en) | 2011-03-17 | 2012-09-20 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
WO2012135786A2 (en) * | 2011-04-01 | 2012-10-04 | The Regents Of The University Of California | Cryoelectric systems and methods for treatment of biological matter |
US8663190B2 (en) | 2011-04-22 | 2014-03-04 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
EP2701795B1 (en) | 2011-04-28 | 2020-12-09 | Interventional Autonomics Corporation | Neuromodulation systems for treating acute heart failure syndromes |
CN103764216B (en) | 2011-05-03 | 2016-08-17 | 施菲姆德控股有限责任公司 | Delivery catheter can be turned to |
CN102274074A (en) * | 2011-05-03 | 2011-12-14 | 上海微创电生理医疗科技有限公司 | Multi-electrode open-type radio frequency ablation catheter |
US20120323233A1 (en) | 2011-05-09 | 2012-12-20 | Cyberheart, Inc. | Renovascular treatment device, system, and method for radiosurgically alleviating hypertension |
US20120290024A1 (en) * | 2011-05-11 | 2012-11-15 | St. Jude Medical, Inc. | Transvenous renal nerve modulation for treatment of hypertension, cardiovascular disorders, and chronic renal diseases |
US8909316B2 (en) * | 2011-05-18 | 2014-12-09 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method of assessing transvascular denervation |
WO2012158864A1 (en) * | 2011-05-18 | 2012-11-22 | St. Jude Medical, Inc. | Apparatus and method of assessing transvascular denervation |
US9220433B2 (en) | 2011-06-30 | 2015-12-29 | Biosense Webster (Israel), Ltd. | Catheter with variable arcuate distal section |
US9446240B2 (en) | 2011-07-11 | 2016-09-20 | Interventional Autonomics Corporation | System and method for neuromodulation |
US20130072995A1 (en) | 2011-07-11 | 2013-03-21 | Terrance Ransbury | Catheter system for acute neuromodulation |
WO2013028274A2 (en) * | 2011-07-11 | 2013-02-28 | Synecor Llc | System and method for neuromodulation |
EP2731531B1 (en) * | 2011-07-12 | 2018-02-14 | Verve Medical, Inc. | Renal nerve denervation via the renal pelvis |
US9662169B2 (en) | 2011-07-30 | 2017-05-30 | Biosense Webster (Israel) Ltd. | Catheter with flow balancing valve |
US9056185B2 (en) | 2011-08-24 | 2015-06-16 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US20130165921A1 (en) * | 2011-08-24 | 2013-06-27 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation |
US20130053732A1 (en) * | 2011-08-24 | 2013-02-28 | Richard R. Heuser | Devices and methods for treating hypertension with energy |
US9278196B2 (en) | 2011-08-24 | 2016-03-08 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US20130053792A1 (en) | 2011-08-24 | 2013-02-28 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
CN203122581U (en) * | 2011-08-26 | 2013-08-14 | 王捷 | Catheter with function of mapping kidney nerves |
US9089668B2 (en) | 2011-09-28 | 2015-07-28 | Surefire Medical, Inc. | Flow directional infusion device |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US9427579B2 (en) | 2011-09-29 | 2016-08-30 | Pacesetter, Inc. | System and method for performing renal denervation verification |
KR20150143881A (en) * | 2011-09-30 | 2015-12-23 | 코비디엔 엘피 | Energy delivery device and methods of use |
JP6017568B2 (en) | 2011-10-07 | 2016-11-02 | イージー メディカル, インコーポレーテッド | Uterine treatment device |
US9204916B2 (en) * | 2011-10-27 | 2015-12-08 | Medtronic Cryocath Lp | Cryogenic balloon device with radiofrequency tip |
US20130116737A1 (en) * | 2011-11-07 | 2013-05-09 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for Assessing Renal Neuromodulation Treatment and Associated Systems and Methods |
US20140350553A1 (en) * | 2011-11-21 | 2014-11-27 | Denerve Inc. | Renal artery ablation catheter and system |
GB201120023D0 (en) * | 2011-11-21 | 2012-01-04 | Univ Dundee | Radio frequency surgical probe |
ITPD20110383A1 (en) * | 2011-12-05 | 2013-06-06 | Cardiac Impulse Srl | ELECTROCATETER FOR NEUROSTIMULATION |
US9844405B2 (en) | 2011-12-20 | 2017-12-19 | Cardiac Pacemakers, Inc. | Method and apparatus for monitoring and ablating nerves |
US20130184703A1 (en) * | 2012-01-17 | 2013-07-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods for making and using the same |
US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
US8986199B2 (en) | 2012-02-17 | 2015-03-24 | Ethicon Endo-Surgery, Inc. | Apparatus and methods for cleaning the lens of an endoscope |
US9089341B2 (en) | 2012-02-28 | 2015-07-28 | Surefire Medical, Inc. | Renal nerve neuromodulation device |
CN107126622A (en) | 2012-03-05 | 2017-09-05 | 西蒙·弗雷瑟大学 | neural stimulation system |
WO2013134121A2 (en) * | 2012-03-07 | 2013-09-12 | Enteromedics Inc. | Devices for regulation of blood pressure and heart rate |
US8934988B2 (en) | 2012-03-16 | 2015-01-13 | St. Jude Medical Ab | Ablation stent with meander structure |
JP5936409B2 (en) * | 2012-03-26 | 2016-06-22 | 国立研究開発法人国立循環器病研究センター | Electrode unit and tissue stimulation system |
JP2013198691A (en) * | 2012-03-26 | 2013-10-03 | Olympus Corp | Nerve stimulation electrode and nerve stimulation system |
US9259261B2 (en) * | 2012-04-12 | 2016-02-16 | Vanderbilt University | Ablation catheter having temperature-controlled anchor and related methods |
US8961550B2 (en) | 2012-04-17 | 2015-02-24 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
WO2013157011A2 (en) | 2012-04-18 | 2013-10-24 | CardioSonic Ltd. | Tissue treatment |
US9113929B2 (en) | 2012-04-19 | 2015-08-25 | St. Jude Medical, Cardiology Division, Inc. | Non-electric field renal denervation electrode |
WO2013163322A1 (en) | 2012-04-24 | 2013-10-31 | Cibiem, Inc. | Endovascular catheters and methods for carotid body ablation |
WO2013165920A1 (en) * | 2012-04-29 | 2013-11-07 | Synecor Llc | Intravascular electrode arrays for neuromodulation |
US11395921B2 (en) | 2012-04-29 | 2022-07-26 | Nuxcel2 Llc | Intravascular electrode arrays for neuromodulation |
WO2013165935A1 (en) * | 2012-05-03 | 2013-11-07 | Sound Interventions, Inc. | Apparatus and method for uniform renal denervation |
US9439722B2 (en) | 2012-05-09 | 2016-09-13 | Biosense Webster (Israel) Ltd. | Ablation targeting nerves in or near the inferior vena cava and/or abdominal aorta for treatment of hypertension |
US9717555B2 (en) | 2012-05-14 | 2017-08-01 | Biosense Webster (Israel), Ltd. | Catheter with helical end section for vessel ablation |
US9427255B2 (en) | 2012-05-14 | 2016-08-30 | Ethicon Endo-Surgery, Inc. | Apparatus for introducing a steerable camera assembly into a patient |
US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
WO2013181660A1 (en) | 2012-06-01 | 2013-12-05 | Cibiem, Inc. | Methods and devices for cryogenic carotid body ablation |
US10206616B2 (en) * | 2012-06-14 | 2019-02-19 | Autonomix Medical, Inc. | Devices, systems, and methods for diagnosis and treatment of overactive bladder |
EP2863987B1 (en) | 2012-06-21 | 2023-08-02 | Lungpacer Medical Inc. | Transvascular diaphragm pacing systems |
US9078662B2 (en) | 2012-07-03 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Endoscopic cap electrode and method for using the same |
JP2015521894A (en) * | 2012-07-05 | 2015-08-03 | エムシー10 インコーポレイテッドMc10,Inc. | Catheter device including flow sensing |
US9295842B2 (en) | 2012-07-05 | 2016-03-29 | Mc10, Inc. | Catheter or guidewire device including flow sensing and use thereof |
US9144459B2 (en) | 2012-07-19 | 2015-09-29 | Cook Medical Technologies Llc | Endoscopic ultrasound ablation needle |
EP3064249A3 (en) * | 2012-07-24 | 2016-09-14 | Clearstream Technologies Limited | Balloon catheter with enhanced locatability |
US9545290B2 (en) | 2012-07-30 | 2017-01-17 | Ethicon Endo-Surgery, Inc. | Needle probe guide |
US9572623B2 (en) | 2012-08-02 | 2017-02-21 | Ethicon Endo-Surgery, Inc. | Reusable electrode and disposable sheath |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
JP6301926B2 (en) | 2012-08-09 | 2018-03-28 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | Catheter, catheter system, and method for piercing tissue structure |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
CN103584909B (en) * | 2012-08-17 | 2016-01-27 | 王涛 | Open mesh radio-frequency ablation electrode |
US20140058372A1 (en) * | 2012-08-22 | 2014-02-27 | Amir Belson | Treatment for renal failure |
CN102784006B (en) * | 2012-08-24 | 2015-11-25 | 邹英华 | Be used for the treatment of hypertensive radio-frequency ablation electrode |
CN103284693B (en) * | 2012-08-24 | 2014-12-24 | 苏州信迈医疗器械有限公司 | Instrument for locating and identifying nerves in vessel wall, and application method thereof |
US9849025B2 (en) | 2012-09-07 | 2017-12-26 | Yale University | Brain cooling system |
JP2014054430A (en) | 2012-09-13 | 2014-03-27 | Nippon Koden Corp | Catheter |
WO2014047355A1 (en) | 2012-09-19 | 2014-03-27 | Denervx LLC | Cooled microwave denervation |
US9554849B2 (en) | 2012-10-29 | 2017-01-31 | Ablative Solutions, Inc. | Transvascular method of treating hypertension |
US10881458B2 (en) | 2012-10-29 | 2021-01-05 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US9301795B2 (en) | 2012-10-29 | 2016-04-05 | Ablative Solutions, Inc. | Transvascular catheter for extravascular delivery |
US10945787B2 (en) | 2012-10-29 | 2021-03-16 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US8740849B1 (en) | 2012-10-29 | 2014-06-03 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10226278B2 (en) | 2012-10-29 | 2019-03-12 | Ablative Solutions, Inc. | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US9526827B2 (en) | 2012-10-29 | 2016-12-27 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10736656B2 (en) | 2012-10-29 | 2020-08-11 | Ablative Solutions | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
EP2914326B1 (en) | 2012-11-02 | 2023-08-16 | Neurotronic, Inc. | Chemical ablation formulations |
US20140172034A1 (en) * | 2012-12-18 | 2014-06-19 | Pacesetter, Inc. | Intra-cardiac implantable medical device with ic device extension for lv pacing/sensing |
WO2014097300A1 (en) | 2012-12-20 | 2014-06-26 | Shlomo Ben-Haim | Multi point treatment probes and methods of using thereof |
US10537286B2 (en) * | 2013-01-08 | 2020-01-21 | Biosense Webster (Israel) Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
JP6134008B2 (en) * | 2013-01-18 | 2017-05-24 | エスアールアイ インターナショナルSRI International | Fixed nerve block catheter |
US9888956B2 (en) | 2013-01-22 | 2018-02-13 | Angiodynamics, Inc. | Integrated pump and generator device and method of use |
EP2759314A1 (en) * | 2013-01-28 | 2014-07-30 | Biotronik AG | Catheter for renal nerve modulation |
US10098527B2 (en) | 2013-02-27 | 2018-10-16 | Ethidcon Endo-Surgery, Inc. | System for performing a minimally invasive surgical procedure |
US20140303617A1 (en) * | 2013-03-05 | 2014-10-09 | Neuro Ablation, Inc. | Intravascular nerve ablation devices & methods |
US9179997B2 (en) | 2013-03-06 | 2015-11-10 | St. Jude Medical, Cardiology Division, Inc. | Thermochromic polyvinyl alcohol based hydrogel artery |
WO2015061621A1 (en) * | 2013-10-24 | 2015-04-30 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for pulmonary artery neuromodulation |
EP2777740A3 (en) | 2013-03-12 | 2015-01-21 | St. Jude Medical, Cardiology Division, Inc. | Catheter system |
EP2777741A3 (en) | 2013-03-12 | 2015-01-21 | St. Jude Medical, Cardiology Division, Inc. | Catheter system |
EP2777739B1 (en) | 2013-03-12 | 2018-09-05 | St. Jude Medical, Cardiology Division, Inc. | Catheter system |
US9510902B2 (en) | 2013-03-13 | 2016-12-06 | St. Jude Medical, Cardiology Division, Inc. | Ablation catheters and systems including rotational monitoring means |
US9861431B2 (en) * | 2013-03-13 | 2018-01-09 | Kyphon SÀRL | Radiofrequency inflatable device |
US8876813B2 (en) | 2013-03-14 | 2014-11-04 | St. Jude Medical, Inc. | Methods, systems, and apparatus for neural signal detection |
US9131982B2 (en) | 2013-03-14 | 2015-09-15 | St. Jude Medical, Cardiology Division, Inc. | Mediguide-enabled renal denervation system for ensuring wall contact and mapping lesion locations |
US20140275993A1 (en) * | 2013-03-15 | 2014-09-18 | Medtronic Ardian Luxembourg S.a.r.I. | Devices, Systems, and Methods for Specialization of Neuromodulation Treatment |
US9974477B2 (en) * | 2013-03-15 | 2018-05-22 | St. Jude Medical, Cardiology Division, Inc. | Quantification of renal denervation via alterations in renal blood flow pre/post ablation |
US9233247B2 (en) * | 2013-03-15 | 2016-01-12 | Boston Scientific Neuromodulation Corporation | Neuromodulation of renal nerve for treatment of hypertension |
US9173701B2 (en) | 2013-03-15 | 2015-11-03 | Warsaw Orthopedic, Inc. | RF enabled inflatable bone tamp |
US9610112B2 (en) | 2013-03-15 | 2017-04-04 | Myoscience, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
WO2014150432A1 (en) | 2013-03-15 | 2014-09-25 | St. Jude Medical, Cardiology Division, Inc. | Ablation system, methods, and controllers |
US10016229B2 (en) | 2013-03-15 | 2018-07-10 | Myoscience, Inc. | Methods and systems for treatment of occipital neuralgia |
US9179973B2 (en) | 2013-03-15 | 2015-11-10 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods for renal denervation utilizing balloon catheter |
US9186212B2 (en) | 2013-03-15 | 2015-11-17 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods utilizing two or more sites along denervation catheter |
US9295512B2 (en) | 2013-03-15 | 2016-03-29 | Myoscience, Inc. | Methods and devices for pain management |
US9713490B2 (en) | 2013-03-15 | 2017-07-25 | St. Jude Medical, Cardiology Division, Inc. | Ablation system, methods, and controllers |
WO2014160832A2 (en) | 2013-03-27 | 2014-10-02 | Tricord Holdings, L.L.C. | Systems and methods for neurological traffic and/or receptor functional evaluation and/or modification |
US10098694B2 (en) | 2013-04-08 | 2018-10-16 | Apama Medical, Inc. | Tissue ablation and monitoring thereof |
KR20150140760A (en) | 2013-04-08 | 2015-12-16 | 아파마 메디칼, 인크. | Cardiac ablation catheters and methods of use thereof |
US10349824B2 (en) | 2013-04-08 | 2019-07-16 | Apama Medical, Inc. | Tissue mapping and visualization systems |
WO2014176205A1 (en) | 2013-04-25 | 2014-10-30 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly for catheter system |
WO2014179768A1 (en) * | 2013-05-02 | 2014-11-06 | Harrington Douglas C | Devices and methods for detection and treatment of the aorticorenal ganglion |
AU2014268737A1 (en) * | 2013-05-20 | 2015-12-03 | Mayo Foundation For Medical Education And Research | Devices and methods for ablation of tissue |
US10933259B2 (en) | 2013-05-23 | 2021-03-02 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
KR102390107B1 (en) | 2013-05-30 | 2022-04-25 | 그라함 에이치. 크리시 | Topical neurological stimulation |
US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
US20160128767A1 (en) * | 2013-06-05 | 2016-05-12 | Metavention, Inc. | Modulation of targeted nerve fibers |
EP3010581B1 (en) * | 2013-06-18 | 2023-10-11 | Nalu Medical, Inc. | Apparatus for minimally invasive implantable modulators |
US9872728B2 (en) | 2013-06-28 | 2018-01-23 | St. Jude Medical, Cardiology Division, Inc. | Apparatuses and methods for affixing electrodes to an intravascular balloon |
US20150011991A1 (en) | 2013-07-03 | 2015-01-08 | St. Jude Medical, Cardiology Division, Inc. | Electrode Assembly For Catheter System |
WO2017123981A1 (en) | 2016-01-15 | 2017-07-20 | Rfemb Holdings, Llc | Immunologic treatment of cancer |
US10154869B2 (en) | 2013-08-02 | 2018-12-18 | Gary M. Onik | System and method for creating radio-frequency energy electrical membrane breakdown for tissue ablation |
TW201517865A (en) * | 2013-08-14 | 2015-05-16 | Vita Technologies Ltd | Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation |
JP2016531612A (en) * | 2013-09-30 | 2016-10-13 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | Intravascular neuromodulation device having a spiral track and related methods |
USD914883S1 (en) | 2013-10-23 | 2021-03-30 | St. Jude Medical, Cardiology Division, Inc. | Ablation generator |
USD747491S1 (en) | 2013-10-23 | 2016-01-12 | St. Jude Medical, Cardiology Division, Inc. | Ablation generator |
US10856936B2 (en) | 2013-10-23 | 2020-12-08 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly for catheter system including thermoplastic-based struts |
USD774043S1 (en) | 2013-10-23 | 2016-12-13 | St. Jude Medical, Cardiology Division, Inc. | Display screen with graphical user interface for ablation generator |
US9913961B2 (en) | 2013-10-24 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Flexible catheter shaft and method of manufacture |
US9999748B2 (en) | 2013-10-24 | 2018-06-19 | St. Jude Medical, Cardiology Division, Inc. | Flexible catheter shaft and method of manufacture |
US10034705B2 (en) | 2013-10-24 | 2018-07-31 | St. Jude Medical, Cardiology Division, Inc. | High strength electrode assembly for catheter system including novel electrode |
US10390881B2 (en) | 2013-10-25 | 2019-08-27 | Denervx LLC | Cooled microwave denervation catheter with insertion feature |
US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
US10517666B2 (en) | 2013-10-25 | 2019-12-31 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US9949652B2 (en) | 2013-10-25 | 2018-04-24 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
EP3062722B1 (en) | 2013-10-28 | 2019-03-20 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly for catheter system including interlinked struts |
US9861433B2 (en) | 2013-11-05 | 2018-01-09 | St. Jude Medical, Cardiology Division, Inc. | Helical-shaped ablation catheter and methods of use |
WO2015070147A1 (en) * | 2013-11-08 | 2015-05-14 | Contego Medical, Llc | Percutaneous catheter-based arterial denervation with integral embolic filter |
US9242088B2 (en) | 2013-11-22 | 2016-01-26 | Simon Fraser University | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
JP6723153B2 (en) | 2013-12-05 | 2020-07-15 | アールエフイーエムビー ホールディングス リミテッド ライアビリティ カンパニー | System for removing unwanted soft tissue in vivo |
US10279184B2 (en) | 2013-12-09 | 2019-05-07 | Ryan Kendall Pierce | Devices and methods for treating cardiovascular and metabolic disease |
CA2934245A1 (en) * | 2014-01-03 | 2015-07-09 | Mc10, Inc. | Catheter or guidewire device including flow sensing and use thereof |
EP3091921B1 (en) | 2014-01-06 | 2019-06-19 | Farapulse, Inc. | Apparatus for renal denervation ablation |
US10166321B2 (en) | 2014-01-09 | 2019-01-01 | Angiodynamics, Inc. | High-flow port and infusion needle systems |
US9511228B2 (en) | 2014-01-14 | 2016-12-06 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation |
US20150202444A1 (en) | 2014-01-17 | 2015-07-23 | Cardiac Pacemakers, Inc. | Systems and methods for selective stimulation of nerve fibers in carotid sinus |
CN106573144A (en) * | 2014-01-17 | 2017-04-19 | 心脏起搏器股份公司 | Depletion block to block nerve communication |
EP3096835B1 (en) | 2014-01-21 | 2019-08-07 | Lungpacer Medical Inc. | Systems for optimization of multi-electrode nerve pacing |
US20150209107A1 (en) | 2014-01-24 | 2015-07-30 | Denervx LLC | Cooled microwave denervation catheter configuration |
US9855402B2 (en) * | 2014-02-15 | 2018-01-02 | Rex Medical, L.P. | Apparatus for delivering fluid to treat renal hypertension |
US10004913B2 (en) | 2014-03-03 | 2018-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for power conversion and data transmission in implantable sensors, stimulators, and actuators |
US20170056104A1 (en) * | 2014-03-10 | 2017-03-02 | Mayo Foundation For Medical Education And Research | Hemodynamic measurement devices and techniques |
EP3116408B1 (en) | 2014-03-12 | 2018-12-19 | Cibiem, Inc. | Ultrasound ablation catheter |
US9889031B1 (en) | 2014-03-25 | 2018-02-13 | Surefire Medical, Inc. | Method of gastric artery embolization |
US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
WO2015157667A1 (en) * | 2014-04-11 | 2015-10-15 | Jeremy Stigall | Imaging and treatment device |
US9999463B2 (en) * | 2014-04-14 | 2018-06-19 | NeuroMedic, Inc. | Monitoring nerve activity |
US10398501B2 (en) | 2014-04-24 | 2019-09-03 | St. Jude Medical, Cardiology Division, Inc. | Ablation systems including pulse rate detector and feedback mechanism and methods of use |
WO2015171921A2 (en) | 2014-05-07 | 2015-11-12 | Mickelson Steven R | Methods and apparatus for selective tissue ablation |
US10434329B2 (en) | 2014-05-09 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Autofocus wireless power transfer to implantable devices in freely moving animals |
CN112807074A (en) | 2014-05-12 | 2021-05-18 | 弗吉尼亚暨州立大学知识产权公司 | Electroporation system |
WO2015175948A1 (en) * | 2014-05-16 | 2015-11-19 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and methods for modulating renal nerve tissue |
CN106794030B (en) | 2014-05-22 | 2019-09-03 | 埃杰亚医疗公司 | System and method for executing endometrial ablation |
WO2015179662A1 (en) | 2014-05-22 | 2015-11-26 | Aegea Medical Inc. | Integrity testing method and apparatus for delivering vapor to the uterus |
EP3154464A4 (en) | 2014-06-12 | 2018-01-24 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US20160008024A1 (en) * | 2014-07-09 | 2016-01-14 | Arapeen Medical, LLC | Renal denervation with staged assessment |
JP6342247B2 (en) * | 2014-07-18 | 2018-06-13 | オリンパス株式会社 | Ultrasonic energy treatment device |
JP2017523849A (en) * | 2014-08-06 | 2017-08-24 | ニューロトロニク アイ・ピー ホールディング (ジャージー) リミテッド | Electrode and electrode positioning system for transvascular neuromodulation therapy |
US20160045257A1 (en) * | 2014-08-14 | 2016-02-18 | Ablative Solutions, Inc. | Method for selection and treatment of hypertensive patients with renal denervation |
KR20170047300A (en) | 2014-08-26 | 2017-05-04 | 아벤트, 인크. | Selective nerve fiber block method and system |
US20160058503A1 (en) * | 2014-08-28 | 2016-03-03 | Medtronic Ardian Luxembourg S.a.r.I. | Methods for modulating renal nerve tissue and associated systems and devices |
JP2017195910A (en) * | 2014-09-12 | 2017-11-02 | テルモ株式会社 | Ablation catheter |
WO2016060983A1 (en) | 2014-10-14 | 2016-04-21 | Iowa Approach Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
JP2016077801A (en) * | 2014-10-22 | 2016-05-16 | オリンパス株式会社 | Electrode unit and nerve stimulation system |
CN113040895A (en) | 2014-10-30 | 2021-06-29 | 纽敦力公司 | Chemical ablation and methods for treating various diseases |
EP3223712B1 (en) * | 2014-11-26 | 2023-08-30 | Sonivie Ltd. | Devices for pulmonary hypertension treatment |
US10271893B2 (en) | 2014-12-15 | 2019-04-30 | Medtronic Ablation Frontiers Llc | Timed energy delivery |
US10694972B2 (en) | 2014-12-15 | 2020-06-30 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US9974946B2 (en) * | 2015-04-07 | 2018-05-22 | NeuroTronik IP Holding (Jersey) Limited | Inflatable intravascular electrode supports for neuromodulation |
US10568687B2 (en) * | 2015-01-16 | 2020-02-25 | The Regents Of The University Of California | Integrated intraoperative diagnosis and thermal therapy system |
CA2974532C (en) | 2015-01-23 | 2023-08-29 | Contego Medical Llc | Interventional device having an integrated embolic filter and associated methods |
WO2016123608A2 (en) * | 2015-01-30 | 2016-08-04 | Rfemb Holdings, Llc | Radio-frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue |
US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
EP3258837A4 (en) | 2015-02-20 | 2018-10-10 | Mc10, Inc. | Automated detection and configuration of wearable devices based on on-body status, location, and/or orientation |
US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
KR102054003B1 (en) * | 2015-02-27 | 2019-12-12 | 주식회사 한독칼로스메디칼 | Catheter and denervation apparatus including the same |
US10820864B2 (en) * | 2015-03-02 | 2020-11-03 | Valencia Technologies Corporation | Methods and systems for predicting patient responsiveness to subcutaneous neuromodulation therapy as a treatment for hypertension |
CA2979884A1 (en) | 2015-03-27 | 2016-10-06 | Shifamed Holdings, Llc | Steerable medical devices, systems, and methods of use |
US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
EP3319689A4 (en) * | 2015-04-13 | 2019-05-08 | NeuroTronik IP Holding (Jersey) Limited | Systems and methods for generating therapeutic electric fields for capture of nervous system targets |
CA2982451C (en) | 2015-04-13 | 2021-01-12 | Carlos Fernando Bazoberry | Radiofrequency denervation needle and method |
EP3285849A4 (en) | 2015-04-24 | 2018-12-26 | Shifamed Holdings, LLC | Steerable medical devices, systems, and methods of use |
CA2984207A1 (en) * | 2015-05-12 | 2016-11-17 | National University Of Ireland Galway | Devices for therapeutic nasal neuromodulation and associated methods and systems |
US20160338769A1 (en) * | 2015-05-18 | 2016-11-24 | Biosense Webster (Israel) Ltd. | Catheter with anchoring balloon assembly |
EP3307188A4 (en) * | 2015-06-10 | 2019-01-23 | CathRx Ltd | Double shape catheter |
US10799287B2 (en) | 2015-07-07 | 2020-10-13 | Boston Scientific Scimed, Inc. | Medical device having extenable members |
CN107847743B (en) * | 2015-07-21 | 2022-06-10 | 皇家飞利浦有限公司 | System for stimulating renal nerves |
US10660691B2 (en) | 2015-10-07 | 2020-05-26 | Angiodynamics, Inc. | Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing |
US10207110B1 (en) | 2015-10-13 | 2019-02-19 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve |
EP3373794B1 (en) | 2015-11-09 | 2022-01-05 | Kalila Medical, Inc. | Steering assemblies for medical devices |
WO2017087549A1 (en) | 2015-11-16 | 2017-05-26 | Apama Medical, Inc. | Energy delivery devices |
US10675085B2 (en) | 2015-11-23 | 2020-06-09 | Boston Scientific Scimed, Inc. | Devices and methods for enhanced denervation procedures |
US20170150922A1 (en) | 2015-11-30 | 2017-06-01 | Palo Alto Investors | Methods of Enhancing Homeostatic Capacity in a Subject by Increasing Homeostatic System Component Responsiveness, and Devices for Use in Practicing the Same |
KR20180118600A (en) * | 2015-12-01 | 2018-10-31 | 사이맵 메디컬 (쑤저우), 엘티디 | Systems and methods for functional neural mapping and 3D mapping to stimulate arterial walls and catheters therefor |
US20170188308A1 (en) * | 2015-12-23 | 2017-06-29 | Intel Corporation | Extending an operational lifetime of an internet of things (IOT) device |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
CN108778173A (en) * | 2016-01-05 | 2018-11-09 | 法拉普尔赛股份有限公司 | Systems, devices and methods for impulse electric field ablation energy to be delivered to endocardial tissue |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11006887B2 (en) | 2016-01-14 | 2021-05-18 | Biosense Webster (Israel) Ltd. | Region of interest focal source detection using comparisons of R-S wave magnitudes and LATs of RS complexes |
US10624554B2 (en) * | 2016-01-14 | 2020-04-21 | Biosense Webster (Israel) Ltd. | Non-overlapping loop-type or spline-type catheter to determine activation source direction and activation source type |
CN108780085A (en) * | 2016-01-15 | 2018-11-09 | 辛辛那提大学 | Advanced electroporation device and method for obtaining the analyte in biofluid |
ES2929383T3 (en) | 2016-02-19 | 2022-11-28 | Aegea Medical Inc | Methods and apparatus for determining the integrity of a body cavity |
US10277386B2 (en) | 2016-02-22 | 2019-04-30 | Mc10, Inc. | System, devices, and method for on-body data and power transmission |
EP3216488B1 (en) | 2016-03-10 | 2023-07-12 | BIOTRONIK SE & Co. KG | Delivery system for implantable stimulation devices and corresponding catheters |
WO2017173089A1 (en) * | 2016-03-31 | 2017-10-05 | Memorial Sloan Kettering Cancer Center | Systems and methods for enhancing delivery of diagnostic and/or therapeutic compositions in vivo using electric pulses |
DE102016106478A1 (en) | 2016-04-08 | 2017-10-12 | Biotronik Ag | Device for emitting energy and / or measuring electrical activity |
WO2017189890A1 (en) * | 2016-04-27 | 2017-11-02 | Neux Technologies, Inc. | Electrotherapeutic treatment |
US11311327B2 (en) | 2016-05-13 | 2022-04-26 | Pacira Cryotech, Inc. | Methods and systems for locating and treating nerves with cold therapy |
EP3457969A4 (en) | 2016-05-20 | 2020-02-26 | Pentax of America, Inc. | Cryogenic ablation system with rotatable and translatable catheter |
CN107440788A (en) * | 2016-06-01 | 2017-12-08 | 四川锦江电子科技有限公司 | A kind of ablation catheter and ablating device with interpolar discharge function |
WO2017218734A1 (en) | 2016-06-16 | 2017-12-21 | Iowa Approach, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US11439460B2 (en) | 2016-06-23 | 2022-09-13 | St. Jude Medical, Cardiology Division, Inc. | Catheter system and electrode assembly for intraprocedural evaluation of renal denervation |
CN114098949B (en) | 2016-06-27 | 2023-12-19 | 盖能适治疗股份有限公司 | Generator and catheter with electrode |
JP7075922B2 (en) * | 2016-07-11 | 2022-05-26 | レトロバスキュラー インコーポレイテッド | Bipolar tissue resection device and how to use it |
EP3484577A4 (en) | 2016-07-18 | 2020-03-25 | Nalu Medical, Inc. | Methods and systems for treating pelvic disorders and pain conditions |
CN114711957A (en) | 2016-07-29 | 2022-07-08 | 阿克松疗法公司 | Devices, systems, and methods for treating heart failure through cardiac nerve ablation |
US10447347B2 (en) | 2016-08-12 | 2019-10-15 | Mc10, Inc. | Wireless charger and high speed data off-loader |
DE102016116871A1 (en) * | 2016-09-08 | 2018-03-08 | Phenox Gmbh | Device and method for the prevention and treatment of vasospasm |
US10780250B1 (en) | 2016-09-19 | 2020-09-22 | Surefire Medical, Inc. | System and method for selective pressure-controlled therapeutic delivery |
US11400263B1 (en) | 2016-09-19 | 2022-08-02 | Trisalus Life Sciences, Inc. | System and method for selective pressure-controlled therapeutic delivery |
WO2018075700A1 (en) | 2016-10-18 | 2018-04-26 | Boston Scientific Scimed, Inc. | Guide extension catheter |
JP2019532741A (en) | 2016-10-20 | 2019-11-14 | レトロバスキュラー インコーポレイテッド | Methods and apparatus for improved composition delivery |
WO2018081763A1 (en) * | 2016-10-31 | 2018-05-03 | The Feinstein Institute For Medical Research | Techniques for neuromodulation using electromagnetic energy |
US11382513B2 (en) | 2016-11-08 | 2022-07-12 | Palo Alto Investors | Methods and compositions for treating a condition in a subject |
US10806942B2 (en) | 2016-11-10 | 2020-10-20 | Qoravita LLC | System and method for applying a low frequency magnetic field to biological tissues |
WO2018087601A1 (en) | 2016-11-11 | 2018-05-17 | National University Of Ireland, Galway | Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
WO2018115141A1 (en) * | 2016-12-20 | 2018-06-28 | Galvani Bioelectronics Limited | Neuromodulation device |
JP2018102650A (en) * | 2016-12-27 | 2018-07-05 | 京セラ株式会社 | Ultrasonic catheter for renal nerve |
EP3565495A4 (en) * | 2017-01-05 | 2020-08-05 | Magneto Thrombectomy Solutions Ltd. | Thrombectomy devices |
EP3585475B1 (en) | 2017-02-24 | 2024-04-03 | Nalu Medical, Inc. | Apparatus with sequentially implanted stimulators |
US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
EP3600434A4 (en) | 2017-03-20 | 2021-01-06 | Sonievie Ltd. | Pulmonary hypertension treatment |
CN106901831A (en) * | 2017-03-23 | 2017-06-30 | 深圳市惠泰医疗器械有限公司 | The arteria renalis stimulates ablating electrode conduit |
EP3606612A4 (en) * | 2017-04-03 | 2021-05-26 | MDSG Innovation Ltd. | Apparatus and method for treating kidneys |
US20190091475A1 (en) * | 2017-04-16 | 2019-03-28 | Jose Carlos Pachon-Mateos | Extracardiac autonomic nerve stimulation |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US10617867B2 (en) * | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10293164B2 (en) | 2017-05-26 | 2019-05-21 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
US20190001126A1 (en) | 2017-06-30 | 2019-01-03 | Lungpacer Medical Inc. | Devices and methods for prevention, moderation, and/or treatment of cognitive injury |
JP6377219B2 (en) * | 2017-07-14 | 2018-08-22 | 株式会社リバーセイコー | Method for manufacturing medical ablation catheter |
US10195429B1 (en) | 2017-08-02 | 2019-02-05 | Lungpacer Medical Inc. | Systems and methods for intravascular catheter positioning and/or nerve stimulation |
US10940308B2 (en) | 2017-08-04 | 2021-03-09 | Lungpacer Medical Inc. | Systems and methods for trans-esophageal sympathetic ganglion recruitment |
CN115844523A (en) * | 2017-09-12 | 2023-03-28 | 波士顿科学医学有限公司 | Systems, devices, and methods for ventricular focal ablation |
US20190117970A1 (en) | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Electric field shaping leads for treatment of cancer |
US11338135B2 (en) | 2017-10-23 | 2022-05-24 | Cardiac Pacemakers, Inc. | Medical devices for cancer therapy with electric field shaping elements |
EP3700620B1 (en) * | 2017-10-23 | 2022-08-03 | Mayo Foundation for Medical Education and Research | Systems for electroporation |
US20190117971A1 (en) * | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Volume-filling leads for treatment of cancer with electric fields |
EP3706856A4 (en) | 2017-11-07 | 2021-08-18 | Neurostim Oab, Inc. | Non-invasive nerve activator with adaptive circuit |
WO2019099677A1 (en) | 2017-11-15 | 2019-05-23 | Myoscience, Inc. | Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods |
US11457975B2 (en) | 2017-11-27 | 2022-10-04 | Prostacare Pty Ltd | Apparatus and a method for the treatment of a prostatic disease |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
WO2019118976A1 (en) | 2017-12-17 | 2019-06-20 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
US10786306B2 (en) | 2018-01-24 | 2020-09-29 | Medtronic Ardian Luxembourg S.A.R.L. | Denervation therapy |
US20190223946A1 (en) | 2018-01-24 | 2019-07-25 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for neuromodulation in heterogeneous tissue environments |
US11751939B2 (en) | 2018-01-26 | 2023-09-12 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
JP6905230B2 (en) * | 2018-01-31 | 2021-07-21 | 国立大学法人広島大学 | Embolization device |
US11224474B2 (en) | 2018-02-28 | 2022-01-18 | Prostacare Pty Ltd | System for managing high impedance changes in a non-thermal ablation system for BPH |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US10780270B2 (en) * | 2018-03-15 | 2020-09-22 | Avent, Inc. | System and method to percutaneously block painful sensations |
CN115836908A (en) | 2018-05-07 | 2023-03-24 | 波士顿科学医学有限公司 | Systems, devices, and methods for delivering ablation energy to tissue |
WO2019217317A1 (en) | 2018-05-07 | 2019-11-14 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
CN112087978B (en) | 2018-05-07 | 2023-01-17 | 波士顿科学医学有限公司 | Epicardial ablation catheter |
US11413084B2 (en) | 2018-07-03 | 2022-08-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating eating disorders in patients via renal neuromodulation |
US10849685B2 (en) | 2018-07-18 | 2020-12-01 | Ablative Solutions, Inc. | Peri-vascular tissue access catheter with locking handle |
US11553960B2 (en) | 2018-07-31 | 2023-01-17 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating patients with catheter-based renal neuromodulation |
US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11338117B2 (en) | 2018-10-08 | 2022-05-24 | Trisalus Life Sciences, Inc. | Implantable dual pathway therapeutic agent delivery port |
EP3866715A4 (en) * | 2018-10-17 | 2022-11-16 | University of Florida Research Foundation | Controlling esophageal temperature during cardiac ablation |
EP3877043A4 (en) | 2018-11-08 | 2022-08-24 | Lungpacer Medical Inc. | Stimulation systems and related user interfaces |
JP7404622B2 (en) * | 2018-11-30 | 2023-12-26 | ニプロ株式会社 | Measuring catheter |
US11419671B2 (en) | 2018-12-11 | 2022-08-23 | Neurent Medical Limited | Systems and methods for therapeutic nasal neuromodulation |
CN109394211B (en) * | 2018-12-18 | 2021-08-06 | 新乡医学院 | Method for preparing in-vivo electrophysiological recording metal electrode |
WO2020188559A1 (en) * | 2019-03-18 | 2020-09-24 | Rambam Medtech Ltd. | Alternating charge to inhibit sorption to surfaces exposed to biological materials |
EP3958959B1 (en) | 2019-04-22 | 2024-04-24 | Boston Scientific Scimed Inc. | Devices for administering electrical stimulation to treat cancer |
US11691006B2 (en) | 2019-04-22 | 2023-07-04 | Boston Scientific Scimed, Inc. | Electrical stimulation devices for cancer treatment |
US11607542B2 (en) | 2019-04-23 | 2023-03-21 | Boston Scientific Scimed, Inc. | Electrical stimulation for cancer treatment with internal and external electrodes |
WO2020219521A1 (en) | 2019-04-23 | 2020-10-29 | Boston Scientific Scimed, Inc. | Electrical stimulation with thermal treatment or thermal monitoring |
CN113747936A (en) | 2019-04-23 | 2021-12-03 | 波士顿科学国际有限公司 | Electrode for electrical stimulation to treat cancer |
WO2020232333A1 (en) | 2019-05-16 | 2020-11-19 | Lungpacer Medical Inc. | Systems and methods for sensing and stimulation |
US11771900B2 (en) | 2019-06-12 | 2023-10-03 | Lungpacer Medical Inc. | Circuitry for medical stimulation systems |
EP4241836A3 (en) | 2019-06-20 | 2023-11-29 | Axon Therapies, Inc. | Devices for endovascular ablation of a splanchnic nerve |
CN114126704A (en) | 2019-06-26 | 2022-03-01 | 神经科学技术有限责任公司 | Non-invasive neural activator with adaptive circuit |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
EP4041096A4 (en) * | 2019-10-09 | 2023-10-18 | Transmural Systems LLC | Tissue excision, cutting, and removal systems and methods |
US10967052B1 (en) | 2019-10-18 | 2021-04-06 | Penland Foundation | Treatment of dyslexia using botulinum toxin |
US10960061B1 (en) | 2019-10-18 | 2021-03-30 | Penland Foundation | Treatment of amyotrophic lateral sclerosis using botulinum toxin |
EP4054460A4 (en) * | 2019-11-05 | 2022-12-07 | Sirona Medical Technologies, Inc. | Multi-modal catheter for improved electrical mapping and ablation |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
JP2023506713A (en) | 2019-12-16 | 2023-02-20 | ニューロスティム テクノロジーズ エルエルシー | Noninvasive nerve activator using booster charge delivery |
ES2960299T3 (en) | 2020-01-17 | 2024-03-04 | Axon Therapies Inc | Devices for endovascular ablation of a splanchnic nerve |
WO2021173509A1 (en) | 2020-02-24 | 2021-09-02 | Boston Scientific Scimed, Inc. | Systems and methods for treatment of pancreatic cancer |
EP4272674A3 (en) * | 2020-02-28 | 2024-01-10 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly including expandable isolation member |
US20210267672A1 (en) * | 2020-02-28 | 2021-09-02 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly including expandable isolation member |
US11896818B2 (en) | 2020-04-09 | 2024-02-13 | Neurent Medical Limited | Systems and methods for therapeutic nasal treatment |
US11883091B2 (en) | 2020-04-09 | 2024-01-30 | Neurent Medical Limited | Systems and methods for improving sleep with therapeutic nasal treatment |
JP2023535723A (en) * | 2020-07-24 | 2023-08-21 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Electroporation catheter with non-tissue contact electrodes |
US20240123232A1 (en) * | 2021-02-23 | 2024-04-18 | Inspire Medical Systems, Inc. | Integrating stimulation therapy, patient management, and external patient monitoring |
EP4056135B1 (en) | 2021-03-09 | 2023-06-07 | Circle Safe | Phrenic nerve stimulation |
JP2021090892A (en) * | 2021-03-22 | 2021-06-17 | 京セラ株式会社 | Ultrasonic catheter for renal nerve |
KR20240000465A (en) * | 2021-04-05 | 2024-01-02 | 주식회사 뉴아인 | Renal denervation catheter |
CA3215962A1 (en) * | 2021-04-26 | 2022-11-03 | Roman Turovskiy | Circumferential ablation devices and methods |
WO2023287729A1 (en) * | 2021-07-12 | 2023-01-19 | Penland Foundation | Treatment of acute and chronic kidney disease |
WO2023287728A1 (en) | 2021-07-12 | 2023-01-19 | Penland Foundation | Treatment of diabetes and chronic pancreatitis using botulinum toxin |
CN113633282A (en) * | 2021-07-19 | 2021-11-12 | 上海安通医疗科技有限公司 | Renal artery sympathetic nerve activity measuring system |
US20230026265A1 (en) * | 2021-07-22 | 2023-01-26 | Boston Scientific Scimed, Inc. | Hybrid electroporation ablation catheter |
CN113633283A (en) * | 2021-07-29 | 2021-11-12 | 上海安通医疗科技有限公司 | Interventional renal artery sympathetic nerve activity detection system |
US20230101016A1 (en) | 2021-09-27 | 2023-03-30 | Medtronic, Inc. | Intra-body electrode with a poly(3,4-ethylenedioxythiophene)-based coating |
CN113768616B (en) * | 2021-10-20 | 2023-02-24 | 四川锦江电子医疗器械科技股份有限公司 | Integrated system for cardiac ablation |
WO2023066799A1 (en) * | 2021-10-22 | 2023-04-27 | Biotronik Se & Co. Kg | Intravascular implant for stimulating of blood pressure |
US20230225791A1 (en) * | 2022-01-18 | 2023-07-20 | Koninklijke Philips N.V. | Guided renal denervation using nerve stimulation with blood pressure and renal blood velocity measurements, and associated systems, device, and methods |
WO2023167343A1 (en) * | 2022-03-02 | 2023-09-07 | 박을준 | Method for evaluating outcome of renal denervation |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050228460A1 (en) * | 2002-04-08 | 2005-10-13 | Levin Howard R | Renal nerve stimulation method and apparatus for treatment of patients |
US6978174B2 (en) * | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US20060041277A1 (en) * | 2002-04-08 | 2006-02-23 | Mark Deem | Methods and apparatus for renal neuromodulation |
US20060206150A1 (en) * | 2002-04-08 | 2006-09-14 | Ardian, Inc. | Methods and apparatus for treating acute myocardial infarction |
US20060235474A1 (en) * | 2002-04-08 | 2006-10-19 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US20060265014A1 (en) * | 2002-04-08 | 2006-11-23 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US20060265015A1 (en) * | 2002-04-08 | 2006-11-23 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US20060276852A1 (en) * | 2002-04-08 | 2006-12-07 | Ardian, Inc. | Methods and apparatus for treating hypertension |
US20070066957A1 (en) * | 2004-11-02 | 2007-03-22 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
US20070083239A1 (en) * | 2005-09-23 | 2007-04-12 | Denise Demarais | Methods and apparatus for inducing, monitoring and controlling renal neuromodulation |
US20070129720A1 (en) * | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US20070129761A1 (en) * | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US20070129760A1 (en) * | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods and apparatus for intravasculary-induced neuromodulation or denervation |
US20070135875A1 (en) * | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20080213331A1 (en) * | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US20080255642A1 (en) * | 2006-06-28 | 2008-10-16 | Ardian, Inc. | Methods and systems for thermally-induced renal neuromodulation |
US7617005B2 (en) * | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US7620451B2 (en) * | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US20100010567A1 (en) * | 2005-07-22 | 2010-01-14 | The Foundry, Llc | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US7653438B2 (en) * | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20100168731A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US20100168739A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US7756583B2 (en) * | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US20100249773A1 (en) * | 2008-12-31 | 2010-09-30 | Ardian, Inc. | Handle assemblies for intravascular treatment devices and associated systems and methods |
Family Cites Families (1248)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1026407A (en) | 1908-12-21 | 1912-05-14 | Steel Shoe Company | Footwear. |
US1017857A (en) | 1910-03-25 | 1912-02-20 | Amphion Piano Player Company | Valve for pneumatic actions. |
US2130758A (en) | 1935-06-01 | 1938-09-20 | E J Rose Mfg Company Of Califo | Electrode for diathermy treatment and the like |
US2276995A (en) | 1938-01-22 | 1942-03-17 | A J Ginsberg | Electrotherapy |
US2276996A (en) | 1940-11-30 | 1942-03-17 | A J Ginsberg | Non-radio-interfering therapeutic apparatus |
US2389453A (en) | 1943-04-15 | 1945-11-20 | Sun Oil Co | Amides |
US3181535A (en) | 1957-10-04 | 1965-05-04 | Diapulse Mfg Corp Of America | Athermapeutic apparatus |
US3043310A (en) | 1959-04-24 | 1962-07-10 | Diapulse Mfg Corp Of America | Treatment head for athermapeutic apparatus |
US3127895A (en) | 1962-07-02 | 1964-04-07 | Dynapower System Corp | Therapeutic pulse generation and control circuit |
US3270746A (en) | 1963-08-26 | 1966-09-06 | Dynapower Systems Corp | High-performance electrotherapeutic treatment head |
US3329149A (en) | 1964-10-28 | 1967-07-04 | Dynapower Systems Corp Of Cali | Supporting arm for electrotherapeutic treatment head |
US3563246A (en) | 1967-04-24 | 1971-02-16 | Intelectron Corp | Method and apparatus for improving neural performance in human subjects by electrotherapy |
US3522811A (en) | 1969-02-13 | 1970-08-04 | Medtronic Inc | Implantable nerve stimulator and method of use |
SE346468B (en) * | 1969-02-24 | 1972-07-10 | Lkb Medical Ab | |
JPS499882Y1 (en) | 1969-09-11 | 1974-03-08 | ||
US3670737A (en) | 1970-07-02 | 1972-06-20 | Diapulse Corp Of America | Ultra-short wave athermapeutic apparatus |
US3760812A (en) | 1971-03-19 | 1973-09-25 | Univ Minnesota | Implantable spiral wound stimulation electrodes |
US3774620A (en) | 1971-06-14 | 1973-11-27 | Nemectron Gmbh | Electromedicinal apparatus for interference current therapy |
US3895639A (en) | 1971-09-07 | 1975-07-22 | Rodler Ing Hans | Apparatus for producing an interference signal at a selected location |
US3800802A (en) | 1972-01-07 | 1974-04-02 | Int Medical Electronics Ltd | Short-wave therapy apparatus |
US3752162A (en) | 1972-04-10 | 1973-08-14 | Dow Corning | Artificial cutaneous stoma |
US3794022A (en) | 1972-06-30 | 1974-02-26 | E Nawracaj | Dual oscillator, variable pulse duration electrotherapeutic device |
US3803463A (en) | 1972-07-10 | 1974-04-09 | J Cover | Weapon for immobilization and capture |
GB1456509A (en) | 1973-02-20 | 1976-11-24 | Dow Corning Ltd | Bonding silicone rubber to wood and masonry |
US3897789A (en) | 1973-09-13 | 1975-08-05 | Stanley J Blanchard | Acupuncture apparatus |
US3894532A (en) | 1974-01-17 | 1975-07-15 | Acupulse Inc | Instruments for transcutaneous and subcutaneous investigation and treatment |
US3911930A (en) | 1974-03-01 | 1975-10-14 | Stimulation Tech | Method and structure of preventing and treating ileus, and reducing acute pain by electrical pulse stimulation |
US4011861A (en) * | 1974-04-03 | 1977-03-15 | Case Western Reserve University | Implantable electric terminal for organic tissue |
US4055190A (en) | 1974-12-19 | 1977-10-25 | Michio Tany | Electrical therapeutic apparatus |
US3952751A (en) | 1975-01-08 | 1976-04-27 | W. Denis Kendall | High-performance electrotherapeutic apparatus |
US4026300A (en) | 1975-03-14 | 1977-05-31 | Liberty Mutual | Method and apparatus for interfacing to nerves |
US3987790A (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4266532A (en) | 1976-11-17 | 1981-05-12 | Electro-Biology, Inc. | Modification of the growth, repair and maintenance behavior of living tissues and cells by a specific and selective change in electrical environment |
US4105017A (en) | 1976-11-17 | 1978-08-08 | Electro-Biology, Inc. | Modification of the growth repair and maintenance behavior of living tissue and cells by a specific and selective change in electrical environment |
US4315503A (en) | 1976-11-17 | 1982-02-16 | Electro-Biology, Inc. | Modification of the growth, repair and maintenance behavior of living tissues and cells by a specific and selective change in electrical environment |
US4071033A (en) | 1976-12-20 | 1978-01-31 | Nawracaj Edward P | Electrotherapeutic device with modulated dual signals |
US4141365A (en) | 1977-02-24 | 1979-02-27 | The Johns Hopkins University | Epidural lead electrode and insertion needle |
US4154246A (en) | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4169464A (en) | 1977-12-16 | 1979-10-02 | Cordis Corporation | Catheter for selective catheterization of aortic branches |
US4360019A (en) | 1979-02-28 | 1982-11-23 | Andros Incorporated | Implantable infusion device |
US4305115A (en) | 1979-03-14 | 1981-12-08 | Harry H. Leveen | Electrostatic shield |
JPS55137141A (en) | 1979-04-13 | 1980-10-25 | Teijin Ltd | Porous polyamide membrane and production thereof |
US4332259A (en) | 1979-09-19 | 1982-06-01 | Mccorkle Jr Charles E | Intravenous channel cardiac electrode and lead assembly and method |
US4692147A (en) | 1980-04-02 | 1987-09-08 | Medtronic, Inc. | Drug administration device |
US4405305A (en) | 1980-10-27 | 1983-09-20 | University Of Utah Research Foundation | Subcutaneous peritoneal injection catheter |
US4379462A (en) | 1980-10-29 | 1983-04-12 | Neuromed, Inc. | Multi-electrode catheter assembly for spinal cord stimulation |
CS226514B1 (en) | 1981-01-28 | 1984-04-16 | Petr Ing Csc Slovak | Apparatus for stimulating live tissues |
US4419819A (en) | 1982-01-29 | 1983-12-13 | Medtronic, Inc. | Method of making biomedical lead with lobed lead anchor |
US4454883A (en) | 1982-02-16 | 1984-06-19 | Therafield Holdings Limited | Electrotherapeutic apparatus |
US4617939A (en) | 1982-04-30 | 1986-10-21 | The University Of Sheffield | Tomography |
US4530840A (en) | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US4467808A (en) | 1982-09-17 | 1984-08-28 | Biolectron, Inc. | Method for preventing and treating osteoporosis in a living body by using electrical stimulation non-invasively |
US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
DE3300668A1 (en) | 1983-01-11 | 1984-07-12 | Siemens AG, 1000 Berlin und 8000 München | ELECTRODE FOR MEDICAL APPLICATIONS |
FR2541902B1 (en) | 1983-03-04 | 1986-02-07 | Cofrem International Sa | THERMAL THERAPEUTIC APPARATUS |
EP0132344A3 (en) | 1983-07-20 | 1986-01-22 | Purdue Research Foundation | Improved catheter based cardiac output sensor |
US4531943A (en) | 1983-08-08 | 1985-07-30 | Angiomedics Corporation | Catheter with soft deformable tip |
WO1985001213A1 (en) | 1983-09-14 | 1985-03-28 | Jacob Zabara | Neurocybernetic prosthesis |
JPS60100516A (en) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | Preparation of sustained release microcapsule |
US4816016A (en) * | 1984-03-16 | 1989-03-28 | Pudenz-Schulte Medical Research Corp. | Subcutaneous infusion reservoir and pump system |
US4587975A (en) * | 1984-07-02 | 1986-05-13 | Cardiac Pacemakers, Inc. | Dimension sensitive angioplasty catheter |
US4674482A (en) | 1984-09-12 | 1987-06-23 | Irt, Inc. | Pulse electro-magnetic field therapy device with auto bias circuit |
US4649936A (en) * | 1984-10-11 | 1987-03-17 | Case Western Reserve University | Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking |
US4602624A (en) | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4608985A (en) | 1984-10-11 | 1986-09-02 | Case Western Reserve University | Antidromic pulse generating wave form for collision blocking |
JPS61116595A (en) | 1984-11-12 | 1986-06-04 | Riso Kagaku Corp | Thermal stencil paper |
JPS61151245A (en) | 1984-12-25 | 1986-07-09 | Sumitomo Electric Ind Ltd | Method for treating surface of porous thin membrane material |
JPS61176324A (en) * | 1985-01-31 | 1986-08-08 | フクダ電子株式会社 | Electrode apparatus |
US4706671A (en) | 1985-05-02 | 1987-11-17 | Weinrib Harry P | Catheter with coiled tip |
US4660571A (en) | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US5449343A (en) | 1985-07-30 | 1995-09-12 | Advanced Cardiovascular Systems, Inc. | Steerable dilatation catheter |
FR2592791A1 (en) | 1986-01-14 | 1987-07-17 | Ire Celltarg Sa | PHARMACEUTICAL COMPOSITION CONTAINING A LOCAL ANESTHETIC AND / OR A CENTRAL ANALGESIC ENCAPSULATED IN LIPOSOMES |
US4865845A (en) | 1986-03-21 | 1989-09-12 | Alza Corporation | Release rate adjustment of osmotic or diffusional delivery devices |
JPS62181225U (en) | 1986-05-07 | 1987-11-17 | ||
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US5014699A (en) | 1986-05-23 | 1991-05-14 | Trustees Of The University Of Pennsylvania | Electromagnetic method and apparatus for healing living tissue |
US4998532A (en) | 1986-05-23 | 1991-03-12 | Lti Biomedical, Inc. | Portable electro-therapy system |
US4715852A (en) | 1986-07-21 | 1987-12-29 | Eaton Corporation | Implanted medication infusion device |
US4774967A (en) | 1986-09-09 | 1988-10-04 | American Biointerface Corporation | Method and apparatus for mammalian nerve regeneration |
US4796643A (en) | 1986-09-30 | 1989-01-10 | Telectronics N.V. | Medical electrode leads |
US5365926A (en) | 1986-11-14 | 1994-11-22 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US4834724A (en) | 1987-04-06 | 1989-05-30 | Geiss Alan C | Device for aspirating fluids from a body cavity or hollow organ |
US4791931A (en) | 1987-08-13 | 1988-12-20 | Pacesetter Infusion, Ltd. | Demand pacemaker using an artificial baroreceptor reflex |
US4781682A (en) | 1987-08-13 | 1988-11-01 | Patel Piyush V | Catheter having support flaps and method of inserting catheter |
US5154705A (en) | 1987-09-30 | 1992-10-13 | Lake Region Manufacturing Co., Inc. | Hollow lumen cable apparatus |
US4819661A (en) | 1987-10-26 | 1989-04-11 | Cardiac Pacemakers, Inc. | Positive fixation cardiac electrode with drug elution capabilities |
US4860769A (en) | 1987-11-12 | 1989-08-29 | Thomas J. Fogarty | Implantable defibrillation electrode |
US4852573A (en) | 1987-12-04 | 1989-08-01 | Kennedy Philip R | Implantable neural electrode |
US4957118A (en) | 1988-01-15 | 1990-09-18 | Jay Erlebacher | Electrode lead |
DE68925030T2 (en) | 1988-01-21 | 1996-07-25 | Massachusetts Inst Technology | MOLECULE TRANSPORT THROUGH FABRICS WITH THE USE OF ELECTROPORATION. |
US5389069A (en) | 1988-01-21 | 1995-02-14 | Massachusetts Institute Of Technology | Method and apparatus for in vivo electroporation of remote cells and tissue |
US4926875A (en) * | 1988-01-25 | 1990-05-22 | Baylor College Of Medicine | Implantable and extractable biological sensor probe |
US4890623A (en) | 1988-03-14 | 1990-01-02 | C. R. Bard, Inc. | Biopotential sensing device and method for making |
CA1319174C (en) * | 1988-04-21 | 1993-06-15 | Lawrence E. Bertolucci | Electrical nerve stimulation device for nausea control |
US5308323A (en) | 1988-06-06 | 1994-05-03 | Sumitomo Electric Industries. Ltd. | Multiple compartment balloon catheter |
GB8814898D0 (en) | 1988-06-22 | 1988-07-27 | Evans J M | Catheters & methods of manufacture |
US4921484A (en) | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
US5249585A (en) | 1988-07-28 | 1993-10-05 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US4995868A (en) | 1988-10-12 | 1991-02-26 | Bard Limited | Catheter |
US4920979A (en) | 1988-10-12 | 1990-05-01 | Huntington Medical Research Institute | Bidirectional helical electrode for nerve stimulation |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US4966597A (en) | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
US5094242A (en) * | 1988-11-07 | 1992-03-10 | Regents Of The University Of California | Implantable nerve stimulation device |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US5059423A (en) | 1988-12-13 | 1991-10-22 | Alza Corporation | Delivery system comprising biocompatible beneficial agent formulation |
US5057318A (en) | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates |
AU4945490A (en) | 1989-01-06 | 1990-08-01 | Angioplasty Systems Inc. | Electrosurgical catheter for resolving atherosclerotic plaque |
JP2513289B2 (en) | 1989-01-06 | 1996-07-03 | 日本電気株式会社 | Modulator |
US5458631A (en) | 1989-01-06 | 1995-10-17 | Xavier; Ravi | Implantable catheter with electrical pulse nerve stimulators and drug delivery system |
US5037391A (en) | 1989-01-09 | 1991-08-06 | Pilot Cardiovascular Systems, Inc. | Steerable angioplasty device |
US5203772A (en) | 1989-01-09 | 1993-04-20 | Pilot Cardiovascular Systems, Inc. | Steerable medical device |
US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US4928688A (en) | 1989-01-23 | 1990-05-29 | Mieczyslaw Mirowski | Method and apparatus for treating hemodynamic disfunction |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5078717A (en) | 1989-04-13 | 1992-01-07 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5125928A (en) | 1989-04-13 | 1992-06-30 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5006119A (en) * | 1989-05-25 | 1991-04-09 | Engineering & Research Associates, Inc. | Hollow core coaxial catheter |
US20030220521A1 (en) | 1989-07-27 | 2003-11-27 | G.D. Searle & Co. | Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension |
US5156610A (en) | 1989-08-18 | 1992-10-20 | Evi Corporation | Catheter atherotome |
US5211651A (en) | 1989-08-18 | 1993-05-18 | Evi Corporation | Catheter atherotome |
US5282484A (en) | 1989-08-18 | 1994-02-01 | Endovascular Instruments, Inc. | Method for performing a partial atherectomy |
US5071424A (en) | 1989-08-18 | 1991-12-10 | Evi Corporation | Catheter atherotome |
US5002067A (en) | 1989-08-23 | 1991-03-26 | Medtronic, Inc. | Medical electrical lead employing improved penetrating electrode |
CA2067110C (en) | 1989-09-08 | 2001-07-31 | John E. Abele | Physiologic low stress angioplasty |
US5112614A (en) * | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
US5133365A (en) | 1989-09-14 | 1992-07-28 | Cardiac Pacemakers, Inc. | Implantable tapered spiral endocardial lead for use in internal defibrillation |
US5016808A (en) * | 1989-09-14 | 1991-05-21 | Cardiac Pacemakers, Inc. | Implantable tapered spiral endocardial lead for use in internal defibrillation |
US5231386A (en) | 1990-07-24 | 1993-07-27 | Home Row, Inc. | Keyswitch-integrated pointing assembly |
RU1785710C (en) | 1989-10-06 | 1993-01-07 | Vremennyj Nauchnyj Kollektiv O | Microwave resonant therapeutic device |
US4979511A (en) | 1989-11-03 | 1990-12-25 | Cyberonics, Inc. | Strain relief tether for implantable electrode |
US5188837A (en) * | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5209723A (en) | 1990-01-08 | 1993-05-11 | The Curators Of The University Of Missouri | Multiple lumen catheter for hemodialysis |
US5158564A (en) | 1990-02-14 | 1992-10-27 | Angiomed Ag | Atherectomy apparatus |
US5851206A (en) | 1990-03-13 | 1998-12-22 | The Regents Of The University Of California | Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment |
US5052998A (en) | 1990-04-04 | 1991-10-01 | Zimmon David S | Indwelling stent and method of use |
US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5193048A (en) | 1990-04-27 | 1993-03-09 | Kaufman Dennis R | Stun gun with low battery indicator and shutoff timer |
US5054501A (en) | 1990-05-16 | 1991-10-08 | Brigham & Women's Hospital | Steerable guide wire for cannulation of tubular or vascular organs |
US5184617A (en) | 1990-06-05 | 1993-02-09 | Staodyn, Inc. | Output pulse compensation for therapeutic-type electronic devices |
US5095905A (en) * | 1990-06-07 | 1992-03-17 | Medtronic, Inc. | Implantable neural electrode |
US5190540A (en) | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
GB9013177D0 (en) * | 1990-06-13 | 1990-08-01 | Brown Brian H | Real-time imaging, etc. |
CA2081896A1 (en) * | 1990-06-15 | 1991-12-16 | James E. Shapland | Drug delivery apparatus and method |
US5498238A (en) * | 1990-06-15 | 1996-03-12 | Cortrak Medical, Inc. | Simultaneous angioplasty and phoretic drug delivery |
US5499971A (en) * | 1990-06-15 | 1996-03-19 | Cortrak Medical, Inc. | Method for iontophoretically delivering drug adjacent to a heart |
US5234692A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5234693A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5188602A (en) | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5058584A (en) | 1990-08-30 | 1991-10-22 | Medtronic, Inc. | Method and apparatus for epidural burst stimulation for angina pectoris |
US5170803A (en) | 1990-09-28 | 1992-12-15 | Brunswick Biomedical Technologies, Inc. | Esophageal displacement electrode |
US5111815A (en) | 1990-10-15 | 1992-05-12 | Cardiac Pacemakers, Inc. | Method and apparatus for cardioverter/pacer utilizing neurosensing |
JP3041967B2 (en) | 1990-12-13 | 2000-05-15 | ソニー株式会社 | Digital signal coding device |
EP0491979A1 (en) | 1990-12-22 | 1992-07-01 | Peter Dr. Ing. Osypka | Pacemaker catheter with two poles |
US5170802A (en) | 1991-01-07 | 1992-12-15 | Medtronic, Inc. | Implantable electrode for location within a blood vessel |
US5163928A (en) | 1991-01-07 | 1992-11-17 | Franklin Electronic Publishers, Incorporated | Self-centering catheter |
US5324255A (en) | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
US5263480A (en) | 1991-02-01 | 1993-11-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5329923A (en) | 1991-02-15 | 1994-07-19 | Lundquist Ingemar H | Torquable catheter |
US5228442A (en) * | 1991-02-15 | 1993-07-20 | Cardiac Pathways Corporation | Method for mapping, ablation, and stimulation using an endocardial catheter |
US5156151A (en) * | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
US5345936A (en) * | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
AU660444B2 (en) | 1991-02-15 | 1995-06-29 | Ingemar H. Lundquist | Torquable catheter and method |
US5425364A (en) | 1991-02-15 | 1995-06-20 | Cardiac Pathways Corporation | Flexible strip assembly without feedthrough holes and device utilizing the same |
US5269303A (en) | 1991-02-22 | 1993-12-14 | Cyberonics, Inc. | Treatment of dementia by nerve stimulation |
US5199428A (en) * | 1991-03-22 | 1993-04-06 | Medtronic, Inc. | Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload |
US5188619A (en) | 1991-04-24 | 1993-02-23 | Gene E. Myers Enterprises, Inc. | Internal thoractic artery catheter |
DE4113703C2 (en) | 1991-04-26 | 1995-05-04 | Thomas Osypka | Guide catheter with pre-bent end area |
US5215086A (en) | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
US5251634A (en) | 1991-05-03 | 1993-10-12 | Cyberonics, Inc. | Helical nerve electrode |
US5335657A (en) | 1991-05-03 | 1994-08-09 | Cyberonics, Inc. | Therapeutic treatment of sleep disorder by nerve stimulation |
US5299569A (en) * | 1991-05-03 | 1994-04-05 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
US5330496A (en) | 1991-05-06 | 1994-07-19 | Alferness Clifton A | Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof |
US5458568A (en) | 1991-05-24 | 1995-10-17 | Cortrak Medical, Inc. | Porous balloon for selective dilatation and drug delivery |
WO1992020291A1 (en) * | 1991-05-24 | 1992-11-26 | Applied Medical Resources, Inc. | Articulating tissue cutter assembly |
US5137727A (en) | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
US5213098A (en) * | 1991-07-26 | 1993-05-25 | Medtronic, Inc. | Post-extrasystolic potentiation stimulation with physiologic sensor feedback |
US5222494A (en) | 1991-07-31 | 1993-06-29 | Cyberonics, Inc. | Implantable tissue stimulator output stabilization system |
US5231988A (en) | 1991-08-09 | 1993-08-03 | Cyberonics, Inc. | Treatment of endocrine disorders by nerve stimulation |
JPH066170B2 (en) * | 1991-08-28 | 1994-01-26 | 中島 博 | Pacemaker pacing leads |
CA2120516A1 (en) | 1991-10-03 | 1993-04-15 | Ralph De La Torre | Apparatus and method for vasodilation |
US5215089A (en) | 1991-10-21 | 1993-06-01 | Cyberonics, Inc. | Electrode assembly for nerve stimulation |
CA2106410C (en) | 1991-11-08 | 2004-07-06 | Stuart D. Edwards | Ablation electrode with insulated temperature sensing elements |
US5628775A (en) | 1991-11-08 | 1997-05-13 | Ep Technologies, Inc. | Flexible bond for sleeves enclosing a bendable electrode tip assembly |
US5304206A (en) | 1991-11-18 | 1994-04-19 | Cyberonics, Inc. | Activation techniques for implantable medical device |
US5193540A (en) * | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5193539A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5203326A (en) * | 1991-12-18 | 1993-04-20 | Telectronics Pacing Systems, Inc. | Antiarrhythmia pacer using antiarrhythmia pacing and autonomic nerve stimulation therapy |
US5358514A (en) | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5301683A (en) | 1991-12-23 | 1994-04-12 | Durkan John A | Diagnosing carpal tunnel syndrome |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5683366A (en) | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US5327905A (en) | 1992-02-14 | 1994-07-12 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
US5354297A (en) | 1992-02-14 | 1994-10-11 | Boaz Avitall | Biplanar deflectable catheter for arrhythmogenic tissue ablation |
US5263493A (en) | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5300099A (en) | 1992-03-06 | 1994-04-05 | Urologix, Inc. | Gamma matched, helical dipole microwave antenna |
EP0630481B1 (en) | 1992-03-09 | 1999-06-30 | University Of Washington | Image neurography and diffusion anisotropy imaging |
US5239999A (en) | 1992-03-27 | 1993-08-31 | Cardiac Pathways Corporation | Helical endocardial catheter probe |
AU4026793A (en) | 1992-04-10 | 1993-11-18 | Cardiorhythm | Shapable handle for steerable electrode catheter |
US5318525A (en) | 1992-04-10 | 1994-06-07 | Medtronic Cardiorhythm | Steerable electrode catheter |
US5345031A (en) | 1992-04-16 | 1994-09-06 | The Trustees Of Princeton University | Reduction of aromatic halide content |
US5300068A (en) | 1992-04-21 | 1994-04-05 | St. Jude Medical, Inc. | Electrosurgical apparatus |
US5263492A (en) | 1992-04-30 | 1993-11-23 | Guy Voyce | Recording goniometer |
US5562720A (en) * | 1992-05-01 | 1996-10-08 | Vesta Medical, Inc. | Bipolar/monopolar endometrial ablation device and method |
US5443470A (en) * | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
US5370680A (en) | 1992-05-27 | 1994-12-06 | Magnetic Resonance Therapeutics, Inc. | Athermapeutic apparatus employing electro-magnetic fields |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
WO1994000188A1 (en) | 1992-06-24 | 1994-01-06 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
WO1994000178A1 (en) | 1992-06-26 | 1994-01-06 | Schneider (Usa) Inc. | Catheter with expandable wire mesh tip |
US5772590A (en) * | 1992-06-30 | 1998-06-30 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire |
US5782239A (en) | 1992-06-30 | 1998-07-21 | Cordis Webster, Inc. | Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire |
US5304120A (en) * | 1992-07-01 | 1994-04-19 | Btx Inc. | Electroporation method and apparatus for insertion of drugs and genes into endothelial cells |
US5507724A (en) * | 1992-07-01 | 1996-04-16 | Genetronics, Inc. | Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells |
US5399164A (en) | 1992-11-02 | 1995-03-21 | Catheter Imaging Systems | Catheter having a multiple durometer |
US5484400A (en) | 1992-08-12 | 1996-01-16 | Vidamed, Inc. | Dual channel RF delivery system |
US5542916A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Dual-channel RF power delivery system |
US6623516B2 (en) | 1992-08-13 | 2003-09-23 | Mark A. Saab | Method for changing the temperature of a selected body region |
US5437288A (en) | 1992-09-04 | 1995-08-01 | Mayo Foundation For Medical Education And Research | Flexible catheter guidewire |
DE4229693A1 (en) | 1992-09-05 | 1994-03-10 | Achim Dr Hansjuergens | Electrotherapeutic device |
WO1994005265A1 (en) * | 1992-09-10 | 1994-03-17 | Children's Medical Center Corporation | Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
US5922340A (en) * | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
US5700485A (en) | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
US5478303A (en) | 1992-09-18 | 1995-12-26 | Foley-Nolan; Darragh | Electromagnetic apparatus for use in therapy |
US5338662A (en) | 1992-09-21 | 1994-08-16 | Bio-Preserve Medical Corporation | Organ perfusion device |
US5553611A (en) | 1994-01-06 | 1996-09-10 | Endocardial Solutions, Inc. | Endocardial measurement method |
JPH08504333A (en) * | 1992-09-25 | 1996-05-14 | イーピー・テクノロジーズ・インコーポレーテッド | Electrode-supported splines for the cardiac system |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5634899A (en) * | 1993-08-20 | 1997-06-03 | Cortrak Medical, Inc. | Simultaneous cardiac pacing and local drug delivery method |
US5336178A (en) * | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US5441483A (en) | 1992-11-16 | 1995-08-15 | Avitall; Boaz | Catheter deflection control |
US5328442A (en) * | 1992-11-20 | 1994-07-12 | Siemens Pacesetter, Inc. | System and method for stimulating a heart having undergone cardiac myoplasty using a single-chamber pacemaker |
CA2109980A1 (en) | 1992-12-01 | 1994-06-02 | Mir A. Imran | Steerable catheter with adjustable bend location and/or radius and method |
SE9203733D0 (en) | 1992-12-11 | 1992-12-11 | Siemens Elema Ab | defibrillation |
US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
US5317155A (en) | 1992-12-29 | 1994-05-31 | The Electrogesic Corporation | Corona discharge apparatus |
US5429634A (en) | 1993-09-09 | 1995-07-04 | Pdt Systems | Biogenic implant for drug delivery and method |
US5387233A (en) | 1993-01-11 | 1995-02-07 | Incontrol, Inc. | Intravenous cardiac lead with improved fixation and method |
IT1266217B1 (en) | 1993-01-18 | 1996-12-27 | Xtrode Srl | ELECTROCATHETER FOR MAPPING AND INTERVENTION ON HEART CAVITIES. |
US5706809A (en) | 1993-01-29 | 1998-01-13 | Cardima, Inc. | Method and system for using multiple intravascular sensing devices to detect electrical activity |
US6620188B1 (en) | 1998-08-24 | 2003-09-16 | Radiant Medical, Inc. | Methods and apparatus for regional and whole body temperature modification |
US5569274A (en) | 1993-02-22 | 1996-10-29 | Heartport, Inc. | Endoscopic vascular clamping system and method |
US5792187A (en) | 1993-02-22 | 1998-08-11 | Angeion Corporation | Neuro-stimulation to control pain during cardioversion defibrillation |
US5476495A (en) | 1993-03-16 | 1995-12-19 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
WO1994021168A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US5636634A (en) | 1993-03-16 | 1997-06-10 | Ep Technologies, Inc. | Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes |
JP3345786B2 (en) | 1993-03-17 | 2002-11-18 | ジャパンゴアテックス株式会社 | Flexible tube and method of manufacturing the same |
US5383856A (en) | 1993-03-19 | 1995-01-24 | Bersin; Robert M. | Helical spiral balloon catheter |
US5397338A (en) | 1993-03-29 | 1995-03-14 | Maven Labs, Inc. | Electrotherapy device |
US5439440A (en) | 1993-04-01 | 1995-08-08 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
FR2704151B1 (en) * | 1993-04-21 | 1995-07-13 | Klotz Antoine Olivier | Electronic device intended for the adrenergic stimulation of the sympathetic system relating to the venous media. |
DK0702723T3 (en) * | 1993-04-21 | 2003-01-13 | Pasteur Institut | Biocompatible implant for the expression and secretion of therapeutic compound in vivo |
US5716410A (en) | 1993-04-30 | 1998-02-10 | Scimed Life Systems, Inc. | Temporary stent and method of use |
US6517811B2 (en) | 1993-05-06 | 2003-02-11 | Research Corporation Technologies, Inc. | Compounds for cancer imaging and therapy |
US5611777A (en) | 1993-05-14 | 1997-03-18 | C.R. Bard, Inc. | Steerable electrode catheter |
US5693082A (en) | 1993-05-14 | 1997-12-02 | Fidus Medical Technology Corporation | Tunable microwave ablation catheter system and method |
US5584863A (en) | 1993-06-24 | 1996-12-17 | Electropharmacology, Inc. | Pulsed radio frequency electrotherapeutic system |
DE69432148T2 (en) | 1993-07-01 | 2003-10-16 | Boston Scient Ltd | CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION |
US5860974A (en) | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
US5487757A (en) | 1993-07-20 | 1996-01-30 | Medtronic Cardiorhythm | Multicurve deflectable catheter |
US5545200A (en) | 1993-07-20 | 1996-08-13 | Medtronic Cardiorhythm | Steerable electrophysiology catheter |
US5458585A (en) | 1993-07-28 | 1995-10-17 | Cardiovascular Imaging Systems, Inc. | Tracking tip for a work element in a catheter system |
US5415633A (en) | 1993-07-28 | 1995-05-16 | Active Control Experts, Inc. | Remotely steered catheterization device |
US5405374A (en) | 1993-08-25 | 1995-04-11 | Medtronic, Inc. | Transvenous defibrillation lead and method of use |
US5980516A (en) | 1993-08-27 | 1999-11-09 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5807395A (en) | 1993-08-27 | 1998-09-15 | Medtronic, Inc. | Method and apparatus for RF ablation and hyperthermia |
US5507791A (en) | 1993-08-31 | 1996-04-16 | Sit'ko; Sergei P. | Microwave resonance therapy |
US5427118A (en) | 1993-10-04 | 1995-06-27 | Baxter International Inc. | Ultrasonic guidewire |
US5673695A (en) | 1995-08-02 | 1997-10-07 | Ep Technologies, Inc. | Methods for locating and ablating accessory pathways in the heart |
US6129724A (en) | 1993-10-14 | 2000-10-10 | Ep Technologies, Inc. | Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements |
WO1995010318A1 (en) | 1993-10-14 | 1995-04-20 | Ep Technologies, Inc. | Electrode elements for forming lesion patterns |
US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
US5400784A (en) | 1993-10-15 | 1995-03-28 | Case Western Reserve University | Slowly penetrating inter-fascicular nerve cuff electrode and method of using |
WO1995010319A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Electrodes for creating lesions in body tissue |
US5575810A (en) | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
WO1995010225A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Multiple electrode element for mapping and ablating |
US5397308A (en) * | 1993-10-22 | 1995-03-14 | Scimed Life Systems, Inc. | Balloon inflation measurement apparatus |
US5470352A (en) | 1993-10-29 | 1995-11-28 | Northeastern University | Balloon angioplasty device |
US5433739A (en) | 1993-11-02 | 1995-07-18 | Sluijter; Menno E. | Method and apparatus for heating an intervertebral disc for relief of back pain |
US5571147A (en) | 1993-11-02 | 1996-11-05 | Sluijter; Menno E. | Thermal denervation of an intervertebral disc for relief of back pain |
US5497774A (en) | 1993-11-03 | 1996-03-12 | Daig Corporation | Guiding introducer for left atrium |
US5564440A (en) | 1993-11-03 | 1996-10-15 | Daig Corporation | Method for mopping and/or ablation of anomalous conduction pathways |
US5575766A (en) | 1993-11-03 | 1996-11-19 | Daig Corporation | Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers |
US5599345A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment apparatus |
US5507743A (en) | 1993-11-08 | 1996-04-16 | Zomed International | Coiled RF electrode treatment apparatus |
WO1995013111A1 (en) | 1993-11-10 | 1995-05-18 | Medtronic Cadiorhythm | Electrode array catheter |
US5730127A (en) | 1993-12-03 | 1998-03-24 | Avitall; Boaz | Mapping and ablation catheter system |
JPH07157424A (en) | 1993-12-03 | 1995-06-20 | Lintec Corp | Gel formulation for local anesthesia |
US5487385A (en) | 1993-12-03 | 1996-01-30 | Avitall; Boaz | Atrial mapping and ablation catheter system |
CA2138076A1 (en) | 1993-12-17 | 1995-06-18 | Philip E. Eggers | Monopolar electrosurgical instruments |
US5458626A (en) | 1993-12-27 | 1995-10-17 | Krause; Horst E. | Method of electrical nerve stimulation for acceleration of tissue healing |
US6099524A (en) | 1994-01-28 | 2000-08-08 | Cardiac Pacemakers, Inc. | Electrophysiological mapping and ablation catheter and method |
US5462545A (en) | 1994-01-31 | 1995-10-31 | New England Medical Center Hospitals, Inc. | Catheter electrodes |
US5697975A (en) * | 1994-02-09 | 1997-12-16 | The University Of Iowa Research Foundation | Human cerebral cortex neural prosthetic for tinnitus |
US6858024B1 (en) | 1994-02-14 | 2005-02-22 | Scimed Life Systems, Inc. | Guide catheter having selected flexural modulus segments |
AU1937795A (en) * | 1994-03-08 | 1995-09-25 | Cardima, Inc. | Intravascular rf occlusion catheter |
GB9407135D0 (en) | 1994-04-11 | 1994-06-01 | Aberdeen University And Plasma | Treatment of osteoporosis |
US5505201A (en) | 1994-04-20 | 1996-04-09 | Case Western Reserve University | Implantable helical spiral cuff electrode |
US5882333A (en) | 1994-05-13 | 1999-03-16 | Cardima, Inc. | Catheter with deflectable distal section |
WO1995033514A1 (en) | 1994-06-09 | 1995-12-14 | Magnetic Resonance Therapeutics, Inc. | Electro-therapeutic method |
US5505700A (en) * | 1994-06-14 | 1996-04-09 | Cordis Corporation | Electro-osmotic infusion catheter |
US5421349A (en) | 1994-06-16 | 1995-06-06 | Cordis Corporation | Atraumatic proximal guidewire end |
US5617854A (en) | 1994-06-22 | 1997-04-08 | Munsif; Anand | Shaped catheter device and method |
US6056744A (en) | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
US6405732B1 (en) | 1994-06-24 | 2002-06-18 | Curon Medical, Inc. | Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors |
US6009877A (en) * | 1994-06-24 | 2000-01-04 | Edwards; Stuart D. | Method for treating a sphincter |
JP3578460B2 (en) | 1994-06-27 | 2004-10-20 | ボストン サイエンティフィック リミテッド | Systems and methods for sensing body temperature |
EP0768841B1 (en) | 1994-06-27 | 2003-12-03 | Boston Scientific Limited | System for controlling tissue ablation using temperature sensors |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
US5690611A (en) | 1994-07-08 | 1997-11-25 | Daig Corporation | Process for the treatment of atrial arrhythima using a catheter guided by shaped giding introducers |
US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US5810802A (en) | 1994-08-08 | 1998-09-22 | E.P. Technologies, Inc. | Systems and methods for controlling tissue ablation using multiple temperature sensing elements |
US5514092A (en) | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
US5454782A (en) | 1994-08-11 | 1995-10-03 | Perkins; Rodney C. | Translumenal circumferential energy delivery device |
US5476498A (en) | 1994-08-15 | 1995-12-19 | Incontrol, Inc. | Coronary sinus channel lead and method |
WO1996004957A1 (en) | 1994-08-17 | 1996-02-22 | Electropharmacology, Inc. | Electrotherapeutic system |
US5609151A (en) | 1994-09-08 | 1997-03-11 | Medtronic, Inc. | Method for R-F ablation |
US5519172A (en) | 1994-09-13 | 1996-05-21 | W. L. Gore & Associates, Inc. | Jacket material for protection of electrical conductors |
US5531778A (en) | 1994-09-20 | 1996-07-02 | Cyberonics, Inc. | Circumneural electrode assembly |
US5545475A (en) | 1994-09-20 | 1996-08-13 | W. L. Gore & Associates | Microfiber-reinforced porous polymer film and a method for manufacturing the same and composites made thereof |
US5540734A (en) | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
US5509909A (en) | 1994-10-06 | 1996-04-23 | Moy; Grant G. | Bent chest tube assembly |
US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
US6142994A (en) | 1994-10-07 | 2000-11-07 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body |
WO1996011723A1 (en) | 1994-10-17 | 1996-04-25 | Australasian Medical Technology Limited | Devices and methods for implementation of pulsed electromagnetic field therapy |
US5722401A (en) | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
US5810742A (en) | 1994-10-24 | 1998-09-22 | Transcan Research & Development Co., Ltd. | Tissue characterization based on impedance images and on impedance measurements |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
AU708529B2 (en) | 1994-11-10 | 1999-08-05 | University Of Kentucky Research Foundation, The | Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body |
US5571150A (en) | 1994-12-19 | 1996-11-05 | Cyberonics, Inc. | Treatment of patients in coma by nerve stimulation |
US5569198A (en) | 1995-01-23 | 1996-10-29 | Cortrak Medical Inc. | Microporous catheter |
GB9501424D0 (en) | 1995-01-25 | 1995-03-15 | Carrie Len | Epidural catheter |
US5595183A (en) * | 1995-02-17 | 1997-01-21 | Ep Technologies, Inc. | Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes |
DE19507929A1 (en) | 1995-02-24 | 1996-09-05 | Biotronik Mess & Therapieg | Electrode system for measuring the monophasic action potential |
DE69637107T2 (en) | 1995-02-28 | 2008-02-28 | Boston Scientific Corp., Natick | Device made of polymer for transmitting a torque |
DE69518337T2 (en) | 1995-03-10 | 2001-02-01 | Impra Inc | ENDOLUMINAL ENCLOSED STENT AND MANUFACTURING METHOD |
US5676662A (en) | 1995-03-17 | 1997-10-14 | Daig Corporation | Ablation catheter |
US5916178A (en) | 1995-03-30 | 1999-06-29 | Medtronic, Inc. | Steerable high support guidewire with thin wall nitinol tube |
NL1000183C2 (en) | 1995-04-20 | 1996-10-22 | Clemens Josephus Jacobs | Catheter. |
WO1996034646A1 (en) | 1995-05-01 | 1996-11-07 | Medtronic Cardiorhythm | Dual curve ablation catheter and method |
US5681280A (en) | 1995-05-02 | 1997-10-28 | Heart Rhythm Technologies, Inc. | Catheter control system |
AU5727096A (en) | 1995-05-04 | 1996-11-21 | Eric R. Cosman | Cool-tip electrode thermosurgery system |
AU5956896A (en) | 1995-06-02 | 1996-12-18 | Guided Medical Systems, Inc. | Composite guide catheter of adjustable shape |
US5984907A (en) | 1995-06-05 | 1999-11-16 | Ep Technologies, Inc. | Transition sleeve assembly for catheters |
US5540730A (en) | 1995-06-06 | 1996-07-30 | Cyberonics, Inc. | Treatment of motility disorders by nerve stimulation |
JPH10503964A (en) | 1995-06-07 | 1998-04-14 | ゴア ハイブリッド テクノロジーズ,インコーポレイティド | Implantable containment device for a therapeutic device and method for loading and reloading the device therein |
US6041252A (en) | 1995-06-07 | 2000-03-21 | Ichor Medical Systems Inc. | Drug delivery system and method |
US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
CN1156961A (en) * | 1995-06-09 | 1997-08-13 | 欧罗赛铁克股份有限公司 | Formulations and method for providing prolonged local anesthesia |
US6322558B1 (en) | 1995-06-09 | 2001-11-27 | Engineering & Research Associates, Inc. | Apparatus and method for predicting ablation depth |
US5983131A (en) | 1995-08-11 | 1999-11-09 | Massachusetts Institute Of Technology | Apparatus and method for electroporation of tissue |
US5672174A (en) | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5711326A (en) * | 1995-08-25 | 1998-01-27 | Whirlpool Corporation | Dishwasher accumulator soil removal grating for a filter system |
US5860922A (en) * | 1995-09-07 | 1999-01-19 | Technion Research And Development Foundation Ltd. | Determining blood flow by measurement of temperature |
US5707400A (en) * | 1995-09-19 | 1998-01-13 | Cyberonics, Inc. | Treating refractory hypertension by nerve stimulation |
JP2000511786A (en) | 1995-09-20 | 2000-09-12 | テキサス・ハート・インスティチュート | Detection of temperature difference in pipe wall |
US6615071B1 (en) | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US6190353B1 (en) | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US5700282A (en) | 1995-10-13 | 1997-12-23 | Zabara; Jacob | Heart rhythm stabilization using a neurocybernetic prosthesis |
US6283951B1 (en) | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US6283960B1 (en) | 1995-10-24 | 2001-09-04 | Oratec Interventions, Inc. | Apparatus for delivery of energy to a surgical site |
US5755750A (en) * | 1995-11-13 | 1998-05-26 | University Of Florida | Method and apparatus for selectively inhibiting activity in nerve fibers |
US6073048A (en) | 1995-11-17 | 2000-06-06 | Medtronic, Inc. | Baroreflex modulation with carotid sinus nerve stimulation for the treatment of heart failure |
US5823955A (en) | 1995-11-20 | 1998-10-20 | Medtronic Cardiorhythm | Atrioventricular valve tissue ablation catheter and method |
SE9504333D0 (en) | 1995-12-04 | 1995-12-04 | Pacesetter Ab | Guidewire assembly |
US6010613A (en) | 1995-12-08 | 2000-01-04 | Cyto Pulse Sciences, Inc. | Method of treating materials with pulsed electrical fields |
DE19546941A1 (en) | 1995-12-15 | 1997-06-19 | Biotronik Mess & Therapieg | Single electrode for two-chamber pacemaker systems, especially for DDD pacemaker systems |
CN2291164Y (en) * | 1996-12-23 | 1998-09-16 | 祝强 | Instrument for bringing high blood pressure down |
ATE284202T1 (en) * | 1996-02-02 | 2004-12-15 | Alza Corp | IMPLANTABLE DELAYED RELEASE SYSTEM |
JP2001508318A (en) * | 1996-02-02 | 2001-06-26 | トランスバスキュラー インコーポレイテッド | Apparatus, systems and methods for interstitial transvascular intervention |
US5895398A (en) | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US5807249A (en) | 1996-02-16 | 1998-09-15 | Medtronic, Inc. | Reduced stiffness, bidirectionally deflecting catheter assembly |
WO1997029802A2 (en) | 1996-02-20 | 1997-08-21 | Advanced Bionics Corporation | Improved implantable microstimulator and systems employing the same |
US5913876A (en) | 1996-02-20 | 1999-06-22 | Cardiothoracic Systems, Inc. | Method and apparatus for using vagus nerve stimulation in surgery |
US6436056B1 (en) | 1996-02-28 | 2002-08-20 | Boston Scientific Corporation | Polymeric implements for torque transmission |
US6036687A (en) | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6032077A (en) | 1996-03-06 | 2000-02-29 | Cardiac Pathways Corporation | Ablation catheter with electrical coupling via foam drenched with a conductive fluid |
US5755760A (en) | 1996-03-11 | 1998-05-26 | Medtronic, Inc. | Deflectable catheter |
JP3529537B2 (en) | 1996-03-25 | 2004-05-24 | テルモ株式会社 | Electrode catheter |
US5997526A (en) | 1996-03-25 | 1999-12-07 | The Uab Research Foundation | Shape memory catheter |
US5747060A (en) * | 1996-03-26 | 1998-05-05 | Euro-Celtique, S.A. | Prolonged local anesthesia with colchicine |
US5690681A (en) | 1996-03-29 | 1997-11-25 | Purdue Research Foundation | Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation |
US5755761A (en) | 1996-04-26 | 1998-05-26 | Pharmatarget, Inc. | Atrial pacing catheter and method having multiple electrodes in the right atrium and coronary sinus |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6735471B2 (en) * | 1996-04-30 | 2004-05-11 | Medtronic, Inc. | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
US6449507B1 (en) * | 1996-04-30 | 2002-09-10 | Medtronic, Inc. | Method and system for nerve stimulation prior to and during a medical procedure |
US5690691A (en) | 1996-05-08 | 1997-11-25 | The Center For Innovative Technology | Gastro-intestinal pacemaker having phased multi-point stimulation |
US5713923A (en) | 1996-05-13 | 1998-02-03 | Medtronic, Inc. | Techniques for treating epilepsy by brain stimulation and drug infusion |
US6042578A (en) | 1996-05-13 | 2000-03-28 | Schneider (Usa) Inc. | Catheter reinforcing braids |
US5938690A (en) | 1996-06-07 | 1999-08-17 | Advanced Neuromodulation Systems, Inc. | Pain management system and method |
US5824026A (en) | 1996-06-12 | 1998-10-20 | The Spectranetics Corporation | Catheter for delivery of electric energy and a process for manufacturing same |
US5861021A (en) * | 1996-06-17 | 1999-01-19 | Urologix Inc | Microwave thermal therapy of cardiac tissue |
US6223070B1 (en) | 1998-03-16 | 2001-04-24 | Cook, Inc. | Indwelling catheter |
US6546280B2 (en) | 1996-06-18 | 2003-04-08 | Cook Incorporated | Indwelling catheter |
US5727555A (en) | 1996-06-18 | 1998-03-17 | Cook Incorporated | Indwelling catheter |
US5827242A (en) | 1996-06-21 | 1998-10-27 | Medtronic, Inc. | Reinforced catheter body and method for its fabrication |
US20020040204A1 (en) | 1996-06-24 | 2002-04-04 | Dev Nagendu B. | Electroporation-enhanced inhibition of vascular neointimal hyperplasia |
US5944710A (en) * | 1996-06-24 | 1999-08-31 | Genetronics, Inc. | Electroporation-mediated intravascular delivery |
US5983141A (en) | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5882346A (en) | 1996-07-15 | 1999-03-16 | Cardiac Pathways Corporation | Shapable catheter using exchangeable core and method of use |
US5972019A (en) | 1996-07-25 | 1999-10-26 | Target Therapeutics, Inc. | Mechanical clot treatment device |
US6245026B1 (en) | 1996-07-29 | 2001-06-12 | Farallon Medsystems, Inc. | Thermography catheter |
US5924997A (en) | 1996-07-29 | 1999-07-20 | Campbell; Thomas Henderson | Catheter and method for the thermal mapping of hot spots in vascular lesions of the human body |
US6058328A (en) * | 1996-08-06 | 2000-05-02 | Pacesetter, Inc. | Implantable stimulation device having means for operating in a preemptive pacing mode to prevent tachyarrhythmias and method thereof |
US6135999A (en) | 1997-02-12 | 2000-10-24 | Oratec Internationals, Inc. | Concave probe for arthroscopic surgery |
US5800494A (en) | 1996-08-20 | 1998-09-01 | Fidus Medical Technology Corporation | Microwave ablation catheters having antennas with distal fire capabilities |
US5906636A (en) * | 1996-09-20 | 1999-05-25 | Texas Heart Institute | Heat treatment of inflamed tissue |
US5954740A (en) | 1996-09-23 | 1999-09-21 | Boston Scientific Corporation | Catheter balloon having raised radial segments |
US5697928A (en) | 1996-09-23 | 1997-12-16 | Uab Research Foundation | Cardic electrode catheter |
US5891134A (en) | 1996-09-24 | 1999-04-06 | Goble; Colin | System and method for applying thermal energy to tissue |
US5800464A (en) | 1996-10-03 | 1998-09-01 | Medtronic, Inc. | System for providing hyperpolarization of cardiac to enhance cardiac function |
US5814079A (en) | 1996-10-04 | 1998-09-29 | Medtronic, Inc. | Cardiac arrhythmia management by application of adnodal stimulation for hyperpolarization of myocardial cells |
US5704908A (en) * | 1996-10-10 | 1998-01-06 | Genetronics, Inc. | Electroporation and iontophoresis catheter with porous balloon |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US6096036A (en) | 1998-05-05 | 2000-08-01 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
US5827268A (en) | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US5893885A (en) | 1996-11-01 | 1999-04-13 | Cordis Webster, Inc. | Multi-electrode ablation catheter |
US6091995A (en) | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
US5910150A (en) | 1996-12-02 | 1999-06-08 | Angiotrax, Inc. | Apparatus for performing surgery |
US5954719A (en) | 1996-12-11 | 1999-09-21 | Irvine Biomedical, Inc. | System for operating a RF ablation generator |
US6048329A (en) | 1996-12-19 | 2000-04-11 | Ep Technologies, Inc. | Catheter distal assembly with pull wires |
US5910129A (en) | 1996-12-19 | 1999-06-08 | Ep Technologies, Inc. | Catheter distal assembly with pull wires |
US6076012A (en) | 1996-12-19 | 2000-06-13 | Ep Technologies, Inc. | Structures for supporting porous electrode elements |
US5871449A (en) * | 1996-12-27 | 1999-02-16 | Brown; David Lloyd | Device and method for locating inflamed plaque in an artery |
WO1998030279A1 (en) * | 1997-01-13 | 1998-07-16 | Neurodan A/S | An implantable nerve stimulator electrode |
US6026326A (en) * | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US5744710A (en) * | 1997-01-17 | 1998-04-28 | Lockheed Martin Corp. | Fast maximum likelihood processor for means wind velocity estimation |
SE9700373L (en) | 1997-02-04 | 1998-07-13 | Stig Bengmark | Probe for providing fluid communication with the small intestine |
US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
US6208894B1 (en) | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
EP1011792B1 (en) | 1997-02-26 | 2005-12-07 | Alfred E. Mann Foundation for Scientific Research | Battery-powered patient implantable device |
US5899898A (en) | 1997-02-27 | 1999-05-04 | Cryocath Technologies Inc. | Cryosurgical linear ablation |
US6416510B1 (en) | 1997-03-13 | 2002-07-09 | Biocardia, Inc. | Drug delivery catheters that attach to tissue and methods for their use |
US6086582A (en) | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
US5954761A (en) | 1997-03-25 | 1999-09-21 | Intermedics Inc. | Implantable endocardial lead assembly having a stent |
CA2284785C (en) | 1997-03-27 | 2006-07-11 | Joseph H. Schulman | System of implantable devices for monitoring and/or affecting body parameters |
JP3274384B2 (en) | 1997-03-31 | 2002-04-15 | 株式会社パイオラックス | Indwelling catheter and its insertion device |
WO1998043530A1 (en) | 1997-03-31 | 1998-10-08 | Biosense Inc. | Deflectable catheter |
US5879295A (en) | 1997-04-02 | 1999-03-09 | Medtronic, Inc. | Enhanced contact steerable bowing electrode catheter assembly |
US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
US5876373A (en) | 1997-04-04 | 1999-03-02 | Eclipse Surgical Technologies, Inc. | Steerable catheter |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US5972026A (en) | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
US5865815A (en) | 1997-04-25 | 1999-02-02 | Contimed, Inc. | Prostatic obstruction relief catheter |
US5948007A (en) | 1997-04-30 | 1999-09-07 | Medtronic, Inc. | Dual channel implantation neurostimulation techniques |
US6078840A (en) | 1997-04-30 | 2000-06-20 | Medtronic, Inc. | Medical electrical lead having improved fixation |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
AU7389098A (en) | 1997-05-16 | 1998-12-08 | Brigham And Women's Hospital | Local anesthetic formulations |
US5827278A (en) | 1997-05-20 | 1998-10-27 | Cordis Webster, Inc. | Deflectable tip electrode catheter with nylon stiffener and compression coil |
DE69840444D1 (en) | 1997-05-23 | 2009-02-26 | Prorhythm Inc | DISMISSABLE FOCUSING ULTRASOUND APPLICATOR OF HIGH INTENSITY |
US5951539A (en) | 1997-06-10 | 1999-09-14 | Target Therpeutics, Inc. | Optimized high performance multiple coil spiral-wound vascular catheter |
US6152912A (en) | 1997-06-10 | 2000-11-28 | Target Therapeutics, Inc. | Optimized high performance spiral-wound vascular catheter |
US20030109778A1 (en) | 1997-06-20 | 2003-06-12 | Cardiac Assist Devices, Inc. | Electrophysiology/ablation catheter and remote actuator therefor |
WO1999000060A1 (en) | 1997-06-26 | 1999-01-07 | Advanced Coronary Intervention | Electrosurgical catheter for resolving obstructions by radio frequency ablation |
USRE40279E1 (en) | 1997-06-26 | 2008-04-29 | Sherwood Services Ag | Method and system for neural tissue modification |
US6251109B1 (en) | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
IL129951A0 (en) * | 1997-07-02 | 2000-02-29 | Euro Celtique Sa | Prolonged anesthesia in joints and body spaces |
US6164283A (en) | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6652515B1 (en) | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6869431B2 (en) | 1997-07-08 | 2005-03-22 | Atrionix, Inc. | Medical device with sensor cooperating with expandable member |
BR9811101A (en) | 1997-07-08 | 2001-12-26 | Univ California | Device assembly and circumferential ablation method |
US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US6966908B2 (en) | 1997-07-08 | 2005-11-22 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
DE69739334D1 (en) * | 1997-07-16 | 2009-05-07 | Metacure N V | Device for controlling a smooth muscle |
US6080151A (en) | 1997-07-21 | 2000-06-27 | Daig Corporation | Ablation catheter |
US6014579A (en) * | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US6125302A (en) | 1997-09-02 | 2000-09-26 | Advanced Bionics Corporation | Precurved modiolar-hugging cochlear electrode |
WO1999011313A1 (en) | 1997-09-04 | 1999-03-11 | Alcon Laboratories, Inc. | Flexible tube with circular grooves of varying width and depth |
US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
US6258084B1 (en) | 1997-09-11 | 2001-07-10 | Vnus Medical Technologies, Inc. | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US5871531A (en) | 1997-09-25 | 1999-02-16 | Medtronic, Inc. | Medical electrical lead having tapered spiral fixation |
US5891114A (en) | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
US6048338A (en) | 1997-10-15 | 2000-04-11 | Scimed Life Systems, Inc. | Catheter with spiral cut transition member |
US6190356B1 (en) | 1997-10-20 | 2001-02-20 | Robert M. Bersin | Helical spiral balloon catheter |
US6156046A (en) | 1997-11-07 | 2000-12-05 | Prolifix Medical, Inc. | Methods and systems for treating obstructions in a body lumen |
WO1999023958A1 (en) | 1997-11-07 | 1999-05-20 | Prolifix Medical, Inc. | Methods and systems for treating obstructions in a body lumen |
US6120500A (en) | 1997-11-12 | 2000-09-19 | Daig Corporation | Rail catheter ablation and mapping system |
US6120476A (en) | 1997-12-01 | 2000-09-19 | Cordis Webster, Inc. | Irrigated tip catheter |
US6917834B2 (en) | 1997-12-03 | 2005-07-12 | Boston Scientific Scimed, Inc. | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates |
US6280441B1 (en) | 1997-12-15 | 2001-08-28 | Sherwood Services Ag | Apparatus and method for RF lesioning |
US6699231B1 (en) | 1997-12-31 | 2004-03-02 | Heartport, Inc. | Methods and apparatus for perfusion of isolated tissue structure |
AU2022999A (en) | 1997-12-31 | 1999-07-19 | Heartport, Inc. | Methods and apparatus for perfusion of isolated tissue structure |
US6146380A (en) | 1998-01-09 | 2000-11-14 | Radionics, Inc. | Bent tip electrical surgical probe |
CA2295134A1 (en) | 1998-01-15 | 1999-07-22 | Amethyst Technologies, Inc. | Improved pulsed electromagnetic energy treatment apparatus and method |
US6251130B1 (en) | 1998-03-24 | 2001-06-26 | Innercool Therapies, Inc. | Device for applications of selective organ cooling |
US6522932B1 (en) | 1998-02-10 | 2003-02-18 | Advanced Bionics Corporation | Implantable, expandable, multicontact electrodes and tools for use therewith |
US6415187B1 (en) | 1998-02-10 | 2002-07-02 | Advanced Bionics Corporation | Implantable, expandable, multicontact electrodes and insertion needle for use therewith |
US6205361B1 (en) | 1998-02-10 | 2001-03-20 | Advanced Bionics Corporation | Implantable expandable multicontact electrodes |
US6645201B1 (en) * | 1998-02-19 | 2003-11-11 | Curon Medical, Inc. | Systems and methods for treating dysfunctions in the intestines and rectum |
US6258087B1 (en) | 1998-02-19 | 2001-07-10 | Curon Medical, Inc. | Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
KR19990072499A (en) | 1998-02-19 | 1999-09-27 | 리페르트 존 | Catheter guidewire apparatus with location specific flexibility |
WO1999042044A1 (en) * | 1998-02-19 | 1999-08-26 | Conway-Stuart Medical, Inc. | Electrosurgical sphincter treatment apparatus |
US6273886B1 (en) | 1998-02-19 | 2001-08-14 | Curon Medical, Inc. | Integrated tissue heating and cooling apparatus |
US7169141B2 (en) | 1998-02-24 | 2007-01-30 | Hansen Medical, Inc. | Surgical instrument |
US6843793B2 (en) | 1998-02-24 | 2005-01-18 | Endovia Medical, Inc. | Surgical instrument |
US6142993A (en) | 1998-02-27 | 2000-11-07 | Ep Technologies, Inc. | Collapsible spline structure using a balloon as an expanding actuator |
US6308090B1 (en) | 1998-03-09 | 2001-10-23 | Irvine Biomedical, Inc. | Devices and methods for coronary sinus mapping |
US5951471A (en) | 1998-03-09 | 1999-09-14 | Irvine Biomedical, Inc. | Catheter-based coronary sinus mapping and ablation |
US6132456A (en) | 1998-03-10 | 2000-10-17 | Medtronic, Inc. | Arrangement for implanting an endocardial cardiac lead |
US6078841A (en) | 1998-03-27 | 2000-06-20 | Advanced Bionics Corporation | Flexible positioner for use with implantable cochlear electrode array |
US6071729A (en) | 1998-04-02 | 2000-06-06 | Jeffries; Thomas W. | Disruption of the cytochrome C gene in xylose-fermenting yeast |
US6086527A (en) | 1998-04-02 | 2000-07-11 | Scimed Life Systems, Inc. | System for treating congestive heart failure |
US6314325B1 (en) | 1998-04-07 | 2001-11-06 | William R. Fitz | Nerve hyperpolarization method and apparatus for pain relief |
US6106518A (en) | 1998-04-09 | 2000-08-22 | Cryocath Technologies, Inc. | Variable geometry tip for a cryosurgical ablation device |
JP2002511292A (en) | 1998-04-13 | 2002-04-16 | プロリフィックス メディカル, インコーポレイテッド | Guidewire for accurate catheter positioning |
US6219577B1 (en) * | 1998-04-14 | 2001-04-17 | Global Vascular Concepts, Inc. | Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues |
JP2003511098A (en) | 1998-04-14 | 2003-03-25 | ジーエムピー・ドラツグ・デリバリー・インコーポレーテツド | Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues |
US6064902A (en) | 1998-04-16 | 2000-05-16 | C.R. Bard, Inc. | Pulmonary vein ablation catheter |
US5968085A (en) | 1998-04-20 | 1999-10-19 | Medtronic, Inc. | Pacing lead with integral guidance using ultrasound |
US5916154A (en) | 1998-04-22 | 1999-06-29 | Nellcor Puritan Bennett | Method of enhancing performance in pulse oximetry via electrical stimulation |
EP0951920B1 (en) | 1998-04-22 | 2004-10-20 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Electrode cable for attachement to a vessel wall |
US20020065542A1 (en) | 1998-04-22 | 2002-05-30 | Ronald G. Lax | Method and apparatus for treating an aneurysm |
US6269269B1 (en) | 1998-04-23 | 2001-07-31 | Medtronic Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US6058331A (en) * | 1998-04-27 | 2000-05-02 | Medtronic, Inc. | Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control |
US6511492B1 (en) | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
US5928272A (en) | 1998-05-02 | 1999-07-27 | Cyberonics, Inc. | Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity |
US6592581B2 (en) | 1998-05-05 | 2003-07-15 | Cardiac Pacemakers, Inc. | Preformed steerable catheter with movable outer sleeve and method for use |
US6146381A (en) | 1998-05-05 | 2000-11-14 | Cardiac Pacemakers, Inc. | Catheter having distal region for deflecting axial forces |
US6042580A (en) | 1998-05-05 | 2000-03-28 | Cardiac Pacemakers, Inc. | Electrode having composition-matched, common-lead thermocouple wire for providing multiple temperature-sensitive junctions |
US6312425B1 (en) | 1998-05-05 | 2001-11-06 | Cardiac Pacemakers, Inc. | RF ablation catheter tip electrode with multiple thermal sensors |
US6049737A (en) | 1998-05-05 | 2000-04-11 | Cardiac Pacemakers, Inc. | Catheter having common lead for electrode and sensor |
US6192889B1 (en) * | 1998-05-05 | 2001-02-27 | Woodside Biomedical, Inc. | Method of suppression and prevention of the gag reflex |
US6074339A (en) | 1998-05-07 | 2000-06-13 | Medtronic Ave, Inc. | Expandable braid device and method for radiation treatment |
WO1999058188A1 (en) * | 1998-05-08 | 1999-11-18 | Genetronics, Inc. | Electrically induced vessel vasodilation |
US6231572B1 (en) | 1998-05-29 | 2001-05-15 | Applied Medical Resources Corporation | Electrosurgical catheter apparatus and method |
US6623474B1 (en) | 1998-06-04 | 2003-09-23 | Biosense Webster, Inc. | Injection catheter with needle stop |
US7198635B2 (en) * | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US6368316B1 (en) | 1998-06-11 | 2002-04-09 | Target Therapeutics, Inc. | Catheter with composite stiffener |
US6292695B1 (en) | 1998-06-19 | 2001-09-18 | Wilton W. Webster, Jr. | Method and apparatus for transvascular treatment of tachycardia and fibrillation |
US6094596A (en) | 1998-06-19 | 2000-07-25 | Angeron Corporation | Transvenous defibrillation lead system for use in middle cardiac vein |
US6287306B1 (en) | 1998-06-22 | 2001-09-11 | Daig Corporation | Even temperature linear lesion ablation catheter |
US6066132A (en) | 1998-06-30 | 2000-05-23 | Ethicon, Inc. | Articulating endometrial ablation device |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6302903B1 (en) | 1998-07-07 | 2001-10-16 | Medtronic, Inc. | Straight needle apparatus for creating a virtual electrode used for the ablation of tissue |
EP2428249B1 (en) | 1998-07-13 | 2015-10-07 | Inovio Pharmaceuticals, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
US6972013B1 (en) | 1998-07-13 | 2005-12-06 | Genetronics, Inc. | Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation |
US7599736B2 (en) | 2001-07-23 | 2009-10-06 | Dilorenzo Biomedical, Llc | Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease |
US6179860B1 (en) | 1998-08-19 | 2001-01-30 | Artemis Medical, Inc. | Target tissue localization device and method |
US6610083B2 (en) | 1998-08-24 | 2003-08-26 | Radiant Medical, Inc. | Multiple lumen heat exchange catheters |
US6304787B1 (en) | 1998-08-26 | 2001-10-16 | Advanced Bionics Corporation | Cochlear electrode array having current-focusing and tissue-treating features |
US6228109B1 (en) | 1998-08-31 | 2001-05-08 | Lily Chen Tu | Methods for treating atherosclerosis and vulnerable plaques |
US6123702A (en) | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6385472B1 (en) | 1999-09-10 | 2002-05-07 | Stereotaxis, Inc. | Magnetically navigable telescoping catheter and method of navigating telescoping catheter |
US6319251B1 (en) * | 1998-09-24 | 2001-11-20 | Hosheng Tu | Medical device and methods for treating intravascular restenosis |
US6544215B1 (en) | 1998-10-02 | 2003-04-08 | Scimed Life Systems, Inc. | Steerable device for introducing diagnostic and therapeutic apparatus into the body |
US6123718A (en) | 1998-11-02 | 2000-09-26 | Polymerex Medical Corp. | Balloon catheter |
US6701176B1 (en) | 1998-11-04 | 2004-03-02 | Johns Hopkins University School Of Medicine | Magnetic-resonance-guided imaging, electrophysiology, and ablation |
US6083156A (en) * | 1998-11-16 | 2000-07-04 | Ronald S. Lisiecki | Portable integrated physiological monitoring system |
US7313444B2 (en) | 1998-11-20 | 2007-12-25 | Pacesetter, Inc. | Self-anchoring coronary sinus lead |
US6638278B2 (en) | 1998-11-23 | 2003-10-28 | C. R. Bard, Inc. | Intracardiac grasp catheter |
US6319250B1 (en) | 1998-11-23 | 2001-11-20 | C.R. Bard, Inc | Tricuspid annular grasp catheter |
US20070066972A1 (en) | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
US7004938B2 (en) | 2001-11-29 | 2006-02-28 | Medwaves, Inc. | Radio-frequency-based catheter system with improved deflection and steering mechanisms |
DE69917484T2 (en) | 1998-12-14 | 2005-05-12 | Tre Esse Progettazione Biomedica S.R.L. | CATHETER SYSTEM FOR CARRYING OUT INTRAMYOCARDIAL THERAPEUTIC TREATMENT |
US6077227A (en) | 1998-12-28 | 2000-06-20 | Medtronic, Inc. | Method for manufacture and implant of an implantable blood vessel cuff |
US6749598B1 (en) | 1999-01-11 | 2004-06-15 | Flowmedica, Inc. | Apparatus and methods for treating congestive heart disease |
US7780628B1 (en) * | 1999-01-11 | 2010-08-24 | Angiodynamics, Inc. | Apparatus and methods for treating congestive heart disease |
US7481803B2 (en) | 2000-11-28 | 2009-01-27 | Flowmedica, Inc. | Intra-aortic renal drug delivery catheter |
US7122019B1 (en) | 2000-11-28 | 2006-10-17 | Flowmedica Inc. | Intra-aortic renal drug delivery catheter |
US7329236B2 (en) | 1999-01-11 | 2008-02-12 | Flowmedica, Inc. | Intra-aortic renal drug delivery catheter |
CA2368707C (en) | 1999-02-02 | 2006-06-06 | Transurgical, Inc. | Intrabody hifu applicator |
US6210408B1 (en) | 1999-02-24 | 2001-04-03 | Scimed Life Systems, Inc. | Guide wire system for RF recanalization of vascular blockages |
US6210339B1 (en) | 1999-03-03 | 2001-04-03 | Endosonics Corporation | Flexible elongate member having one or more electrical contacts |
JP4102031B2 (en) | 1999-03-09 | 2008-06-18 | サーメイジ インコーポレイテッド | Apparatus and method for treating tissue |
US6508774B1 (en) | 1999-03-09 | 2003-01-21 | Transurgical, Inc. | Hifu applications with feedback control |
US6464687B1 (en) | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
US6129750A (en) | 1999-03-23 | 2000-10-10 | Cardiac Pacemakers, Inc. | Fixation mechanism for a coronary venous pacing lead |
US6136021A (en) * | 1999-03-23 | 2000-10-24 | Cardiac Pacemakers, Inc. | Expandable electrode for coronary venous leads |
US6678558B1 (en) * | 1999-03-25 | 2004-01-13 | Genetronics, Inc. | Method and apparatus for reducing electroporation-mediated muscle reaction and pain response |
US6161049A (en) | 1999-03-26 | 2000-12-12 | Urologix, Inc. | Thermal therapy catheter |
US20010007070A1 (en) | 1999-04-05 | 2001-07-05 | Medtronic, Inc. | Ablation catheter assembly and method for isolating a pulmonary vein |
US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
US20050010095A1 (en) | 1999-04-05 | 2005-01-13 | Medtronic, Inc. | Multi-purpose catheter apparatus and method of use |
US6366808B1 (en) | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US6738663B2 (en) | 1999-04-09 | 2004-05-18 | Oncostim, A Minnesota Corporation | Implantable device and method for the electrical treatment of cancer |
US6178349B1 (en) * | 1999-04-15 | 2001-01-23 | Medtronic, Inc. | Drug delivery neural stimulation device for treatment of cardiovascular disorders |
US6317615B1 (en) | 1999-04-19 | 2001-11-13 | Cardiac Pacemakers, Inc. | Method and system for reducing arterial restenosis in the presence of an intravascular stent |
US6939346B2 (en) | 1999-04-21 | 2005-09-06 | Oratec Interventions, Inc. | Method and apparatus for controlling a temperature-controlled probe |
US6923784B2 (en) * | 1999-04-30 | 2005-08-02 | Medtronic, Inc. | Therapeutic treatment of disorders based on timing information |
US6341236B1 (en) | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
WO2000066211A1 (en) | 1999-04-30 | 2000-11-09 | Usaminanotechnology, Inc. | Catheter and guide wire |
WO2000066017A1 (en) | 1999-05-04 | 2000-11-09 | Curon Medical, Inc. | Electrodes for creating lesions in tissue regions at or near a sphincter |
US6178352B1 (en) * | 1999-05-07 | 2001-01-23 | Woodside Biomedical, Inc. | Method of blood pressure moderation |
ES2279757T3 (en) | 1999-05-11 | 2007-09-01 | Atrionix, Inc. | BALL ANCHORING THREAD. |
US6758830B1 (en) | 1999-05-11 | 2004-07-06 | Atrionix, Inc. | Catheter positioning system |
US7343195B2 (en) | 1999-05-18 | 2008-03-11 | Mediguide Ltd. | Method and apparatus for real time quantitative three-dimensional image reconstruction of a moving organ and intra-body navigation |
US6692490B1 (en) * | 1999-05-18 | 2004-02-17 | Novasys Medical, Inc. | Treatment of urinary incontinence and other disorders by application of energy and drugs |
DE29909082U1 (en) | 1999-05-25 | 1999-07-22 | Starck | Stimulation, sensing and / or defibrillation electrode and balloon catheter for inserting the electrode |
US6304777B1 (en) | 1999-05-26 | 2001-10-16 | Impulse Dynamics N.V. | Induction of cardioplegia applied electrical signals |
US6442424B1 (en) | 1999-05-26 | 2002-08-27 | Impulse Dynamics N.V. | Local cardiac motion control using applied electrical signals |
US7171263B2 (en) * | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
US6890329B2 (en) | 1999-06-15 | 2005-05-10 | Cryocath Technologies Inc. | Defined deflection structure |
US6546272B1 (en) | 1999-06-24 | 2003-04-08 | Mackinnon Nicholas B. | Apparatus for in vivo imaging of the respiratory tract and other internal organs |
CA2376903A1 (en) * | 1999-06-25 | 2001-01-04 | Emory University | Devices and methods for vagus nerve stimulation |
US6272383B1 (en) | 1999-06-28 | 2001-08-07 | Woodside Biomedical, Inc. | Electro-acupuncture method using an electrical stimulator |
US6620172B1 (en) | 1999-07-01 | 2003-09-16 | Medsource Technologies, Inc. | Entraining biological calculi |
US6364904B1 (en) | 1999-07-02 | 2002-04-02 | Scimed Life Systems, Inc. | Helically formed stent/graft assembly |
US6605061B2 (en) | 1999-07-14 | 2003-08-12 | Tricardia, L.L.C. | Catheter for drug injection in cardiovascular system |
US6927049B2 (en) | 1999-07-21 | 2005-08-09 | The Regents Of The University Of California | Cell viability detection using electrical measurements |
US6300108B1 (en) | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
US7053063B2 (en) | 1999-07-21 | 2006-05-30 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes in tissue |
US6508804B2 (en) | 1999-07-28 | 2003-01-21 | Scimed Life Systems, Inc. | Catheter having continuous lattice and coil reinforcement |
US6326177B1 (en) | 1999-08-04 | 2001-12-04 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Method and apparatus for intracellular electro-manipulation |
FR2797389B1 (en) | 1999-08-09 | 2001-11-30 | Novatech Inc | BIFURCED AORTIC PROSTHESIS |
US6767544B2 (en) | 2002-04-01 | 2004-07-27 | Allergan, Inc. | Methods for treating cardiovascular diseases with botulinum toxin |
US6611720B2 (en) | 1999-08-12 | 2003-08-26 | Irvine Biomedical Inc. | High torque catheter possessing multi-directional deflectability and methods thereof |
US6442415B1 (en) | 1999-08-12 | 2002-08-27 | Magnetic Moments, L.L.C. | Contrast-enhanced coronary artery and coronary artery bypass graft imaging using an aortic root catheter injection with either magnetic resonance angiography or computed tomographic angiography |
US7171275B2 (en) | 1999-08-12 | 2007-01-30 | Irvine Biomedical Inc. | High torque balloon catheter possessing multi-directional deflectability and methods thereof |
US6246914B1 (en) | 1999-08-12 | 2001-06-12 | Irvine Biomedical, Inc. | High torque catheter and methods thereof |
US6450942B1 (en) | 1999-08-20 | 2002-09-17 | Cardiorest International Ltd. | Method for reducing heart loads in mammals |
US6575966B2 (en) * | 1999-08-23 | 2003-06-10 | Cryocath Technologies Inc. | Endovascular cryotreatment catheter |
WO2001017455A2 (en) | 1999-09-10 | 2001-03-15 | Transurgical, Inc. | Occlusion of tubular anatomical structures by energy application |
US6607520B2 (en) | 1999-09-15 | 2003-08-19 | The General Hospital Corporation | Coiled ablation catheter system |
US6632223B1 (en) * | 2000-03-30 | 2003-10-14 | The General Hospital Corporation | Pulmonary vein ablation stent and method |
US6454775B1 (en) | 1999-12-06 | 2002-09-24 | Bacchus Vascular Inc. | Systems and methods for clot disruption and retrieval |
US7510536B2 (en) | 1999-09-17 | 2009-03-31 | University Of Washington | Ultrasound guided high intensity focused ultrasound treatment of nerves |
WO2001022897A1 (en) | 1999-09-28 | 2001-04-05 | Novasys Medical, Inc. | Treatment of tissue by application of energy and drugs |
US6272377B1 (en) | 1999-10-01 | 2001-08-07 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
US6473644B1 (en) | 1999-10-13 | 2002-10-29 | Cyberonics, Inc. | Method to enhance cardiac capillary growth in heart failure patients |
US6287304B1 (en) | 1999-10-15 | 2001-09-11 | Neothermia Corporation | Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes |
US6669655B1 (en) | 1999-10-20 | 2003-12-30 | Transurgical, Inc. | Sonic element and catheter incorporating same |
EP1224436A1 (en) | 1999-10-29 | 2002-07-24 | Universität Zürich | Method of volumetric blood flow measurement |
US6436091B1 (en) | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
US6613046B1 (en) | 1999-11-22 | 2003-09-02 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6542781B1 (en) * | 1999-11-22 | 2003-04-01 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
EP1233716B1 (en) | 1999-11-22 | 2014-07-30 | Boston Scientific Limited | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6711444B2 (en) | 1999-11-22 | 2004-03-23 | Scimed Life Systems, Inc. | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
US6745080B2 (en) | 1999-11-22 | 2004-06-01 | Scimed Life Systems, Inc. | Helical and pre-oriented loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
EP1106202A3 (en) * | 1999-11-30 | 2004-03-31 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Electrode for intravascular stimulation, cardioversion and /or defibrillation |
US6690971B2 (en) | 1999-11-30 | 2004-02-10 | Biotronik Mess - Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin | Device for regulating heart rate and heart pumping force |
US6575932B1 (en) * | 1999-12-02 | 2003-06-10 | Ottawa Heart Institute | Adjustable multi-balloon local delivery device |
US6280466B1 (en) | 1999-12-03 | 2001-08-28 | Teramed Inc. | Endovascular graft system |
US6592567B1 (en) | 1999-12-07 | 2003-07-15 | Chf Solutions, Inc. | Kidney perfusion catheter |
US6415183B1 (en) | 1999-12-09 | 2002-07-02 | Cardiac Pacemakers, Inc. | Method and apparatus for diaphragmatic pacing |
US20030150464A1 (en) | 1999-12-17 | 2003-08-14 | Casscells S. Ward | Inducing apoptosis of atrial myocytes to treat atrial fibrillation |
US7896872B2 (en) | 1999-12-21 | 2011-03-01 | Philip Michael Finch | Apparatus for thermal treatment of an intervertebral disc |
DE10042330A1 (en) | 1999-12-22 | 2002-03-14 | Hans Sachse | Small intestine probe, wall-reinforced |
US6328699B1 (en) | 2000-01-11 | 2001-12-11 | Cedars-Sinai Medical Center | Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure |
US7865237B2 (en) | 2000-01-20 | 2011-01-04 | The Cleveland Clinic Foundation | Methods and systems of achieving hemodynamic control through neuromodulation |
US6356787B1 (en) | 2000-02-24 | 2002-03-12 | Electro Core Techniques, Llc | Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain |
US6438423B1 (en) | 2000-01-20 | 2002-08-20 | Electrocore Technique, Llc | Method of treating complex regional pain syndromes by electrical stimulation of the sympathetic nerve chain |
US20060085046A1 (en) * | 2000-01-20 | 2006-04-20 | Ali Rezai | Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system |
US6356786B1 (en) | 2000-01-20 | 2002-03-12 | Electrocore Techniques, Llc | Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain |
US6885888B2 (en) * | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
US7184827B1 (en) | 2000-01-24 | 2007-02-27 | Stuart D. Edwards | Shrinkage of dilatations in the body |
US6628976B1 (en) | 2000-01-27 | 2003-09-30 | Biosense Webster, Inc. | Catheter having mapping assembly |
AU2001231196A1 (en) * | 2000-01-27 | 2001-08-07 | The General Hospital Corporation | Delivery of therapeutic biological from implantable tissue matrices |
US6514226B1 (en) | 2000-02-10 | 2003-02-04 | Chf Solutions, Inc. | Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney |
US7163504B1 (en) | 2000-02-16 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Multi-lumen fluted balloon radiation centering catheter |
US6868289B2 (en) | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
US7565206B2 (en) | 2000-02-17 | 2009-07-21 | Standen Ltd. | Treating a tumor or the like with electric fields at different orientations |
US6536949B1 (en) * | 2000-03-07 | 2003-03-25 | Richard R. Heuser | Catheter for thermal evaluation of arteriosclerotic plaque |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US6554774B1 (en) * | 2000-03-23 | 2003-04-29 | Tensys Medical, Inc. | Method and apparatus for assessing hemodynamic properties within the circulatory system of a living subject |
US6605084B2 (en) | 2000-03-24 | 2003-08-12 | Transurgical, Inc. | Apparatus and methods for intrabody thermal treatment |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US6287608B1 (en) | 2000-04-11 | 2001-09-11 | Intellicardia, Inc. | Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney by infusion of a vasodilator |
US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
US20010044596A1 (en) | 2000-05-10 | 2001-11-22 | Ali Jaafar | Apparatus and method for treatment of vascular restenosis by electroporation |
ATE413848T1 (en) | 2000-05-12 | 2008-11-15 | Cardima Inc | MULTI-CHANNEL HIGH FREQUENCY DELIVERY SYSTEM WITH COAGULATION REDUCTION |
US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
EP1289439B1 (en) | 2000-06-13 | 2005-03-16 | Atrionix, Inc. | Surgical ablation probe for forming a circumferential lesion |
US6546270B1 (en) | 2000-07-07 | 2003-04-08 | Biosense, Inc. | Multi-electrode catheter, system and method |
US6405067B1 (en) | 2000-07-07 | 2002-06-11 | Biosense Webster, Inc. | Catheter with tip electrode having a recessed ring electrode mounted thereon |
WO2002005868A2 (en) | 2000-07-13 | 2002-01-24 | Transurgical, Inc. | Thermal treatment methods and apparatus with focused energy application |
ATE412445T1 (en) | 2000-07-26 | 2008-11-15 | Boston Scient Neuromodulation | STIMULATION SYSTEM |
US6892099B2 (en) * | 2001-02-08 | 2005-05-10 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation |
US6697670B2 (en) * | 2001-08-17 | 2004-02-24 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients |
US6795728B2 (en) | 2001-08-17 | 2004-09-21 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation |
US6862479B1 (en) | 2000-08-30 | 2005-03-01 | Advanced Bionics Corporation | Spinal cord stimulation as a therapy for sexual dysfunction |
US6584362B1 (en) * | 2000-08-30 | 2003-06-24 | Cardiac Pacemakers, Inc. | Leads for pacing and/or sensing the heart from within the coronary veins |
DE60020171T2 (en) | 2000-09-07 | 2006-01-26 | Sherwood Services Ag | DEVICE FOR TREATING DISCS |
US6405079B1 (en) | 2000-09-22 | 2002-06-11 | Mehdi M. Ansarinia | Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions |
US7616997B2 (en) | 2000-09-27 | 2009-11-10 | Kieval Robert S | Devices and methods for cardiovascular reflex control via coupled electrodes |
US7840271B2 (en) | 2000-09-27 | 2010-11-23 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
US7499742B2 (en) | 2001-09-26 | 2009-03-03 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
US6985774B2 (en) * | 2000-09-27 | 2006-01-10 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
US7623926B2 (en) | 2000-09-27 | 2009-11-24 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
US6850801B2 (en) * | 2001-09-26 | 2005-02-01 | Cvrx, Inc. | Mapping methods for cardiovascular reflex control devices |
US6522926B1 (en) * | 2000-09-27 | 2003-02-18 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control |
US7158832B2 (en) * | 2000-09-27 | 2007-01-02 | Cvrx, Inc. | Electrode designs and methods of use for cardiovascular reflex control devices |
US6845267B2 (en) * | 2000-09-28 | 2005-01-18 | Advanced Bionics Corporation | Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation |
WO2002026194A2 (en) * | 2000-09-28 | 2002-04-04 | Non-Invasive Monitoring Systems, Inc. | External addition of pulses to fluid channels of body to release or suppress endothelial mediators and to determine effectiveness of such intervention |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US6640120B1 (en) | 2000-10-05 | 2003-10-28 | Scimed Life Systems, Inc. | Probe assembly for mapping and ablating pulmonary vein tissue and method of using same |
US6926669B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Heart wall ablation/mapping catheter and method |
US6802857B1 (en) | 2000-10-11 | 2004-10-12 | Uab Research Foundation | MRI stent |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US7646544B2 (en) | 2005-05-14 | 2010-01-12 | Batchko Robert G | Fluidic optical devices |
JP2004512105A (en) * | 2000-10-26 | 2004-04-22 | メドトロニック・インコーポレーテッド | Method and apparatus for protecting heart tissue from seizures |
DE60134878D1 (en) | 2000-10-26 | 2008-08-28 | Medtronic Inc | DEVICE FOR THE ELECTRICAL STIMULATION OF THE NERVOUS SYSTEM FOR THE THERAPY OF VENTRICULAR MALFUNCTIONS, HEART FAILURES AND OTHER CARDIAL STATES |
EP1201198A1 (en) | 2000-10-27 | 2002-05-02 | MicroNet Medical, Inc. | Catheter with thin film electrodes and method for making same |
US6616624B1 (en) | 2000-10-30 | 2003-09-09 | Cvrx, Inc. | Systems and method for controlling renovascular perfusion |
US6942692B2 (en) | 2000-11-16 | 2005-09-13 | Cordis Corporation | Supra-renal prosthesis and renal artery bypass |
US6579308B1 (en) | 2000-11-28 | 2003-06-17 | Scimed Life Systems, Inc. | Stent devices with detachable distal or proximal wires |
US6728563B2 (en) | 2000-11-29 | 2004-04-27 | St. Jude Medical, Daig Division, Inc. | Electrophysiology/ablation catheter having “halo” configuration |
US7081114B2 (en) | 2000-11-29 | 2006-07-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrophysiology/ablation catheter having lariat configuration of variable radius |
US6681136B2 (en) * | 2000-12-04 | 2004-01-20 | Science Medicus, Inc. | Device and method to modulate blood pressure by electrical waveforms |
US6676657B2 (en) | 2000-12-07 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Endoluminal radiofrequency cauterization system |
US6772015B2 (en) * | 2000-12-29 | 2004-08-03 | Medtronic, Inc | Bifurcated lead system for a cardiac vein |
US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
US6527739B1 (en) | 2000-12-29 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Spiraled balloon arrangement for treatment of a tortuous vessel |
US6666845B2 (en) | 2001-01-04 | 2003-12-23 | Advanced Neuromodulation Systems, Inc. | Implantable infusion pump |
WO2002053207A2 (en) | 2001-01-04 | 2002-07-11 | Advanced Neuromodulation Systems, Inc. | Implantable infusion pump |
CA2434151C (en) | 2001-01-11 | 2009-12-22 | Rita Medical Systems, Inc. | Bone-treatment instrument and method |
US6480747B2 (en) | 2001-01-16 | 2002-11-12 | Quetzal Biomedical, Inc. | Cardiac electrode catheter and method of manufacturing same |
US6602241B2 (en) * | 2001-01-17 | 2003-08-05 | Transvascular, Inc. | Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites |
CA2435304C (en) | 2001-01-19 | 2010-01-05 | Boston Scientific Limited | Introducer for deployment of branched prosthesis |
US6600954B2 (en) | 2001-01-25 | 2003-07-29 | Biocontrol Medical Bcm Ltd. | Method and apparatus for selective control of nerve fibers |
US6672312B2 (en) | 2001-01-31 | 2004-01-06 | Transurgical, Inc. | Pulmonary vein ablation with myocardial tissue locating |
US6451045B1 (en) | 2001-02-22 | 2002-09-17 | Alsius Corporation | Heat exchange catheter having a helically wrapped heat exchanger |
US6564096B2 (en) * | 2001-02-28 | 2003-05-13 | Robert A. Mest | Method and system for treatment of tachycardia and fibrillation |
WO2002070039A2 (en) * | 2001-03-01 | 2002-09-12 | Three Arch Partners | Intravascular device for treatment of hypertension |
US6620151B2 (en) | 2001-03-01 | 2003-09-16 | Advanced Neuromodulation Systems, Inc. | Non-constant pressure infusion pump |
US20020177846A1 (en) | 2001-03-06 | 2002-11-28 | Mulier Peter M.J. | Vaporous delivery of thermal energy to tissue sites |
US6786904B2 (en) | 2002-01-10 | 2004-09-07 | Triton Biosystems, Inc. | Method and device to treat vulnerable plaque |
DE10114725A1 (en) | 2001-03-21 | 2002-09-26 | Biotronik Mess & Therapieg | Intravascular lead |
WO2002076344A1 (en) | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
EP1395330A1 (en) | 2001-04-20 | 2004-03-10 | The Board of Regents for the University of Oklahoma | Cardiac neuromodulation and methods of using same |
WO2002085192A2 (en) | 2001-04-23 | 2002-10-31 | Transurgical, Inc. | Improvements in ablation therapy |
US6684105B2 (en) | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US7959626B2 (en) | 2001-04-26 | 2011-06-14 | Medtronic, Inc. | Transmural ablation systems and methods |
US6663627B2 (en) | 2001-04-26 | 2003-12-16 | Medtronic, Inc. | Ablation system and method of use |
US6909920B2 (en) * | 2001-04-27 | 2005-06-21 | Medtronic, Inc. | System and method for positioning an implantable medical device within a body |
DE60223794T2 (en) | 2001-04-27 | 2008-10-30 | C.R. Bard, Inc. | ELECTROPHYSIOLOGY CATHETERS FOR MAPPING AND ABLATION |
US6972016B2 (en) | 2001-05-01 | 2005-12-06 | Cardima, Inc. | Helically shaped electrophysiology catheter |
US20020169444A1 (en) | 2001-05-08 | 2002-11-14 | Mest Robert A. | Catheter having continuous braided electrode |
WO2002089908A1 (en) | 2001-05-10 | 2002-11-14 | Super Dimension Ltd. | Steerable multiple electrode catheter and method |
EP1385439A1 (en) | 2001-05-10 | 2004-02-04 | Rita Medical Systems, Inc. | Rf tissue ablation apparatus and method |
US6716207B2 (en) | 2001-05-22 | 2004-04-06 | Scimed Life Systems, Inc. | Torqueable and deflectable medical device shaft |
US6771996B2 (en) | 2001-05-24 | 2004-08-03 | Cardiac Pacemakers, Inc. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
JP2004533297A (en) | 2001-05-29 | 2004-11-04 | メドトロニック・インコーポレーテッド | Closed loop neuromodulation system for prevention and treatment of heart disease |
US7674245B2 (en) | 2001-06-07 | 2010-03-09 | Cardiac Pacemakers, Inc. | Method and apparatus for an adjustable shape guide catheter |
US7127284B2 (en) | 2001-06-11 | 2006-10-24 | Mercator Medsystems, Inc. | Electroporation microneedle and methods for its use |
FR2827548A1 (en) | 2001-07-17 | 2003-01-24 | Michelin Soc Tech | Tubeless tire and wheel rim assembly, especially for bicycles, has stepped rim making contact with tire bead at two or more points |
US20060167498A1 (en) | 2001-07-23 | 2006-07-27 | Dilorenzo Daniel J | Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease |
ES2242048T3 (en) * | 2001-07-27 | 2005-11-01 | Prof. Dr. Med. Patrick Schauerte | NEUROSTIMULATION UNIT FOR THE IMMOBILIZATION OF THE HEART DURING CARDIAC SURGERY OPERATIONS. |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US6622041B2 (en) | 2001-08-21 | 2003-09-16 | Cyberonics, Inc. | Treatment of congestive heart failure and autonomic cardiovascular drive disorders |
US6600956B2 (en) | 2001-08-21 | 2003-07-29 | Cyberonics, Inc. | Circumneural electrode assembly |
US20030050635A1 (en) | 2001-08-22 | 2003-03-13 | Csaba Truckai | Embolization systems and techniques for treating tumors |
US7778703B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Selective nerve fiber stimulation for treating heart conditions |
WO2003020138A1 (en) | 2001-08-31 | 2003-03-13 | Scimed Life Systems, Inc. | Percutaneous pringle occlusion device |
DE60226501D1 (en) | 2001-08-31 | 2008-06-19 | Cyto Pulse Sciences Inc | DIELECTROPHORESE WAVEFORM WITH NONLINEAR AMPLITUDE FOR CELL FUSION |
US7252679B2 (en) | 2001-09-13 | 2007-08-07 | Cordis Corporation | Stent with angulated struts |
WO2003024309A2 (en) | 2001-09-19 | 2003-03-27 | Urologix, Inc. | Microwave ablation device |
US6547803B2 (en) | 2001-09-20 | 2003-04-15 | The Regents Of The University Of California | Microfabricated surgical device for interventional procedures |
US7547294B2 (en) | 2001-09-20 | 2009-06-16 | The Regents Of The University Of California | Microfabricated surgical device for interventional procedures |
JP3607231B2 (en) | 2001-09-28 | 2005-01-05 | 有限会社日本エレクテル | High frequency heating balloon catheter |
EP1434621A2 (en) | 2001-10-01 | 2004-07-07 | AM Discovery, Incorporated | Devices for treating atrial fibrilation |
US8974446B2 (en) | 2001-10-11 | 2015-03-10 | St. Jude Medical, Inc. | Ultrasound ablation apparatus with discrete staggered ablation zones |
NL1019161C2 (en) | 2001-10-11 | 2003-04-14 | Itsac Nv | Plastic spout. |
US6829508B2 (en) * | 2001-10-19 | 2004-12-07 | Alfred E. Mann Foundation For Scientific Research | Electrically sensing and stimulating system for placement of a nerve stimulator or sensor |
US20030078618A1 (en) * | 2001-10-19 | 2003-04-24 | Fey Kate E. | System and method for removing implanted devices |
US20030082225A1 (en) | 2001-10-19 | 2003-05-01 | Mason Paul Arthur | Sterile, breathable patch for treating wound pain |
US6926716B2 (en) | 2001-11-09 | 2005-08-09 | Surgrx Inc. | Electrosurgical instrument |
US7517349B2 (en) | 2001-10-22 | 2009-04-14 | Vnus Medical Technologies, Inc. | Electrosurgical instrument and method |
AUPR847201A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal graft |
US7488313B2 (en) * | 2001-11-29 | 2009-02-10 | Boston Scientific Scimed, Inc. | Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment |
EP1453425B1 (en) | 2001-12-03 | 2006-03-08 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US6748255B2 (en) | 2001-12-14 | 2004-06-08 | Biosense Webster, Inc. | Basket catheter with multiple location sensors |
US20030125790A1 (en) | 2001-12-27 | 2003-07-03 | Vitaly Fastovsky | Deployment device, system and method for medical implantation |
US6980858B2 (en) * | 2001-12-31 | 2005-12-27 | Biosense Webster, Inc. | Method and system for atrial defibrillation |
US6817999B2 (en) | 2002-01-03 | 2004-11-16 | Afx, Inc. | Flexible device for ablation of biological tissue |
US6893436B2 (en) | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
EP1465701A4 (en) | 2002-01-15 | 2008-08-13 | Univ California | System and method providing directional ultrasound therapy to skeletal joints |
US20060189941A1 (en) | 2002-01-22 | 2006-08-24 | Mercator Medsystems, Inc. | Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation |
EP1503685B1 (en) | 2002-01-23 | 2012-10-31 | The Regents of The University of California | Implantable thermal treatment apparatus |
US7155284B1 (en) | 2002-01-24 | 2006-12-26 | Advanced Bionics Corporation | Treatment of hypertension |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
US6814733B2 (en) | 2002-01-31 | 2004-11-09 | Biosense, Inc. | Radio frequency pulmonary vein isolation |
US7477945B2 (en) | 2002-02-01 | 2009-01-13 | The Cleveland Clinic Foundation | Delivery device for stimulating the sympathetic nerve chain |
US7831308B2 (en) * | 2002-02-01 | 2010-11-09 | The Cleveland Clinic Foundation | Neural stimulation delivery device with independently moveable delivery structures |
AU2003212870A1 (en) * | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Methods of affecting hypothalamic-related conditions |
US7311705B2 (en) | 2002-02-05 | 2007-12-25 | Medtronic, Inc. | Catheter apparatus for treatment of heart arrhythmia |
US6949121B1 (en) | 2002-02-07 | 2005-09-27 | Sentient Engineering & Technology, Llc | Apparatus and methods for conduits and materials |
US8133501B2 (en) | 2002-02-08 | 2012-03-13 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled drug delivery |
US20040073117A1 (en) | 2002-02-14 | 2004-04-15 | Schwarz Karl Q. | Method and system for delivering contrast agent |
US7236821B2 (en) * | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
US6733499B2 (en) | 2002-02-28 | 2004-05-11 | Biosense Webster, Inc. | Catheter having circular ablation assembly |
CN1652841A (en) | 2002-03-14 | 2005-08-10 | 布雷恩斯盖特有限公司 | Technique for blood pressure regulation |
US6882885B2 (en) | 2002-03-19 | 2005-04-19 | Solarant Medical, Inc. | Heating method for tissue contraction |
ITBS20020039U1 (en) | 2002-03-20 | 2003-09-22 | Fogazzi Di Venturelli Andrea & | CATHETER WITH FLEXIBLE COOLED ELECTRODE |
US6736835B2 (en) * | 2002-03-21 | 2004-05-18 | Depuy Acromed, Inc. | Early intervention spinal treatment methods and devices for use therein |
EP3505143B1 (en) | 2002-03-22 | 2022-12-14 | Cardinal Health Switzerland 515 GmbH | Rapid exchange balloon catheter shaft |
WO2003082403A2 (en) | 2002-03-27 | 2003-10-09 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control via coupled electrodes |
US9636174B2 (en) * | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
EP1496956B1 (en) | 2002-04-11 | 2011-04-06 | Medtronic Vascular, Inc. | Devices for transluminal or transthoracic interstitial electrode placement |
JP4499427B2 (en) | 2002-04-16 | 2010-07-07 | サイト パルス サイエンシズ、インコーポレイテッド | A method of treating biomaterials by moving electric fields and reversing electrode polarity. |
US20030236443A1 (en) | 2002-04-19 | 2003-12-25 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20030199768A1 (en) | 2002-04-19 | 2003-10-23 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20030199767A1 (en) | 2002-04-19 | 2003-10-23 | Cespedes Eduardo Ignacio | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20030199747A1 (en) | 2002-04-19 | 2003-10-23 | Michlitsch Kenneth J. | Methods and apparatus for the identification and stabilization of vulnerable plaque |
US20040147828A1 (en) | 2002-04-22 | 2004-07-29 | Gibson Charles A. | Telescoping tip electrode catheter |
DE10218426A1 (en) | 2002-04-24 | 2003-11-06 | Biotronik Mess & Therapieg | Ablation device for cardiac tissue, in particular for producing linear lesions between two vascular orifices in the heart |
DE10218427A1 (en) | 2002-04-24 | 2003-11-06 | Biotronik Mess & Therapieg | Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart |
US20030204161A1 (en) | 2002-04-25 | 2003-10-30 | Bozidar Ferek-Petric | Implantable electroporation therapy device and method for using same |
US6746474B2 (en) | 2002-05-31 | 2004-06-08 | Vahid Saadat | Apparatus and methods for cooling a region within the body |
US6748953B2 (en) | 2002-06-11 | 2004-06-15 | Scimed Life Systems, Inc. | Method for thermal treatment of type II endoleaks in arterial aneurysms |
JP2004016333A (en) | 2002-06-13 | 2004-01-22 | Unique Medical Co Ltd | Catheter for extradural anesthesia, and electrostimulator using the catheter for extradural anesthesia |
JP3813112B2 (en) | 2002-06-26 | 2006-08-23 | テルモ株式会社 | Catheter and medical tubing |
US6717384B2 (en) | 2002-07-10 | 2004-04-06 | Kentfa Electric Motorbike Corporation | Frequency changer protection circuit for controlling the acceleration of an electric vehicle |
US7115134B2 (en) | 2002-07-22 | 2006-10-03 | Chambers Technology, Llc. | Catheter with flexible tip and shape retention |
EP1545680B1 (en) | 2002-07-25 | 2010-09-08 | Boston Scientific Limited | Medical device for navigation through anatomy |
US7914467B2 (en) | 2002-07-25 | 2011-03-29 | Boston Scientific Scimed, Inc. | Tubular member having tapered transition for use in a medical device |
US20040024392A1 (en) * | 2002-08-05 | 2004-02-05 | Lewis James D. | Apparatus and method for cryosurgery |
US7058456B2 (en) | 2002-08-09 | 2006-06-06 | Concentric Medical, Inc. | Methods and devices for changing the shape of a medical device |
US6893414B2 (en) | 2002-08-12 | 2005-05-17 | Breg, Inc. | Integrated infusion and aspiration system and method |
US20040193228A1 (en) | 2003-03-31 | 2004-09-30 | Gerber Martin T. | Method, system and device for treating various disorders of the pelvic floor by electrical stimulation of the left and right pudendal nerves |
US6780183B2 (en) | 2002-09-16 | 2004-08-24 | Biosense Webster, Inc. | Ablation catheter having shape-changing balloon |
US7063679B2 (en) | 2002-09-20 | 2006-06-20 | Flowmedica, Inc. | Intra-aortic renal delivery catheter |
WO2004107965A2 (en) | 2002-09-20 | 2004-12-16 | Flowmedica, Inc. | Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens |
US20050197624A1 (en) | 2004-03-04 | 2005-09-08 | Flowmedica, Inc. | Sheath for use in peripheral interventions |
AU2003278858A1 (en) | 2002-09-20 | 2004-04-08 | Flowmedica, Inc. | Method and apparatus for selective drug infusion via an intraaortic flow diverter delivery catheter |
US7585836B2 (en) | 2004-05-14 | 2009-09-08 | Goodson Iv Harry Burt | Bi-lateral local renal delivery for treating congestive heart failure and for BNP therapy |
US7993325B2 (en) * | 2002-09-20 | 2011-08-09 | Angio Dynamics, Inc. | Renal infusion systems and methods |
JP2006513809A (en) | 2002-09-20 | 2006-04-27 | フローメディカ,インコーポレイテッド | Apparatus and method for inserting an intra-aortic catheter through a delivery sheath |
WO2004032791A2 (en) | 2002-09-20 | 2004-04-22 | Flowmedica, Inc. | Method and apparatus for selective material delivery via an intra-renal catheter |
US7150741B2 (en) | 2002-09-20 | 2006-12-19 | Advanced Neuromodulation Systems, Inc. | Programmable dose control module |
WO2004030718A2 (en) | 2002-09-20 | 2004-04-15 | Flowmedica, Inc. | Method and apparatus for intra aortic substance delivery to a branch vessel |
DE60325240D1 (en) | 2002-09-26 | 2009-01-22 | Angiotech Int Ag | PERIVASCULAR COVERS |
US7282213B2 (en) | 2002-09-30 | 2007-10-16 | Medtronic, Inc. | Method for applying a drug coating to a medical device |
US7599737B2 (en) | 2002-10-04 | 2009-10-06 | Microchips, Inc. | Medical device for neural stimulation and controlled drug delivery |
AU2003279842A1 (en) | 2002-10-04 | 2004-05-04 | Microchips, Inc. | Medical device for controlled drug delivery and cardiac monitoring and/or stimulation |
US20050033137A1 (en) | 2002-10-25 | 2005-02-10 | The Regents Of The University Of Michigan | Ablation catheters and methods for their use |
WO2004039273A2 (en) | 2002-10-31 | 2004-05-13 | C.R. Bard, Inc. | Electrophysiology catheter with biased tip |
US20030229380A1 (en) * | 2002-10-31 | 2003-12-11 | Adams John M. | Heart failure therapy device and method |
DE10257146A1 (en) * | 2002-12-06 | 2004-06-24 | Admedes Schuessler Gmbh | Thermal ablation probe for minimal invasive body tissue high frequency thermal treatment has temperature sensor on star shaped flexible arms with adjustable protrusion from insulating sheath |
DE10252325B4 (en) | 2002-11-11 | 2012-10-25 | Admedes Schuessler Gmbh | Radiofrequency thermal ablation probe and method of making the same |
AU2002952663A0 (en) * | 2002-11-14 | 2002-11-28 | Western Sydney Area Health Service | An intramural needle-tipped surgical device |
US20040106954A1 (en) * | 2002-11-15 | 2004-06-03 | Whitehurst Todd K. | Treatment of congestive heart failure |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US20050004515A1 (en) | 2002-11-15 | 2005-01-06 | Hart Charles C. | Steerable kink resistant sheath |
US7317950B2 (en) * | 2002-11-16 | 2008-01-08 | The Regents Of The University Of California | Cardiac stimulation system with delivery of conductive agent |
ITBS20020107A1 (en) | 2002-11-25 | 2004-05-26 | Invatec Srl | METAL TUBE WITH AT LEAST ONE PART OF LENGTH WITH VARIABLE FLEXIBILITY. |
US8509916B2 (en) * | 2002-12-16 | 2013-08-13 | Medtronic, Inc. | Bilumen guide catheters for accessing cardiac sites |
US20040162590A1 (en) | 2002-12-19 | 2004-08-19 | Whitehurst Todd K. | Fully implantable miniature neurostimulator for intercostal nerve stimulation as a therapy for angina pectoris |
US7890188B2 (en) | 2002-12-19 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable lead for septal placement of electrode with fixation mechanism in the pulmonary artery |
EP1587576A2 (en) | 2003-01-03 | 2005-10-26 | Advanced Neuromodulation Systems Inc. | SYSTEM AND METHOD FOR STIMULATION OF A PERSON’S BRAIN STEM |
US6847848B2 (en) | 2003-01-07 | 2005-01-25 | Mmtc, Inc | Inflatable balloon catheter structural designs and methods for treating diseased tissue of a patient |
US6960207B2 (en) | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
US7013169B2 (en) | 2003-01-27 | 2006-03-14 | Cardiac Pacemakers, Inc. | Dual steer preshaped catheter |
WO2006020920A2 (en) | 2003-01-29 | 2006-02-23 | Medtronic, Inc. | Catheter apparatus for treatment of heart arrhythmia |
US8066700B2 (en) | 2003-01-31 | 2011-11-29 | Smith & Nephew, Inc. | Cartilage treatment probe |
US7167750B2 (en) | 2003-02-03 | 2007-01-23 | Enteromedics, Inc. | Obesity treatment with electrically induced vagal down regulation |
US6941953B2 (en) | 2003-02-20 | 2005-09-13 | Medwaves, Inc. | Preformed catheter set for use with a linear ablation system to produce ablation lines in the left and right atrium for treatment of atrial fibrillation |
CN1764419A (en) | 2003-02-20 | 2006-04-26 | 普罗里森姆股份有限公司 | Cardiac ablation devices |
JP2006518758A (en) | 2003-02-24 | 2006-08-17 | ピーエルシー システムズ インク. | Method and catheter system applicable to acute renal failure |
US6923808B2 (en) | 2003-02-24 | 2005-08-02 | Boston Scientific Scimed, Inc. | Probes having helical and loop shaped inflatable therapeutic elements |
US7004911B1 (en) | 2003-02-24 | 2006-02-28 | Hosheng Tu | Optical thermal mapping for detecting vulnerable plaque |
US20040176699A1 (en) | 2003-03-03 | 2004-09-09 | Volcano Therapeutics, Inc. | Thermography catheter with improved wall contact |
US7097643B2 (en) | 2003-03-03 | 2006-08-29 | Sinus Rhythm Technologies, Inc. | Electrical block positioning devices and methods of use therefor |
US7250041B2 (en) | 2003-03-12 | 2007-07-31 | Abbott Cardiovascular Systems Inc. | Retrograde pressure regulated infusion |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US7938828B2 (en) | 2003-03-28 | 2011-05-10 | Boston Scientific Scimed, Inc. | Cooled ablation catheter |
WO2004086993A2 (en) | 2003-03-28 | 2004-10-14 | C.R. Bard, Inc. | Method and apparatus for adjusting electrode dimensions |
US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
US7517342B2 (en) | 2003-04-29 | 2009-04-14 | Boston Scientific Scimed, Inc. | Polymer coated device for electrically medicated drug delivery |
US7221979B2 (en) | 2003-04-30 | 2007-05-22 | Medtronic, Inc. | Methods and apparatus for the regulation of hormone release |
CA2777958C (en) | 2003-05-06 | 2015-01-20 | Enpath Medical, Inc. | Rotatable lead introducer |
DE10323566B4 (en) | 2003-05-26 | 2006-03-23 | Fehling Ag | Instrument for unipolar ablation of cardiac tissue |
JP2006526464A (en) | 2003-06-05 | 2006-11-24 | フローメディカ,インコーポレイテッド | System and method for performing bilateral intervention or diagnosis in a branched body lumen |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
US7738952B2 (en) | 2003-06-09 | 2010-06-15 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system |
US20060167437A1 (en) | 2003-06-17 | 2006-07-27 | Flowmedica, Inc. | Method and apparatus for intra aortic substance delivery to a branch vessel |
US7789877B2 (en) | 2003-07-02 | 2010-09-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode arrangement |
CA2533116C (en) | 2003-07-18 | 2016-06-07 | Eastern Virginia Medical School | Apparatus for generating electrical pulses and methods of using the same |
US7670335B2 (en) | 2003-07-21 | 2010-03-02 | Biosense Webster, Inc. | Ablation device with spiral array ultrasound transducer |
EP1659970A4 (en) | 2003-08-05 | 2008-05-21 | Flowmedica Inc | Sytem and method for prevention of radiocontrast induced nephropathy |
US7742809B2 (en) * | 2003-08-25 | 2010-06-22 | Medtronic, Inc. | Electroporation catheter with sensing capabilities |
US7766868B2 (en) | 2003-09-05 | 2010-08-03 | Medtronic, Inc. | Deflectable medical therapy delivery device having common lumen profile |
US7156843B2 (en) | 2003-09-08 | 2007-01-02 | Medtronic, Inc. | Irrigated focal ablation tip |
EP3045136B1 (en) | 2003-09-12 | 2021-02-24 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7502650B2 (en) * | 2003-09-22 | 2009-03-10 | Cvrx, Inc. | Baroreceptor activation for epilepsy control |
US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
US7998112B2 (en) | 2003-09-30 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Deflectable catheter assembly and method of making same |
US7591813B2 (en) | 2003-10-01 | 2009-09-22 | Micrus Endovascular Corporation | Long nose manipulatable catheter |
US20050153885A1 (en) | 2003-10-08 | 2005-07-14 | Yun Anthony J. | Treatment of conditions through modulation of the autonomic nervous system |
US7186209B2 (en) * | 2003-10-09 | 2007-03-06 | Jacobson Jerry I | Cardioelectromagnetic treatment |
US7416549B2 (en) | 2003-10-10 | 2008-08-26 | Boston Scientific Scimed, Inc. | Multi-zone bipolar ablation probe assembly |
WO2005037070A2 (en) | 2003-10-11 | 2005-04-28 | The Regents Of The University Of California | Method and system for nerve repair, nanoknife, mems platform and uses thereof |
US7480532B2 (en) | 2003-10-22 | 2009-01-20 | Cvrx, Inc. | Baroreflex activation for pain control, sedation and sleep |
US7220374B2 (en) * | 2003-10-22 | 2007-05-22 | Cadillac Products Automotive Company | Molded foam vehicle energy absorbing device and method of manufacture |
US7254451B2 (en) | 2003-11-20 | 2007-08-07 | Medtronic, Inc. | Implantable lead including sensor |
CN1882288A (en) | 2003-11-25 | 2006-12-20 | 导管治疗有限公司 | A modular catheter |
US7783353B2 (en) | 2003-12-24 | 2010-08-24 | Cardiac Pacemakers, Inc. | Automatic neural stimulation modulation based on activity and circadian rhythm |
US20080015659A1 (en) | 2003-12-24 | 2008-01-17 | Yi Zhang | Neurostimulation systems and methods for cardiac conditions |
PL1696812T3 (en) | 2003-12-24 | 2015-12-31 | Univ California | Tissue ablation with irreversible electroporation |
US8396560B2 (en) | 2004-11-18 | 2013-03-12 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
CN1913935B (en) | 2004-01-26 | 2010-05-12 | 导管治疗有限公司 | A catheter assembly with an adjustable loop |
US7637903B2 (en) | 2004-02-09 | 2009-12-29 | Cryocor, Inc. | Catheter articulation segment with alternating cuts |
US7245955B2 (en) | 2004-02-23 | 2007-07-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrophysiology/ablation catheter having deflection assembly |
JP2007526817A (en) | 2004-03-02 | 2007-09-20 | シーブイアールエックス, インコーポレイテッド | Activation of baroreflex from outside |
US7976539B2 (en) | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US20050209548A1 (en) | 2004-03-19 | 2005-09-22 | Dev Sukhendu B | Electroporation-mediated intravascular delivery |
CA2563817C (en) | 2004-04-23 | 2018-07-10 | Yoram Palti | Treating a tumor or the like with electric fields at different frequencies |
WO2006007048A2 (en) | 2004-05-04 | 2006-01-19 | The Cleveland Clinic Foundation | Methods of treating medical conditions by neuromodulation of the sympathetic nervous system |
US7231260B2 (en) | 2004-05-06 | 2007-06-12 | Boston Scientific Scimed, Inc. | Intravascular self-anchoring electrode body with arcuate springs, spring loops, or arms |
US7758564B2 (en) | 2004-05-14 | 2010-07-20 | Ethicon Endo-Surgery, Inc. | Medical instrument having a catheter and a medical guidewire |
US7686803B2 (en) | 2004-05-14 | 2010-03-30 | Cardima, Inc. | Ablation probe with stabilizing member |
US20050261672A1 (en) | 2004-05-18 | 2005-11-24 | Mark Deem | Systems and methods for selective denervation of heart dysrhythmias |
US7632265B2 (en) | 2004-05-28 | 2009-12-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Radio frequency ablation servo catheter and method |
US7294119B2 (en) | 2004-06-10 | 2007-11-13 | Safety Syringes, Inc. | Passive delivery system diluents mixing and delivery |
US20050277868A1 (en) | 2004-06-11 | 2005-12-15 | University Of South Florida | Electroporation Device and Method for Delivery to Ocular Tissue |
US20060004346A1 (en) | 2004-06-17 | 2006-01-05 | Begg John D | Bend relief |
US20060067972A1 (en) * | 2004-06-23 | 2006-03-30 | Flowmedica, Inc. | Devices for renal-based heart failure treatment |
WO2006012181A1 (en) | 2004-06-24 | 2006-02-02 | Ksn Energies, Llc | Electrical impedance tomography to characterize tissue |
US20060004417A1 (en) | 2004-06-30 | 2006-01-05 | Cvrx, Inc. | Baroreflex activation for arrhythmia treatment |
WO2006012050A2 (en) | 2004-06-30 | 2006-02-02 | Cvrx, Inc. | Connection structures for extra-vascular electrode lead body |
US7850675B2 (en) | 2004-07-20 | 2010-12-14 | Boston Scientific Scimed, Inc. | Reinforced venous access catheter |
FR2873385B1 (en) | 2004-07-23 | 2006-10-27 | Centre Nat Rech Scient Cnrse | MONITORING AND CONTROL OF ELECTROPORATION |
EP1799302B1 (en) | 2004-07-28 | 2015-03-04 | Ardian, Inc. | Devices for renal nerve blocking |
US7373204B2 (en) * | 2004-08-19 | 2008-05-13 | Lifestim, Inc. | Implantable device and method for treatment of hypertension |
US20060085054A1 (en) | 2004-09-09 | 2006-04-20 | Zikorus Arthur W | Methods and apparatus for treatment of hollow anatomical structures |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US7753906B2 (en) | 2004-09-14 | 2010-07-13 | Richard Esposito | Catheter having anchoring and stabilizing devices |
US7542808B1 (en) | 2004-09-17 | 2009-06-02 | Cardiac Pacemakers, Inc. | Lead and catheter assembly |
US20060069323A1 (en) * | 2004-09-24 | 2006-03-30 | Flowmedica, Inc. | Systems and methods for bi-lateral guidewire cannulation of branched body lumens |
US20060074403A1 (en) | 2004-09-29 | 2006-04-06 | Nasser Rafiee | Curved catheter comprising a solid-walled metal tube with varying stiffness |
US20060074453A1 (en) * | 2004-10-04 | 2006-04-06 | Cvrx, Inc. | Baroreflex activation and cardiac resychronization for heart failure treatment |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
EP1809272A4 (en) | 2004-10-18 | 2008-01-02 | Maroon Biotech Corp | Methods and compositions for treatment of free radical injury |
US7524318B2 (en) | 2004-10-28 | 2009-04-28 | Boston Scientific Scimed, Inc. | Ablation probe with flared electrodes |
US8409191B2 (en) | 2004-11-04 | 2013-04-02 | Boston Scientific Scimed, Inc. | Preshaped ablation catheter for ablating pulmonary vein ostia within the heart |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US20060100618A1 (en) | 2004-11-08 | 2006-05-11 | Cardima, Inc. | System and method for performing ablation and other medical procedures using an electrode array with flex circuit |
MX2007005891A (en) | 2004-11-15 | 2007-11-23 | Johnson & Johnson | Catheter with microfabricated temperature sensing. |
US8332047B2 (en) | 2004-11-18 | 2012-12-11 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
US20060116720A1 (en) | 2004-12-01 | 2006-06-01 | Penny Knoblich | Method and apparatus for improving renal function |
US7937160B2 (en) | 2004-12-10 | 2011-05-03 | Boston Scientific Neuromodulation Corporation | Methods for delivering cortical electrode leads into patient's head |
US7402151B2 (en) | 2004-12-17 | 2008-07-22 | Biocardia, Inc. | Steerable guide catheters and methods for their use |
US8983582B2 (en) | 2004-12-20 | 2015-03-17 | Advanced Cardiovascular Systems, Inc. | Methods and apparatuses for positioning within an internal channel |
JP5111116B2 (en) | 2004-12-21 | 2012-12-26 | イービーアール システムズ, インコーポレイテッド | Leadless cardiac system for pacing and arrhythmia treatment |
US20060135953A1 (en) | 2004-12-22 | 2006-06-22 | Wlodzimierz Kania | Tissue ablation system including guidewire with sensing element |
US9833618B2 (en) | 2005-02-04 | 2017-12-05 | Palo Alto Investors | Methods and compositions for treating a disease condition in a subject |
US7828837B2 (en) | 2005-02-17 | 2010-11-09 | Khoury Medical Devices, LLC. | Vascular endograft |
US20060182873A1 (en) | 2005-02-17 | 2006-08-17 | Klisch Leo M | Medical devices |
US7548780B2 (en) | 2005-02-22 | 2009-06-16 | Cardiac Pacemakers, Inc. | Cell therapy and neural stimulation for cardiac repair |
CN101132743A (en) | 2005-03-02 | 2008-02-27 | 导管治疗有限公司 | A heat treatment catheter |
EP2438877B1 (en) | 2005-03-28 | 2016-02-17 | Vessix Vascular, Inc. | Intraluminal electrical tissue characterization and tuned RF energy for selective treatment of atheroma and other target tissues |
US7727187B2 (en) | 2005-04-04 | 2010-06-01 | Cook Incorporated | Scored catheter device |
US7499748B2 (en) | 2005-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Transvascular neural stimulation device |
CA2606108A1 (en) | 2005-05-02 | 2006-11-09 | Resqmedical Ltd. | Self-withdrawing catheter for injecting into body passageways and kit containing same |
WO2006121883A1 (en) | 2005-05-05 | 2006-11-16 | Boston Scientific Scimed, Inc. | Steerable catheter for performing medical procedure adjacent pulmonary vein ostia |
US7806871B2 (en) | 2005-05-09 | 2010-10-05 | Boston Scientific Scimed, Inc. | Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent |
DE102005023303A1 (en) | 2005-05-13 | 2006-11-16 | Celon Ag Medical Instruments | Biegeweiche application device for high-frequency therapy of biological tissue |
US7857810B2 (en) | 2006-05-16 | 2010-12-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation electrode assembly and methods for improved control of temperature and minimization of coagulation and tissue damage |
CA2612679A1 (en) | 2005-06-20 | 2007-01-04 | Richardo D. Roman | Ablation catheter |
WO2007002304A2 (en) | 2005-06-22 | 2007-01-04 | Vnus Medical Technologies, Inc. | Methods and apparatus for introducing tumescent fluid to body tissue |
US7717853B2 (en) | 2005-06-24 | 2010-05-18 | Henry Nita | Methods and apparatus for intracranial ultrasound delivery |
US8911485B2 (en) | 2005-06-29 | 2014-12-16 | Zoll Circulation, Inc. | Devices, systems and methods for rapid endovascular cooling |
AU2006268238A1 (en) | 2005-07-11 | 2007-01-18 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
DE102005047073A1 (en) | 2005-09-30 | 2007-04-05 | BSH Bosch und Siemens Hausgeräte GmbH | Dust bagless vacuum cleaner, has centrifugal force separator and dust collecting container that are arranged in housing between vacuum cleaner cover and vacuum cleaner lower part, where centrifugal force separator is fixed at cover |
US8712522B1 (en) | 2005-10-18 | 2014-04-29 | Cvrx, Inc. | System for setting programmable parameters for an implantable hypertension treatment device |
WO2007055521A1 (en) | 2005-11-09 | 2007-05-18 | Korea University Industrial & Academic Collaboration Foundation | Radio frequency ablation electrode for selected tissue removal |
US7647124B2 (en) | 2005-11-15 | 2010-01-12 | Medtronic, Inc. | Delivery catheter |
US7729782B2 (en) | 2005-11-15 | 2010-06-01 | Medtronic, Inc. | Delivery catheter |
US20080045890A1 (en) | 2005-12-16 | 2008-02-21 | Mercator Medsystems, Inc. | Methods and systems for ablating tissue |
US7993334B2 (en) | 2005-12-29 | 2011-08-09 | Boston Scientific Scimed, Inc. | Low-profile, expanding single needle ablation probe |
US20070156200A1 (en) | 2005-12-29 | 2007-07-05 | Lilian Kornet | System and method for regulating blood pressure and electrolyte balance |
US20070162109A1 (en) | 2006-01-11 | 2007-07-12 | Luis Davila | Intraluminal stent graft |
CA2638029A1 (en) | 2006-01-27 | 2007-08-09 | Medtronic, Inc. | Ablation device and system for guiding said ablation device into a patient's body |
US7662151B2 (en) | 2006-02-15 | 2010-02-16 | Boston Scientific Scimed, Inc. | Contact sensitive probes |
US8571650B2 (en) | 2006-03-03 | 2013-10-29 | Palo Alto Investors | Methods and compositions for treating a renal associated condition in a subject |
US20070208256A1 (en) | 2006-03-03 | 2007-09-06 | Medtronic Vascular, Inc. | Multiple Branch Tubular Prosthesis and Methods |
US20070225781A1 (en) | 2006-03-21 | 2007-09-27 | Nidus Medical, Llc | Apparatus and methods for altering temperature in a region within the body |
US7747334B2 (en) | 2006-03-23 | 2010-06-29 | Cardiac Pacemakers, Inc. | Left ventricular lead shapes |
US7579550B2 (en) | 2006-03-31 | 2009-08-25 | Boston Scientific Scimed, Inc. | Flexible device shaft with angled spiral wrap |
US20080004673A1 (en) | 2006-04-03 | 2008-01-03 | Cvrx, Inc. | Implantable extravascular electrostimulation system having a resilient cuff |
US20070255270A1 (en) | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
AU2007247768B2 (en) | 2006-05-08 | 2012-09-20 | Cathrx Ltd | Shape imparting mechanism insertion |
US20080004596A1 (en) | 2006-05-25 | 2008-01-03 | Palo Alto Institute | Delivery of agents by microneedle catheter |
US7615067B2 (en) | 2006-06-05 | 2009-11-10 | Cambridge Endoscopic Devices, Inc. | Surgical instrument |
US20070282376A1 (en) | 2006-06-06 | 2007-12-06 | Shuros Allan C | Method and apparatus for neural stimulation via the lymphatic system |
US7647101B2 (en) | 2006-06-09 | 2010-01-12 | Cardiac Pacemakers, Inc. | Physical conditioning system, device and method |
EP2049184B1 (en) | 2006-07-26 | 2013-02-13 | Johan Willem Pieter Marsman | Facilitation of antegrade insertion of a guidewire into the superficial femoral artery |
US7708704B2 (en) | 2006-07-31 | 2010-05-04 | Codman & Shurtleff, Pc | Interventional medical device component having an interrupted spiral section and method of making the same |
US20080039904A1 (en) | 2006-08-08 | 2008-02-14 | Cherik Bulkes | Intravascular implant system |
US7674253B2 (en) | 2006-08-18 | 2010-03-09 | Kensey Nash Corporation | Catheter for conducting a procedure within a lumen, duct or organ of a living being |
US20080051704A1 (en) | 2006-08-28 | 2008-02-28 | Patel Rajnikant V | Catheter and system for using same |
WO2008031033A2 (en) | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US20080091255A1 (en) | 2006-10-11 | 2008-04-17 | Cardiac Pacemakers | Implantable neurostimulator for modulating cardiovascular function |
US8317773B2 (en) | 2006-11-07 | 2012-11-27 | Angio Dynamics, Inc. | Catheter with open faced sloped end portion |
US8915926B2 (en) | 2006-11-08 | 2014-12-23 | Advanced Bionics Ag | Pre-curved electrode array loading tools |
CA2670149A1 (en) | 2006-11-28 | 2008-06-05 | Cathrx Ltd | Catheter steering/insertion mechanism |
US7955326B2 (en) | 2006-12-29 | 2011-06-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive conductive composite electrode and method for ablation |
US20080183187A1 (en) | 2007-01-30 | 2008-07-31 | Cardiac Pacemakers, Inc. | Direct delivery system for transvascular lead |
WO2008101244A2 (en) | 2007-02-18 | 2008-08-21 | Via Biomedical, Inc. | Guiding catheter support devices and methods |
US10166066B2 (en) | 2007-03-13 | 2019-01-01 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US8187267B2 (en) | 2007-05-23 | 2012-05-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with flexible tip and methods of making the same |
WO2008128070A2 (en) | 2007-04-11 | 2008-10-23 | The Cleveland Clinic Foundation | Method and apparatus for renal neuromodulation |
DE102007018277A1 (en) | 2007-04-18 | 2008-10-30 | Medical Service Gmbh | Catheter set |
US8103359B2 (en) | 2007-05-17 | 2012-01-24 | Cardiac Pacemakers, Inc. | Systems and methods for fixating transvenously implanted medical devices |
US8630704B2 (en) | 2007-06-25 | 2014-01-14 | Cardiac Pacemakers, Inc. | Neural stimulation with respiratory rhythm management |
US8864675B2 (en) | 2007-06-28 | 2014-10-21 | W. L. Gore & Associates, Inc. | Catheter |
US7863897B2 (en) | 2007-09-07 | 2011-01-04 | The General Hospital Corporation | Method and apparatus for characterizing the temporal resolution of an imaging device |
EP2211701A1 (en) | 2007-10-26 | 2010-08-04 | St. Jude Medical Systems AB | Sensor guide wire with micro-cable winding |
US20100286626A1 (en) | 2007-12-21 | 2010-11-11 | Petersen Scott R | Longitudinally incompressible, laterally flexible interior shaft for catheter |
US8118809B2 (en) | 2007-12-21 | 2012-02-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Flexible conductive polymer electrode and method for ablation |
US7848816B1 (en) | 2007-12-27 | 2010-12-07 | Pacesetter, Inc. | Acquiring nerve activity from carotid body and/or sinus |
US7949398B1 (en) | 2007-12-27 | 2011-05-24 | Pacesetter, Inc. | Acquiring nerve activity from carotid body and/or sinus |
US7985215B2 (en) | 2007-12-28 | 2011-07-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Deflectable catheter with distal deflectable segment |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
WO2009108997A1 (en) | 2008-03-03 | 2009-09-11 | Mk International Pty Ltd | Catheter with friction reducing surface shaping |
WO2009121017A1 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California | Balloon catheter for reducing restenosis via irreversible electroporation |
EP2106821B1 (en) | 2008-03-31 | 2019-04-17 | Dentsply IH AB | Catheter assembly comprising a tubular member having pleated regions, and methods of activating and manufacturing the same |
JP4362536B2 (en) | 2008-04-11 | 2009-11-11 | 日本ライフライン株式会社 | catheter |
DE102008019827A1 (en) | 2008-04-19 | 2009-10-29 | Biotronik Crm Patent Ag | Controllable electrode for deep brain stimulation |
CN102014779B (en) | 2008-05-09 | 2014-10-22 | 赫莱拉公司 | Systems, assemblies, and methods for treating a bronchial tree |
WO2009140067A1 (en) | 2008-05-15 | 2009-11-19 | Boston Scientific Scimed, Inc. | Apparatus for cryogenically ablating tissue and adjusting cryogenic ablation regions |
US8437832B2 (en) | 2008-06-06 | 2013-05-07 | Biosense Webster, Inc. | Catheter with bendable tip |
US20090306651A1 (en) | 2008-06-09 | 2009-12-10 | Clint Schneider | Catheter assembly with front-loaded tip |
JP2010021134A (en) | 2008-06-11 | 2010-01-28 | Sumitomo Chemical Co Ltd | Method for manufacturing lithium complex metal oxide |
US9138559B2 (en) | 2008-06-16 | 2015-09-22 | Twin Star Medical, Inc | Flexible catheter |
US8100859B2 (en) | 2008-06-24 | 2012-01-24 | Cook Medical Technologies Llc | Bent obturator |
US20100004632A1 (en) | 2008-07-03 | 2010-01-07 | Kirk Kochin Wu | Magnetic guided ablation catheter |
US20100022989A1 (en) | 2008-07-25 | 2010-01-28 | Parasmo Ronald S | Steerable catheter and method of making the same |
US8123739B2 (en) | 2008-08-19 | 2012-02-28 | Cook Medical Technologies Llc | Drainage catheter and method for catheterizing a patient |
US8172831B2 (en) | 2008-09-02 | 2012-05-08 | Abbott Cardiovascular Systems Inc. | Catheter configured for incremental rotation |
US20100069882A1 (en) | 2008-09-18 | 2010-03-18 | Boston Scientific Scimed, Inc. | Medical device with preferential bending |
US20100099952A1 (en) | 2008-10-22 | 2010-04-22 | Boston Scientific Scimed, Inc. | Steerable Shaft Having Micromachined Tube |
JP5531352B2 (en) | 2008-10-31 | 2014-06-25 | キャスリックス リミテッド | Catheter assembly |
ES2615826T3 (en) | 2008-11-11 | 2017-06-08 | Shifamed Holdings, Llc | Low Profile Electrode Set |
US20150105659A1 (en) | 2008-11-11 | 2015-04-16 | Covidien Lp | Energy delivery device and methods of use |
US11376061B2 (en) | 2008-11-11 | 2022-07-05 | Covidien Lp | Energy delivery device and methods of use |
US8317810B2 (en) | 2008-12-29 | 2012-11-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Tissue puncture assemblies and methods for puncturing tissue |
US8123721B2 (en) | 2008-12-31 | 2012-02-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter having independently-deflectable segments and method of its manufacture |
JP2012515024A (en) | 2009-01-15 | 2012-07-05 | キャスリックス リミテッド | Steerable stylet |
JP2012517306A (en) | 2009-02-12 | 2012-08-02 | イューエムセー ユトレヒト ホールディング ベースローテン フェンノートシャップ | Ablation catheter and method for electrically insulating heart tissue |
WO2010096347A1 (en) | 2009-02-20 | 2010-08-26 | Boston Scientific Scimed, Inc. | Asymmetric dual directional steerable catheter sheath |
WO2010096579A1 (en) | 2009-02-20 | 2010-08-26 | Boston Scientific Scimed, Inc. | Steerable catheter having intermediate stiffness transition zone |
CN201356648Y (en) | 2009-03-04 | 2009-12-09 | 微创医疗器械(上海)有限公司 | Saline perfusion RF ablation catheter |
US8929969B2 (en) | 2009-04-14 | 2015-01-06 | Medtronic Ablation Frontiers Llc | Catheter assembly and associated method |
US8399443B2 (en) | 2009-04-22 | 2013-03-19 | Mercator Medsystems, Inc. | Treatment of hypertension by renal vascular delivery of guanethidine |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US20120035615A1 (en) | 2009-05-22 | 2012-02-09 | Advanced Bionics, Llc | Composite Stylet |
US8282633B2 (en) | 2009-06-15 | 2012-10-09 | Olympus Medical Systems Corp. | High-frequency surgical apparatus and high-frequency surgical method for closure of patent foramen ovale |
CA2764859C (en) | 2009-06-24 | 2018-09-25 | Shifamed, Llc | Steerable medical delivery devices and methods of use |
WO2011015218A1 (en) | 2009-08-06 | 2011-02-10 | Ls Medcap Gmbh | Catheter with two fenestrations |
US8435228B2 (en) | 2009-08-12 | 2013-05-07 | Medrad, Inc. | Interventional catheter assemblies incorporating guide wire brake and management systems |
US8380275B2 (en) | 2009-08-14 | 2013-02-19 | Boston Scientific Scimed, Inc. | Systems and methods for making and using medical ablation systems and having mapping catheters with improved anchoring ability |
CN201469401U (en) | 2009-08-21 | 2010-05-19 | 刘小青 | Spiral renal-artery-around renal sympathetic nerve radio-frequency ablation electrode catheter |
US9439721B2 (en) | 2009-08-25 | 2016-09-13 | Medtronic Ablation Frontiers Llc | Bi-modal linear and loop ablation catheter, and method |
US8568401B2 (en) | 2009-10-27 | 2013-10-29 | Covidien Lp | System for monitoring ablation size |
CN102686180B (en) | 2009-11-04 | 2015-09-30 | 艾姆西森有限公司 | Intracavity remodeling device and method |
US20110112400A1 (en) | 2009-11-06 | 2011-05-12 | Ardian, Inc. | High intensity focused ultrasound catheter apparatuses, systems, and methods for renal neuromodulation |
WO2011060200A1 (en) | 2009-11-11 | 2011-05-19 | Innovative Pulmonary Solutions, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
EP2332607A1 (en) | 2009-12-14 | 2011-06-15 | The Royal College of Surgeons in Ireland | A urethral catheter |
US8920415B2 (en) | 2009-12-16 | 2014-12-30 | Biosense Webster (Israel) Ltd. | Catheter with helical electrode |
US8608735B2 (en) | 2009-12-30 | 2013-12-17 | Biosense Webster (Israel) Ltd. | Catheter with arcuate end section |
US20110263921A1 (en) | 2009-12-31 | 2011-10-27 | Anthony Vrba | Patterned Denervation Therapy for Innervated Renal Vasculature |
WO2011091069A1 (en) | 2010-01-19 | 2011-07-28 | Ardian, Inc. | Methods and apparatus for renal neuromodulation via stereotactic radiotherapy |
WO2013169741A1 (en) | 2012-05-08 | 2013-11-14 | Stein Emily A | Agents and devices for affecting nerve function |
WO2011094367A1 (en) | 2010-01-26 | 2011-08-04 | Evans Michael A | Methods, devices, and agents for denervation |
WO2013063331A1 (en) | 2011-10-26 | 2013-05-02 | Stein Emily A | Agents, methods, and devices for affecting nerve function |
JP5750506B2 (en) | 2010-03-23 | 2015-07-22 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | A device for brain stimulation |
CN102917748B (en) | 2010-03-24 | 2015-04-01 | 施菲姆德控股有限责任公司 | Intravascular tissue disruption |
WO2011123689A1 (en) | 2010-03-31 | 2011-10-06 | Boston Scientific Scimed, Inc. | Guidewire with a flexural rigidity profile |
EP2558016A2 (en) | 2010-04-14 | 2013-02-20 | Boston Scientific Scimed, Inc. | Renal artery denervation apparatus employing helical shaping arrangement |
US8870863B2 (en) | 2010-04-26 | 2014-10-28 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
EP3175808B1 (en) | 2010-04-26 | 2019-08-21 | Medtronic Ardian Luxembourg S.à.r.l. | Catheter apparatuses and systems for renal neuromodulation |
US10631912B2 (en) | 2010-04-30 | 2020-04-28 | Medtronic Xomed, Inc. | Interface module for use with nerve monitoring and electrosurgery |
EP2568902A1 (en) | 2010-05-10 | 2013-03-20 | Medtronic, Inc. | System for selecting an ablation procedure based on comparing a biological response with a mathematical model |
JP5886274B2 (en) | 2010-05-11 | 2016-03-16 | キャスアールエックス リミテッドCathrx Ltd | Catheter shape release mechanism |
US20130109987A1 (en) | 2011-05-12 | 2013-05-02 | Medical Device Innovations Inc. | Method and device for treatment of arrhythmias and other maladies |
EP2568905A4 (en) | 2010-05-12 | 2017-07-26 | Shifamed Holdings, LLC | Low profile electrode assembly |
CN102266245B (en) | 2010-06-04 | 2015-08-26 | 心诺普医疗技术(北京)有限公司 | Perfusion-type radiofrequency ablation catheter |
US8753352B2 (en) | 2010-06-25 | 2014-06-17 | Advanced Bionics Ag | Tools, systems, and methods for inserting a pre-curved electrode array portion of a lead into a bodily orifice |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US20120029512A1 (en) | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
US20120029505A1 (en) | 2010-07-30 | 2012-02-02 | Jenson Mark L | Self-Leveling Electrode Sets for Renal Nerve Ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US20120065506A1 (en) | 2010-09-10 | 2012-03-15 | Scott Smith | Mechanical, Electromechanical, and/or Elastographic Assessment for Renal Nerve Ablation |
TWI556849B (en) | 2010-10-21 | 2016-11-11 | 美敦力阿福盧森堡公司 | Catheter apparatus for renal neuromodulation |
CN202665687U (en) | 2010-10-25 | 2013-01-16 | 美敦力Af卢森堡有限责任公司 | Catheter device used for treatment of human patient via renal denervation |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US20120265198A1 (en) | 2010-11-19 | 2012-10-18 | Crow Loren M | Renal nerve detection and ablation apparatus and method |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
EP2645955B1 (en) | 2010-12-01 | 2016-10-26 | Boston Scientific Scimed, Inc. | Expandable angular vascular electrode for renal nerve ablation |
US20120157992A1 (en) | 2010-12-15 | 2012-06-21 | Scott Smith | Off-wall electrode device for renal nerve ablation |
US10016233B2 (en) | 2010-12-06 | 2018-07-10 | Biosense Webster (Israel) Ltd. | Treatment of atrial fibrillation using high-frequency pacing and ablation of renal nerves |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
CN203354638U (en) | 2010-12-21 | 2013-12-25 | 泰尔茂株式会社 | Balloon catheter and electrification system |
US20120184952A1 (en) | 2011-01-19 | 2012-07-19 | Jenson Mark L | Low-profile off-wall electrode device for renal nerve ablation |
US20120191083A1 (en) | 2011-01-20 | 2012-07-26 | Hansen Medical, Inc. | System and method for endoluminal and translumenal therapy |
EP2667812A1 (en) | 2011-01-28 | 2013-12-04 | Medtronic Ardian Luxembourg S.à.r.l. | Ablation catheter equipped with a shape memory material |
IN2013MN01699A (en) | 2011-02-18 | 2015-06-12 | Medivation Technologies Inc | |
EP2688502A1 (en) | 2011-03-25 | 2014-01-29 | Medtronic Ablation Frontiers LLC | Cooling systems for electrode arrays |
WO2012130337A1 (en) | 2011-04-01 | 2012-10-04 | Flux Medical N.V. | System, device and method for ablation of a vessel's wall from the inside |
EP2694150A1 (en) | 2011-04-08 | 2014-02-12 | Covidien LP | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US9358066B2 (en) | 2011-04-08 | 2016-06-07 | Covidien Lp | Flexible microwave catheters for natural or artificial lumens |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US9526572B2 (en) | 2011-04-26 | 2016-12-27 | Aperiam Medical, Inc. | Method and device for treatment of hypertension and other maladies |
CN102198015B (en) | 2011-05-03 | 2013-11-06 | 上海微创电生理医疗科技有限公司 | Retractable spiral laminar ring type electrode catheter |
CN102274075A (en) | 2011-05-03 | 2011-12-14 | 上海微创电生理医疗科技有限公司 | Multipolar punctiform electrode catheter for heat-induced kidney neuroregulation |
US20120323233A1 (en) | 2011-05-09 | 2012-12-20 | Cyberheart, Inc. | Renovascular treatment device, system, and method for radiosurgically alleviating hypertension |
US20120290053A1 (en) | 2011-05-11 | 2012-11-15 | St. Jude Medical, Inc. | Renal nerve stimulation lead, delivery system, and method |
WO2012158864A1 (en) | 2011-05-18 | 2012-11-22 | St. Jude Medical, Inc. | Apparatus and method of assessing transvascular denervation |
US8909316B2 (en) | 2011-05-18 | 2014-12-09 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method of assessing transvascular denervation |
US20120296232A1 (en) | 2011-05-18 | 2012-11-22 | St. Jude Medical, Inc. | Method and apparatus of assessing transvascular denervation |
US20140135715A1 (en) | 2011-07-12 | 2014-05-15 | David Lambert | Device for reducing renal sympathetic nerve activity |
CN103813745B (en) | 2011-07-20 | 2016-06-29 | 波士顿科学西美德公司 | In order to visualize, be directed at and to melt transcutaneous device and the method for nerve |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
US20130035681A1 (en) | 2011-08-04 | 2013-02-07 | Boston Scientific Scimed, Inc. | Novel catheter for contiguous rf ablation |
US20130165921A1 (en) | 2011-08-24 | 2013-06-27 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation |
US9278196B2 (en) | 2011-08-24 | 2016-03-08 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US20130274674A1 (en) | 2011-08-24 | 2013-10-17 | Ablative Solutions, Inc. | Intravascular ablation catheter with precision depth of penetration calibration |
US9056185B2 (en) | 2011-08-24 | 2015-06-16 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US20130053792A1 (en) | 2011-08-24 | 2013-02-28 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US8702619B2 (en) | 2011-08-26 | 2014-04-22 | Symap Holding Limited | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
KR101862903B1 (en) | 2011-08-26 | 2018-05-30 | 사이맵 홀딩 리미티드 | System and method for locating and identifying functional nerves innervating wall of arteries and catheters for same |
WO2013030806A1 (en) | 2011-09-01 | 2013-03-07 | Perseus-Biomed Inc. | Method and system for tissue modulation |
JP6117209B2 (en) | 2011-09-14 | 2017-04-19 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Ablation device with multiple ablation modes and system including the ablation device |
US9427579B2 (en) | 2011-09-29 | 2016-08-30 | Pacesetter, Inc. | System and method for performing renal denervation verification |
KR20150143881A (en) | 2011-09-30 | 2015-12-23 | 코비디엔 엘피 | Energy delivery device and methods of use |
US8498686B2 (en) | 2011-10-04 | 2013-07-30 | Biosense Webster (Israel), Ltd. | Mapping catheter with spiral electrode assembly |
US20130090637A1 (en) | 2011-10-05 | 2013-04-11 | St. Jude Medical, Inc. | Catheter device and method for denervation |
US20130090649A1 (en) | 2011-10-11 | 2013-04-11 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation |
CN103857353B (en) | 2011-10-11 | 2017-03-01 | 波士顿科学西美德公司 | There is the ablation catheter of dielectric tip |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10849879B2 (en) | 2011-10-19 | 2020-12-01 | Mercator Medsystems, Inc. | Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation |
CN102551874B (en) | 2011-10-20 | 2015-07-22 | 上海微创电生理医疗科技有限公司 | Renal artery radiofrequency ablation catheter |
WO2013074813A1 (en) | 2011-11-15 | 2013-05-23 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US20140350553A1 (en) | 2011-11-21 | 2014-11-27 | Denerve Inc. | Renal artery ablation catheter and system |
CN202386778U (en) | 2011-11-29 | 2012-08-22 | 北京天助畅运医疗技术股份有限公司 | Radio-frequency melting device |
EP2788078B1 (en) | 2011-12-09 | 2020-09-02 | Metavention, Inc. | Therapeutic neuromodulation of the hepatic system |
CN102488552B (en) | 2011-12-15 | 2015-04-15 | 四川锦江电子科技有限公司 | Manageable spiral electrophysiology catheter |
US9844405B2 (en) | 2011-12-20 | 2017-12-19 | Cardiac Pacemakers, Inc. | Method and apparatus for monitoring and ablating nerves |
CN202426649U (en) | 2011-12-22 | 2012-09-12 | 王涛 | Ringlike multi-point radio-frequency ablation electrode |
EP2797534A1 (en) | 2011-12-28 | 2014-11-05 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US20130172879A1 (en) | 2011-12-29 | 2013-07-04 | Boston Scientific Scimed, Inc. | Renal nerve modulation medical devices |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US20130172880A1 (en) | 2011-12-29 | 2013-07-04 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods for renal nerve modulation |
WO2013101485A1 (en) | 2011-12-29 | 2013-07-04 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US20130184703A1 (en) | 2012-01-17 | 2013-07-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods for making and using the same |
US8571654B2 (en) | 2012-01-17 | 2013-10-29 | Cyberonics, Inc. | Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction |
MX347625B (en) | 2012-01-26 | 2017-05-04 | Autonomix Medical Inc | Controlled sympathectomy and micro-ablation systems and methods. |
CN202538132U (en) | 2012-02-06 | 2012-11-21 | 北京中孵友信医药科技股份有限公司 | Snakelike intracavitary catheter |
US20130218029A1 (en) | 2012-02-16 | 2013-08-22 | Pacesetter, Inc. | System and method for assessing renal artery nerve density |
US9510777B2 (en) | 2012-03-08 | 2016-12-06 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring of neuromodulation using biomarkers |
US20130253628A1 (en) | 2012-03-22 | 2013-09-26 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation |
CN202537649U (en) | 2012-04-10 | 2012-11-21 | 北京中孵友信医药科技股份有限公司 | Intracavity catheter with global location function |
US20130274730A1 (en) | 2012-04-12 | 2013-10-17 | Boston Scientific Scimed, Inc. | Ablation catheter and methods for nerve modulation |
US9439598B2 (en) | 2012-04-12 | 2016-09-13 | NeuroMedic, Inc. | Mapping and ablation of nerves within arteries and tissues |
CN102631240A (en) | 2012-04-13 | 2012-08-15 | 上海微创电生理医疗科技有限公司 | Cold brine infusion type radiofrequency ablation catheter |
EP2836151B1 (en) | 2012-04-13 | 2016-10-26 | Covidien LP | Energy delivery device |
EP2838459A1 (en) | 2012-04-16 | 2015-02-25 | Boston Scientific Scimed, Inc. | Helical tubing devices for fluid renal nerve modulation |
US20130274737A1 (en) | 2012-04-16 | 2013-10-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation catheter design |
US9113929B2 (en) | 2012-04-19 | 2015-08-25 | St. Jude Medical, Cardiology Division, Inc. | Non-electric field renal denervation electrode |
WO2013165920A1 (en) | 2012-04-29 | 2013-11-07 | Synecor Llc | Intravascular electrode arrays for neuromodulation |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9439722B2 (en) | 2012-05-09 | 2016-09-13 | Biosense Webster (Israel) Ltd. | Ablation targeting nerves in or near the inferior vena cava and/or abdominal aorta for treatment of hypertension |
US9717555B2 (en) | 2012-05-14 | 2017-08-01 | Biosense Webster (Israel), Ltd. | Catheter with helical end section for vessel ablation |
US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
US20150151077A1 (en) | 2012-06-13 | 2015-06-04 | Douglas C. Harrington | Devices And Methods For Renal Denervation |
CN102772249B (en) | 2012-06-19 | 2015-01-21 | 深圳市惠泰医疗器械有限公司 | Radiofrequency ablation electrode catheter of renal artery rail |
CN102688093B (en) | 2012-06-20 | 2014-08-27 | 深圳市惠泰医疗器械有限公司 | Renal artery cold saline water radio frequency ablation controllable electrode catheter |
JP2015521894A (en) | 2012-07-05 | 2015-08-03 | エムシー10 インコーポレイテッドMc10,Inc. | Catheter device including flow sensing |
US9295842B2 (en) | 2012-07-05 | 2016-03-29 | Mc10, Inc. | Catheter or guidewire device including flow sensing and use thereof |
CN102743225B (en) | 2012-07-18 | 2014-04-02 | 深圳市惠泰医疗器械有限公司 | Radiofrequency ablation controlled electrode catheter for renal artery |
WO2014031165A1 (en) | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
CN103284693B (en) | 2012-08-24 | 2014-12-24 | 苏州信迈医疗器械有限公司 | Instrument for locating and identifying nerves in vessel wall, and application method thereof |
CN104540465A (en) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | Intravascular catheter with a balloon comprising separate microporous regions |
WO2014036163A1 (en) | 2012-08-28 | 2014-03-06 | Boston Scientific Scimed, Inc. | Renal rf ablation system with a movable virtual electrode and related methods of use |
US20140067029A1 (en) | 2012-08-28 | 2014-03-06 | Boston Scientific Scimed, Inc. | Renal nerve modulation and ablation catheter electrode design |
CN202843784U (en) | 2012-08-29 | 2013-04-03 | 中国人民解放军第三军医大学第一附属医院 | Renal sympathetic nerve ablation catheter system |
CN102908189B (en) | 2012-08-29 | 2015-04-08 | 中国人民解放军第三军医大学第一附属医院 | Multifunctional ablation catheter system for denervation of renal sympathetic nerves |
CN102885649B (en) | 2012-08-29 | 2015-01-21 | 中国人民解放军第三军医大学第一附属医院 | Radio frequency cable controlled ablation catheter system for removing sympathetic nerve from kidney |
CN102908188B (en) | 2012-08-29 | 2015-04-08 | 中国人民解放军第三军医大学第一附属医院 | Radio frequency ablation (RFA) catheter system for denervation of renal sympathetic nerves |
CN202761434U (en) | 2012-08-29 | 2013-03-06 | 中国人民解放军第三军医大学第一附属医院 | Kidney sympathetic denervation multifunctional ablation catheter system |
WO2014056460A1 (en) | 2012-08-29 | 2014-04-17 | 第三军医大学第一附属医院 | Multifunctional ablation catheter system for renal sympathetic denervation |
CN102885648B (en) | 2012-08-29 | 2015-03-18 | 中国人民解放军第三军医大学第一附属医院 | Sympathetic nerve denervation ablation catheter system for kidneys |
TWI498101B (en) | 2012-08-30 | 2015-09-01 | Univ Nat Chiao Tung | Method of analyzing nerve fiber distribution and measuring standardized induced compound motion electric potential |
JP2014054430A (en) | 2012-09-13 | 2014-03-27 | Nippon Koden Corp | Catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10004557B2 (en) | 2012-11-05 | 2018-06-26 | Pythagoras Medical Ltd. | Controlled tissue ablation |
US9770593B2 (en) | 2012-11-05 | 2017-09-26 | Pythagoras Medical Ltd. | Patient selection using a transluminally-applied electric current |
US20140316496A1 (en) | 2012-11-21 | 2014-10-23 | NeuroTronik IP Holding (Jersey) Limited | Intravascular Electrode Arrays for Neuromodulation |
US20140163360A1 (en) | 2012-12-07 | 2014-06-12 | Boston Scientific Scimed, Inc. | Irrigated catheter |
WO2014091401A2 (en) | 2012-12-10 | 2014-06-19 | Perseus-Biomed Inc. | Dynamic denervation procedures and systems for the implementation thereof |
EP2928404A1 (en) | 2012-12-10 | 2015-10-14 | Koninklijke Philips N.V. | Digital ruler and reticule for renal denervation. |
US10028764B2 (en) | 2013-02-21 | 2018-07-24 | Boston Scientific Scimed, Inc. | Ablation catheter with wireless temperature sensor |
US10195467B2 (en) | 2013-02-21 | 2019-02-05 | Boston Scientific Scimed, Inc. | Ablation catheter system with wireless radio frequency temperature sensor |
US20140249524A1 (en) | 2013-03-01 | 2014-09-04 | Boston Scientific Scimed, Inc. | System and method for performing renal nerve modulation |
US20140246465A1 (en) | 2013-03-03 | 2014-09-04 | Joan Darnell Peterson | Fish n stow |
US20140303617A1 (en) | 2013-03-05 | 2014-10-09 | Neuro Ablation, Inc. | Intravascular nerve ablation devices & methods |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US20140276755A1 (en) | 2013-03-12 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical systems and methods for modulating nerves |
US9510902B2 (en) | 2013-03-13 | 2016-12-06 | St. Jude Medical, Cardiology Division, Inc. | Ablation catheters and systems including rotational monitoring means |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US8876813B2 (en) | 2013-03-14 | 2014-11-04 | St. Jude Medical, Inc. | Methods, systems, and apparatus for neural signal detection |
US9131982B2 (en) | 2013-03-14 | 2015-09-15 | St. Jude Medical, Cardiology Division, Inc. | Mediguide-enabled renal denervation system for ensuring wall contact and mapping lesion locations |
WO2014150432A1 (en) | 2013-03-15 | 2014-09-25 | St. Jude Medical, Cardiology Division, Inc. | Ablation system, methods, and controllers |
US9186212B2 (en) | 2013-03-15 | 2015-11-17 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods utilizing two or more sites along denervation catheter |
US9713490B2 (en) | 2013-03-15 | 2017-07-25 | St. Jude Medical, Cardiology Division, Inc. | Ablation system, methods, and controllers |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9179973B2 (en) | 2013-03-15 | 2015-11-10 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods for renal denervation utilizing balloon catheter |
US9974477B2 (en) | 2013-03-15 | 2018-05-22 | St. Jude Medical, Cardiology Division, Inc. | Quantification of renal denervation via alterations in renal blood flow pre/post ablation |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
JP6139772B2 (en) | 2013-03-15 | 2017-05-31 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Control unit for use with electrode pads and method for estimating leakage |
US9333113B2 (en) | 2013-03-15 | 2016-05-10 | Abbott Cardiovascular Systems Inc. | System and method for denervation |
WO2014162660A1 (en) | 2013-04-01 | 2014-10-09 | テルモ株式会社 | Monitoring device and monitoring device kit |
WO2014179768A1 (en) | 2013-05-02 | 2014-11-06 | Harrington Douglas C | Devices and methods for detection and treatment of the aorticorenal ganglion |
WO2014176785A1 (en) | 2013-05-03 | 2014-11-06 | 上海安通医疗科技有限公司 | Nerve regulation device |
EP2994068A2 (en) | 2013-05-08 | 2016-03-16 | Boston Scientific Scimed, Inc. | Systems and methods for temperature monitoring and control during an ablation procedure |
US20160128767A1 (en) | 2013-06-05 | 2016-05-12 | Metavention, Inc. | Modulation of targeted nerve fibers |
JP6204579B2 (en) | 2013-07-01 | 2017-09-27 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal nerve ablation medical device |
US20150025524A1 (en) | 2013-07-18 | 2015-01-22 | St. Jude Medical, Cardiology Division, Inc. | Renal denervation monitoring and feedback apparatus, system and method |
WO2015010074A1 (en) | 2013-07-19 | 2015-01-22 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US9913684B2 (en) | 2013-08-23 | 2018-03-13 | Oscor Inc. | Steerable ablation catheter for renal denervation |
US20150126992A1 (en) | 2013-11-05 | 2015-05-07 | Mogul Enterprises, Inc | Helical DeNervation Ablation Catheter Apparatus |
JP2015119831A (en) | 2013-12-24 | 2015-07-02 | テルモ株式会社 | Ablation catheter |
CN106572875A (en) | 2014-02-07 | 2017-04-19 | 沃夫医药公司 | Methods and systems for ablation of the renal pelvis |
US20150223877A1 (en) | 2014-02-12 | 2015-08-13 | Perseus-Biomed Inc. | Methods and systems for treating nerve structures |
EP3139853B1 (en) | 2014-05-07 | 2018-12-19 | Pythagoras Medical Ltd. | Controlled tissue ablation apparatus |
CN105167840A (en) | 2014-06-20 | 2015-12-23 | 上海安通医疗科技有限公司 | Multi-electrode renal artery radiofrequency ablation catheter |
CN105326562A (en) | 2014-06-24 | 2016-02-17 | 上海安通医疗科技有限公司 | Catheter device for regulating renal nerves |
JP2016086999A (en) | 2014-10-31 | 2016-05-23 | テルモ株式会社 | Ablation catheter |
US20180000540A1 (en) | 2014-12-17 | 2018-01-04 | Cathrx Ltd | An improved catheter and method of manufacture thereof |
US9737361B2 (en) | 2014-12-18 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | System and method for a catheter |
US9795780B2 (en) | 2014-12-18 | 2017-10-24 | Abbott Cardiovascular Systems Inc. | System for denervation |
CN205433879U (en) | 2015-12-08 | 2016-08-10 | 上海安通医疗科技有限公司 | Radiofrequency ablation catheter for renal arteries |
CN205433878U (en) | 2015-12-08 | 2016-08-10 | 上海安通医疗科技有限公司 | Radiofrequency ablation catheter for renal arteries |
-
2005
- 2005-05-13 US US11/129,765 patent/US7653438B2/en not_active Expired - Lifetime
- 2005-10-05 ES ES12180431.4T patent/ES2494119T3/en active Active
- 2005-10-05 DE DE602005025789T patent/DE602005025789D1/en active Active
- 2005-10-05 JP JP2007535766A patent/JP5646135B2/en active Active
- 2005-10-05 CN CN201010279054.8A patent/CN101972513B/en active Active
- 2005-10-05 ES ES12180430T patent/ES2570927T3/en active Active
- 2005-10-05 EP EP21195951.5A patent/EP3939531B1/en active Active
- 2005-10-05 EP EP12180430.6A patent/EP2561904B1/en not_active Not-in-force
- 2005-10-05 PL PL12180431T patent/PL2561905T3/en unknown
- 2005-10-05 ES ES16184488T patent/ES2740836T3/en active Active
- 2005-10-05 DE DE202005022059U patent/DE202005022059U1/en not_active Expired - Lifetime
- 2005-10-05 ES ES11192514.5T patent/ES2532077T3/en active Active
- 2005-10-05 DE DE202005022061U patent/DE202005022061U1/en not_active Expired - Lifetime
- 2005-10-05 CN CN2010102788980A patent/CN101940815A/en active Pending
- 2005-10-05 EP EP11192514.5A patent/EP2457615B1/en not_active Revoked
- 2005-10-05 DE DE202005022083U patent/DE202005022083U1/en not_active Expired - Lifetime
- 2005-10-05 WO PCT/US2005/035757 patent/WO2006041881A2/en active Application Filing
- 2005-10-05 ES ES12180427.2T patent/ES2538708T3/en active Active
- 2005-10-05 EP EP16183801.6A patent/EP3132825B1/en active Active
- 2005-10-05 CA CA2583463A patent/CA2583463C/en active Active
- 2005-10-05 DE DE202005022123.6U patent/DE202005022123U1/en not_active Expired - Lifetime
- 2005-10-05 EP EP18200365.7A patent/EP3446747B1/en active Active
- 2005-10-05 AT AT05806045T patent/ATE494039T1/en not_active IP Right Cessation
- 2005-10-05 ES ES16160715.5T patent/ES2691040T3/en active Active
- 2005-10-05 CN CN2010102790641A patent/CN101940816B/en active Active
- 2005-10-05 EP EP12180427.2A patent/EP2570154B1/en active Active
- 2005-10-05 DE DE202005022057U patent/DE202005022057U1/en not_active Expired - Lifetime
- 2005-10-05 EP EP14190890.5A patent/EP2868344B1/en active Active
- 2005-10-05 DE DE202005022060U patent/DE202005022060U1/en not_active Expired - Lifetime
- 2005-10-05 EP EP16160715.5A patent/EP3056242B1/en active Active
- 2005-10-05 CN CN2005800417112A patent/CN101084038B/en active Active
- 2005-10-05 EP EP11192511.1A patent/EP2457614B1/en active Active
- 2005-10-05 EP EP16200322.2A patent/EP3159037A1/en not_active Withdrawn
- 2005-10-05 ES ES16183801T patent/ES2743974T3/en active Active
- 2005-10-05 DE DE202005022058U patent/DE202005022058U1/en not_active Expired - Lifetime
- 2005-10-05 ES ES12180428.0T patent/ES2684499T3/en active Active
- 2005-10-05 DE DE202005022096U patent/DE202005022096U1/en not_active Expired - Lifetime
- 2005-10-05 EP EP12180432.2A patent/EP2572753B1/en active Active
- 2005-10-05 ES ES12180426.4T patent/ES2531888T3/en active Active
- 2005-10-05 EP EP12180426.4A patent/EP2561902B1/en not_active Not-in-force
- 2005-10-05 ES ES12180432.2T patent/ES2534535T3/en active Active
- 2005-10-05 EP EP05806045A patent/EP1802370B1/en not_active Revoked
- 2005-10-05 EP EP10190952A patent/EP2329859A1/en not_active Withdrawn
- 2005-10-05 EP EP12180428.0A patent/EP2561903B1/en active Active
- 2005-10-05 MX MX2007004238A patent/MX2007004238A/en active IP Right Grant
- 2005-10-05 EP EP16184488.1A patent/EP3108930B1/en active Active
- 2005-10-05 EP EP12180431.4A patent/EP2561905B1/en active Active
- 2005-10-05 EP EP12167931A patent/EP2495012A1/en not_active Ceased
-
2007
- 2007-07-24 US US11/782,451 patent/US20070265687A1/en not_active Abandoned
-
2010
- 2010-05-11 US US12/777,892 patent/US8768470B2/en not_active Expired - Fee Related
-
2012
- 2012-02-01 JP JP2012020266A patent/JP2012110738A/en not_active Withdrawn
- 2012-03-02 JP JP2012047200A patent/JP2012135630A/en not_active Withdrawn
- 2012-03-02 JP JP2012047201A patent/JP2012143573A/en not_active Withdrawn
- 2012-03-02 JP JP2012047198A patent/JP2012110748A/en not_active Withdrawn
- 2012-03-02 JP JP2012047199A patent/JP2012106081A/en not_active Withdrawn
- 2012-09-14 US US13/619,851 patent/US8548600B2/en not_active Expired - Lifetime
- 2012-09-14 US US13/619,950 patent/US20130116685A1/en not_active Abandoned
-
2013
- 2013-06-28 US US13/930,863 patent/US8852163B2/en not_active Expired - Lifetime
- 2013-10-17 US US14/056,885 patent/US20140058377A1/en not_active Abandoned
- 2013-10-17 US US14/056,888 patent/US9125661B2/en not_active Expired - Lifetime
-
2014
- 2014-04-22 US US14/258,802 patent/US8934978B2/en not_active Expired - Lifetime
- 2014-08-22 JP JP2014169723A patent/JP5952356B2/en active Active
-
2015
- 2015-03-03 US US14/636,317 patent/US9289255B2/en not_active Expired - Fee Related
-
2016
- 2016-02-09 US US15/019,793 patent/US9675413B2/en not_active Expired - Fee Related
- 2016-04-28 US US15/141,764 patent/US20160296279A1/en not_active Abandoned
-
2017
- 2017-08-03 US US15/667,781 patent/US20170326363A1/en not_active Abandoned
-
2018
- 2018-04-06 US US15/946,919 patent/US10245429B2/en not_active Expired - Lifetime
-
2019
- 2019-02-08 US US16/271,728 patent/US11033328B2/en not_active Expired - Lifetime
-
2021
- 2021-06-14 US US17/347,179 patent/US11963714B2/en not_active Expired - Lifetime
Patent Citations (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070173899A1 (en) * | 2002-04-08 | 2007-07-26 | Ardian, Inc. | Renal nerve stimulation method for treatment of patients |
US20060025821A1 (en) * | 2002-04-08 | 2006-02-02 | Mark Gelfand | Methods and devices for renal nerve blocking |
US6978174B2 (en) * | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US20080213331A1 (en) * | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US20060041277A1 (en) * | 2002-04-08 | 2006-02-23 | Mark Deem | Methods and apparatus for renal neuromodulation |
US20060206150A1 (en) * | 2002-04-08 | 2006-09-14 | Ardian, Inc. | Methods and apparatus for treating acute myocardial infarction |
US20060212078A1 (en) * | 2002-04-08 | 2006-09-21 | Ardian, Inc. | Methods and apparatus for treating congestive heart failure |
US20060212076A1 (en) * | 2002-04-08 | 2006-09-21 | Ardian, Inc. | Methods and apparatus for treating end-stage renal disease |
US20060235474A1 (en) * | 2002-04-08 | 2006-10-19 | Ardian, Inc. | Methods and apparatus for multi-vessel renal neuromodulation |
US20060265014A1 (en) * | 2002-04-08 | 2006-11-23 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US20060265015A1 (en) * | 2002-04-08 | 2006-11-23 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US20060271111A1 (en) * | 2002-04-08 | 2006-11-30 | Ardian, Inc. | Methods and apparatus for treating contrast nephropathy |
US20060276852A1 (en) * | 2002-04-08 | 2006-12-07 | Ardian, Inc. | Methods and apparatus for treating hypertension |
US7162303B2 (en) * | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US20100268307A1 (en) * | 2002-04-08 | 2010-10-21 | Ardian,Inc. | Methods for intravascularly-induced neuromodulation |
US20050228460A1 (en) * | 2002-04-08 | 2005-10-13 | Levin Howard R | Renal nerve stimulation method and apparatus for treatment of patients |
US20070129720A1 (en) * | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US20070129761A1 (en) * | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US20070129760A1 (en) * | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods and apparatus for intravasculary-induced neuromodulation or denervation |
US20070135875A1 (en) * | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20100222854A1 (en) * | 2002-04-08 | 2010-09-02 | Ardian, Inc. | Apparatuses for inhibiting renal nerve activity via an intra-to-extravascular approach |
US20050234523A1 (en) * | 2002-04-08 | 2005-10-20 | Levin Howard R | Renal nerve stimulation method and apparatus for treatment of patients |
US20100191112A1 (en) * | 2002-04-08 | 2010-07-29 | Ardian, Inc. | Ultrasound apparatuses for thermally-induced renal neuromodulation |
US20090036948A1 (en) * | 2002-04-08 | 2009-02-05 | Ardian, Inc. | Renal nerve stimulation methods for treatment of patients |
US7756583B2 (en) * | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US20100174282A1 (en) * | 2002-04-08 | 2010-07-08 | Ardian, Inc. | Apparatus for thermal modulation of nerves contributing to renal function |
US7617005B2 (en) * | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20100137860A1 (en) * | 2002-04-08 | 2010-06-03 | Ardian, Inc. | Apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7647115B2 (en) * | 2002-04-08 | 2010-01-12 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US20100137952A1 (en) * | 2002-04-08 | 2010-06-03 | Ardian, Inc. | Apparatuses for thermally-induced renal neuromodulation |
US7653438B2 (en) * | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US20100057150A1 (en) * | 2002-04-08 | 2010-03-04 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US7717948B2 (en) * | 2002-04-08 | 2010-05-18 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20070066957A1 (en) * | 2004-11-02 | 2007-03-22 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
US20100010567A1 (en) * | 2005-07-22 | 2010-01-14 | The Foundry, Llc | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US20070083239A1 (en) * | 2005-09-23 | 2007-04-12 | Denise Demarais | Methods and apparatus for inducing, monitoring and controlling renal neuromodulation |
US7620451B2 (en) * | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US20090076409A1 (en) * | 2006-06-28 | 2009-03-19 | Ardian, Inc. | Methods and systems for thermally-induced renal neuromodulation |
US20090062873A1 (en) * | 2006-06-28 | 2009-03-05 | Ardian, Inc. | Methods and systems for thermally-induced renal neuromodulation |
US20080255642A1 (en) * | 2006-06-28 | 2008-10-16 | Ardian, Inc. | Methods and systems for thermally-induced renal neuromodulation |
US20100168731A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US20100168739A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US20100249773A1 (en) * | 2008-12-31 | 2010-09-30 | Ardian, Inc. | Handle assemblies for intravascular treatment devices and associated systems and methods |
Cited By (579)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9713483B2 (en) | 1995-10-13 | 2017-07-25 | Medtronic Vascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US9204889B2 (en) | 1998-03-27 | 2015-12-08 | Tsunami Medtech, Llc | Medical instrument and method of use |
US8858549B2 (en) | 1998-03-27 | 2014-10-14 | Tsunami Medtech, Llc | Medical instruments and techniques for treating pulmonary disorders |
US8388535B2 (en) | 1999-10-25 | 2013-03-05 | Kona Medical, Inc. | Methods and apparatus for focused ultrasound application |
US8622937B2 (en) | 1999-11-26 | 2014-01-07 | Kona Medical, Inc. | Controlled high efficiency lesion formation using high intensity ultrasound |
US9615875B2 (en) | 2000-12-09 | 2017-04-11 | Tsunami Med Tech, LLC | Medical instruments and techniques for thermally-mediated therapies |
US9433457B2 (en) | 2000-12-09 | 2016-09-06 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US10524847B2 (en) | 2000-12-09 | 2020-01-07 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US9468487B2 (en) | 2001-12-07 | 2016-10-18 | Tsunami Medtech, Llc | Medical instrument and method of use |
US8444636B2 (en) | 2001-12-07 | 2013-05-21 | Tsunami Medtech, Llc | Medical instrument and method of use |
US9827040B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Adrian Luxembourg S.a.r.l. | Methods and apparatus for intravascularly-induced neuromodulation |
US9192715B2 (en) | 2002-04-08 | 2015-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal nerve blocking |
US20060212078A1 (en) * | 2002-04-08 | 2006-09-21 | Ardian, Inc. | Methods and apparatus for treating congestive heart failure |
US8986294B2 (en) | 2002-04-08 | 2015-03-24 | Medtronic Ardian Luxembourg S.a.rl. | Apparatuses for thermally-induced renal neuromodulation |
US9186213B2 (en) | 2002-04-08 | 2015-11-17 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US20100222851A1 (en) * | 2002-04-08 | 2010-09-02 | Ardian, Inc. | Methods for monitoring renal neuromodulation |
US20100222854A1 (en) * | 2002-04-08 | 2010-09-02 | Ardian, Inc. | Apparatuses for inhibiting renal nerve activity via an intra-to-extravascular approach |
US10039596B2 (en) | 2002-04-08 | 2018-08-07 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus for renal neuromodulation via an intra-to-extravascular approach |
US8983595B2 (en) | 2002-04-08 | 2015-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of patients with chronic heart failure |
US8548600B2 (en) | 2002-04-08 | 2013-10-01 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatuses for renal neuromodulation and associated systems and methods |
US11033328B2 (en) | 2002-04-08 | 2021-06-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US9486270B2 (en) | 2002-04-08 | 2016-11-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for bilateral renal neuromodulation |
US9138281B2 (en) | 2002-04-08 | 2015-09-22 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets |
US9474563B2 (en) | 2002-04-08 | 2016-10-25 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US10850091B2 (en) | 2002-04-08 | 2020-12-01 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for bilateral renal neuromodulation |
US9468497B2 (en) | 2002-04-08 | 2016-10-18 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US9265558B2 (en) | 2002-04-08 | 2016-02-23 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for bilateral renal neuromodulation |
US9125661B2 (en) | 2002-04-08 | 2015-09-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US20110202098A1 (en) * | 2002-04-08 | 2011-08-18 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US9289255B2 (en) | 2002-04-08 | 2016-03-22 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US20110208096A1 (en) * | 2002-04-08 | 2011-08-25 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US20110257564A1 (en) * | 2002-04-08 | 2011-10-20 | Ardian, Inc. | Methods for thermal modulation of nerves contributing to renal function |
US9308043B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monopolar renal neuromodulation |
US8958871B2 (en) | 2002-04-08 | 2015-02-17 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US9308044B2 (en) | 2002-04-08 | 2016-04-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US9131978B2 (en) | 2002-04-08 | 2015-09-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for bilateral renal neuromodulation |
US9629679B2 (en) | 2002-04-08 | 2017-04-25 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal denervation |
US8131372B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Renal nerve stimulation method for treatment of patients |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8150518B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US8150520B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods for catheter-based renal denervation |
US10441356B2 (en) | 2002-04-08 | 2019-10-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation via neuromodulatory agents |
US10420606B2 (en) | 2002-04-08 | 2019-09-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US8175711B2 (en) | 2002-04-08 | 2012-05-08 | Ardian, Inc. | Methods for treating a condition or disease associated with cardio-renal function |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US9072527B2 (en) | 2002-04-08 | 2015-07-07 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatuses and methods for renal neuromodulation |
US9463066B2 (en) | 2002-04-08 | 2016-10-11 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US10376516B2 (en) | 2002-04-08 | 2019-08-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for renal nerve blocking |
US10376311B2 (en) | 2002-04-08 | 2019-08-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravascularly-induced neuromodulation |
US10376312B2 (en) | 2002-04-08 | 2019-08-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for monopolar renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US8948865B2 (en) | 2002-04-08 | 2015-02-03 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating heart arrhythmia |
US9675413B2 (en) | 2002-04-08 | 2017-06-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US9314630B2 (en) | 2002-04-08 | 2016-04-19 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of patients |
US8934978B2 (en) | 2002-04-08 | 2015-01-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US10293190B2 (en) | 2002-04-08 | 2019-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Thermally-induced renal neuromodulation and associated systems and methods |
US10272246B2 (en) | 2002-04-08 | 2019-04-30 | Medtronic Adrian Luxembourg S.a.r.l | Methods for extravascular renal neuromodulation |
US20100137860A1 (en) * | 2002-04-08 | 2010-06-03 | Ardian, Inc. | Apparatus for performing a non-continuous circumferential treatment of a body lumen |
US10245429B2 (en) | 2002-04-08 | 2019-04-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US9320561B2 (en) | 2002-04-08 | 2016-04-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for bilateral renal neuromodulation |
US10194983B2 (en) | 2002-04-08 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal denervation |
US9707035B2 (en) | 2002-04-08 | 2017-07-18 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US20090036948A1 (en) * | 2002-04-08 | 2009-02-05 | Ardian, Inc. | Renal nerve stimulation methods for treatment of patients |
US8444640B2 (en) | 2002-04-08 | 2013-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US8880186B2 (en) | 2002-04-08 | 2014-11-04 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of patients with chronic heart failure |
US10179027B2 (en) | 2002-04-08 | 2019-01-15 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable baskets for renal neuromodulation and associated systems and methods |
US8454594B2 (en) | 2002-04-08 | 2013-06-04 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus for performing a non-continuous circumferential treatment of a body lumen |
US10179235B2 (en) | 2002-04-08 | 2019-01-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for bilateral renal neuromodulation |
US10179028B2 (en) | 2002-04-08 | 2019-01-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating patients via renal neuromodulation |
US9327122B2 (en) | 2002-04-08 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US9326817B2 (en) | 2002-04-08 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating heart arrhythmia |
US9731132B2 (en) | 2002-04-08 | 2017-08-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US9743983B2 (en) | 2002-04-08 | 2017-08-29 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of patients |
US8852163B2 (en) | 2002-04-08 | 2014-10-07 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods |
US10130792B2 (en) | 2002-04-08 | 2018-11-20 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation using neuromodulatory agents or drugs |
US10124195B2 (en) | 2002-04-08 | 2018-11-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for thermally-induced renal neuromodulation |
US10111707B2 (en) | 2002-04-08 | 2018-10-30 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of human patients |
US10105180B2 (en) | 2002-04-08 | 2018-10-23 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravascularly-induced neuromodulation |
US9186198B2 (en) | 2002-04-08 | 2015-11-17 | Medtronic Ardian Luxembourg S.A.R.L. | Ultrasound apparatuses for thermally-induced renal neuromodulation and associated systems and methods |
US20100268307A1 (en) * | 2002-04-08 | 2010-10-21 | Ardian,Inc. | Methods for intravascularly-induced neuromodulation |
US8845629B2 (en) | 2002-04-08 | 2014-09-30 | Medtronic Ardian Luxembourg S.A.R.L. | Ultrasound apparatuses for thermally-induced renal neuromodulation |
US9757192B2 (en) | 2002-04-08 | 2017-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of patients |
US10034708B2 (en) | 2002-04-08 | 2018-07-31 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for thermally-induced renal neuromodulation |
US8620423B2 (en) * | 2002-04-08 | 2013-12-31 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for thermal modulation of nerves contributing to renal function |
US8626300B2 (en) * | 2002-04-08 | 2014-01-07 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for thermally-induced renal neuromodulation |
US9456869B2 (en) | 2002-04-08 | 2016-10-04 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for bilateral renal neuromodulation |
US8818514B2 (en) | 2002-04-08 | 2014-08-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for intravascularly-induced neuromodulation |
US9968611B2 (en) | 2002-04-08 | 2018-05-15 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for renal nerve blocking |
US9757193B2 (en) | 2002-04-08 | 2017-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatus for renal neuromodulation |
US8684998B2 (en) | 2002-04-08 | 2014-04-01 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for inhibiting renal nerve activity |
US9364280B2 (en) | 2002-04-08 | 2016-06-14 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US9956410B2 (en) | 2002-04-08 | 2018-05-01 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for renal neuromodulation |
US9814873B2 (en) | 2002-04-08 | 2017-11-14 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for bilateral renal neuromodulation |
US9445867B1 (en) | 2002-04-08 | 2016-09-20 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation via catheters having expandable treatment members |
US8784463B2 (en) | 2002-04-08 | 2014-07-22 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for thermally-induced renal neuromodulation |
US9827041B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatuses for renal denervation |
US8721637B2 (en) | 2002-04-08 | 2014-05-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons |
US9439726B2 (en) | 2002-04-08 | 2016-09-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US9907611B2 (en) | 2002-04-08 | 2018-03-06 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation for treatment of patients |
US8728138B2 (en) | 2002-04-08 | 2014-05-20 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for thermally-induced renal neuromodulation |
US8728137B2 (en) | 2002-04-08 | 2014-05-20 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for thermally-induced renal neuromodulation |
US8740896B2 (en) | 2002-04-08 | 2014-06-03 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons |
US9895195B2 (en) | 2002-04-08 | 2018-02-20 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US8768470B2 (en) | 2002-04-08 | 2014-07-01 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for monitoring renal neuromodulation |
US9023037B2 (en) | 2002-04-08 | 2015-05-05 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatus for renal neuromodulation |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
US8774922B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods |
US8771252B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for renal nerve blocking |
US9867663B2 (en) | 2002-04-08 | 2018-01-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal denervation |
US9700372B2 (en) | 2002-07-01 | 2017-07-11 | Recor Medical, Inc. | Intraluminal methods of ablating nerve tissue |
US10368944B2 (en) | 2002-07-01 | 2019-08-06 | Recor Medical, Inc. | Intraluminal method and apparatus for ablating nerve tissue |
US9707034B2 (en) | 2002-07-01 | 2017-07-18 | Recor Medical, Inc. | Intraluminal method and apparatus for ablating nerve tissue |
US9113944B2 (en) | 2003-01-18 | 2015-08-25 | Tsunami Medtech, Llc | Method for performing lung volume reduction |
US10953170B2 (en) | 2003-05-13 | 2021-03-23 | Nuvaira, Inc. | Apparatus for treating asthma using neurotoxin |
US9339618B2 (en) | 2003-05-13 | 2016-05-17 | Holaira, Inc. | Method and apparatus for controlling narrowing of at least one airway |
US8172827B2 (en) | 2003-05-13 | 2012-05-08 | Innovative Pulmonary Solutions, Inc. | Apparatus for treating asthma using neurotoxin |
US8116883B2 (en) | 2003-06-04 | 2012-02-14 | Synecor Llc | Intravascular device for neuromodulation |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US9510901B2 (en) | 2003-09-12 | 2016-12-06 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US10188457B2 (en) | 2003-09-12 | 2019-01-29 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US8579892B2 (en) | 2003-10-07 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
US9907599B2 (en) | 2003-10-07 | 2018-03-06 | Tsunami Medtech, Llc | Medical system and method of use |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US10537734B2 (en) | 2004-10-05 | 2020-01-21 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for multi-vessel renal neuromodulation |
US8433423B2 (en) | 2004-10-05 | 2013-04-30 | Ardian, Inc. | Methods for multi-vessel renal neuromodulation |
US8805545B2 (en) | 2004-10-05 | 2014-08-12 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for multi-vessel renal neuromodulation |
US9108040B2 (en) | 2004-10-05 | 2015-08-18 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for multi-vessel renal neuromodulation |
US9402992B2 (en) | 2004-10-05 | 2016-08-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for multi-vessel renal neuromodulation |
US9950161B2 (en) | 2004-10-05 | 2018-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for multi-vessel renal neuromodulation |
US8364237B2 (en) | 2005-03-28 | 2013-01-29 | Vessix Vascular, Inc. | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8676309B2 (en) | 2005-07-22 | 2014-03-18 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US8504147B2 (en) | 2005-07-22 | 2013-08-06 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US8989859B2 (en) | 2005-07-22 | 2015-03-24 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US9345538B2 (en) | 2005-07-22 | 2016-05-24 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for neuromodulation for treatment of disorders associated with nerve conduction |
US20100010567A1 (en) * | 2005-07-22 | 2010-01-14 | The Foundry, Llc | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
US8579893B2 (en) | 2005-08-03 | 2013-11-12 | Tsunami Medtech, Llc | Medical system and method of use |
US20110166499A1 (en) * | 2005-09-20 | 2011-07-07 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
US8372009B2 (en) | 2005-10-20 | 2013-02-12 | Kona Medical, Inc. | System and method for treating a therapeutic site |
US20070213616A1 (en) * | 2005-10-20 | 2007-09-13 | Thomas Anderson | Systems and methods for arteriotomy localization |
US9220488B2 (en) | 2005-10-20 | 2015-12-29 | Kona Medical, Inc. | System and method for treating a therapeutic site |
US20110077628A1 (en) * | 2006-01-10 | 2011-03-31 | Tsunami Medtech, Llc | Medical system and method of use |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US9345900B2 (en) | 2006-06-28 | 2016-05-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for thermally-induced renal neuromodulation |
US10722288B2 (en) | 2006-06-28 | 2020-07-28 | Medtronic Ardian Luxembourg S.A.R.L. | Devices for thermally-induced renal neuromodulation |
US11801085B2 (en) | 2006-06-28 | 2023-10-31 | Medtronic Ireland Manufacturing Unlimited Company | Devices for thermally-induced renal neuromodulation |
US9314644B2 (en) | 2006-06-28 | 2016-04-19 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for thermally-induced renal neuromodulation |
US10413356B2 (en) | 2006-10-18 | 2019-09-17 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US10213252B2 (en) | 2006-10-18 | 2019-02-26 | Vessix, Inc. | Inducing desirable temperature effects on body tissue |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US20080119907A1 (en) * | 2006-11-22 | 2008-05-22 | Cardiac Pacemakers, Inc. | Renal function modulation via application of electrical energy stimulation |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US8489192B1 (en) | 2008-02-15 | 2013-07-16 | Holaira, Inc. | System and method for bronchial dilation |
US11058879B2 (en) | 2008-02-15 | 2021-07-13 | Nuvaira, Inc. | System and method for bronchial dilation |
US8731672B2 (en) | 2008-02-15 | 2014-05-20 | Holaira, Inc. | System and method for bronchial dilation |
US9125643B2 (en) | 2008-02-15 | 2015-09-08 | Holaira, Inc. | System and method for bronchial dilation |
US10595925B2 (en) | 2008-02-20 | 2020-03-24 | Tsunami Medtech, Llc | Medical system and method of use |
US9924992B2 (en) | 2008-02-20 | 2018-03-27 | Tsunami Medtech, Llc | Medical system and method of use |
US7925352B2 (en) | 2008-03-27 | 2011-04-12 | Synecor Llc | System and method for transvascularly stimulating contents of the carotid sheath |
US8369954B2 (en) | 2008-03-27 | 2013-02-05 | Synecor Llc | System and method for transvascularly stimulating contents of the carotid sheath |
US8961508B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8088127B2 (en) | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US10149714B2 (en) | 2008-05-09 | 2018-12-11 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8808280B2 (en) | 2008-05-09 | 2014-08-19 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8961507B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US11937868B2 (en) | 2008-05-09 | 2024-03-26 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8821489B2 (en) | 2008-05-09 | 2014-09-02 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8226638B2 (en) | 2008-05-09 | 2012-07-24 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US9668809B2 (en) | 2008-05-09 | 2017-06-06 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US11478291B2 (en) | 2008-05-31 | 2022-10-25 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US11284932B2 (en) | 2008-05-31 | 2022-03-29 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US11179187B2 (en) | 2008-05-31 | 2021-11-23 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US11141210B2 (en) | 2008-05-31 | 2021-10-12 | Tsunami Medtech, Llc | Systems and methods for delivering energy into a target tissue of a body |
US11129664B2 (en) | 2008-05-31 | 2021-09-28 | Tsunami Medtech, Llc | Systems and methods for delivering energy into a target tissue of a body |
US9616231B2 (en) | 2008-08-08 | 2017-04-11 | Enteromedics Inc. | Systems for regulation of blood pressure and heart rate |
US8768469B2 (en) | 2008-08-08 | 2014-07-01 | Enteromedics Inc. | Systems for regulation of blood pressure and heart rate |
US20100204741A1 (en) * | 2008-08-08 | 2010-08-12 | Tweden Katherine S | Systems for regulation of blood pressure and heart rate |
US9095711B2 (en) | 2008-08-08 | 2015-08-04 | Enteromedics Inc. | Systems for regulation of blood pressure and heart rate |
US10548653B2 (en) | 2008-09-09 | 2020-02-04 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US8721632B2 (en) | 2008-09-09 | 2014-05-13 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
US9314169B2 (en) | 2008-09-22 | 2016-04-19 | 3Dt Holdings, Llc | Devices, systems, and methods to determine fractional flow reserve |
US10898086B2 (en) | 2008-09-22 | 2021-01-26 | 3Dt Holdings, Llc | Devices for determining flow reserve within a luminal organ |
US20110178417A1 (en) * | 2008-09-22 | 2011-07-21 | Kassab Ghassan S | Methods for determining fractional flow reserve |
US20110178383A1 (en) * | 2008-09-22 | 2011-07-21 | Kassab Ghassan S | Devices and systems for determining fractional flow reserve |
US9585572B2 (en) * | 2008-09-22 | 2017-03-07 | 3Dt Holdings, Llc | Devices and systems for determining fractional flow reserve |
US8702613B2 (en) * | 2008-09-22 | 2014-04-22 | 3Dt Holdings, Llc | Methods for determining fractional flow reserve |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US10842549B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9561067B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US10842557B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element and configured to treat duodenal tissue |
US11589920B2 (en) | 2008-10-06 | 2023-02-28 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply an ablative zone to tissue |
US11813014B2 (en) | 2008-10-06 | 2023-11-14 | Santa Anna Tech Llc | Methods and systems for directed tissue ablation |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US10842548B2 (en) | 2008-10-06 | 2020-11-24 | Santa Anna Tech Llc | Vapor ablation system with a catheter having more than one positioning element |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US9700365B2 (en) | 2008-10-06 | 2017-07-11 | Santa Anna Tech Llc | Method and apparatus for the ablation of gastrointestinal tissue |
US11020175B2 (en) | 2008-10-06 | 2021-06-01 | Santa Anna Tech Llc | Methods of ablating tissue using time-limited treatment periods |
US11779430B2 (en) | 2008-10-06 | 2023-10-10 | Santa Anna Tech Llc | Vapor based ablation system for treating uterine bleeding |
US20100114244A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Electrical renal autonomic blockade |
US20100114254A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Subclavian ansae stimulation |
US8386053B2 (en) | 2008-10-31 | 2013-02-26 | Medtronic, Inc. | Subclavian ansae stimulation |
US20100119792A1 (en) * | 2008-11-10 | 2010-05-13 | Zheng-Dong Ma | Three-dimensional auxetic structures and applications thereof |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8401667B2 (en) | 2008-11-17 | 2013-03-19 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8923970B2 (en) | 2008-12-09 | 2014-12-30 | Nephera Ltd. | Stimulation of the urinary system |
US9498624B2 (en) | 2008-12-09 | 2016-11-22 | Nephera Ltd. | Stimulation of the urinary system |
US8725249B2 (en) | 2008-12-09 | 2014-05-13 | Nephera Ltd. | Stimulation of the urinary system |
US20100152725A1 (en) * | 2008-12-12 | 2010-06-17 | Angiodynamics, Inc. | Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation |
US8777942B2 (en) | 2008-12-31 | 2014-07-15 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
WO2010078175A1 (en) * | 2008-12-31 | 2010-07-08 | Ardian, Inc. | Apparatus, systems and methods for achieving intravascular, thermally-induced renal neuromodulation |
US10561460B2 (en) | 2008-12-31 | 2020-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation systems and methods for treatment of sexual dysfunction |
US8808345B2 (en) | 2008-12-31 | 2014-08-19 | Medtronic Ardian Luxembourg S.A.R.L. | Handle assemblies for intravascular treatment devices and associated systems and methods |
US20100168731A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
CN102438690A (en) * | 2008-12-31 | 2012-05-02 | 美敦力阿迪安有限公司 | Apparatus, systems and methods for achieving intravascular, thermally-induced renal neuromodulation |
AU2009333040B2 (en) * | 2008-12-31 | 2014-08-21 | Medtronic Af Luxembourg S.A.R.L. | Apparatus, systems and methods for achieving intravascular, thermally-induced renal neuromodulation |
US8652129B2 (en) | 2008-12-31 | 2014-02-18 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US10537385B2 (en) | 2008-12-31 | 2020-01-21 | Medtronic Ardian Luxembourg S.A.R.L. | Intravascular, thermally-induced renal neuromodulation for treatment of polycystic ovary syndrome or infertility |
US20100168739A1 (en) * | 2008-12-31 | 2010-07-01 | Ardian, Inc. | Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation |
US8974445B2 (en) | 2009-01-09 | 2015-03-10 | Recor Medical, Inc. | Methods and apparatus for treatment of cardiac valve insufficiency |
US8457761B2 (en) | 2009-01-14 | 2013-06-04 | Cardiac Pacemakers, Inc. | System and method for promoting diuresis and natriuresis by the application of electric fields to the kidney |
US20100179620A1 (en) * | 2009-01-14 | 2010-07-15 | Ramesh Wariar | System and method for promoting diuresis and natriuresis by the application of electric fields to the kidney |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US9119951B2 (en) | 2009-10-12 | 2015-09-01 | Kona Medical, Inc. | Energetic modulation of nerves |
US10772681B2 (en) | 2009-10-12 | 2020-09-15 | Utsuka Medical Devices Co., Ltd. | Energy delivery to intraparenchymal regions of the kidney |
US8992447B2 (en) | 2009-10-12 | 2015-03-31 | Kona Medical, Inc. | Energetic modulation of nerves |
US9199097B2 (en) | 2009-10-12 | 2015-12-01 | Kona Medical, Inc. | Energetic modulation of nerves |
US9005143B2 (en) | 2009-10-12 | 2015-04-14 | Kona Medical, Inc. | External autonomic modulation |
US8986231B2 (en) | 2009-10-12 | 2015-03-24 | Kona Medical, Inc. | Energetic modulation of nerves |
US20110137149A1 (en) * | 2009-10-12 | 2011-06-09 | Michael Gertner | Nerve treatment system |
US8556834B2 (en) | 2009-10-12 | 2013-10-15 | Kona Medical, Inc. | Flow directed heating of nervous structures |
US8295912B2 (en) | 2009-10-12 | 2012-10-23 | Kona Medical, Inc. | Method and system to inhibit a function of a nerve traveling with an artery |
US9125642B2 (en) * | 2009-10-12 | 2015-09-08 | Kona Medical, Inc. | External autonomic modulation |
US9174065B2 (en) | 2009-10-12 | 2015-11-03 | Kona Medical, Inc. | Energetic modulation of nerves |
US8517962B2 (en) | 2009-10-12 | 2013-08-27 | Kona Medical, Inc. | Energetic modulation of nerves |
US8374674B2 (en) * | 2009-10-12 | 2013-02-12 | Kona Medical, Inc. | Nerve treatment system |
US9119952B2 (en) | 2009-10-12 | 2015-09-01 | Kona Medical, Inc. | Methods and devices to modulate the autonomic nervous system via the carotid body or carotid sinus |
US20140236048A1 (en) * | 2009-10-12 | 2014-08-21 | Kona Medical, Inc. | External autonomic modulation |
US11154356B2 (en) | 2009-10-12 | 2021-10-26 | Otsuka Medical Devices Co., Ltd. | Intravascular energy delivery |
US8512262B2 (en) | 2009-10-12 | 2013-08-20 | Kona Medical, Inc. | Energetic modulation of nerves |
US9352171B2 (en) | 2009-10-12 | 2016-05-31 | Kona Medical, Inc. | Nerve treatment system |
US9358401B2 (en) | 2009-10-12 | 2016-06-07 | Kona Medical, Inc. | Intravascular catheter to deliver unfocused energy to nerves surrounding a blood vessel |
US8469904B2 (en) | 2009-10-12 | 2013-06-25 | Kona Medical, Inc. | Energetic modulation of nerves |
US8986211B2 (en) | 2009-10-12 | 2015-03-24 | Kona Medical, Inc. | Energetic modulation of nerves |
US8715209B2 (en) | 2009-10-12 | 2014-05-06 | Kona Medical, Inc. | Methods and devices to modulate the autonomic nervous system with ultrasound |
US9579518B2 (en) | 2009-10-12 | 2017-02-28 | Kona Medical, Inc. | Nerve treatment system |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9931162B2 (en) | 2009-10-27 | 2018-04-03 | Nuvaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9649153B2 (en) | 2009-10-27 | 2017-05-16 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9005195B2 (en) | 2009-10-27 | 2015-04-14 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9675412B2 (en) | 2009-10-27 | 2017-06-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8932289B2 (en) | 2009-10-27 | 2015-01-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9017324B2 (en) | 2009-10-27 | 2015-04-28 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8777943B2 (en) | 2009-10-27 | 2014-07-15 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US11185662B2 (en) | 2009-10-30 | 2021-11-30 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
US9943666B2 (en) | 2009-10-30 | 2018-04-17 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
US9981108B2 (en) | 2009-10-30 | 2018-05-29 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
US10039901B2 (en) | 2009-10-30 | 2018-08-07 | Recor Medical, Inc. | Method and apparatus for treatment of hypertension through percutaneous ultrasound renal denervation |
US8900223B2 (en) | 2009-11-06 | 2014-12-02 | Tsunami Medtech, Llc | Tissue ablation systems and methods of use |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US10610283B2 (en) | 2009-11-11 | 2020-04-07 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US11389233B2 (en) | 2009-11-11 | 2022-07-19 | Nuvaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US11712283B2 (en) | 2009-11-11 | 2023-08-01 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9649154B2 (en) | 2009-11-11 | 2017-05-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US20110118600A1 (en) * | 2009-11-16 | 2011-05-19 | Michael Gertner | External Autonomic Modulation |
WO2011075328A1 (en) | 2009-12-14 | 2011-06-23 | Mayo Foundation For Medical Education And Research | Device and method for treating cardiac disorders by modulating autonomic response |
US11701172B2 (en) | 2009-12-14 | 2023-07-18 | Mayo Foundation For Medical Education And Research | Device and method for treating cardiac disorders by modulating autonomic response |
US9392971B2 (en) | 2009-12-14 | 2016-07-19 | Mayo Foundation For Medical Education And Research | Device and method for treating cardiac disorders by modulating autonomic response |
US10973573B2 (en) | 2009-12-14 | 2021-04-13 | Mayo Foundation For Medical Education And Research | Device and method for treating cardiac disorders by modulating autonomic response |
US9161801B2 (en) | 2009-12-30 | 2015-10-20 | Tsunami Medtech, Llc | Medical system and method of use |
WO2011088399A1 (en) * | 2010-01-18 | 2011-07-21 | Stanford University | Method and apparatus for radioablation of regular targets such as sympathetic nerves |
US9072894B2 (en) * | 2010-01-18 | 2015-07-07 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for radioablation of regular targets such as sympathetic nerves |
US20120294424A1 (en) * | 2010-01-18 | 2012-11-22 | The Board Of Trustees Of The Leland Stanford Junior University | Method And Apparatus for Radioablation of Regular Targets such as Sympathetic Nerves |
US20110200171A1 (en) * | 2010-01-19 | 2011-08-18 | Ardian, Inc. | Methods and apparatus for renal neuromodulation via stereotactic radiotherapy |
US20110202052A1 (en) * | 2010-02-12 | 2011-08-18 | Daniel Gelbart | System for treating benign prostatic hyperplasia |
US9155590B2 (en) | 2010-03-03 | 2015-10-13 | Medtronic Ablation Frontiers, Llc | Variable-output radiofrequency ablation power supply |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US20110264086A1 (en) * | 2010-04-14 | 2011-10-27 | Frank Ingle | Renal artery denervation apparatus employing helical shaping arrangement |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8728075B2 (en) | 2010-04-26 | 2014-05-20 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-directional deflectable catheter apparatuses, systems, and methods for renal neuromodulation |
US8870863B2 (en) | 2010-04-26 | 2014-10-28 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
WO2011150200A3 (en) * | 2010-05-26 | 2012-05-03 | University Of Miami | Non occluding firing catheter for prolonged drug delivery |
WO2011150200A2 (en) * | 2010-05-26 | 2011-12-01 | University Of Miami | Non occluding firing catheter for prolonged drug delivery |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
WO2012016135A1 (en) * | 2010-07-30 | 2012-02-02 | Boston Scientific Scimed, Inc. | Balloon with surface electrodes and integral cooling for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US10004550B2 (en) | 2010-08-05 | 2018-06-26 | Medtronic Ardian Luxembourg S.A.R.L. | Cryoablation apparatuses, systems, and methods for renal neuromodulation |
US10499973B2 (en) | 2010-08-13 | 2019-12-10 | Tsunami Medtech, Llc | Medical system and method of use |
US11457969B2 (en) | 2010-08-13 | 2022-10-04 | Tsunami Medtech, Llc | Medical system and method of use |
US8934956B2 (en) * | 2010-08-31 | 2015-01-13 | Interventional Autonomics Corporation | Intravascular electrodes and anchoring devices for transvascular stimulation |
US20130018247A1 (en) * | 2010-08-31 | 2013-01-17 | Glenn Richard A | Intravascular electrodes and anchoring devices for transvascular stimulation |
US20150126997A1 (en) * | 2010-10-20 | 2015-05-07 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter Apparatuses Having Expandable Mesh Structures for Renal Neuromodulation and Associated Systems and Methods |
US9084610B2 (en) | 2010-10-21 | 2015-07-21 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US9636173B2 (en) | 2010-10-21 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US9855097B2 (en) | 2010-10-21 | 2018-01-02 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US10342612B2 (en) | 2010-10-21 | 2019-07-09 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US20120116486A1 (en) * | 2010-10-25 | 2012-05-10 | Medtronic Ardian Luxembourg S.A.R.L. | Microwave catheter apparatuses, systems, and methods for renal neuromodulation |
US9066720B2 (en) | 2010-10-25 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
US11006999B2 (en) | 2010-10-25 | 2021-05-18 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
US9345530B2 (en) | 2010-10-25 | 2016-05-24 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
US10179020B2 (en) | 2010-10-25 | 2019-01-15 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
US8998894B2 (en) | 2010-10-25 | 2015-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
US10076382B2 (en) | 2010-10-25 | 2018-09-18 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
US8956352B2 (en) | 2010-10-25 | 2015-02-17 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods |
US10182865B2 (en) | 2010-10-25 | 2019-01-22 | Medtronic Ardian Luxembourg S.A.R.L. | Microwave catheter apparatuses, systems, and methods for renal neuromodulation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US11129674B2 (en) | 2010-10-25 | 2021-09-28 | Medtronic Ardian Luxembourg S.A.R.L. | Microwave catheter apparatuses, systems, and methods for renal neuromodulation |
US9750560B2 (en) | 2010-10-25 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems and methods for evaluation and feedback of neuromodulation treatment |
US8945107B2 (en) | 2010-10-26 | 2015-02-03 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US10188445B2 (en) | 2010-10-26 | 2019-01-29 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9439708B2 (en) | 2010-10-26 | 2016-09-13 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9060755B2 (en) | 2010-10-26 | 2015-06-23 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US10842547B2 (en) | 2010-10-26 | 2020-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9060754B2 (en) | 2010-10-26 | 2015-06-23 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9066713B2 (en) | 2010-10-26 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation cryotherapeutic devices and associated systems and methods |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9848946B2 (en) | 2010-11-15 | 2017-12-26 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US10292754B2 (en) | 2010-11-17 | 2019-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Therapeutic renal neuromodulation for treating dyspnea and associated systems and methods |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US20120232409A1 (en) * | 2010-12-15 | 2012-09-13 | Stahmann Jeffrey E | System and method for renal artery occlusion during renal denervation therapy |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9919144B2 (en) | 2011-04-08 | 2018-03-20 | Medtronic Adrian Luxembourg S.a.r.l. | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US10588682B2 (en) | 2011-04-25 | 2020-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US11633230B2 (en) * | 2011-07-29 | 2023-04-25 | Medtronic Ablation Frontiers Llc | Intracardiac tools and methods for delivery of electroporation therapies |
US20200297418A1 (en) * | 2011-07-29 | 2020-09-24 | Medtronic Ablation Frontiers Llc | Intracardiac tools and methods for delivery of electroporation therapies |
US9820811B2 (en) * | 2011-08-26 | 2017-11-21 | Symap Medical (Suzhou), Ltd | System and method for mapping the functional nerves innervating the wall of arteries, 3-D mapping and catheters for same |
US9743845B2 (en) | 2011-08-26 | 2017-08-29 | Symap Medical (Suzhou), Ltd | Mapping sympathetic nerve distribution for renal ablation and catheters for same |
US20210393320A9 (en) * | 2011-08-26 | 2021-12-23 | Symap Medical (Suzhou), Ltd | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US20160374568A1 (en) * | 2011-08-26 | 2016-12-29 | Symap Holding Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US20160081744A1 (en) * | 2011-08-26 | 2016-03-24 | Symap Holding Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-d mapping and catheters for same |
US20140213873A1 (en) * | 2011-08-26 | 2014-07-31 | Symap Holding Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US20180078307A1 (en) * | 2011-08-26 | 2018-03-22 | Symap Medical (Suzhou), Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-d mapping and catheters for same |
US10842559B2 (en) * | 2011-08-26 | 2020-11-24 | Symap Medical (Suzhou), Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
KR101862903B1 (en) | 2011-08-26 | 2018-05-30 | 사이맵 홀딩 리미티드 | System and method for locating and identifying functional nerves innervating wall of arteries and catheters for same |
US20190076191A1 (en) * | 2011-08-26 | 2019-03-14 | Symap Medical (Suzhou), Ltd | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US9014821B2 (en) * | 2011-08-26 | 2015-04-21 | Symap Holding Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US10722303B2 (en) * | 2011-08-26 | 2020-07-28 | Symap Medical (Suzhou), Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-D mapping and catheters for same |
US9770291B2 (en) | 2011-08-26 | 2017-09-26 | Symap Medical (Suzhou), Ltd | Device for mapping and ablating renal nerves distributed on the renal artery |
US9022948B2 (en) | 2011-08-26 | 2015-05-05 | Symap Holding Limited | System and method for locating and identifying the functional nerves innervating the wall of arteries |
US9723998B2 (en) * | 2011-08-26 | 2017-08-08 | Symap Medical (Suzhou), Ltd | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US9375154B2 (en) | 2011-08-26 | 2016-06-28 | Symap Medical (Suzhou), Ltd | System and method for locating and identifying the functional nerves innervating the wall of arteries and catheters for same |
US9332916B2 (en) | 2011-10-05 | 2016-05-10 | 3Dt Holdings, Llc | Systems, devices, and methods for determining fractional flow reserve in the presence of a catheter |
US9808167B2 (en) | 2011-10-05 | 2017-11-07 | 3Dt Holdings, Llc | Systems, devices, and methods for determining severity of a stenosis within a luminal organ in the presence of a catheter |
WO2013052595A1 (en) * | 2011-10-05 | 2013-04-11 | St. Jude Medical, Inc. | Catheter device and method for denervation |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US20160287325A1 (en) * | 2011-11-07 | 2016-10-06 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular Nerve Monitoring Devices and Associated Systems and Methods |
US9327123B2 (en) | 2011-11-07 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular nerve monitoring devices and associated systems and methods |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US20130116683A1 (en) * | 2011-11-09 | 2013-05-09 | Tsunami Medtech, Llc | Medical system and method of use |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9192766B2 (en) | 2011-12-02 | 2015-11-24 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and devices for treatment of polycystic kidney disease |
US9827042B2 (en) | 2011-12-02 | 2017-11-28 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and devices for treatment of polycystic kidney disease |
US11179195B2 (en) | 2011-12-02 | 2021-11-23 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and devices for treatment of polycystic kidney disease |
US10070911B2 (en) | 2011-12-09 | 2018-09-11 | Metavention, Inc. | Neuromodulation methods to alter glucose levels |
US9999461B2 (en) | 2011-12-09 | 2018-06-19 | Metavention, Inc. | Therapeutic denervation of nerves surrounding a hepatic vessel |
US10543034B2 (en) | 2011-12-09 | 2020-01-28 | Metavention, Inc. | Modulation of nerves innervating the liver |
US10856926B2 (en) | 2011-12-09 | 2020-12-08 | Metavention, Inc. | Neuromodulation for metabolic conditions or syndromes |
US10617460B2 (en) | 2011-12-09 | 2020-04-14 | Metavention, Inc. | Neuromodulation for metabolic conditions or syndromes |
US10064674B2 (en) | 2011-12-09 | 2018-09-04 | Metavention, Inc. | Methods of modulating nerves of the hepatic plexus |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9402684B2 (en) | 2011-12-23 | 2016-08-02 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9592386B2 (en) | 2011-12-23 | 2017-03-14 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9072902B2 (en) | 2011-12-23 | 2015-07-07 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9186211B2 (en) | 2011-12-23 | 2015-11-17 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9037259B2 (en) | 2011-12-23 | 2015-05-19 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US11247076B2 (en) | 2012-01-30 | 2022-02-15 | Auris Health, Inc. | Tissue necrosis methods and apparatus |
WO2013116380A1 (en) | 2012-01-30 | 2013-08-08 | Vytronus, Inc. | Tissue necrosis methods and apparatus |
US10286231B2 (en) | 2012-01-30 | 2019-05-14 | Vytronus, Inc. | Tissue necrosis methods and apparatus |
US20130231659A1 (en) * | 2012-03-01 | 2013-09-05 | Boston Scientific Scimed, Inc. | Off-wall and contact electrode devices and methods for nerve modulation |
US10342592B2 (en) | 2012-03-07 | 2019-07-09 | Medtronic Ardian Luxembourg S.A.R.L. | Selective modulation of renal nerves |
US9510777B2 (en) | 2012-03-08 | 2016-12-06 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring of neuromodulation using biomarkers |
US20180117363A1 (en) * | 2012-03-08 | 2018-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter-based devices and associated methods for immune system neuromodulation |
US11338140B2 (en) | 2012-03-08 | 2022-05-24 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring of neuromodulation using biomarkers |
US10729365B2 (en) | 2012-03-08 | 2020-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Biomarker sampling in the context of neuromodulation devices, systems, and methods |
US9974593B2 (en) | 2012-03-08 | 2018-05-22 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the treatment of sexual dysfunction |
US10874455B2 (en) | 2012-03-08 | 2020-12-29 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
US11013549B2 (en) | 2012-03-08 | 2021-05-25 | Medtronic Ardian Luxembourg S.A.R.L. | Gastrointestinal neuromodulation and associated systems and methods |
US9750568B2 (en) | 2012-03-08 | 2017-09-05 | Medtronic Ardian Luxembourg S.A.R.L. | Ovarian neuromodulation and associated systems and methods |
US11515029B2 (en) | 2012-03-08 | 2022-11-29 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the management of pain |
US9883909B2 (en) | 2012-03-08 | 2018-02-06 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and systems for treatment of hyperaldosteronism |
US10737123B2 (en) | 2012-03-08 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the management of pain |
US9597018B2 (en) | 2012-03-08 | 2017-03-21 | Medtronic Ardian Luxembourg S.A.R.L. | Biomarker sampling in the context of neuromodulation devices, systems, and methods |
US10368791B2 (en) | 2012-03-08 | 2019-08-06 | Medtronic Adrian Luxembourg S.a.r.l. | Devices and associated methods for monitoring of neuromodulation using biomarkers |
US9439598B2 (en) | 2012-04-12 | 2016-09-13 | NeuroMedic, Inc. | Mapping and ablation of nerves within arteries and tissues |
US9943354B2 (en) | 2012-04-27 | 2018-04-17 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for localized inhibition of inflammation by ablation |
US11020176B2 (en) | 2012-04-27 | 2021-06-01 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for localized disease treatment by ablation |
US10905490B2 (en) | 2012-04-27 | 2021-02-02 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices for renal neuromodulation and associated systems and methods |
US9848950B2 (en) | 2012-04-27 | 2017-12-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and devices for localized disease treatment by ablation |
US11213674B2 (en) | 2012-04-27 | 2022-01-04 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods |
US9241752B2 (en) | 2012-04-27 | 2016-01-26 | Medtronic Ardian Luxembourg S.A.R.L. | Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods |
US10258791B2 (en) | 2012-04-27 | 2019-04-16 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies for neuromodulation proximate a bifurcation of a renal artery and associated systems and methods |
US9872718B2 (en) | 2012-04-27 | 2018-01-23 | Medtronic Adrian Luxembourg S.a.r.l. | Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods |
US11751931B2 (en) | 2012-04-27 | 2023-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices for renal neuromodulation and associated systems and methods |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US8888773B2 (en) | 2012-05-11 | 2014-11-18 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US10512504B2 (en) | 2012-05-11 | 2019-12-24 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US9138292B2 (en) | 2012-05-11 | 2015-09-22 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US9855096B2 (en) | 2012-05-11 | 2018-01-02 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US9452017B2 (en) | 2012-05-11 | 2016-09-27 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods |
US8951296B2 (en) | 2012-06-29 | 2015-02-10 | Medtronic Ardian Luxembourg S.A.R.L. | Devices and methods for photodynamically modulating neural function in a human |
US9381063B2 (en) | 2012-07-13 | 2016-07-05 | Magnetecs Inc. | Method and apparatus for magnetically guided catheter for renal denervation employing MOSFET sensor array |
US20140025069A1 (en) * | 2012-07-17 | 2014-01-23 | Boston Scientific Scimed, Inc. | Renal nerve modulation catheter design |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US8612022B1 (en) | 2012-09-13 | 2013-12-17 | Invatec S.P.A. | Neuromodulation catheters and associated systems and methods |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10080864B2 (en) | 2012-10-19 | 2018-09-25 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for catheter treatment devices and associated devices, systems, and methods |
US9744333B2 (en) | 2012-10-19 | 2017-08-29 | Medtronic Ardian Luxembourg S.A.R.L. | Packaging for catheter treatment devices and associated devices, systems and methods |
US20140114215A1 (en) * | 2012-10-20 | 2014-04-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for Renal Neuromodulation and Associated Systems and Devices |
US9492635B2 (en) | 2012-10-22 | 2016-11-15 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9399115B2 (en) | 2012-10-22 | 2016-07-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US11147948B2 (en) | 2012-10-22 | 2021-10-19 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9044575B2 (en) | 2012-10-22 | 2015-06-02 | Medtronic Adrian Luxembourg S.a.r.l. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US10188829B2 (en) | 2012-10-22 | 2019-01-29 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US20140128865A1 (en) * | 2012-11-05 | 2014-05-08 | Yossi Gross | Controlled renal artery ablation |
US10004557B2 (en) | 2012-11-05 | 2018-06-26 | Pythagoras Medical Ltd. | Controlled tissue ablation |
US9770593B2 (en) * | 2012-11-05 | 2017-09-26 | Pythagoras Medical Ltd. | Patient selection using a transluminally-applied electric current |
US9095321B2 (en) | 2012-11-21 | 2015-08-04 | Medtronic Ardian Luxembourg S.A.R.L. | Cryotherapeutic devices having integral multi-helical balloons and methods of making the same |
US9017317B2 (en) | 2012-12-06 | 2015-04-28 | Medtronic Ardian Luxembourg S.A.R.L. | Refrigerant supply system for cryotherapy including refrigerant recompression and associated devices, systems, and methods |
US20150343221A1 (en) * | 2012-12-19 | 2015-12-03 | Surgical Electronics SA | Systems and Methods for Hypertension Control |
US10238875B2 (en) * | 2012-12-19 | 2019-03-26 | Adi Mashiach | Systems and methods for hypertension control |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US11154696B2 (en) | 2013-02-08 | 2021-10-26 | Arrinex, Inc. | Surgical device with integrated visualization and cauterization |
US10201687B2 (en) | 2013-02-08 | 2019-02-12 | Arrinex, Inc. | Surgical device with integrated visualization and cauterization |
US10076384B2 (en) | 2013-03-08 | 2018-09-18 | Symple Surgical, Inc. | Balloon catheter apparatus with microwave emitter |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10350440B2 (en) | 2013-03-14 | 2019-07-16 | Recor Medical, Inc. | Ultrasound-based neuromodulation system |
US10456605B2 (en) | 2013-03-14 | 2019-10-29 | Recor Medical, Inc. | Ultrasound-based neuromodulation system |
US10230041B2 (en) | 2013-03-14 | 2019-03-12 | Recor Medical, Inc. | Methods of plating or coating ultrasound transducers |
US9179974B2 (en) | 2013-03-15 | 2015-11-10 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US9510773B2 (en) | 2013-03-15 | 2016-12-06 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode apposition judgment using pressure elements |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US11413086B2 (en) | 2013-03-15 | 2022-08-16 | Tsunami Medtech, Llc | Medical system and method of use |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
US11672584B2 (en) | 2013-03-15 | 2023-06-13 | Tsunami Medtech, Llc | Medical system and method of use |
US10433905B2 (en) | 2013-03-15 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode apposition judgment using pressure elements |
US9888961B2 (en) | 2013-03-15 | 2018-02-13 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US10543037B2 (en) | 2013-03-15 | 2020-01-28 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled neuromodulation systems and methods of use |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9066726B2 (en) | 2013-03-15 | 2015-06-30 | Medtronic Ardian Luxembourg S.A.R.L. | Multi-electrode apposition judgment using pressure elements |
US10792098B2 (en) | 2013-03-15 | 2020-10-06 | Medtronic Ardian Luxembourg S.A.R.L. | Helical push wire electrode |
US20140276756A1 (en) * | 2013-03-15 | 2014-09-18 | Boston Scientific Scimed, Inc. | Wall-sparing renal nerve ablation catheter with spaced electrode structures |
US11058484B2 (en) | 2013-04-15 | 2021-07-13 | Mayo Foundation For Medical Education And Research | Method and apparatus for percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury |
US10426545B2 (en) | 2013-04-15 | 2019-10-01 | Mayo Foundation For Medical Education And Research | Method and apparatus for percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury |
US10548663B2 (en) | 2013-05-18 | 2020-02-04 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10813533B2 (en) | 2013-07-24 | 2020-10-27 | Arrinex, Inc. | Direct vision cryosurgical probe and methods of use |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US10292610B2 (en) | 2013-08-30 | 2019-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation systems having nerve monitoring assemblies and associated devices, systems, and methods |
US9931047B2 (en) | 2013-08-30 | 2018-04-03 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with nerve monitoring features for transmitting digital neural signals and associated systems and methods |
US9339332B2 (en) | 2013-08-30 | 2016-05-17 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with nerve monitoring features for transmitting digital neural signals and associated systems and methods |
US9326816B2 (en) | 2013-08-30 | 2016-05-03 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation systems having nerve monitoring assemblies and associated devices, systems, and methods |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US11213678B2 (en) | 2013-09-09 | 2022-01-04 | Medtronic Ardian Luxembourg S.A.R.L. | Method of manufacturing a medical device for neuromodulation |
US9138578B2 (en) | 2013-09-10 | 2015-09-22 | Medtronic Ardian Luxembourg S.A.R.L. | Endovascular catheters with tuned control members and associated systems and methods |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US10512498B2 (en) | 2013-09-30 | 2019-12-24 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US9763723B2 (en) | 2013-09-30 | 2017-09-19 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US10307200B2 (en) | 2013-09-30 | 2019-06-04 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US9687288B2 (en) | 2013-09-30 | 2017-06-27 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US10448985B2 (en) | 2013-09-30 | 2019-10-22 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US10028781B2 (en) | 2013-09-30 | 2018-07-24 | Arrinex, Inc. | Apparatus and methods for treating rhinitis |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10433902B2 (en) | 2013-10-23 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Current control methods and systems |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US20160331447A1 (en) * | 2013-12-20 | 2016-11-17 | The Johns Hopkins University | Method and apparatus for selective treatment inside a body lumen |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US20150190194A1 (en) * | 2014-01-06 | 2015-07-09 | Boston Scientific Scimed, Inc. | Sympathetic nerve ablation devices with an expansion-limiting member |
US11154353B2 (en) | 2014-01-27 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US10166069B2 (en) | 2014-01-27 | 2019-01-01 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US10492842B2 (en) | 2014-03-07 | 2019-12-03 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring and controlling internally administered cryotherapy |
US11406437B2 (en) | 2014-03-07 | 2022-08-09 | Medtronic Ardian Luxembourg S.A.R.L. | Monitoring and controlling internally administered cryotherapy |
US10463424B2 (en) | 2014-03-11 | 2019-11-05 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with independent radial-expansion members and associated devices, systems, and methods |
US9579149B2 (en) | 2014-03-13 | 2017-02-28 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
US10433907B2 (en) | 2014-03-13 | 2019-10-08 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
US10194979B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US9980766B1 (en) | 2014-03-28 | 2018-05-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for renal neuromodulation |
US10194980B1 (en) | 2014-03-28 | 2019-02-05 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for catheter-based renal neuromodulation |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US11464563B2 (en) | 2014-04-24 | 2022-10-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10610292B2 (en) | 2014-04-25 | 2020-04-07 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10478249B2 (en) | 2014-05-07 | 2019-11-19 | Pythagoras Medical Ltd. | Controlled tissue ablation techniques |
US10470837B2 (en) | 2014-07-25 | 2019-11-12 | Arrinex, Inc. | Apparatus and method for treating rhinitis |
US9763743B2 (en) | 2014-07-25 | 2017-09-19 | Arrinex, Inc. | Apparatus and method for treating rhinitis |
US10159538B2 (en) | 2014-07-25 | 2018-12-25 | Arrinex, Inc. | Apparatus and method for treating rhinitis |
US11154712B2 (en) | 2014-08-28 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for assessing efficacy of renal neuromodulation and associated systems and devices |
US10368775B2 (en) | 2014-10-01 | 2019-08-06 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for evaluating neuromodulation therapy via hemodynamic responses |
US11311205B2 (en) | 2014-10-01 | 2022-04-26 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for evaluating neuromodulation therapy via hemodynamic responses |
US10925579B2 (en) | 2014-11-05 | 2021-02-23 | Otsuka Medical Devices Co., Ltd. | Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery |
US11154351B2 (en) | 2014-11-14 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses for modulation of nerves in communication with the pulmonary system and associated systems and methods |
US11013554B2 (en) | 2014-11-14 | 2021-05-25 | Medtronic Ardian Lexembourg S.A.R.L. | Catheter apparatuses for modulation of nerves in communication with pulmonary system and associated systems and methods |
US10667736B2 (en) | 2014-12-17 | 2020-06-02 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing sympathetic nervous system tone for neuromodulation therapy |
US10383685B2 (en) | 2015-05-07 | 2019-08-20 | Pythagoras Medical Ltd. | Techniques for use with nerve tissue |
US11642061B2 (en) * | 2015-07-29 | 2023-05-09 | Recor Medical, Inc. | Intraluminal microneurography denervation probe with radio frequency ablation |
US20200077907A1 (en) * | 2015-07-29 | 2020-03-12 | NeuroMedic, Inc. | Intraluminal microneurography denervation probe with radio frequency ablation |
US11602260B2 (en) | 2016-02-11 | 2023-03-14 | Arrinex, Inc. | Method and device for image guided post-nasal nerve ablation |
US10736692B2 (en) | 2016-04-28 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation and associated systems and methods for the treatment of cancer |
US11678932B2 (en) | 2016-05-18 | 2023-06-20 | Symap Medical (Suzhou) Limited | Electrode catheter with incremental advancement |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US10524859B2 (en) | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
US11026738B2 (en) | 2016-06-15 | 2021-06-08 | Arrinex, Inc. | Devices and methods for treating a lateral surface of a nasal cavity |
US11786292B2 (en) | 2016-10-17 | 2023-10-17 | Arrinex, Inc. | Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use |
US11253312B2 (en) | 2016-10-17 | 2022-02-22 | Arrinex, Inc. | Integrated nasal nerve detector ablation-apparatus, nasal nerve locator, and methods of use |
US10231784B2 (en) | 2016-10-28 | 2019-03-19 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics |
US11311340B2 (en) | 2016-10-28 | 2022-04-26 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics |
US10646713B2 (en) | 2017-02-22 | 2020-05-12 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for treating patients via renal neuromodulation to reduce a risk of developing cognitive impairment |
US11278356B2 (en) | 2017-04-28 | 2022-03-22 | Arrinex, Inc. | Systems and methods for locating blood vessels in the treatment of rhinitis |
US11116564B2 (en) | 2017-07-05 | 2021-09-14 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating anxiety disorders in patients via renal neuromodulation |
US11284934B2 (en) | 2017-07-05 | 2022-03-29 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating sleep disorders in patients via renal neuromodulation |
US10945788B2 (en) | 2017-07-05 | 2021-03-16 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating depression in patients via renal neuromodulation |
US11160982B2 (en) | 2017-07-05 | 2021-11-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for treating post-traumatic stress disorder in patients via renal neuromodulation |
CN109464187A (en) * | 2017-09-08 | 2019-03-15 | 泽丹医疗股份有限公司 | The device and method for treating lung tumors |
US10842560B2 (en) * | 2017-09-08 | 2020-11-24 | Zidan Medical Inc. | Devices and methods for treating lung tumors |
US20190343581A1 (en) * | 2017-09-08 | 2019-11-14 | Zidan Medical Inc. | Devices and methods for treating lung tumors |
US11925409B2 (en) * | 2017-09-08 | 2024-03-12 | Zidan Medical Inc. | Devices and methods for treating lung tumors |
US20210068895A1 (en) * | 2017-09-08 | 2021-03-11 | Zidan Medical Inc. | Devices and methods for treating lung tumors |
US11304749B2 (en) | 2017-11-17 | 2022-04-19 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting |
US10959669B2 (en) | 2018-01-24 | 2021-03-30 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing the efficacy of neuromodulation therapy |
US11478298B2 (en) | 2018-01-24 | 2022-10-25 | Medtronic Ardian Luxembourg S.A.R.L. | Controlled irrigation for neuromodulation systems and associated methods |
US11253189B2 (en) | 2018-01-24 | 2022-02-22 | Medtronic Ardian Luxembourg S.A.R.L. | Systems, devices, and methods for evaluating neuromodulation therapy via detection of magnetic fields |
US11116561B2 (en) | 2018-01-24 | 2021-09-14 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, agents, and associated methods for selective modulation of renal nerves |
US11806066B2 (en) | 2018-06-01 | 2023-11-07 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
US11864809B2 (en) | 2018-06-01 | 2024-01-09 | Santa Anna Tech Llc | Vapor-based ablation treatment methods with improved treatment volume vapor management |
US11633120B2 (en) | 2018-09-04 | 2023-04-25 | Medtronic Ardian Luxembourg S.A.R.L. | Systems and methods for assessing efficacy of renal neuromodulation therapy |
US11832965B2 (en) | 2018-10-06 | 2023-12-05 | Symap Medical (Suzhou), Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-D mapping and catheters for same |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11963714B2 (en) | Methods and apparatus for renal neuromodulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ARDIAN, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DEEM, MARK;GIFFORD, HANSON, III;DEMARAIS, DENISE;AND OTHERS;SIGNING DATES FROM 20050808 TO 20050817;REEL/FRAME:024667/0631 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |